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Abstract 
 
Since the early 1980s in sub-Saharan Africa (SSA), substantial human and financial 
resources have been dedicated to monitoring the HIV/AIDS epidemic. Throughout, 
surveillance data collected at antenatal care (ANC) clinics have been a key data 
source.  
ANC surveillance data are well-known to be biased when quantifying 
population HIV prevalence levels in SSA. Nonetheless, a routinely-accepted, 
although rarely-tested assumption has been that the data are representative of 
population-level HIV prevalence trends. More recently, HIV testing data from 
prevention of mother-to-child transmission (PMTCT) programmes have been 
proposed as a substitute for ANC surveillance, although these data can be subject to 
temporal biases too.  
The primary objective of this thesis is to add to the limited evidence regarding 
the representativeness of HIV testing data from pregnant women to monitor 
population-level HIV prevalence trends. Empirical analyses from repeated 
household-based population surveys and ANC surveillance were done for seven 
countries in SSA from 2000 to 2010 and among youth aged 15 to 24 years in 
Manicaland, Zimbabwe from 1985 to 2003. Also, a mathematical model was used to 
explore temporal bias in ANC surveillance trends in epidemics similar to those in 
Botswana, Côte d’Ivoire and rural Zimbabwe from 1985 to 2030. Finally, PMTCT 
programme data were assessed for their representativeness as compared to ANC 
surveillance data in Manicaland, Zimbabwe from 2006 to 2008. 
Results showed the representativeness of ANC surveillance data to vary by 
time period and setting, although trends among youth were more robust than those 
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among adults aged 15 to 49 years across settings, and particularly so among men. 
Representativeness in the ART-era depends on coverage and scale-up, the setting, 
and the potential for changing fertility patterns among ART users. PMTCT data for 
surveillance purposes was of limited use in Manicaland, Zimbabwe from 2006 to 
2008. In summary, caution is needed when using HIV testing data from pregnant 
women to monitor population HIV prevalence trends in SSA. 
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Chapter 1: Introduction 
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1.1 Background  
Thirty years ago, in the summer of 1981, the Centers for Disease Control and 
Prevention (CDC) published an article about what would later become the first 
reported cases of human immunodeficiency virus (HIV) and acquired 
immunodeficiency syndrome (AIDS) in the United States (US) [1]. The article 
described pneumocystis carinii pneumonia among five previously healthy young men 
in Los Angeles. The report’s authors also identified a set of risk factors associated 
with the newly-recognized infection that would subsequently be used as the 
preliminary case definition for future disease reporting purposes.  
Not long after the publication of the 1981 article, reports of additional cases 
from across the US were received by CDC, followed closely by case reports from 
Haiti [2], Uganda [3] and several countries in Europe [4-6]. By 1983, the CDC had 
received notification of 3064 AIDS cases in the US [7]. Reports of these US cases, 
along with those from Canada, Haiti, Zaire, 15 European countries, and seven Latin 
American countries, were compiled and published in a report at the World Health 
Organization’s (WHO) inaugural meeting to assess the global AIDS situation [7]. The 
1983 report represented the first attempt to monitor the epidemic through a fledgling 
global HIV/AIDS surveillance system.  
Since this first WHO report, substantial financial and human resources have 
been invested to monitor and disseminate information about the epidemic and how it 
is changing over time. Accurate estimates of new and existing cases of HIV are 
arguably the most important measure of the success or failure of a country’s 
response to control transmission [8, 9]. When countries fall short in their 
measurements of HIV incidence and prevalence, it can have devastating 
consequences. Failure to document increases in the number of persons newly 
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infected and living with HIV can result in inadequate allocation of resources for 
prevention, treatment and care programs. Conversely, overestimation of the number 
of HIV-infected individuals will unnecessarily draw scarce resources away from other 
public health priorities, result in wasted expenditures, and generate scepticism about 
future resource needs [10-12].  
Beginning in the late 1980s, as the true scale of the epidemic was emerging, 
the impracticality of relying on HIV and AIDS case reporting alone became evident, 
particularly in sub-Saharan Africa (SSA) where the provision of health care services 
and public health infrastructure were weak [13-15]. In place of -- or at least in 
complement to -- case reporting, WHO recommended in 1988 that countries set up 
surveillance of HIV infections in sentinel populations. These populations included 
high risk groups, such as patients at sexually transmitted infection (STI) clinics, and 
groups more representative of the general population, such as pregnant women 
attending antenatal care clinics (ANC). It was suggested that ultimately, ANC 
surveillance could produce the most accurate data for monitoring HIV prevalence 
trends (i.e., relative changes in the number of HIV-individuals over time) in resource-
constrained settings with severe HIV burdens [16]. There was also considerable 
evidence at the time to suggest that ANC surveillance data could be used to monitor 
population prevalence levels (i.e., the proportion of HIV-infected individuals in the 
population at any given time).  
Although the transition to ANC sentinel surveillance systems in the late 1980s 
represented a considerable improvement in the quality and timeliness of data, bias in 
ANC surveillance estimates resulting in inconsistencies between estimates of HIV 
prevalence among pregnant women and the population generally were increasingly 
flagged as problematic. Starting in 2001, to respond to the need for more accurate 
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estimates of HIV prevalence in the population, many countries in SSA began adding 
anonymous HIV testing to nationally-representative population-based surveys [17].  
Since the early 2000s, WHO has recommended that countries use testing 
data from nationally-representative population surveys to determine HIV prevalence 
levels in countries in SSA. Given the cost and complexity of conducting such 
surveys, though, countries would still need to use ANC surveillance data to monitor 
population prevalence trends [18]. In the last few years, many countries in SSA also 
have begun to explore the potential for using HIV prevalence estimates from 
prevention of mother-to-child transmission (PMTCT) programmes to complement, or 
in some cases, replace ANC surveillance data to monitor HIV prevalence trends in 
the population [19].  
Despite the continued reliance on surveillance data from pregnant women as 
the primary data source for monitoring population prevalence trends in SSA, there 
has been relatively limited, and definitely not systematic, research into whether 
trends in HIV prevalence from pregnant women accurately reflect population 
prevalence trends. This is especially true in recent years where the epidemic has 
been marked by changes in prevalence and incidence in many countries in SSA [20-
22]. These changes, which are due to the natural dynamics of the epidemic, the 
scale-up of prevention programmes, and the rapid expansion of antiretroviral therapy 
(ART) programmes, [17, 22-24] have the potential to alter the magnitude and 
direction of bias that has previously observed in ANC prevalence estimates. Also, 
improvements in the way that PMTCT services are delivered may mean that 
participation biases change from year to year.  
20 
 
1.1.1  Overall aims and key research questions of this thesis 
Although the dynamics of the HIV epidemic in the general population have 
been well-described, relatively less is known about the dynamics of the HIV epidemic 
among pregnant women and women at risk of becoming pregnant specifically. 
Therefore, the first aim of this thesis is to contribute to an improved understanding of 
whether HIV surveillance data among pregnant women attending ANC clinics can be 
used to monitor population-level HIV prevalence trends in sub-Saharan Africa. 
Further to this aim, the key research questions that this thesis will address are (i) 
have historical trends in HIV prevalence among pregnant women mirrored those in 
the population in selected countries in SSA?; and (ii) can ANC surveillance data be 
used to reliably monitor future population HIV prevalence trends? Underlying each of 
these questions is whether or not changes in the natural dynamics of the HIV 
epidemic or a country’s response to the epidemic through the scale-up of prevention 
and treatment programmes bias ANC surveillance data over time. 
As a second aim, the feasibility of using HIV testing data from PMTCT 
programmes to replace or complement ANC surveillance data to monitor population 
prevalence trends will be considered, based on an assumption that repeated 
estimates of HIV prevalence among pregnant women will mirror those in the general 
population. With regard to this secondary aim, key research questions are: (i) do 
estimates of HIV prevalence among women participating in PMTCT programmes 
accurately reflect HIV prevalence among ANC attendees?; and (ii) what factors 
related to the geographic scale-up of PMTCT services or selective participation 
(either being offered or accepting testing) by HIV status might bias these estimates? 
A variety of analytic approaches, including mathematical modelling and analysis of 
data from demographic and health survey (DHS) and a population-based cohort 
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study with parallel ANC surveillance data in Manicaland, Zimbabwe, are used to 
inform responses to these questions.  
 
1.1.2  Structure of this thesis 
By way of introduction, this chapter provides background information on the 
important role that HIV/AIDS surveillance data have played in mobilizing a response 
to the epidemic. In Chapter 2, the types of bias that can influence the accuracy of 
HIV prevalence levels using (a) ANC data and (b) PMTCT data are explored, along 
with how these biases might change with time.  
With regard to the specific aims and key research questions described in the 
previous section, Chapters’ 3 through 5 address the representativeness of ANC 
surveillance data to monitor population prevalence trends. Chapter 3 uses data from 
seven countries in SSA with repeated DHS and DHS-like surveys and ANC 
surveillance data to assess the representativeness of ANC data during the 2000s. 
Chapter 4 addresses the historical reliability of ANC surveillance trends from 1985 
through 2002 using a mathematical model of HIV/AIDS epidemics similar to those in 
Botswana, Côte d’Ivoire and rural Zimbabwe. In each of these settings, the model is 
also used to explore the potential for the introduction and scale-up of ART from 2003 
to 2030 to cause further shifts in temporal bias in ANC data due to a change in 
fertility patterns and increased survival among users. Chapter 5 considers the 
historical representativeness of ANC data in Manicaland, Zimbabwe, where parallel 
cohort and ANC surveillance data were available at three time points from 1998 to 
2005. The final analytical chapter, Chapter 6, addresses the second aim of this 
thesis by exploring the extent to which HIV prevalence data from PMTCT 
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programme records can be used for HIV surveillance purposes in Manicaland, 
Zimbabwe. Geographic, socio-demographic and behavioural risk determinants of 
testing and HIV status are described in the ANC surveillance and population survey 
data.  
The main findings from each chapter and directions for future research are 
summarized in the final chapter, Chapter 7. Appendix A, containing summary tables 
of the key studies about bias included in the literature review in Chapter 1, Appendix, 
B, with a description of the parameters used in the mathematical model in Chapter 4, 
and Appendix C, which includes published manuscripts based on work from 
Chapters’ 2 and 5 of this thesis, follow the complete list of citations referenced in 
Chapters’ 1 through 7. Three commissioned reports for the WHO and UNAIDS, upon 
which Chapters’ 2 through 6 were based, are available upon request but not included 
in this thesis due to their length.  
 
1.2 Aims and organization of the chapter 
In this introductory chapter, the trajectories of the HIV/AIDS epidemic globally and in 
SSA are described. In subsequent sections, methods that have been commonly 
used to collect HIV surveillance data, along with the strengths and limitations that 
characterize them, are reviewed. This critique serves as a useful starting point for 
subsequent chapters in this thesis, which explore the extent to which data from HIV 
surveillance from pregnant women can be used to monitor levels and trends in HIV 
prevalence among the wider population.  
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1.3 The HIV/AIDS epidemic globally and in sub-Saharan Africa 
HIV/AIDS has had a devastating impact on the health of the population globally, 
especially in SSA where the burden of HIV infection is most severe. In 2009, 
UNAIDS estimated that there were 30.8 million [Uncertainty bound (UB): 29.2 million 
- 32.6 million] adults aged 15 and over worldwide living with HIV [22]. Of these, 
nearly two thirds, or 20.3 million [UB: 19.0 million -21.6 million] of all HIV-infected 
people were living in SSA. Although the rate of new infections has slowed over time, 
the estimate of the number of newly infected individuals is still high. In 2009, of the 
2.6 million [UB: 2.3 million – 2.8 million] new infections, just under 70% were in SSA 
[1.8 million; UB: 1.6 million – 2.0 million]. This number outpaces the estimated 1.8 
million [UB: 1.6 million – 2.1 million] individuals, including adults and children, in 
2009 who died from an AIDS-related condition. An estimated 28% of these deaths 
were estimated to have occurred outside SSA. 
Although statistics describing HIV prevalence, incidence and mortality are 
commonly provided for SSA as a whole, in aggregate, they can mask important 
differences in sub-regional and country-specific epidemics and how these epidemics 
are evolving over time. In southern Africa, for example, the most severe infection 
levels were observed in Swaziland, with an estimated HIV prevalence of 25.9% [UB: 
24.9%-27.0%] in adults aged 15 years and older in 2009 [22]. High levels of HIV 
prevalence above 20% have also been observed in Botswana, Lesotho, and 
Zimbabwe [22]. Although the HIV prevalence estimate in South Africa of 17.1% [UB: 
16.7% - 17.5%] was not among the highest in SSA, it had the greatest number of 
infected persons of any country [22]. In Southern and Eastern Africa, HIV prevalence 
was lowest in Angola at 1.9% [UB: 1.4% - 2.4%] and Eritrea at 1.2% [UB: 0.9% - 
1.5%], respectively [22].  
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In Western and Central Africa, where the epidemic has been less severe, HIV 
prevalence in 2009 was highest in Cameroon at 5.3% [UB: 4.9% - 5.8%] and above 
3% in Central African Republic, Côte d’Ivoire, Gabon and Nigeria [22]. The remaining  
countries in Western and Central Africa (Benin, Burkina Faso, Democratic Republic 
of the Congo, Gambia, Ghana, Liberia, Mali, Mauritania, Niger, Senegal and Sierra 
Leone) had an HIV prevalence of less than 2% among adults [22].  
The 2009 HIV prevalence estimates reflect the changes in HIV incidence and 
mortality due to the introduction of ART, the scale-up of effective behaviour change 
and biomedical interventions, and the natural evolution of the epidemic [22, 24-27]. 
In several countries in SSA, HIV incidence rose rapidly during the 1980s before 
peaking in the mid to late 1990s [20]. Between 2001 and 2009, UNAIDS estimates 
that incidence fell by more than 25% in 22 countries in SSA [22].  
With regard to AIDS mortality, the estimated number of deaths over time has 
decreased gradually, primarily due to the introduction of ART[22]. By the end of 
2009, 37% of the population in need of ART (based on a CD4-count threshold of 
350) were receiving it, contributing to a decline in number of AIDS-related deaths in 
SSA from 740 000 [670 000- 820 000] in 2004 to 610 000 [530 000 – 700 000] in 
2009 [22]. Of those countries most severely impacted in SSA, Rwanda, Botswana, 
and Namibia have achieved ART coverage levels upwards of 75% by 2009. In six 
countries in SSA (Côte d’Ivoire, Ghana, Mozambique, South Africa, United Republic 
of Tanzania, and Zimbabwe), however, ART coverage was still less than 40% [22].  
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1.4 Methods for conducting HIV/AIDS surveillance in sub-Saharan Africa 
In the most general sense, public health surveillance has been defined as “the 
ongoing systematic collection, analysis and interpretation of outcome-specific data 
for use in the planning, implementation, and evaluation of public health practice.” 
[28]. This definition has guided the public health practice of surveillance for diseases 
ranging from smallpox in the 1970s to avian influenza in the late 2000s.  
In 1990, Jim Chin, the first chief of the Surveillance, Forecasting and Impact 
Assessment unit at the Global Programme on AIDS at the WHO, suggested that 
methods typically used to conduct public health surveillance of other infectious 
diseases should be considered equally useful for monitoring the HIV/AIDS epidemic 
globally [14]. However, the WHO recognized at the time that HIV/AIDS was not just 
another infectious disease that could be monitored by adding it to a list of notifiable 
conditions. Key attributes of the disease, including its long incubation period, 
geographic differences in disease burden, and, in particular, the widespread stigma 
associated with being identified as infected, would make the process of monitoring 
the epidemic especially challenging.  
Since the early 1990s, surveillance data have been used to varying degrees 
of success to monitor the HIV/AIDS epidemic. As Chin originally suggested in his 
1990 article, these sources can be categorized into five systems as outlined in 
Teutsch and Churchill’s 1994 book, Principles and Practice of Public Health 
Surveillance, with some allowances made for the “exceptionalism” of the HIV/AIDS 
epidemic  [29]. These five systems are (i) notifiable disease and disease registry 
reporting systems, (ii) routine vital statistics systems; (iii) sentinel surveillance 
systems; (iv) surveys; and (v) programme-specific monitoring systems. A description 
of the methods and contributions of each of the systems to monitoring the HIV/AIDS 
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epidemic is described below, with a particular focus on the use of these systems in 
SSA. 
 
1.4.1 Notifiable disease and disease registry reporting systems 
As mentioned in the background section of this chapter, case-based notifiable 
disease reporting systems were first used to monitor the HIV/AIDS epidemic 
internationally. In most countries, including those in SSA, AIDS case reports were 
filled out by local health care providers and then sent via a reporting system to the 
national level for aggregation and reporting to WHO. Case reports typically consisted 
of basic socio-demographic information, such as the gender and age of the 
individual, laboratory data, and any known risk factors for transmission. In areas 
without access to diagnostic HIV testing, a points-based clinical case definition using 
AIDS-defining symptoms called the Bangui definition was used to confirm cases 
beginning in 1985 [30].  
Despite the contribution of this early system to gaining some initial insight into 
transmission patterns, AIDS case-based reporting was heavily criticized in SSA as 
an inadequate method for monitoring HIV prevalence in the population [13]. The two 
biggest concerns regarding the accuracy of estimates were under-reporting and 
delays in reporting cases [13]. This was particularly true in non-urban health care 
facilities where reporting systems were weak and timeliness of reporting often 
depended on a functioning transportation system. Missed diagnoses, or false 
diagnosis were also problematic, as many clinics in SSA did not have the laboratory 
capacity to conduct HIV testing. As evidence of these problems, the WHO estimated 
the number of AIDS cases globally at over 350 000 in 1988 using a mathematical 
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model, but the number of confirmed case reports received by the agency during that 
year was less than half that number [13].  
A further limitation of relying on an AIDS case-based reporting system was 
that this focus provided only a snapshot of transmission patterns which, due to the 
long asymptomatic period, had occurred five to ten years earlier [31]. To address this 
problem, many countries added HIV to their notifiable disease reporting system. 
While this might have provided a better strategy for determining the true proportion 
of the population infected, lack of testing opportunities and the stigma associated 
with testing positive meant that most HIV infections continued to go undiagnosed. As 
a result, in most countries in SSA, the reliance on HIV and AIDS case reporting  
declined, although in limited instances, this system is still used by some to describe 
basic shifts in risk and demographic characteristics of HIV infection in the population 
[32].   
 
1.4.2 Routine vital statistics systems 
Because the time from AIDS to death is relatively short (in the absence of ART), at 
first, death registries were also considered a potential source of surveillance data for 
monitoring the epidemic [33]. In many countries where national vital reporting 
systems were well-developed and specified causes of death were certified by 
physicians, the number of AIDS-related deaths could be used to approximate 
infection levels in the population using back-calculation [34] and other methods [35].  
Ultimately in SSA, however, two factors prevented the use of national vital 
registry systems for surveillance purposes. In the first instance, vital reporting 
systems were often weak, with few national systems collecting and analysing death 
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events  [33]. In the second instance, coding and classification of disease done by a 
physician may not have identified AIDS-related conditions as a primary or secondary 
cause of death, either through simple misclassification or intentional obfuscation [36]. 
As a result, very few countries in SSA found national vital reporting systems of 
sufficient quality to be useful. 
As an aside, some public health researchers have been able to use trends in 
the number of reported deaths nationally, as well as locally available data from burial 
societies, to better quantify AIDS-related mortality in a geographic area [36-38]. In 
particular, vital reports have been used to estimate the number of AIDS deaths 
based on changes in mortality rates over time in South Africa [36]. Additionally, in 
some longitudinal community-based surveys, verbal autopsies of deceased persons 
have been carried out with previous caregivers to quantify the proportion of deaths 
that were likely due to AIDS [37, 38]. In most cases, however, these methods have 
not been used systematically at a national level or across countries in SSA given the 
intensity of resources required to conduct these types of studies.  
 
1.4.3 Sentinel surveillance systems 
To address limitations in data quality from case-based and vital reporting systems in 
SSA, in 1988, the WHO recommended that countries consider implementing sentinel 
surveillance to monitor HIV infection levels and trends [16]. In draft guidance 
released at the IV International Conference on AIDS in Stockholm, Sweden, the 
organization outlined a method by which selected population groups at chosen sites 
would be anonymously tested for HIV antibodies using leftover blood collected for 
other diagnostic purposes on a repeated basis [16]. Using leftover blood collected 
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would not require individuals to consent to testing, thus estimates would not be 
biased by selective participation.  
The main purpose of the initial sentinel surveillance activities was to detect 
trends in infections for specific population groups and not necessarily to estimate 
infection levels in the population as a whole [16]. In most countries in SSA, HIV 
surveillance among pregnant women, STI patients, military conscripts, and blood 
donors was considered relatively straightforward to implement since blood samples 
and routine socio-demographic data were collected during visits to health facilities 
[39]. Also, facilities were chosen in a convenient, rather than systematic manner, 
with more accessible, better-resourced areas typically included [16]. Facilities where 
HIV prevalence was expected to be higher (e.g., in urban areas with good 
transportation networks or in areas where higher sexual risk behaviour was 
previously documented) were also given preference for inclusion.  
After several years of conducting surveillance in a variety of facilities, it was 
observed that estimates of HIV prevalence among pregnant women attending ANC 
clinics were a reasonably good approximation of HIV prevalence in the community, 
especially where contraceptive use was low and uptake of ANC services was high 
[13, 40, 41]. Data from pregnant women relative to sexually active women in general, 
however, were found to be subject to three types of systematic bias: (i) the 
purposeful selection of participating clinics; (ii) the self-selection of women who 
choose to access antenatal care, and (iii) the impact of testing only women who 
became pregnant [42]. Generally, due to the first bias, ANC estimates systematically 
overstated HIV prevalence at the national level (e.g., among men and women 
combined) due to over-representation of clinics in urban areas [43-46]. In community 
level comparisons, however, the more usual pattern was for ANC data to understate 
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prevalence among older women in the population due to HIV-related sub-fertility 
biases and to overestimate prevalence among women under age 25 due to bias in 
ANC data from selection for high risk sexual activity [42, 47-54]. Where uptake of 
ANC was low or contraception was high, biases in ANC data relative to the 
surrounding female population were less consistent [55, 56]. To improve their 
accuracy, demographic and statistical methods were proposed to adjust for these 
biases [42, 45, 57]. Countries were also encouraged to collect behavioural data as 
part of a “second-generation” surveillance effort to aid in the interpretation of 
changes in the HIV epidemic over time [58-60]. 
Since the mid-1990s, most countries in SSA have adopted similar 
methodologies for conducting HIV surveillance among pregnant women. According 
to WHO and UNAIDS recommendations, ANC surveillance protocols typically dictate 
that surveillance occurs over a one or two month period on an annual or bi-annual 
basis at a convenience sample of selected clinics [39]. The number of participating 
clinics can vary from country to country, but range from as low as six clinics to 
hundreds or more [31, 61].  
In the last ten years, many countries have expanded the number of 
participating ANC clinics in an attempt to increase the geographic 
representativeness of urban and rural estimates [31, 61-63]. Despite this change, 
and the availability of standardized protocols and guidance, a recent study in 2009 
by Garcia-Calleja and colleagues found the quality of the ANC surveillance systems 
across SSA to be variable [63]. In nine countries in SSA, HIV surveillance systems 
were described either as being of low quality or non-functioning. The reason for this 
designation in many countries was that there were long gaps between surveillance 
rounds.   
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ANC surveillance is usually conducted using an unlinked and anonymous 
(UAT) testing protocol [39]. Protocols relying on UAT use leftover blood from syphilis 
testing, which usually occurs at a woman’s first prenatal visit. Routinely-collected 
information regarding a woman’s socio-demographic and fertility characteristics at 
the time of the visit, which in most countries includes her age, residence, parity, 
gravidity, educational level and marital status, are used to aid in the interpretation of 
trends in HIV prevalence [39]. Women are often excluded from participating in ANC 
surveillance if they are not attending their first prenatal care visit or have been 
referred from another facility.  
In each ANC surveillance round, data from approximately 200 to 300 women 
is collected at each participating clinic over a four to eight week period [39]. An 
overall sample size target of 300 women per age group across all clinics is set. 
Based on UNAIDS recommendations also, some countries in SSA have  
oversampled younger women aged 15 to 24 years (with a goal of approximately 
3000 women across all clinics) as a proxy for monitoring trends in new infections 
[39].  Because HIV-related morbidity and mortality in recently infected women is low, 
HIV prevalence should be a reasonably good indicator of underlying HIV incidence 
among young people, including men and women [64].  
With regard to interpretation and presentation of ANC surveillance data, 
UNAIDS recommends that countries report HIV prevalence among all pregnant 
women as the median clinic estimate from the survey round, followed by the lower 
and upper range of clinic-specific estimates so as to highlight any disparities in sub-
regional HIV prevalence [39]. Countries with repeated estimates of HIV prevalence 
greater than 1% in pregnant women (e.g., sustained transmission in the population) 
from ANC sentinel surveillance are considered to have generalized HIV epidemics, 
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while countries with HIV prevalence of less than 1% (e.g., in select high-risk groups 
only) are categorized as having concentrated epidemics. In SSA today, 39 of the 45 
countries are described as having a generalized HIV epidemic [63]. Those countries 
in SSA with concentrated epidemics are Comoros, Madagascar, Mauritius, 
Mauritania, Senegal and Somalia [63].  
Although ANC surveillance data have provided a relatively reasonable 
indicator of community-level HIV prevalence, the accuracy of ANC surveillance data 
to describe national-level HIV prevalence was, as previously mentioned, eventually 
found to be lacking [65]. In particular, the effect of choosing ANC clinics 
disproportionately located in more urban areas proved difficult to quantify and adjust 
for systematically across countries  [44]. Beginning in the early 2000s, UNAIDS and 
WHO recommended that countries in SSA replace ANC surveillance data with data 
from nationally-representative household-based surveys in men and women to more 
accurately estimate HIV prevalence [65, 66]. Nevertheless, UNAIDS has 
recommended that ANC surveillance data, despite its limitations, still serve as the 
primary means by which trends (i.e., changes in population prevalence over time) in 
the epidemic are monitored [41, 65]. The methods used to produce country and 
global estimates and projections of HIV prevalence and incidence are described in 
more detail in Section 1.5. 
 
1.4.4 Surveys 
Concerns about the representativeness and accuracy of national HIV estimates 
derived from ANC surveillance in the early 2000s, along with the increased 
availability of financial and human resources to monitor the epidemic, created an 
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increased demand for nationally-representative estimates of population HIV 
prevalence [65, 66]. To meet this demand, many countries, beginning with Mali and 
Zambia in 2001, added HIV testing to household-based nationally-representative 
surveys, such as the DHS [67].  
DHS and DHS-like surveys typically use census-driven sampling frameworks 
to select enumeration areas in which all, or a select sample, of participants domiciled 
in households are interviewed on basic demographic and health indicators [68]. 
Sample sizes typically range from 5000 to over 10000 men and women aged 15 to 
49 years, depending on the size of the country [68]. Individuals selected to 
participate are also asked to provide blood for HIV and other testing [69]. 
Since 2001, upwards of three dozen DHS and DHS-like surveys with HIV 
testing have been carried out in SSA. While most countries have published results 
from at least one survey, seven countries have reported on two (Botswana, Kenya, 
Lesotho, Mali, Niger, Tanzania, and Zambia) and Sierra Leone and South Africa 
have reported on three.   
Due to the complexity and expense of carrying out population surveys, 
nationally-representative surveys are typically conducted every five to 10 years [39]. 
Also, given their complexity, high levels of technical support and longer periods of 
time are often required to clean, interpret and publish results. As a result, data 
collected from these systems are not available as frequently as those obtained from 
ANC surveillance.  
Not unlike the ANC surveillance data, the accuracy of estimates from 
population surveys  can be of concern, especially if refusal  rates at the household 
and individual levels are high and differentially associated with HIV status [39, 70, 
71]. Garcia-Calleja and colleagues, in a review of national population-based HIV 
34 
 
prevalence surveys from 19 countries in SSA from 2001 to 2005, found that 
household refusal rates ranged from less than 1% to 17%, with higher individual-
level refusal rates typically observed in men (ranging from 4.6% to 37.8%) as 
compared to women (ranging from 2.7% to 31.8%) and in urban as compared to 
rural areas [44]. Of the 19 countries, rates of refusal were the highest in South Africa, 
for both men and women [44], and especially in the province of KwaZulu-Natal, 
where 59.1% of individuals refused to provide a blood sample [72, 73].  
In Garcia-Calleja’s 19 country study, it was not possible to directly measure 
the impact of bias due to refusals, although the authors suggested that countries with 
high refusal rates may find significant differences between observed and actual 
population prevalence estimates, assuming that those refusing were twice as likely 
to be HIV infected than those participating. To assess the impact that refusal bias 
might have had on estimates of HIV prevalence from the population survey in the 
KwaZulu-Natal province in 2005, in particular, researchers developed a 
mathematical model that sought to infer HIV prevalence among non-testers from 
background mortality rates among HIV infected and uninfected individuals in the 
surrounding population in the pre-ART era [73]. Mortality rates were available 
separately for HIV infected and uninfected individuals via a series of demographic 
health studies in the province.  
From the model, HIV prevalence, adjusted for refusers, was estimated to be 
27.5% (95% CI 23.6–31.3), or approximately 7% higher than the observed 
prevalence of 19.7% (95% CI 19.6–21.3) among testers only. Analysis also showed 
that some proportion of this bias likely resulted from refusers who already knew their 
HIV serostatus to be positive, since relative to HIV negative individuals, persons 
testing positive at an earlier round were 23% less likely to test in the follow-up 2005 
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survey round. This latter finding was similar to a study conducted in Malawi, which  
showed that individuals who knew their HIV status to be positive were five time more 
likely to refuse to participate in testing than those who had previously tested negative 
[71]. A greater increase in refusals among women previously testing positive in rural 
South Africa was also noted, but crude adjustment methods to account for this bias 
had a negligible influence on the population prevalence estimate [56]. As access to 
HIV testing expands, it is conceivable that household surveys could increasingly 
understate HIV prevalence in the population in the future due to issues related to 
repeat testing refusals, but evidence that this will have a measurable impact on 
changes in bias in estimates is still limited.   
Although the finding for bias from the population survey estimates in KwaZulu-
Natal was not surprising given the high and differential refusal rates by persons 
assumed to be HIV positive, this result contrasts with those from a larger study by 
Mishra and colleagues using DHS and DHS-like data from 14 countries. Results 
from this analysis suggested that the effect of individual-level non-response bias 
(including absentees) on population estimates was likely to be minimal [74], One key 
limitation to the study’s conclusions was that the accuracy of the adjusted population 
prevalence estimates were only valid to the extent that the socio-demographic and 
behavioural characteristics included in the multivariate statistical analysis correlated 
with the risk of HIV infection. Evidence from the regression models in the countries 
suggested that these variables did a relatively poor job at predicting HIV prevalence 
among testers, with only 20% of the variation in prevalence explained by over 30 
predictor variables. For this reason, it is possible to conclude that population based 
estimates may not always be a perfect ‘gold standard’ when refusal biases are very 
high, and that analyses relying on this method of adjustment may not produce more 
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accurate estimates of underlying population prevalence under this circumstance. In 
Zambia, an analysis of DHS data suggested that HIV prevalence would have needed 
to be at least 41% higher among non-respondents to have a significant effect on the 
estimate of prevalence from the national survey [70].  
A second concern beyond refusals and non-response at the individual level is 
that population surveys may be biased by the exclusion of high risk groups, such as 
prisoners, military personnel, homeless persons, or migrant workers, not domiciled in 
a permanent household. In the previously described 14 country study, which also 
considered this potential source of bias, household response rates and census data 
from five countries with varying rates of HIV infection (Cambodia, India, Ghana, 
Uganda and Lesotho) were used to explore the impact of excluding non-household 
populations on survey-based HIV prevalence estimates.  
To do this, estimates of the proportion of the non-household populations who 
were adults was constructed, assuming  three scenarios where: (i) household and 
non-household prevalence estimates were the same (e.g., baseline); (ii) non-
household members comprised 66.7% of non-household population, and the HIV 
prevalence among the non-household adults, as compared to adults in households, 
was 10 times in India and Cambodia, five times in Ghana, two times in Uganda, and 
one and a half times in Lesotho; and (iii) the non-household adult population was 
75.0%, with HIV prevalence among non-household adults as compared to household 
adults, 20 times in India and Cambodia, 10 times in Ghana, four times in Uganda, 
and two times that in Lesotho.  
Results from these analyses indicated that exclusion of non-household adults 
was likely to have only a minimal effect on the observed national HIV prevalence 
estimates from the surveys, regardless of the non-household proportion and infection 
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level assumed. In India, for example, even under the most extreme scenario 
(scenario iii), the adjustment for missing adults would have resulted in an increase in 
population prevalence from 0.28% to 0.35%. In countries with higher HIV 
prevalence, such as Uganda and Lesotho, the exclusion of a substantial proportion 
of the non-household based adult population would not change HIV prevalence 
overall in the countries.  
Even given the potential for inaccuracies described above, the  benefits from 
population-based household surveys have increasingly outweighed any limitations 
as a means for estimating overall HIV prevalence in a country, because most 
importantly, they are often the only source of data to describe HIV prevalence among 
men nationally. Population-based surveys also provide an opportunity to directly link 
socio-demographic, behavioural and health service use data to an individual’s HIV 
status, thereby producing a more comprehensive understanding of the dynamics of 
the epidemic. Finally, repeated population-based surveys have been used most 
recently to monitor changes in HIV incidence by examining changes in mortality and 
HIV prevalence within age cohorts [75, 76]. In ANC surveillance, sample sizes are 
generally too small to provide stable estimates of incidence using these methods, 
while results from smaller, geographically-localized cohort studies likely would not be 
generalizable to the national level.  
 
1.4.5 Programme-specific monitoring systems 
Although population-based survey and ANC surveillance data are currently 
considered to be the best sources for monitoring HIV prevalence levels and trends 
respectively, in 2006, UNAIDS also recommended that alternative data sources, 
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such as from the scale-up of routinely-offered HIV testing through PMTCT 
programmes, be explored as possible proxies for ANC-derived HIV prevalence levels 
and trends [77]. In terms of the availability of PMTCT data, the roll-out of  
programmes to test pregnant women through routine pre-natal care services has 
been somewhat slow, but by 2008, about 28% of pregnant women in SSA had been 
tested during their ANC visit [78]. A variety of interventions, including the adoption of 
the 2007 WHO recommended provider-initiated ‘opt-out’ testing strategy have been 
credited with increasing uptake [79]. Studies have shown that the ‘opt-out’ strategy, 
where HIV testing is included in the battery of prenatal tests conducted during a 
woman’s pregnancy unless she refuses, substantially increased testing uptake 
compared to when client-initiated or ‘opt-in’ testing strategies were used [80-87]. 
With ‘opt-in’ testing, although all women may have been informed about the benefits 
of HIV testing during their prenatal care, they would have been required to request 
the test from their health care provider. [79]  
Using PMTCT data for surveillance purposes offers certain advantages over 
ANC surveillance in that (i) more ANC clinics can participate, (ii) ethical concerns of 
testing women without consent are avoided, and (iii) data on the number of women 
testing and their HIV status are routinely available as part of programme monitoring 
activities [88-90]. However, possible disadvantages have also been raised. Of 
greatest concern has been that HIV-infected women refusing or, conversely, 
preferentially seeking out HIV testing could bias PMTCT-based estimates [91, 92]. 
The impact of this participation bias on prevalence estimates could also vary in 
magnitude and direction with time as uptake levels increase or approaches to 
delivering HIV testing and counselling services change [93]. Finally, whether PMTCT 
data are sufficiently standardized across clinics, detailed enough for surveillance 
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purposes, and accessible in their current form has also been debated [77, 89, 94-
96].  
With regard to methods for collecting and analysing PMTCT data for 
surveillance purposes, a variety of approaches have been explored [88, 89, 93-98]. 
Initial recommendations for countries wishing to begin collecting and using PMTCT 
data for surveillance purposes have been developed, based on lessons learned from 
the studies conducted to date [19] . As part of these recommendations, countries 
were encouraged to prioritize collecting PMTCT data from the same sample of clinics 
that previously participated in ANC surveillance in order to be able to continue to 
monitor population prevalence trends. To avoid the possible influences of non-
participation bias, it was also suggested that countries set minimum standards for 
the amount of time a clinic had to have been offering services and the level of uptake 
required before permitting the clinic to contribute PMTCT-based HIV prevalence 
estimates for surveillance purposes. Finally, issues regarding data collection 
methods and reporting systems were raised for further consideration, including what 
minimum set of data should be collected and whether PMTCT data should be 
collected during a specific surveillance period or abstracted from existing registries in 
the clinics on an on-going basis.  
Preliminary guidelines for using PMTCT data for surveillance purposes have 
also been developed based on the recommendations references above [99]. If, 
during the process of evaluating the PMTCT programme data for surveillance 
purposes, the data are found to accurately reflect underlying HIV prevalence in 
countries, the guidelines encourage countries to transition from ANC surveillance to 
routine PMTCT reporting data. Chapter 2 provides more background on the types 
and magnitude of bias associated with PMTCT data that may complicate this 
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potential transition. In Chapter 6, these issues are discussed further with regard to 
the representativeness of PMTCT data for monitoring ANC prevalence in 
Manicaland, Zimbabwe.  
 
1.5 Selected examples of how ANC surveillance data are used 
As previously discussed, ANC surveillance data have played an important role in 
monitoring the HIV epidemic and the effectiveness of a country’s response. In their 
crude form, ANC surveillance data from women aged 15 to 24 years have been used 
to monitor changes in HIV prevalence and incidence among youth [21]. In the 
absence of repeated population survey data and without the benefit of a reliable 
laboratory test for incidence, ANC surveillance data are the easiest way to monitor 
trends in this population. Accordingly, UNAIDS recommends that countries rely on 
these data under the assumption that trends in HIV prevalence among young 
pregnant women reflect trends in young men and women aged 15 to 24 years [64]. 
 ANC surveillance data have also been used to determine why changes in the 
epidemic may be observed. For example, Hallett and colleagues used a 
counterfactual mathematical model to determine whether changes in HIV prevalence 
in countries with generalized HIV epidemics were caused by changes in sexual risk 
behaviour in eight countries [27]. In this example, HIV prevalence trends for each 
country were produced assuming no change and various levels of changes in 
transmission due to increased condom use, fewer partnerships, smaller age-
disparities between partners, and other risk reduction behaviours. These curves 
were then fitted to ANC surveillance data to determine what changes in sexual 
behaviour would have been required in the population to produce the observed 
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changes in prevalence among pregnant women. The model assumes that ANC 
surveillance data are representative of underlying population prevalence trends, 
which is validated using the model also. 
 ANC surveillance data have also been used to measure the effectiveness of 
HIV programme services and to improve programme performance [100]. For 
example, Bolu and colleagues in 2005 used ANC surveillance data from Kenya, 
Ethiopia and Zimbabwe to calculate the proportion of HIV-infected women not 
participating in the PMTCT programme. As these proportion were high in Ethiopia 
and Zimbabwe (57% and 59%, respectively), recommendations were made to 
strengthen and improve a woman’s first encounter with the PMTCT programme so 
as to increase participation [101].  
Perhaps the most important use of HIV surveillance data from sentinel 
surveillance of HIV infections among pregnant women, and more recently, from 
population survey data, is to model the HIV epidemic in SSA. Results from country-
specific mathematical models are used to describe estimates and short-term 
projections of HIV prevalence and incidence among adults aged 15 to 49 years [18, 
39]. Depending on country needs, estimates and projections can also be produced 
separately for rural and urban areas or for sub-regions or specific population groups.  
To generate national HIV prevalence estimates and short-term projections, 
most countries in SSA use the Estimates and Projection Package (EPP)-Spectrum 
software package developed and supported by UNAIDS and the UNAIDS Reference 
Group on Estimates, Modelling and Projections [102]. The UNAIDS Reference 
Group is a multi-disciplinary, multi-institution team of individuals who work to ensure 
the accuracy and comparability of estimates and projections globally [11]. Public 
health officials from countries typically convene alongside members of the UNAIDS 
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Reference Group at bi-annual workshops to produce models of their country’s 
epidemic. Typically, these models are published in national and international 
surveillance reports and are also used to inform a wide-range of policy and funding 
decisions.  
When using EPP-Spectrum to generate estimates and projections, the 
software provides users with an Excel-like spreadsheet to enter ANC surveillance 
and population survey data [103]. For the ANC surveillance data, the names of 
clinics located in urban areas are entered in a sheet separately from clinics in rural 
areas. Within each sheet, the names of ANC clinics are listed in the first column by 
row, with subsequent column headings representing years, dating back to the 
earliest ANC surveillance rounds.  
For each clinic and year, the sample size and the number testing HIV-positive 
are entered. Where information on sample size is not available, the software 
assumes a default value of 300 women per clinic. The overarching purpose of 
entering the ANC surveillance data is to select which of the curves produced through 
the EPP-Spectrum model best fit the trends in these data. 
For population survey data, the year in which the survey was conducted, the 
number of persons sampled, HIV prevalence in the group, and their standard errors 
are entered [103]. For the purposes of fitting the epidemic curve, population survey 
estimates are treated as if they were a separate ANC surveillance clinic. More 
detailed information on how population survey data are used to calibrate overall 
infection levels is discussed below. 
In addition to the HIV surveillance data, country-specific demographic data 
and data on ART use are also entered into EPP-Spectrum to inform the construction 
of prevalence and incidence curves. These data include: the population living in rural 
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and urban areas over time, the ratio of males to females, sub-fertility, CD4 eligibility 
threshold for starting ART in the country, progression patterns to death among ART 
users, the rate of survival of individuals on ART over time, annual numbers of first-
line and second-line ART users, and the coverage of the ART among sub-
populations of interest, such as men versus women.  
Based on the country-specific ART and demographic data, a simple 
compartmental mathematical model in EPP-Spectrum is used to derive an initial set 
of epidemic curves for a population of adults aged 15 to 49 years [102, 104-106].  
The basic four parameters of the model are:  
 
– r – the force of infection  
– f0 – the proportion of the population newly at risk 
– t0 – the start year of the epidemic 
–  – a behaviour change parameter representing increased or 
decreased levels of risk over time 
 
Other parameters, including the time from infection to ART eligibility and from ART 
eligibility to death, are fixed.  
To choose the combination of parameter values that best fits trends in the 
surveillance data, a method known as incremental mixture importance sampling 
(IMIS) is used [107]. In this method, a small set of randomly generated curves are 
initially produced from a distribution of values from the four parameters and then the 
resulting curves are evaluated for their fit to the surveillance data. Curves that best fit 
the data are assigned the highest weight, with special weight assigned to curves that 
fit data from ANC clinics which have participated in more surveillance rounds. Next, 
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the values for the four parameter estimates that produced the most heavily weighted 
curves are used as the starting point for producing additional curves. Through 
repeated sampling, this process eventually produces a single curve of HIV 
prevalence and underlying incidence, with uncertainty estimates that capture 95% of 
the distribution of all potential curves that could reasonably fit the surveillance data 
[102, 107].   
While the final curve represents the best fit to the trend in the ANC (and 
population surveillance data when available), the overall level of the prevalence and 
incidence curves can be modified in special cases [103]. For example, countries 
without population survey data can calibrate a prevalence curve downward based on 
observed biases in ANC surveillance data for urban and rural areas. Countries can 
also modify prevalence curves to fit through specific point prevalence estimates, 
such as those estimated from repeated population surveys. Finally, countries can 
manually input incidence patterns over time based on other country-specific 
information, such as changes that might have occurred in a specific region or a sub-
group population.  
As the technical description of EPP-Spectrum demonstrates, ANC 
surveillance data are integral to selecting the best-fitting curves describing national 
and sub-national incidence and prevalence trends. For this reason alone, and apart 
from the many other ways countries use ANC surveillance data to monitor the HIV 
epidemic, it is critical to ensure that ANC surveillance data accurately reflect 
underlying changes in prevalence in the population over time. In Chapter 2, biases in 
ANC surveillance estimates and their sensitivity to changes in behavioural and 
biological determinants of HIV infection in an evolving epidemic are therefore 
examined in further detail.  
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Chapter 2: Assessing bias in levels 
and trends in HIV surveillance data 
from pregnant women 
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2.1 Aims and organization of the chapter 
The central aim of this chapter is to provide a comprehensive review of published 
and unpublished literature describing (i) the types of bias that have previously been 
found to influence the accuracy of HIV prevalence levels and methods applied to 
adjust for them using (a) ANC surveillance data and (b) PMTCT data and (ii) how 
these biases may be changing with time to influence the representativeness of 
surveillance trends. Also, analytical methods for detecting changes in bias over time 
that have been used in previous studies are described as an introduction to the 
remaining analytical chapters. Finally, a description of the Manicaland HIV/STD 
Prevention project is provided, since subsequent chapters make extensive use of 
data from this project.   
 
2.2 Bias in HIV prevalence levels from ANC surveillance data 
As briefly discussed in Chapter 1, estimates of HIV prevalence from ANC 
surveillance data can be influenced by three types of bias. These biases are: (i) the 
purposeful selection of participating ANC clinics; (ii) the self-selection of women who 
access ANC services and (iii) only testing women who became pregnant [42]. 
Understanding the nature and direction of these biases is important even though 
UNAIDS no longer recommends using ANC surveillance data to estimate overall 
levels of population prevalence in a country. Without this understanding, it would be 
difficult to predict how changes in these biases over time could affect the 
representativeness of trends in HIV prevalence at a local or national level, for which 
ANC surveillance data are still used.  
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Studies describing the experiences of countries in SSA with regard to bias in 
ANC estimates are numerous. Studies included in this review were identified through 
an online search of published literature using Google Scholar and PubMed in 
February 2012. Search parameters included: ANC sentinel surveillance, population 
surveys, HIV prevalence, measurement error and sub-Saharan Africa. This search 
returned 746 references, of which all abstracts were reviewed for their relevance.  
In total, nine of the 746 articles explored bias in ANC estimates relative to 
national population estimates or relative to estimates among adult men and women 
combined [40, 43, 45, 46, 48, 70, 108-110]. These studies are summarized in 
Appendix A, Supplemental Table 2.1. Ten studies were identified that primarily 
explored differences in HIV prevalence among ANC attendees relative to female 
population in community-based comparisons [47, 51-53, 55, 56, 111-114]. These 
articles are also summarized in Appendix A in Supplemental Table 2.2. In some 
instances, where population level data could be disaggregated to the catchment 
level, a few articles considered both types of comparisons [43, 46, 95, 110]. 
Summaries of findings for both comparisons are included in Supplemental Table 2.1.  
Importantly, supporting articles for which bias in ANC estimates was 
considered a secondary topic or which provided context for the type of bias reported 
(e.g., most importantly those describing HIV-related fertility differences in women) 
are referenced in the text but not summarized in the supplemental table, unless the 
study attempted to quantify a magnitude of bias [47, 113, 114]. From this initial 
search, seven studies that directly address issues of bias in ANC surveillance data 
specific to trends were also identified. These studies are reviewed in Section 2.3 and 
summarized in Supplemental Table 2.3 of Appendix A [21, 27, 50, 113, 115-117].  
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2.2.1 The purposeful selection of participating ANC clinics 
Based on findings from studies comparing HIV prevalence estimates from pregnant 
women attending ANC clinics and men and women living in the catchment areas of 
those communities, estimates of HIV prevalence in both groups have generally been 
found to be similar throughout SSA [40, 46]. However, due to resource and practical 
constraints, not all ANC clinics in a country can participate in ANC surveillance. 
Consequently, those clinics that are selected to participate in ANC surveillance must 
serve as reliable proxies for areas without participating clinics.  
One of the biggest concerns when relying on only a sub-set of clinics is 
whether the chosen clinics will have sufficient spatial diversity to capture geographic 
differences in HIV prevalence that can occur [45]. For example, in most countries in 
SSA, HIV prevalence is higher in urban, more populated areas such as towns and 
commercial centres, and lower in rural, less populated areas such as subsistence 
farming areas [26, 45, 118]. Accordingly, clinics are usually identified as either 
representing urban or rural areas when constructing population prevalence trends. 
Associations between geographic location and HIV prevalence are often more 
nuanced, however, than just a division between rural and urban areas. For example, 
in Kenya, HIV prevalence levels were found to increase as the distance that women 
lived from a major road or to Lake Victoria declined, and these types of geographic 
differential in prevalence must also be anticipated when choosing ANC clinics [119].  
Another concern is whether the sub-set of clinics selected to participate in 
ANC surveillance adequately reflect the unique mixture of cultural norms and 
behaviours that influence HIV transmission in specific geographic areas [120]. For 
example, an early ecological study of male circumcision and HIV prevalence showed 
that, in four countries in SSA (Côte d’Ivoire, Kenya, Tanzania and Zaire), geographic 
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areas where circumcision was either practiced or not could be defined [121]. In those 
areas where circumcision was not practiced, HIV prevalence was 2.0 to 4.5 times 
greater than in areas where circumcision was practiced. Religion is another factor 
that has been associated with differences in HIV infection levels by geographic area. 
In rural Manicaland, Zimbabwe, members of  Apostolic churches living in some 
communities were found to have lower HIV prevalence levels than members of other 
religions living in other communities [122]. Given the limited number of clinics that 
can participate in ANC surveillance, it would be nearly impossible for this system to 
capture all of these differences.  
A final, more recent concern is whether the sub-set of ANC clinics selected to 
participate accurately capture differences in geographic access to HIV prevention, 
treatment and care programmes [123]. This is especially of concern since 
populations with access to these programmes will experience higher levels of HIV 
prevalence due to extended survival [25] and lower HIV incidence due to reductions 
in onward transmission through decreased viral loads [102, 124]. As a case in point, 
ART and PMTCT programmes in South Africa were initially concentrated in urban 
clinics with better diagnostic and laboratory infrastructure while expansion to more 
rural clinics lagged behind [125-127]. Also, in some countries, ANC surveillance 
protocols dictate that clinics selected to participate must offer PMTCT services; thus, 
ANC surveillance prevalence estimates may be weighted more heavily towards 
populations with better access to PMTCT and ART programmes [128].  
Given the above, it is not surprising that at a national level, ANC surveillance 
data from participating clinics have tended to overstate population HIV prevalence in 
most countries in SSA [43, 45, 46, 109] by about 20% on average [45]. Further 
stratification of these comparisons also revealed that the differential tended to be 
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greater in rural as compared to urban areas and in countries in western and central 
Africa as compared to countries in southern and eastern Africa. Despite these 
overarching commonalities, country-specific variations have also been observed. In 
Zimbabwe [108] and Zambia [70], for example, ANC surveillance estimates were 
found to be similar to those in the general population in surveys conducted in the 
early to mid-2000s. In Uganda, where estimates of population prevalence are 
believed to have stabilized in the mid-2000s [129], ANC surveillance estimates of 
HIV prevalence were observed to be lower than those in the general population [46]. 
In these three countries, either ANC surveillance estimates are not influenced (or in 
the case of Uganda, influenced differently) by the usual clinic selection biases 
observed in other parts of SSA, or, in contrast, other types of biases, such as those 
arising from the self-selection of women who access ANC services or from 
differences in who becomes pregnant, are more influential.   
 
2.2.2  Self-selection of women who access ANC services 
The WHO recommends that women have at least one, and preferably four or 
more, prenatal visits during pregnancy [130]. Findings from DHS have shown that 
ANC uptake is higher than might initially be expected in countries in SSA, with 72% 
of women reporting at least one prenatal visit and 43% reporting four or more 
between 2005 and 2009 [131]. In two countries with generalized HIV epidemics 
(Namibia and Rwanda) 95% or more of women reported at least one visit. In nine 
countries, (Botswana, Kenya, Lesotho, Malawi, Mozambique, South Africa, Uganda, 
Zambia and Zimbabwe), uptake ranged from 90% to 94%. Not all countries have 
been as successful at promoting the use of prenatal services. In Ethiopia and 
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Nigeria, only 28%, and 58% of women, respectively, reported attending at least one 
prenatal visit. 
Socio-demographic factors associated with increased uptake of prenatal care 
in countries in SSA with generalized HIV epidemics have included higher education, 
being married, higher income, being employed, and having a history of obstetric 
complications [130, 132]. Age has also been associated with increased uptake, 
except among the youngest women (below aged 20 years) and older women (above 
aged 35 years) [130]. Women from urban areas have also been reported to be 
significantly more likely to use ANC services than women from rural areas [130, 
132]. Higher parity and higher birth orders were negatively associated with use of 
ANC services, although not consistently [130, 132]. With the exception of being 
married, all of the above factors have also been shown to be associated with higher 
levels of HIV infection in SSA [51, 120, 133-135]. This latter finding suggests that, on 
average, ANC surveillance data might overestimate HIV prevalence due to self-
selection bias, even among recently pregnant women in the surrounding community.  
However, in the only study comparing HIV prevalence estimates of ANC 
attendees and recently pregnant women from the surrounding clinic catchment 
areas, which occurred in rural Manicaland, Zimbabwe, ANC surveillance data were 
actually found to  underestimate HIV prevalence among recently pregnant women 
(21.7% in the ANC surveillance data versus 25.7% in recently pregnant women) [55]. 
The authors suggested that the most likely explanation for this difference was that 
women from rural areas with lower HIV prevalence were visiting clinics in towns 
where HIV prevalence was higher. Many of these women reported attending clinics 
in urban areas because they perceived that an urban clinic would offer better 
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services or because the clinic was located near an urban market that they also 
visited routinely.  
Based only on this single study, and given the paucity of other studies to 
assess the associations between ANC uptake and HIV infection, it is difficult to 
generalize broadly about the magnitude or the direction that bias due to self-
selection might exert on ANC surveillance estimates. At the national level, WHO 
recommends that countries carefully monitor changes in the socio-demographic 
characteristics of pregnant women participating in ANC surveillance or who report 
attending ANCs in DHSs to ascertain if self-selection biases are changing.  
Although not specifically related to access to ANC uptake, socio-demographic 
factors associated with HIV infection and differently distributed between ANC clinics 
and the population have also been reported to have introduced a bias in ANC 
estimates. For example, in Zimbabwe, differences in the age structure and religious 
affiliations of ANC and study population participants in two areas of Manicaland 
exaggerated differences in HIV prevalence estimates from ANC clinics since women 
in their 20s with high HIV prevalence were over-represented in the ANC clinic, while 
women of apostolic faith with low HIV prevalence were under-represented [122]. 
Standardization of the estimates to the local population age distribution partially 
removed these differences, reducing prevalence in one of the areas from 24.3% to 
18.4%.  Differences in the distribution of age between ANC and population survey 
participants is common throughout sub-Saharan Africa, and as a result, comparisons 
of estimates between community and female population prevalence estimates is 
usually done adjusting for differences in age distributions between the two 
populations [48, 50, 51, 53, 56, 136]. As noted by Zaba [42] and Gregson [113], 
however age standardization can have the effect of reducing ANC estimates even 
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further by giving more weight to lower HIV prevalence among older pregnant women 
than what would have otherwise occurred in the crude estimates. As a result, age-
standardization is not always appropriate when comparing ANC and female HIV 
prevalence estimates.  
In addition to age, other socio-demographic factors in SSA that have been 
differently associated with HIV prevalence in ANC attendees as compared to 
sexually active women generally have included: marital status [51, 53], education 
[48, 116, 137, 138] and having moved within the last five years [53]. Women 
attending from rural areas, where HIV prevalence is typically lower, has also been 
identified as a factor in differentially biasing ANC estimates relative to the female 
population [138]. Various factors related to the use of contraception and other 
aspects of a woman’s fertility history have been associated with bias in many of 
these studies, and these factors are discussed in more detail in the section below.  
 
2.2.3  The effect of testing only women who become pregnant 
In SSA, women’s fertility rates are among the highest in the world, with an average 
total fertility rate (TFR) of 5.0 children per woman in 2009 [131]. Exceptions to these 
higher rates include countries such as Botswana, South Africa, Lesotho and 
Zimbabwe, where TFRs ranged from 2.5 to 3.5 children per woman [131]. In part, 
these lower fertility levels represent an underlying demographic transition 
independent of the HIV epidemic [139]. However, these lower fertility rates also 
reflect the high levels of HIV prevalence in these populations, which has tended to 
suppress overall fertility rates in HIV-infected women.  
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The extent to which HIV influences fertility in the population was heavily 
studied in countries in SSA so as to be able to interpret and predict how the 
demographic structure and economic security of the population might be changing 
as the epidemic grew [47, 113, 114, 138, 140-143]. At the community level, 
household-based population surveys from six countries in SSA in the early and mid-
1980s showed TFRs that were from 25% to 40% lower in infected as compared to 
uninfected women [47]. These lower fertility levels among HIV-infected women 
resulted in estimates of HIV prevalence at ANCs that were 5% lower (ranging from 
2% to 8%) than estimates of HIV prevalence in the surrounding female population. A 
subsequent review in 2004 of 19 settings also in SSA showed similar findings, with a 
population-attributable decline in total fertility of 0.37% (95% CI: 0.30% - 0.44%) for 
each percentage point increase in HIV prevalence [114]. More recently, using DHS 
data collected from 20 countries between 2003 and 2008, the age-specific fertility 
rate (ASFR) was higher for HIV-infected as compared to uninfected women aged 15 
to 19 years (ASFR ratio: 1.20) but it then declined with increasing five year age 
intervals for women aged 20 to 44 years (ASFR ratio: 0.76, 0.71, 0.65, 0.59 and 
0.53) [144]. 
In each of the studies summarized above, the authors highlighted the specific 
role that (i) selection for high-risk sexual activity, (ii) varying levels of contraceptive 
use, and (iii) sub-fertility in HIV-infected women might play in biasing ANC 
surveillance prevalence estimates. The potential direction and magnitude of these 
biases are explored in the sections which follow. 
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2.2.3.1 Selection for high-risk sexual activity  
Comparisons of HIV prevalence estimates from ANC surveillance data and those 
estimates obtained from population surveys show that ANC data frequently 
overestimate HIV prevalence in women aged 15 to 19 year in SSA [117]. The 
primary reason for this is that many young women have little or no sexual 
experience, and therefore are highly unlikely to become pregnant or infected with 
HIV. However, the select group of young women who have initiated sex are at a 
much higher risk of HIV infection given that they often choose older men as partners, 
who are more likely to be infected [145-147]. These women also report less 
consistent use of condoms and other contraception, and thus are more likely to 
become pregnant [146, 147]. In a study in rural Tanzania, HIV-infected women aged 
15 to 19 years had fertility rates that were 40% greater than uninfected women of the  
same age [54].  
As evidence for the effect of selection for high risk sexual activity among 
young women on ANC-based estimates, HIV prevalence among pregnant women 
aged 15 to 19 years in Manicaland, Zimbabwe from 1998 to 2000 was more than 
twice that of females of the same age group in the surrounding population (15.7% 
among ANC attendees versus 7.0% in all women) [55]. Similar age-specific 
disparities among women aged 15 to 19 years have also been reported in, Zambia 
[116], eastern Malawi [53] and South Africa [56]. Using national DHS and ANC 
surveillance data, this bias can also be observed among women in the broader 15 to 
24 year age group in Ethiopia, Malawi, Tanzania and Uganda [46]  Typically, the 
later the age of sexual debut in a country, the more ANC surveillance will 
overestimate female population prevalence among those aged 15 to 19 years and 15 
to 24 years also [117].   
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Although selection for sexual activity primarily introduces an upwards bias in 
ANC estimates among younger women, the opposite (i.e., a downwards bias) can 
occur in some countries for estimates among older women. In this latter group, HIV-
infected women who have been widowed or divorced may either choose or are 
strongly encouraged through societal norms to not remarry or re-initiate sexual 
activity after losing a partner. As a result, they will be excluded from the ANC sample 
because of selection biases for sexual activity. Since the proportion of older women 
who are currently divorced or widowed in SSA is relatively small though, the 
influence of this bias is likely to be minimal. In practice, ANC surveillance estimates 
are typically biased downwards for older women because of the biological effect of 
HIV on fertility, and to a lesser extent, higher levels of contraceptive use at older 
ages. These scenarios are reviewed in more detail in the following two sections. 
 
2.2.3.2  Contraceptive use 
Contraceptive use among women has been shown to bias ANC prevalence 
estimates in SSA [55, 56]. The magnitude and direction of the bias depends on the 
type of contraceptive used -- either barrier (e.g., condoms) or hormonal (e.g., pills, 
injections, intrauterine devices) -- and the context in which they are used; that is, 
either at high- or low-risk encounters. These different facets of contraceptive use and 
their influence on HIV prevalence estimates from ANC surveillance data are 
discussed here separately.  
In the case of barrier contraceptive use, studies have shown that condom use 
within stable partnerships is infrequent in SSA, where risk of HIV transmission is 
believed to be low and strong cultural norms make their use in such partnerships 
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unacceptable [148-151]. Conversely, condom use during high-risk or casual 
relationships has increased greatly since the start of the epidemic in SSA [152]. As a 
result, women engaging in higher-risk behaviour will be under-represented in ANC 
surveillance relative to women in lower-risk, stable relationships. In turn, ANC 
prevalence estimates will be biased downwards relative to those in the surrounding 
female population due to the exclusion of these women at higher risk.  
An alternative, albeit less likely scenario, is that women begin using condoms 
at the start of sexual activity (when the likelihood of a previous infection is very low) 
and that they continue using condoms until they enter stable relationships and 
decide to become pregnant. Using a mathematical model, Gregson and colleagues 
demonstrated that, in this situation, HIV prevalence levels from ANC surveillance 
would overstate those in the community, since only higher risk women not 
consistently using condoms would be susceptible to pregnancy and HIV [113]. This 
model also highlighted the fact that ANC prevalence as compared to HIV prevalence 
in the surrounding female population will be more sensitive to increasing condom 
use.  
Use of contraceptives other than condoms, such as hormonal pills, injections 
or intrauterine devices, has typically been limited throughout SSA. In some countries, 
however, including Botswana, South Africa, and Zimbabwe, between 50% and 65% 
of sexually active women have reported using these types of contraceptives [131]. In 
these settings, hormonal contraceptive use has frequently been a marker of low- 
rather than high-risk activity by women since contraceptives are frequently used 
within stable partnerships to reduce unwanted pregnancies or to space out births 
[153]. When young women use contraception effectively and at high levels, ANC 
surveillance prevalence estimates will over-estimate population HIV prevalence 
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because only high-risk women will be at risk of infection and pregnancy [55, 56, 153]. 
As Gregson and colleagues showed, this over-estimation also will persist among 
older age groups [55]. In one of the more extreme examples of this tendency, HIV 
prevalence estimates among women aged 30 to 34 years at six urban and peri-
urban ANC clinics was 51.7% compared to 47.0% in the surrounding female 
population in KwaZulu-Natal, South Africa [56]. Among women aged 35 and older, 
the ANC surveillance estimate was 36.5% compared to 27.7% in the female 
population. Contraceptive use in the study area exceeded 50% in both age groups, 
and was identified as one possible explanation for the higher ANC estimates. Other 
sources of bias that might have contributed to this discrepancy include (i) the 
unrepresentative selection of ANC clinics, (ii) under-reporting of pregnancies within 
the study area, and (iii) the inclusion of women from outside the clinic catchment 
area at higher risk of infection.  
When hormonal contraceptive use is low in a population, as it is throughout 
most of SSA, only those women most at risk of pregnancy will be motivated to 
regularly use contraceptives (hormonal or otherwise). Since hormonal contraception 
does not prevent transmission of HIV, however, ANC surveillance prevalence 
estimates would likely under-represent HIV prevalence in the female population, 
especially if women rely heavily on hormonal methods.  
One final, more recent concern that has yet to be fully measured with regard 
to its potential impact on the representativeness of ANC surveillance estimates is the 
extent to which hormonal contraceptive use may place women at a greater risk of 
either acquiring HIV or experiencing more rapid disease progression [154]. If 
hormonal contraceptives are found to increase susceptibility or exacerbate illness, 
this association could result in an under-representation of HIV prevalence in the 
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population due to the exclusion of HIV infected women from ANC surveillance. This 
exclusion could occur either through the use of hormonal contraception to prevent 
pregnancy or through HIV-related sub-fertility due to biological or behavioural 
causes, as discussed further in Section 2.2.3.3. 
Although early studies have found mixed evidence for the influence of 
contraceptives on HIV susceptibility and disease progression [154], a rigorous seven 
country study in SSA conducted from 2004 to 2010 has provided convincing 
evidence for a significant positive association between hormonal contraceptive use 
and HIV acquisition. In the study, female partners in serodiscordant couples using 
injectable and oral contraceptives were nearly twice as likely as non-users to 
become infected during the study period (adjusted hazard ratio: 1.98; 95% CI: 1.06-
3.68) [155]. Although a major limitation of the study was that it relied on self-reported 
contraceptive use, the majority of women were using long-acting injectable 
hormones which, unlike daily oral contraceptives, would have been subject to fewer 
adherence issues. Also, HIV sero-conversion was highest in the group using 
injectable hormones.  
In summary, because of the variety of contraceptive methods and manners in 
which they could introduce bias into ANC surveillance prevalence estimates, specific 
knowledge of these practices in a community and more information on the biological 
mechanisms through which contraceptive use influences HIV infection will be 
required. Additional information is also needed about the role that contraceptive use 
plays in either protecting or increasing the risk women have from acquiring HIV, 
along with better data on the magnitude of bias in estimates that is likely to occur 
because of this factor.  
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2.2.3.3  Sub-fertility due to HIV and other STIs 
As discussed in Section 2.2.3, HIV infection has been associated with a range 
of adverse reproductive health outcomes, which can lead to lower fertility rates in 
HIV-infected women. The biological reasons for this are twofold. First, HIV-infected 
women may experience more difficulty than uninfected women in becoming 
pregnant. In a study of sequelae from HIV infection in 15 hospitals throughout 
Uganda, 26% of women reported amenorrhea due to severe weight loss from 
advanced infection [156]. Reductions in spermatozoa by HIV-infected male partners 
and reduced coital frequency in individuals with advanced HIV disease may also 
lower the likelihood of conception among HIV-infected women [113].  
Second, where pregnancy does occur, spontaneous abortion, stillbirth and 
perinatal mortality have each been found to occur more frequently in HIV-infected as 
compared to uninfected women [157, 158]. Importantly, the risk of foetal loss has 
also been observed to increase as time since infection increases [158, 159]. 
Additionally, a history of, or co-infection with, bacterial STIs has also been identified 
to adversely impact a woman’s fertility, although the strength of this association has 
depended on the type of STI [153, 160-162]. In a community-based study in Rakai, 
Uganda, HIV-infected women with syphilis were 1.5 times less likely to be pregnant 
as compared to HIV-infected women without syphilis [161]. However, neither 
gonorrhoea nor trichomonal infection were found to reduce the prevalence of 
pregnancy in this population. In another Ugandan study, a current bacterial STI co-
infection had no significant impact on pregnancy rates, but previous bacterial STI 
infections were thought to be responsible for at least 50% of the total sub-fertility in 
HIV-infected women [162]. When left untreated, bacterial STIs can cause pelvic 
inflammatory disease, which in turn can cause twice the number of ectopic 
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pregnancies in women with histories of infection [160]. Where bacterial STI infections 
are infrequent in a population though, fertility differences among older HIV-infected 
and uninfected women will be reduced [153]. 
As a result of HIV-related sub-fertility, ANC surveillance prevalence estimates 
are typically lower than population prevalence among older women [55, 153], except 
as previously noted in South Africa and in Zimbabwe [55, 56, 108]. Most recently, in 
a comparison of DHS and ANC surveillance prevalence estimates from 2002 through 
2005 from four countries (Ethiopia, Malawi, Tanzania and Uganda), HIV prevalence 
among women aged 35 years and older attending ANC surveillance clinics was 1.3 
to 2.5 times lower than prevalence among women of a similar age living in the clinic 
catchment areas [46]. In part, these lower levels of HIV prevalence at ANC clinics 
could arise from the concentration of HIV infection among older ages as incidence 
falls and survival due to ART increases. The impact of expanding ART use on fertility 
patterns and ANC surveillance prevalence estimates are discussed further in Section 
2.3.3 and in Chapter 4. 
One final consideration regarding HIV-related sub-fertility is that, in its 
absence, HIV prevalence estimates among ANC attendees would almost always 
overstate female prevalence because HIV prevalence is highest in women with the 
highest fertility [115]. Typically, women aged 15 to 24 years represent half of all ANC 
attendees in SSA clinics. Among those women aged 15 to 24 years, however, the 
majority will be aged 20 to 24 years (except in settings where the age of sexual 
debut is very early) [117]. Along similar lines, there is also some evidence that 
pregnant women are at higher risk of HIV infection during their pregnancy, either due 
to behavioural or biological changes [163]. The influence of this factor on ANC 
estimates is likely to be minimal, provided the infection can be detected at ANC 
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surveillance clinics. If infection is too recent to be detected, ANC surveillance 
estimates will under-represent HIV prevalence among females generally. 
 
2.2.4 Summary of bias in ANC surveillance HIV prevalence estimates 
Table 2.1 summarizes the primary sources of bias that can influence the accuracy of 
HIV prevalence estimates from ANC surveillance data in SSA and their expected 
impact on the direction of bias in ANC estimates. These biases operate at multiple 
levels, however, so the relationship between ANC surveillance and estimates of HIV 
prevalence in the population can vary. At the national level, the most frequently 
documented bias in ANC estimates due to over-representation of urban clinics has 
historically resulted in an overstatement of prevalence in the population [43, 45, 46, 
109], although more recent studies in a few countries, including Uganda and 
Zimbabwe, have found these estimates to be relatively similar [108, 110]. In contrast, 
when compared to women in the surrounding population, bias due to self-selection 
and testing only pregnant women more often results in an underestimate of HIV 
prevalence [42, 51-53, 137]; however, this relationship has been observed to vary by 
setting and especially for those areas with low fertility and high contraception levels, 
such as South Africa [56] and Zimbabwe [55, 108].  
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Type of 
bias Factor 
ANC attendance at 
clinic(s) relative to the 
female population Direction of bias 
Clinic 
selection* 
More urban sites included in 
sample [45, 46]  
More HIV-infected ANC 
attendees 
ANC >POP 
More ART/PMTCT sites included 
in sample [123] 
More HIV-infected ANC 
attendees 
ANC>POP 
Self- 
selection† 
Socio-demographic characteristics 
(age, education) are associated 
with attendance at ANC clinics 
and HIV infection [51, 53, 122, 
137, 164] 
May work in either 
direction depending on 
factor 
Depends on local context 
Women with planned pregnancies 
(at lower risk of HIV) attend ANC 
clinics [154, 155] 
Fewer HIV-infected ANC 
attendees 
ANC<POP 
Women from rural areas attend 
urban ANC clinics [55, 56] 
Fewer HIV-infected ANC 
attendees 
ANC<POP (in urban areas) 
Testing 
only 
women 
who 
become 
pregnant† 
Young women who have an early 
age of sexual debut are at higher 
risk of HIV infection and 
pregnancy than virgins[117] 
More HIV-infected ANC 
attendees 
ANC>POP (at younger ages) 
Some older, higher risk women 
stop having sex [113, 165] 
Fewer HIV-infected ANC 
attendees 
ANC<POP (at older ages) 
Condoms or hormonal 
contraceptives are used primarily 
by women at high risk [47, 113] 
Fewer HIV-infected ANC 
attendees 
ANC<POP 
Condoms or hormonal 
contraceptives are used primarily 
by women at risk [47, 113] 
More HIV-infected ANC 
attendees 
ANC>POP 
 Hormonal contraceptives may 
place women at increased risk of 
infection [154, 155] 
Fewer HIV-infected ANC 
attendees 
ANC<POP 
 HIV-infected women have 
reduced fertility with greater time 
since infection [158, 159] 
Fewer HIV-infected ANC 
attendees 
ANC<POP (at older ages) 
 High prevalence of bacterial STIs 
in the population [115, 153] 
Fewer HIV-infected ANC 
attendees 
ANC<POP 
 Peaks in natural fertility patterns 
overlap with patterns of HIV 
infection by age [115, 153] 
More HIV-infected ANC 
attendees 
ANC>POP 
 Women who are pregnant may be 
more susceptible to  HIV infection 
[166] 
More HIV-infected ANC 
attendees (so long as 
infection is detectable) 
ANC>POP 
* Refers to comparisons of ANC surveillance including all clinics and the general female adult population aged 
15 to 49 years in a country 
†Refers to comparisons of ANC surveillance prevalence estimates from a single clinic and the general female 
adult population aged 15 to 49 years in the surrounding catchment area 
 
Table 2.1  Selected factors common to the HIV epidemic in SSA and their expected impact on bias in ANC 
estimates.  
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For the most part, bias due to clinic selection and self-selection has been 
dealt with by making informed decisions about how ANC surveillance data are used. 
For example, the seemingly intractable problem of overestimating overall population 
prevalence due to non-representative clinic selection has led UNAIDS to discourage 
use of ANC surveillance data for this purpose [18]. In the case of self-selection 
biases, the WHO recommends that countries monitor DHS and the socio-
demographic data from individual ANC surveillance clinics to look for potential 
factors that may differentially include or exclude women from accessing ANC 
depending on their HIV status [39]. When evidence suggests that an ANC clinic 
becomes unrepresentative of the population living in the catchment areas that 
surround it, possibly due to a shift in the economic welfare of a community or the 
influx of migrants, countries are advised to consider excluding these clinics from 
further analyses [39].  
 Bias from testing only pregnant women is not so easily dealt with because it 
depends on a complex and interwoven set of biological and behavioural factors that, 
at a minimum, can vary from woman to woman, and will most definitely vary from 
community to community. Section 2.4, however, summarizes adjustment methods 
that have been proposed to address these biases due to HIV-related fertility 
differences while, in the next section, Section 2.3, the potential for biases to change 
over time as a result of changes in the natural dynamics of the epidemic and 
behaviour change is considered .  
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2.3 Bias in HIV prevalence trends from ANC surveillance data 
As previously mentioned in Chapter 1, relative to the literature describing the overall 
levels of bias in ANC surveillance estimates, there are remarkably few studies 
quantifying bias in ANC surveillance trends. From the previous search strategy 
described in Section 2.1, the 746 articles originally identified there were reviewed for 
their contribution to describing bias in ANC trends. In summary, seven articles were 
identified, of which four described mathematical models exploring bias [27, 113, 115, 
117], two related results from comparisons of ANC and population prevalence trends 
from two community-based studies in Lusaka, Zambia and Kigera, Tanzania [50, 
116] and one provided data on trends among youth aged 15 to 24 years in South 
Africa, Zambia and Zimbabwe [21]. 
Of the four modelling papers, Garnett [115] and Zaba [117] quantified bias in 
ANC data over time as one of the primary objectives of the study, whereas models 
by Hallett [27] and Gregson [104] only briefly explored this topic as part of a larger 
effort to assess how changes in sexual behaviour could influence population 
prevalence over time. The model by Zaba focused exclusively on women aged 15 to 
24 years whereas the model for Garnett reported results for women of all 
reproductive ages. The two empirical studies occurred in smaller communities, with 
comparisons made to adult females and males separately and to the adult 
population overall. The other study explored differences in national-level estimates. 
Each of these studies is discussed in further detail in Sections 2.3.1 and 2.3.2 
related to (i) changes in the natural dynamics of the epidemic (which can alter the 
age-structure of HIV-infected women in the population with time) [50, 115], and (ii) 
changes in patterns of behaviour (such as increases in age of sexual debut or 
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condom use, due to the scale-up of effective prevention interventions) [27, 113, 116, 
117]. These studies are also summarized in Supplemental Table 2.3 in Appendix A.  
One challenge that arises with regard exploring the current or future potential 
for bias in ANC estimates is that all of the seven studies identified above were 
conducted prior to the wide-scale introduction of ART in the regions. As suggested in 
Chapter 1, however, it is possible that ART could influence the fertility patterns of 
HIV-infected women through a variety of biological and behavioural mechanisms, 
and thereby introduce a temporal bias in ANC trends. The potential for this bias over 
time, which is as yet unmeasured in any study, is considered in Section 2.3.3. Four 
studies that have explored or documented the influence of ART on fertility patterns in 
SSA [165, 167-169] are described alongside other articles that document changes in 
factors due to the introduction of ART that could influence bias in ANC trends. Table 
2.2 summarizes what is currently known according to the models and empirical 
evidence from these studies, and in the case of ART, what effect might be expected 
as access to therapy expands in SSA.  
  
2.3.1 The natural dynamics of the epidemic 
As discussed in Section 2.2.3.3, if not for HIV-related and other STI-related 
sub-fertility, HIV prevalence among ANC attendees would rise more rapidly than 
population HIV prevalence and remain at a higher level throughout the epidemic 
because prevalence of HIV is typically highest among women with the highest fertility 
rates. Due to HIV-related sub-fertility, however, ANC estimates are almost always 
lower than female prevalence estimates in the community. Nevertheless, variations 
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in the magnitude of bias in ANC prevalence trends can still occur as the average age 
of HIV-infection among women in the population changes.  
In the mid-1990s, Garnett and Gregson developed an age-structured 
mathematical model of HIV transmission via heterosexual transmission to explore 
how changes in the natural dynamics of infection, including changes in the age of 
HIV-infected women and fertility patterns could influence the representativeness of 
ANC trend data. In the model, HIV prevalence among pregnant women and the 
general female population aged 15 to 49 years were compared during the first 30 
years of a generalized HIV epidemic typical of SSA [115]. The model stratified the 
population by sex, sexual activity levels, and age. Age-specific fertility levels 
associated with HIV-infection, as compared to those among uninfected women, were 
assumed to be either 30% lower or progressively reduced from 10% to 25% to 60% 
to 80% until AIDS. An additional 50% reduction in fertility among women with the 
highest level of sexual activity was incorporated to represent morbidity due to pre-
existing STIs and early mortality in the high-risk population.  
Results from the model showed that, in the epidemic initially, the average age 
of the infected woman increased, which led ANC surveillance prevalence estimates 
to increase relative to female population prevalence over time. Gradually, however, 
as the average age of HIV-infected women increased beyond peak fertility ages, this 
overestimation would decline. At the same time, however, bias due to HIV-related 
sub-fertility and a reduction in fertility due to other STIs in high-risk groups was 
shown to result in an opposing underestimate of HIV prevalence in the population. 
As a result of these opposing biases, which cancel each other out, the authors 
suggest that ANC surveillance data would be reasonably representative of female 
population prevalence trends in SSA with similar fertility patterns and transmission 
69 
 
patterns. They also note, however, the potential for these biases to change over time 
depending on the extent to which HIV incidence might become concentrated in one 
age group as opposed to another, as an example.  
An empirical study of bias in ANC trends, conducted under similar 
circumstances as those used to parameterize the Garnett and Gregson model, was 
carried out in the rural Kagera region of Tanzania in the early to mid-1990s  [50]. The 
study findings also showed that ANC surveillance prevalence estimates may have 
been differentially biased over time, but not drastically so. It was suggested that the 
reasons why these biases were not more dramatic was because declines in 
prevalence occurred largely before large-scale prevention interventions reached the 
community [116]. Behaviour change and their influence on bias in trends in HIV 
prevalence among pregnant women are discussed in the following section.  
 
2.3.2 Behaviour change  
One of the key assumptions in the mathematical model by Garnett is that HIV 
incidence in the population remained relatively stable after the early and steep rise 
when the epidemic took off [115]. Similarly, in the Tanzania study, there was no 
apparent decline in incidence; instead, declines in prevalence were thought to have 
occurred due to high levels of mortality in the population [136]. When HIV incidence 
declines with time because of the expansion of effective behaviour change 
interventions, however, it is possible that these programmes may have a different 
influence on HIV prevalence among the ANC population than the population more 
generally. As a result, ANC estimates may be increasingly or decreasingly biased 
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over time. The magnitude and direction of the change in this bias will depend, in part, 
on the type of intervention responsible for introducing these declines. 
In SSA, behaviour change campaigns have focused primarily on three 
approaches: abstinence (i.e. delay in sexual debut), faithfulness among married or 
cohabitating couples, and condom use at high-risk sexual encounters [27]. To 
investigate the impact of reductions in incidence due to delays in sexual debut and 
increased condom use among young women, Zaba and colleagues developed a 
mathematical cohort projection model that compared ANC and population 
surveillance estimates for young women aged 15 to 24 years over a 25 year period 
of a generalized epidemic [117]. The model included three scenarios in which 
declines in HIV incidence resulted from (i) reduced transmission due to changes in 
sexual activity (i.e., condom use and less risky partner selection), (ii) delays in sexual 
debut, and (iii) both reduction due to less risky sexual behaviour and delays in sexual 
debut [117].  
As expected, biases in ANC estimates due to declines in transmission 
resulted in generally stable biases throughout the course of the epidemic. This was 
the case for the period of time when incidence was declining because, at young ages 
the limited influence of HIV-related sub-fertility and mortality excludes very few HIV-
infected women from ANC surveillance. In the latter two scenarios, in which 
interventions led to rapid and substantial delays in sexual debut alone or in 
combination with reductions in risky behaviour, bias in ANC prevalence trends was 
particularly unstable. In both scenarios, HIV prevalence among pregnant women 
continued to rise even after the decline in incidence in the population was observed 
because the proportion of women who had been sexually active for a relatively long 
time initially increased as fewer younger women started sexual activity. After some 
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years, those who experienced the earlier pattern of sexual debut cease to dominate 
the population of pregnant women aged 15 to 24 years and are replaced by pregnant 
women with sexual activity that reflect the new, later pattern of age at first sex and 
the lower rates of transmission. Because women overall in the ANC population aged 
15 to 24 years were still somewhat older than their peers in the corresponding age 
group, ANC prevalence trends were still higher than those in the population.   
Gregson and colleagues also briefly explored the potential for increased 
condom use over time to introduce bias in ANC estimates within an age-structured 
cohort model [113]. In this case, the scale-up of condom use in the population was 
not limited to young people alone. Results from the model suggested that, as 
condom use increased over time and incidence declined, ANC surveillance would fail 
to capture the full extent of this decline because riskier women having unprotected 
sex would still be at risk of pregnancy. In Lusaka, Zambia, a study in a single urban 
clinic comparing trends in ANC surveillance and population survey estimates found 
that ANC trends under-estimated declines in prevalence in the population from 1995 
to 2003 [116]. The authors show that the reason for this was changing fertility and 
education patterns among younger women.  
 
2.3.3 ART use 
Because of the relatively recent introduction of ART in SSA, there is limited 
understanding of how and to what extent treatment programmes could impact fertility 
patterns, and in turn, biases in ANC trends. Of the three studies that have explored 
the interaction between ART and fertility in SSA to date, two have reported increases 
in fertility rates among users [167, 168] while the third showed a negative association 
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[169]. If fertility rates among ART users rebounded as access to ART expanded, bias 
in ANC estimates relative to the population would be expected to decline since fewer 
HIV-infected women would be excluded. If, on the other hand, fertility rates among 
ART users declined further, possibly due to increased use of contraception, bias in 
ANC trends would become even greater with time.  
In the first study offering evidence for a positive association, a significantly 
higher overall fertility rate among ART users compared to HIV-infected non-ART 
users (adjusted hazard ratio: 1.74; 95% CI: 1.19-2.54; median duration on pre-ART: 
482 days; post-ART: 696 days) was found in six countries in SSA [167]. Fertility 
rates among ART users were also found to increase with time, in contrast with the 
stable and lower pregnancy incidence rates observed among HIV-infected treatment-
naïve women. In the second study in eastern Uganda, pregnancy incidence among 
ART users was found to increase (p-value for linear trend over the 27 month study 
period: <0.001) even though 93% of ART users expressed no additional desire for 
children  [168].  
In the single study showing a negative association, ART users in western 
Uganda had fewer recognized pregnancies (OR: 0.56; 95% CI: 0.33-0.95) and live 
births (OR: 0.30; 95% CI: 0.13-0.66) compared to treatment-naïve women, but they 
did report a relatively greater fertility desire (OR: 2.99; 95% CI: 1.38-6.28) [169]. As 
ART had only been recently introduced at the time of the study, it is possible that 
fertility intention outpaced improvements in health, and that the direction of this 
association could change over time.  
These findings somewhat contradict the early experiences of introducing ART 
in the US and Europe. In an early cohort of HIV-infected women in the 1990s, the 
introduction of ART appeared to have no impact on age-adjusted pregnancy 
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incidence trends [170]. Two studies in the US also showed lower incidence of 
pregnancy among women on ART compared to those that were not [171, 172]. Still, 
researchers noted a 20% increase in pregnancy among HIV-positive women 
(independent of ART status) from the 1992-1996 pre-ART period to the 1998-2001 
ART period in the US, suggesting that women may have a more positive outlook 
toward pregnancy after seeing improvements in the quality of life and life expectancy 
of women on ART [171]. 
In 2006, recognizing the limited research on the impact of ART on fertility 
patterns, particularly in SSA, Kaida and colleagues suggested a framework for 
exploring this interaction [141] based on Bongaarts’ proximate determinants of 
fertility model [173]. The extension of this framework was based on a previous 
adaptation of Bongaarts’ model considering the impact of HIV on fertility in 1994 by 
Gregson [141]. Kaida’s framework could be extended even further to explore 
possible changes in bias in ANC-based HIV prevalence estimates that might result 
from the introduction of ART over time. These changes can be considered within the 
original structure of biases observed from testing only those women who become 
pregnant, namely: (i) selection for sexual activity, (ii) varying levels and types of 
contraceptive use, and (iii) sub-fertility due to HIV-infection and other STIs. A brief 
discussion on bias related to self-selection due to ART and PMTCT programme 
scale-up follows the discussion of the first three types of bias related to testing only 
women who become pregnant. 
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2.3.3.1  Selection for sexual activity 
The impact of ART on selection for sexual activity among youth is largely unknown. 
On one hand, it is possible that young people may be influenced by the availability of 
ART to increase the riskiness of sexual behaviour. On the other hand, the availability 
of ART is unlikely to be the only driver of the decision about whether or not to begin 
having sex or to marry thus would not likely have a large influence on ANC trends. . 
Regarding marital status at older ages, however, it is possible to consider a scenario 
where ART increases the reproductive lifespan by extending the quantity and the 
quality of years that an HIV-infected women stays in a partnership [165]. The impact 
of an extended reproductive lifespan could reduce some of the sub-fertility biases 
observed among older women, while bias in the youngest women (aged 15-19), who 
are unlikely to be married, would remain unaffected. As a consequence of these 
changes in fertility, it is unlikely that bias would change over time at the youngest 
ages so long as risk dis-inhibition was not a factor. However, among older women, 
bias in ANC surveillance trends could decline as the length of monogamous 
relationships increases, thereby increasing fertility.  
 
2.3.3.2  Contraceptive use 
The impact of ART on fertility and contraceptive choice, including induced 
abortions, is still unknown in SSA. In theory, women on ART or with access to 
PMTCT may choose to become pregnant based on the potential health benefits of 
treatment and prophylaxis for their unborn child. In addition, societal pressures to 
conceive may also greatly encourage pregnancies to replace children who died from 
HIV infection. At the same time, some women on ART may still consider the risk of 
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orphaning children too great or may be in a serodiscordant relationship [165]. In this 
latter scenario, fertility patterns may remain unchanged, even in light of the 
introduction of ART or PMTCT services. Ultimately, whether women on ART 
preferentially choose to use or avoid contraception will impact biases in ANC 
estimates, but it is difficult to predict the direction and magnitude of this bias. If bias 
does change with time due to changes in contraception, it would likely have little 
effect on the youngest women. In older women, depending on existing contraception 
levels and types, the effects of increasing hormonal contraception due to better 
linkages with family planning could be cancelled out by the reduction in contraceptive 
use that might occur from women wishing to become pregnant [174].   
 
2.3.3.3  Sub-fertility due to HIV and other STIs 
Given that access to contraception was low in the three studies thus far, it is likely 
that sub-fertility or rebound fertility is occurring due to improvements in health. In 
addition, more frequent access to health care systems could lead to earlier treatment 
of STIs, thus preventing pre-infection infertility. Finally, healthier women (and their 
partners) may also increase coital frequency, thereby further increasing the 
likelihood of pregnancy. Whether women might choose to breastfeed longer on ART, 
thereby decreasing fertility, or whether they continue to follow recommendations for 
a shortened breastfeeding period is unknown [165, 175].  
Despite the potential decline in fertility owing to extended breastfeeding, it is 
possible that health-related improvements from ART could result in significant 
increases in fertility among HIV-infected women, particularly in women who have 
been infected longer where sub-fertility is greatest. In turn, ANC estimates of HIV 
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prevalence for these women could increase with time, reflecting not an actual 
increase in underlying HIV prevalence but rather fertility resumption or prevention of 
STI-related infertility.  
Although the rationale for why biases could change with time is clear, whether 
these biases will be sufficiently large to distort ANC surveillance estimates is not so 
obvious. For example, if the benefits of ART occur most among women who have 
been infected longest, these women are also likely to be relatively older, thus a 
return to fertility in this age group may cause relatively small increases in the number 
of HIV pregnant women appearing in ANC clinics. Still, as Lee found, HIV-related 
fertility declines do begin to occur almost immediately after the onset of infection 
[159], suggesting that ART may benefit younger women as well as older women. 
Research from Braitstein and colleagues has also shown that women are more likely 
to access ART when they are younger and healthier, thus potentially preventing 
substantial HIV and STI-related sub-fertility and infertility [176].  Accounting for these 
relationships, once again, it is unlikely that the introduction of ART would introduce 
any biases into ANC trends among younger women. However, among older women, 
bias in ANC estimates could decline over time if natural fecundity increases; thus, 
ANC and population estimates should converge over time  
 
2.3.3.4 Self-selection due to ART and PMTCT programme scale-up 
As previously discussed, access to ART programmes, including PMTCT services, is 
increasing in many countries in SSA. Nonetheless, the scale-up of services has not 
always been geographically equitable owing to the limited availability of trained 
health care personnel and access to adequate laboratory infrastructure. As a result, 
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many clinics participating in ANC surveillance will have initiated ART or PMTCT 
services in the last three to five years, while other clinics may still be waiting to 
begin. As previously mentioned, in large part, this scale-up has occurred fastest in 
urban areas, with rural access to PMTCT and ART services lagging somewhat 
behind [177]. 
Fragmentation in the availability of services means that some women may 
seek prenatal services further away from their home if HIV-related services are not 
available at their nearest clinic. If ANC surveillance prevalence estimates come from 
sites that offer HIV services, they could preferentially attract HIV-infected women 
from outside the catchment area, which could lead in turn to an artificial increase in 
ANC-based HIV prevalence estimates over time. Conversely, declines in HIV 
prevalence from women at non-PMTCT sites could reflect the fact that women are 
choosing to access prenatal care elsewhere where HIV services are offered.  
 
2.3.4 Summary of the potential for bias in ANC surveillance HIV prevalence 
trends 
Table 2.2 summarizes the potential for bias in ANC surveillance trends due to 
changes in the natural dynamics of infection, behaviour change interventions, and 
the influence of introducing ART and PMTCT in the population. 
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Factor Factor 
Impact of factor on ANC 
attendance at clinic(s)  
over time 
Expected direction of 
bias in ANC 
surveillance trends 
over time relative to 
the population 
Natural 
change in the 
epidemic[115] 
Average age of HIV-infected 
women increases  
Increasing number of HIV-
infected ANC attendees over 
time until the average age of 
the infected woman reaches 
the peak age of fertility 
ANC HIV prevalence trends 
move toward population 
prevalence trends 
Decreasing number of HIV-
infected ANC attendees over 
time after the average age of 
the infected women 
surpasses the peak age of 
fertility 
ANC HIV prevalence trends 
move away from population 
prevalence trends 
Behaviour 
change [27, 
113, 116]  
Increased condom use 
among youth 
No change Stable trends 
Delays in the age of sexual 
debut 
Proportion of ANC attendees 
who are HIV-infected 
increases over time 
ANC HIV prevalence trends 
move away from population 
prevalence trends   
until sexually active women 
age out and are replaced by 
lower risk women 
Increased condom use at all 
ages 
Proportion of ANC attendees 
who are HIV-infected 
increases over time 
ANC HIV prevalence trends 
move away from population 
prevalence trends 
Introduction 
of ART  
(Based on 
HIV-related 
impact on 
determinants 
of fertility 
[140, 165, 
173])  
Length of span of marriage 
increases 
Increasing number of HIV-
infected ANC attendees 
ANC HIV prevalence trends 
move toward population 
prevalence trends  
ART leads to more 
partnerships or dis-inhibition 
Increasing number of HIV-
infected ANC attendees 
ANC HIV prevalence trends 
move toward population 
prevalence trends 
Increase in hormonal 
contraception due to family 
planning linkages 
Decreasing number of HIV-
infected ANC attendees 
ANC HIV prevalence trends 
move away from population 
prevalence trends 
Contraceptive use decreases 
as HIV-infected women 
increase fertility demand 
Increasing number of HIV-
infected ANC attendees 
ANC HIV prevalence trends 
move toward population 
prevalence trends 
 Natural fertility returns Increasing number of HIV-
infected ANC attendees 
ANC HIV prevalence trends 
move toward population 
prevalence trends 
 Better reproductive health 
care reduces influence of 
STIs 
Increasing number of HIV-
infected ANC attendees 
ANC HIV prevalence trends 
move toward population 
prevalence trends 
 Increased number of women 
breastfeeding or period of 
time increased 
Decreasing number of HIV-
infected ANC attendees 
ANC HIV prevalence trends 
move away from population 
prevalence trends 
 Increased coitus Increasing number of HIV-
infected ANC attendees 
ANC HIV prevalence trends 
move toward population 
prevalence trends 
Table 2.2  Selected factors common to the HIV epidemic in SSA and their expected impact on bias in ANC 
trends. 
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With regard to the introduction of ART, it is worth emphasising that these biases in 
ANC surveillance trends are only hypothesized, as the interaction between ART and 
fertility use over time is still unknown. With regard to the potential biases in ANC 
estimates as a result, it is also important to remember that changes in population 
HIV prevalence will also be occurring as a result of increased survival on ART and 
reductions in transmission. Consequently, the overall size of the reductions or 
increases in bias will be relative to whether and by how much population HIV 
prevalence is increasing or decreasing. 
 
2.4 Adjusting for bias in ANC surveillance estimates and trends 
Standardized methods to correct for differences in HIV prevalence estimates 
and trends between ANC surveillance and the population have been proposed since 
early on in the epidemic when data on infections in the population overall were 
scarce [178]. These methods primarily attempted to account for (i) fertility differences 
between HIV infected and uninfected women, which resulted in lower estimates of 
HIV prevalence in the female population in some locations; and (ii) inadequate 
geographic representativeness of ANC surveillance data, which often resulted in an 
overestimate of prevalence in the population. Controlling for differences due to the 
distribution of other demographic characteristics associated with uptake of ANC 
services and HIV infection may also benefit from standardization, although these 
factors were found to vary by setting [51, 53].  
For those adjustment methods that have been proposed relating to fertility 
differences, the approach, their strengths and weakness, and a description of how 
others have applied these adjustments are described below in Section 2.4.1 and 
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Appendix A, Supplemental Table 2.4. To identify relevant articles on the topic of 
adjusting ANC surveillance data to monitor population prevalence estimates and 
trends, a search was performed on January 24, 2012 in Google Scholar using the 
key words HIV prevalence, population-based surveys, ANC sentinel surveillance, 
measurement bias, and adjustment method. Of the 87 papers identified, four 
proposed methods for adjusting for differences between ANC and population survey 
estimates and an additional five applied or validated these methods in settings in 
SSA. Articles referenced in papers were also reviewed if they were not originally 
identified in the search but were considered potentially relevant based on the text. 
Articles excluded from the table, but that may be presented in the text, were 
those that quantified the relative differences of fertility in HIV infected versus 
unaffected women but did not adjust for these differences in population prevalence 
estimates. Also, articles that considered adjustment methods unrelated to ANC 
surveillance data specifically (e.g., adjusting for non-response in population surveys) 
were excluded. Finally, articles referencing results that use these adjustment 
methods as routine practice, such as country-specific or global estimates and 
projections from EPP, were excluded unless they described the process of 
constructing the adjustment method for the first time. Articles that reference methods 
for adjusting for geographic biases are described in the text in Section 2.4.2. 
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2.4.1 Methods to adjust for bias in ANC surveillance estimates and trends 
relative to HIV prevalence in women of reproductive ages 
As mentioned above, various methods have been proposed to correct for the 
differences observed in HIV prevalence among ANC attendees and women in the 
general population, which typically result in lower HIV prevalence among ANC 
attendees due to HIV-related sub-fertility and infertility biases. Prior to the 
quantification of this bias in the 1990s, it was first thought that female population HIV 
prevalence estimates could be obtained from surveillance data by direct age 
standardization alone [178]. As evidence of strong fertility differentials between HIV 
infected and uninfected women emerged, however, it was recognized that this 
method could actually lead to a greater underestimate of HIV prevalence in the 
population because it gives a heavier weight to the older ANC population, where 
prevalence differences are greatest [42].  
Nicoll and colleagues in 1998 proposed one of the first methods to 
systematically adjust HIV prevalence estimates from pregnant women to account for 
fertility differentials [179]. Briefly, this method involved the direct comparison of live 
birth and termination rates among women known to be HIV positive and those in the 
entire female population. Based on these data, a calculation of the probability that 
HIV-infected women would be seen at an ANC clinic was made. This value, called 
the relative inclusion ratio (RIR), could then be used to adjust ANC prevalence 
estimates.  
Validation of this method, which was done by Nicoll and colleagues using data 
from England and Wales, showed estimates in pregnant women and the female 
population to be similar. However, outside of London, ANC prevalence estimates 
would have understated HIV prevalence in the population slightly based on an RIR of 
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0.80 (CI: 0.71-0.89). As the prevalence in the country was less than 1%, the impact 
of this underestimate still would have been very small on absolute prevalence, 
although the relative difference between the crude and adjusted estimate would have 
reached 28%. No recommendations were provided for standard RIR values as these 
were seen to depend on the distribution of risk behaviour and fertility patterns 
specific to the location.  
Several concerns with the approach developed by Nicoll were identified when 
considering the application of this method to adjusting ANC surveillance data from 
countries in SSA [42]. First, and most importantly, prevalence in the general 
population was considerably higher than in England, thus the RIR value would be 
diluted due to the inclusion of a relatively larger proportion of HIV-infected women in 
the denominator. Second, birth and termination rates separately for HIV-infected 
women were not well-documented at the time in many countries in SSA. As a result, 
a second approach was proposed by Zaba and colleagues in 2000 that would allow 
for a different method to estimate sub-fertility and infertility in the population in 
countries where prevalence was high [42]. In this method, parity and birth order data 
collected from ANC surveillance attendees was used to account for differences in 
fertility in HIV infected and uninfected women. Estimates of the relative risk of HIV 
prevalence in women giving birth were constructed separately for childless women 
and for mothers by sexual activity categories. The relative distributions of women in 
these populations were then obtained from demographic health survey data to apply 
the adjustment factors. Estimates were developed separately for those countries 
where contraception use was low (<20%) or high (>20%), as contraceptive use 
among women can be considered either high-risk (if contraceptive use is low in the 
population) or low-risk (if contraceptive use is high in the population).  
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Initial findings from the application of this adjustment method to areas with low 
contraceptive populations published in the Zaba paper were generally successful. 
For example, using data from rural Uganda, the adjusted estimate of prevalence in 
the female population was calculated to be 10.3% (based on a crude ANC 
surveillance estimate of 7.7%,) which was similar to estimates of adult female HIV 
prevalence taken from a nearby community-based survey around the same time. A 
similar outcome was also observed using data from Kisesa, Tanzania where 
adjusted ANC and female population survey estimates were determined to be very 
close, and when further standardized to the age structure of the population, the 
estimates were virtually identical (ANC adjusted prevalence estimate of 7.2% and an 
observed community prevalence of 7.3%). In Zimbabwe, where contraception was 
high, it was suggested that ANC prevalence estimates may already be 
representative of those in the female population, however, population distributions by 
risk categories using data from DHS suggested that an adjustment factor of 60% 
would need to be applied to ANC estimates of prevalence among primigravida 
women and a factor of 110% would need to be applied to estimates of prevalence in 
multigravida women. In low contraceptive populations, the adjustment factors were 
estimated to be 80% and 150% respectively.  
At about the same time that Zaba and colleagues proposed the method 
described above, Fabiani and colleagues proposed an alternative approach which 
adjusted for differences in age-specific fertility risk between HIV infected and 
uninfected women and then standardized the overall prevalence according to the 
age structure of the female population generally [57]. Data for age-specific fertility 
differences among HIV infected and uninfected women were required to be known or 
estimates based on local data. Using data from the Gulu District in Northern Uganda 
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and a nearby community, Fabiani and colleagues found that adjusting HIV 
prevalence estimates among ANC attendees of 26.0% (95% CI: 23.2-29.0%) in 1993 
and 16.1% in 1997, would have resulted in population prevalence declines of 25.4% 
in 1993-1994 and 17.8% in 1996-1997. As no measurements of prevalence in the 
population were available, however, this adjustment method could not be validated. 
Following on the heels of these two proposed methods, and in line with the 
increasing availability of population and community-based estimates of female 
prevalence available from longitudinal and cross-sectional surveys, a number of 
countries undertook studies which used the above methods to adjust, and in some 
cases, validate adjusted estimates. The most comprehensive of these studies was a 
comparison of the methods proposed by Fabiani and Zaba using data from Fort 
Portal in Uganda, Mwanza municipality and a rural area of Mwanza in Tanzania, 
from Lusaka, Zambia and from a more rural area in Zambia, and finally from Ndola, 
Zambia [180]. Overall, the validation found that ANC prevalence using either method 
provided fairly accurate estimates of female population prevalence, although both 
performed poorly in one instance in Zambia where the unadjusted data was a better 
representation of underlying female population prevalence. Due to a lack of data on 
parity in ANC surveillance data in Uganda, the municipality of Tanzania, rural 
Mposhi, Zambia and for one year in Lusaka, Zambia, Zaba’s method could not be 
validated.  
Other subsequent evaluations of Zaba’s method in low contracepting 
populations were conducted elsewhere in rural Malawi [53] and in rural Tanzania 
[52], and in two high contraceptive locations in Manicaland, Zimbabwe [55] and 
South Africa [56]. In rural Malawi, applying the proposed adjustment factor for low 
contraceptive populations resulted in an adjusted ANC prevalence of 15.0% 
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compared with a community-observed prevalence of 13.9% [53] and a similar result 
was obtained in rural Mwanza, Tanzania (4.6%  versus 4.7%) [52],. In the high 
contraceptive areas, the methods did not produce similarly robust results however. In 
Manicaland, HIV prevalence among the female population reporting ANC attendance 
was 27.0%, and revised estimates of 22.6% and 23.5% with and without adjustment 
for birth intervals were still slightly lower than the actual estimate of prevalence of 
25.5% obtained from the population survey [55]. As the population survey estimate 
did not take into account refusal bias, which could have potentially been differential 
with regard to HIV infection, it is possible that unadjusted ANC surveillance data 
were still the best reflection of the underlying population prevalence among women. 
In South Africa, similar discrepancies were observed, where the correction factors 
would have been relatively similar for conversions between primigravida to childless 
estimates (0.6 in Zaba versus 0.5 in South Africa), however the proposed correction 
factor for multigravida women of 1.1 was much higher than the 0.7 factor that was 
actually needed [56].  
With regard to the adjustment methods described above, it is worth noting that 
the increasing availability of DHS survey data with HIV testing may make it more 
feasible to apply the adjustment method originally suggested by Fabiani, which is 
also similar to the method used by Nicoll. This method was first applied to ANC-
surveillance estimates in SSA in 1998 in Abidjan, Côte d’Ivoire [181], although the 
study incorrectly calculated an RIR based on data from an ANC clinic thereby 
underestimating the true level of infertility in the population [182]. More recently, 
Kongnyuy and colleagues [183] in Cameroon used DHS data to calculate RIRs, 
finding values similar to those calculated from population surveys in Uganda by Gray 
[161] and in rural Zimbabwe by Terceira [153] although most countries in SSA now 
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have population survey data which provide a more robust estimate of population HIV 
prevalence. Further validation and application of this method as DHS data becomes 
available should be considered, however, as a means of validating ANC estimates 
and trends. Also, monitoring changes in fertility patterns in HIV infected and 
uninfected women from repeated DHS surveys will provide insight into the extent to 
which bias in ANC estimates may be changing over time.  
Along these lines, although many of the authors above identify the potential 
for the magnitude of bias in ANC data to change over time, none of these have been 
used to explicitly validate trends. As described in Section 2.3.1, however, Garnett 
suggests that one potential method for ensuring stability in bias in ANC estimates 
over time is to adjust for age between the ANC and female population [115]. 
Although this may exacerbate differences in the overall levels for the reasons 
mentioned previously, it should prevent much of the change in bias due to changes 
in the age of infected women as the epidemic progresses. This could be particularly 
relevant with the introduction of ART, as an example.   
 
2.4.2 Methods to adjust for bias in ANC surveillance HIV prevalence estimates 
and trends relative to national population HIV prevalence 
In addition to adjusting for differences between HIV prevalence estimates among 
pregnant women and adult women, methods for adjusting ANC surveillance data to 
estimate national population HIV prevalence have also been proposed and applied. 
This has been necessary because ANC surveillance clinics selected to participate 
typically do a poor job at covering rural or more isolated areas. As a result, certain 
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adjustments may need to be considered for those countries where nationally 
representative population survey data are not yet available [184].  
To compensate for biases with regard to the lack of geographic 
representation, UNAIDS recommended in 2001 that countries adjust rural population 
prevalence estimates from ANC surveillance data downwards by 20% [185]. These 
adjusted rural estimates were then combined with unadjusted urban estimates to 
produce weighted national estimates of HIV prevalence in the adult population. A 
major weakness of this approach was that studies comparing ANC and population 
prevalence in rural areas was truly sparse, thus the appropriateness of a 20% 
adjustment was unable to be validated for most countries.  
Questions about the appropriateness of the 20% adjustment factor were 
raised when a number of population surveys done in countries in SSA suggested 
that ANC surveillance data were still overstating population HIV prevalence 
estimates [12]. In 2008, Gouws and colleagues published a comparison of adult HIV 
prevalence from national population surveys and ANC clinics from 26 countries, of 
which 24 were in sub-Saharan Africa [45]. This study, with regard to the overall 
magnitude and direction of biases in ANC surveillance estimates also was described 
briefly in Section 2.2.1. The objective of the study was to validate the 20% 
adjustment factor and to explore if other adjustments to population HIV prevalence 
estimates from ANC surveillance data might be required also.  
Results from the multi-country study showed that the median ratio of 
population HIV prevalence to ANC prevalence was 0.82 in rural areas, which 
corresponded closely to the 20% reduction in rural estimates that was already 
recommended by UNAIDS. However, the study also suggested this bias was equally 
large in urban areas, and could vary by region. For example, biases in western 
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Africa, where prevalence was low, were estimated to be 0.73 in urban areas and 
0.59 in rural areas. In southern and western Africa where the epidemic was more 
severe, ANC surveillance was marginally better at representing overall levels of HIV 
prevalence, although both urban and rural areas still required adjustment of up to 
10%.  
Following recommendation by the UNAIDS reference group, estimates of 
population prevalence obtained from EPP were recommended to be adjusted 
downwards by 20% in those countries without a population survey [17, 65]. 
Application of the adjustment resulted in a reduction of prevalence in SSA in 2005 
from 6.1% to 5.4%. This bias was still assumed to be constant over time, however, 
so per annum calibrations have remained at 20% for those countries without a 
population survey. Gouws and colleagues recommended that as additional 
population survey data becomes available, analyses should be conducted that 
explore the extent to which this bias might be changing over time [45]. Chapter 3 
considers this latter concern regarding bias in trends in more detail.  
 
2.5 Bias in surveillance estimates from PMTCT programme data 
Since PMTCT programmes rely on collecting data from pregnant women, it is 
clear that levels and trends in HIV prevalence will be subject to the same set of 
biases that have been described in Section 2.2 and 2.3. However, PMTCT-based 
estimate may also suffer from the additional bias of selective participation to the 
extent that HIV testing is associated with HIV status. The magnitude and direction of 
this bias will depend on whether HIV-infected women have access to, are offered 
and accept HIV testing more than uninfected women. Shifts in how these services 
89 
 
are provided could also differentially bias estimates over time. As briefly discussed in 
Chapter 1, participation bias may be higher in ‘opt-in’ than ‘opt-out’ settings.    
To identify relevant published studies assessing the use of PMTCT data for 
surveillance purposes (including potential biases in these estimates), a 
comprehensive online literature review was conducted in April 2009 using Google 
Scholar. Key words included: Antenatal Care, HIV prevalence, HIV testing 
determinants, HIV risk factors, pregnant women, prevention of mother-to-child 
transmission, sentinel surveillance, seroprevalence, and voluntary counselling and 
testing. To identify relevant unpublished studies, proceedings from international 
meetings, conference abstracts, protocols and presentations, colleagues working on 
HIV surveillance and PMTCT were contacted.  
Through these two search strategies, a total of 74 documents were identified 
and read in full to obtain a broad understanding of the issues around using PMTCT 
data for surveillance purposes. Subsequent to that, the documents were categorized 
into broad topic areas (see the following paragraph), in addition to assigning the type 
of document (e.g., published article, draft paper, conference abstract, presentation, 
guideline, etc.), its source if published, and, for studies, the geographic location, the 
period of time, the primary research questions with key results, and a brief critique of 
the methods and results.  
Of the 74 documents reviewed, 19 were determined to have explored issues 
around bias in PMTCT and ANC surveillance data empirically. Three studies from 
outside SSA were excluded and a small number of document from the same study 
presented in multiple formats were consolidated. In the end, nine unique studies 
from seven countries in SSA were found to have sufficient information and data for 
further review. Notably, other documents initially reviewed, but not specific to the 
90 
 
topic of bias, were categorized with regard to their primary topic (with the numbers of 
documents in parentheses) as follows: information on ethics of HIV testing (2), ethics 
of PMTCT programmes (1), ethics of unlinked anonymous testing (2), predictors of 
testing and impact of differences in PMTCT delivery strategies on uptake (24), 
protocols for assessing the use of PMTCT data for surveillance purposes (1), 
PMTCT programme and CT testing effectiveness (23), and comparisons of VCT 
versus population prevalence (2).  
From the nine remaining studies, studies were further categorized depending 
on whether they considered 1) the extent to which accepting HIV testing is 
associated with HIV serostatus (which can be used in turn to measure the impact of 
non-participation bias on PMTCT-based estimates) or 2) whether PMTCT-based 
data from clinics were as accurate and of sufficient quality as ANC surveillance data 
to monitor HIV prevalence in the population. Studies associated with the first 
category are described in Section 2.5.1. As noted in the initial categorization of the 
documents identified, although many studies have considered determinants of 
uptake of PMTCT-based HIV testing with the goal of increasing uptake [80, 83, 91, 
92, 186-199], only three have directly linked these determinants to HIV serostatus 
[91, 92, 192]. Studies in the second category, which are more common, are 
summarized in Section 2.5.2. Appendix A, Supplemental Table 2.5 and 
Supplemental Table 2.6 briefly describes key characteristics of all nine studies 
grouped according to the two topics described above. 
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2.5.1  Studies of the association between accepting HIV testing and HIV 
serostatus in PMTCT programmes 
The first study of factors associated with HIV testing and serostatus in a 
PMTCT programme was carried out in a rural North Ugandan hospital from 2001 to 
2003. During this period, 13% (1,841/14,040) of ANC attendees were not offered 
testing, 48% (6,785/14,040) accepted ‘opt-in’ testing when offered and 39% 
(5,414/14,040) refused [92]. Women who were not offered testing had similar socio-
demographic characteristics to those who were offered testing. Among those who 
were offered testing, women who lived at their current address for two years or less, 
were cohabitating but not married, and who had a partner with a non-agricultural 
occupation accepted HIV testing more often and were also more likely to test HIV-
positive, although these associations were found to be only weakly significant. In the 
end, the authors concluded that PMTCT-based and ANC-based surveillance 
estimates did not differ greatly (10.9% and 11.1% respectively).  
The second study, also in Uganda, followed 4,867 women who attended an 
urban Entebbe ANC clinic from May 2002 to April 2003 [91]. Similar to the rural 
Northern Uganda site, 25% (1,239/4,867) of the women were not offered testing, 
54% (2,635/4,867) accepted when offered and 20% refused (993/4,867) and were 
tested anonymously.  Among those women who were offered testing, women with no 
education or only primary education, those who had an HIV-infected partner and 
those who believed themselves exposed to HIV accepted testing and tested positive 
more often than others without these characteristics. Women who perceived 
themselves to be at high risk of HIV were also more likely to accept testing and to 
test positive. Despite these associations, no differences in prevalence levels were 
observed between individuals accepting or refusing testing (14% among acceptors 
92 
 
versus 12% among refusers; p-value=0.26). Differences in estimates were observed, 
however, in the month following introduction of PMTCT services (20% among 
acceptors vs. 11% among non-acceptors; p-value=0.05) and in months when testing 
uptake was below 70%, (17% in acceptors vs. 8% among non-acceptors; p-
value<0.001). The authors suggested that women who accepted testing when 
services were initially introduced or when testing uptake was low represented a more 
motivated group of women who strongly perceived or knew themselves to be HIV-
infected.  
The third study in Burkina Faso evaluated, among other factors, the extent to 
which a woman’s obstetrical history, age, and risk history were associated with 
accepting HIV testing and testing positive in an urban ANC clinic [192]. During the 
study period from 2002 to 2004, only 18% (1,216/6,639) of women accepted testing, 
and of those, 45% (97/215) of women testing positive reported they already knew 
their status from a prior test. Excluding these women, factors associated with uptake 
of testing and testing positive included older age and a history of miscarriage. Unlike 
the previous study, however, perceived risk of infection was not associated with 
increased uptake of testing and testing positive. Still, the authors suggested that a 
higher PMTCT prevalence during the 2002 to 2004 study period, compared to ANC 
surveillance prevalence estimates at the same clinic in 2002 (10.6% versus 4.0% 
respectively) could have resulted from attendance at the clinic by HIV-infected 
women who were more motivated to seek PMTCT services. Since these estimates 
were taken at different time points, other factors – such as increases in incidence or 
reductions in HIV-related mortality or changes in the patterns of ANC attendance that 
were also associated with HIV status - could also explain this disparity.  
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2.5.2 Studies directly comparing PMTCT programme and ANC surveillance 
estimates 
Thailand was the first country to explore the potential use of PMTCT data for 
surveillance purposes in a study carried out in the late 1990s [200]. By 2001, 96.7% 
of women attending clinics where PMTCT services were offered reported accepting 
to test [200]. Given the near-universal uptake, ANC surveillance and PMTCT 
estimates differed by just 0.1% in 2001 [88]. A follow-up analysis in 2002 showed 
similar results. Based on these findings, and since 2003, Thailand has relied on 
PMTCT data alone to monitor HIV prevalence trends in the country [88].  
Using the Thai study as a model, seven studies in five countries in SSA have 
been conducted to assess the usefulness of PMTCT data for surveillance purposes. 
Of these, Kenya [89], Cameroon [97], Uganda [94] and Zimbabwe [95] conducted 
evaluations using data from all clinics where PMTCT services overlapped with ANC 
surveillance activities. In Botswana, PMTCT-based HIV testing data from two of the 
most frequently attended clinics per health district were compared to ANC 
surveillance prevalence estimates from the same clinics [96]. Finally, the remaining 
two studies [93, 98] occurred at a single hospital in rural Uganda (where the 
determinants of HIV testing uptake and HIV serostatus were also assessed, as 
reported in Section 2.4.1). 
In Kenya, ANC surveillance and PMTCT programme data from six clinics 
were used to compare HIV prevalence estimates in 2003 [89]. Acceptance of opt-out 
testing was 56% (1,258/2,239). Overall median prevalence estimates were similar 
(PMTCT: 14.4% (range: 7.0%-27.2%) versus ANC: 12.8% (range: 8.1%-26.3%)) as 
were estimates from those clinics with low (<60%) versus high testing uptake 
(≥60%).  Despite these similarities, the authors found evidence for large relative 
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differences in HIV prevalence estimates by clinic (-30% to +38%) and problems with 
accessing PMTCT registers, interpreting nurses’ handwriting, a lack of 
standardization in the format and availability of variables collected across clinic and 
substantial amounts of missing data. Based on these findings, the authors did not 
recommend using PMTCT data for surveillance purposes.  
Also in 2003, HIV prevalence estimates from ANC surveillance and PMTCT 
data were compared in Cameroon [97]. Overall uptake was 69%. No information was 
available from the study authors on whether ‘opt-in’ or ‘opt-out’ testing was offered or 
the number clinics that participated. Findings from the study, however, showed 
overall prevalence estimates for those clinics that participated to be similar (PMTCT: 
7.8% (95% CI: 7.5-7.9) versus ANC 7.3% (95% CI: 6.7-7.9%)). Given these results, 
the authors concluded that PMTCT data was adequate to monitor the HIV epidemic 
in Cameroon. Nevertheless, ANC surveillance data are still used in the country to 
monitor population prevalence trends as of 2011.  
In Uganda, PMTCT-based and ANC surveillance prevalence estimates were 
compared in seven clinics where these activities overlapped in 2003 [94]. Data on 
HIV testing uptake and the type of testing offered (i.e., ‘opt-in’ or ‘opt-out’) was not 
recorded. While HIV prevalence estimates were determined to be roughly similar 
(9.8% in PMTCT versus 8.3% in ANC), in two clinics, the estimates were found to 
differ substantially due to sampling and refusal bias. In Arua clinic, HIV prevalence 
was approximately 5% among PMTCT acceptors, 23% among PMTCT refusers, and 
8% among ANC surveillance participants overall. In Rubaga clinic, prevalence was 
7% among PMTCT acceptors, 17% among PMTCT refusers, and 11% among ANC 
surveillance participants overall. Further investigation into these differences identified 
confusion around the two protocols which led some women to be sampled twice in 
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ANC surveillance while others were excluded inappropriately from participating in 
PMTCT services. Stock-outs in syphilis and HIV test kits also contributed to non-
consecutive sampling during ANC surveillance. Substantial inconsistencies in 
documentation procedures across clinics and incorrect application of testing 
algorithms applied to discordant test results were also found. Based on these 
findings, PMTCT data were deemed inadequate for surveillance purposes. 
Furthermore, the authors cautioned that jointly conducting PMTCT and ANC 
surveillance in the same clinics could jeopardize both sets of estimates unless staff 
are well trained on procedures for conducting both activities.  
Similar to the Cameroonian, Kenyan and Ugandan experience, the Ministry of 
Health and Child Welfare (MOHCW) in Zimbabwe evaluated the comparability of HIV 
prevalence estimates from 19 clinics where overlapping ANC surveillance and opt-in 
PMTCT data were available in the country in 2004 [95]. Unlike these previous 
evaluations, however, nationally-reported -- rather than clinic-level -- PMTCT data 
were used. Median uptake of ‘opt-in’ testing at the 19 clinics was found to be 42.1% 
(range: 2.3%-89.4%). Testing was reportedly low due to refusals as well as 
insufficient availability of test kits and staff to offer testing. Although overall HIV 
prevalence was observed to be similar (21.8% in PMTCT data versus 21.3% in the 
ANC clinics), substantial differences in clinic-specific estimates were identified. As 
national data were used as well, no age or socio-demographic data were available to 
further interpret trends. Based on these results, the Zimbabwean MOHCW 
concluded that national-level PMTCT data were unacceptable for surveillance 
purposes. 
At the national level, the most recent and most comprehensive evaluation of 
ANC and PMTCT data occurred in Botswana during the 2005, 2006 and 2007 
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surveillance periods using data from two of the most highly attended ANC clinics in 
each of their 24 health districts [96]. Uptake of ‘opt-out’ testing exceeded 95% at all 
clinics during the study period. In general, annual estimates and estimates among 
rural and urban areas stratified by 5 year age intervals were similar, especially 
among those aged 15 to 24. Despite these similarities, however, the authors noted 
that socio-demographic data collected during ANC surveillance were more complete 
than PMTCT data. Nonetheless, their availability was considered sufficient. In light of 
this finding, a working group was created to transition from using ANC surveillance 
data to PMTCT program data for surveillance purposes in Botswana. As of 2011, 
ANC surveillance data are still used to monitor HIV prevalence trends in the 
population.  
In a final study of the usefulness of PMTCT data for surveillance purposes, 
estimates of PMTCT prevalence and ANC prevalence were compared in a rural 
Ugandan clinic for the years 2001 to 2005 in two studies published separately [93, 
98]. In the first study, the authors found that despite relatively low but slowly 
increasing levels of opt-in HIV testing from 2001 to 2003 (45.8% in 2001 to 48.2% in 
2003), age-adjusted HIV prevalence from the two data sources were similar (11.1% 
in ANC and 10.9% in PMTCT) [98]. In the follow-up study from 2004 to 2005, ANC 
data overestimated PMTCT prevalence in 2004 (10.5% versus 9.0%) but 
underestimated PMTCT prevalence in 2005 (10.9% versus 11.8%). This shift 
occurred despite only a marginal increase in uptake (from 49.9% in 2004 to 52.2% in 
2005) [93]. Based on these results, further studies were recommended before 
transitioning to using PMTCT estimates for surveillance purposes.   
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2.5.3 Summary of bias in PMTCT estimates 
As outlined above, evidence from these studies is mixed regarding the 
usefulness of PMTCT data for surveillance purposes. While most studies found 
overall crude or adjusted ANC surveillance and PMTCT estimates to be similar, non-
participation bias, either at the clinic-level or when services had just commenced or 
participation was low, affected the accuracy of these data. Unfortunately, factors 
predicting HIV testing uptake and association with serostatus that could help account 
for non-participation bias appeared to vary by age and across studies [91, 98, 192] 
and in the northern Uganda rural study, with time [93]. Potential biases in PMTCT 
estimates are summarized in the Table 2.3 below: 
 
Type of 
bias 
Factor PMTCT participation 
relative to all ANC 
attendees 
Direction of bias in 
PMTCT data 
relative to ANC 
surveillance data 
Self- 
selection 
Socio-demographic characteristics 
associated with being offered testing are 
positively associated with HIV infection 
More HIV-infected 
PMTCT participants 
PMTCT>ANC 
 Socio-demographic characteristics 
associated with being offered testing are 
negatively associated with HIV infection 
Fewer HIV-infected 
PMTCT participants 
PMTCT<ANC 
 Socio-demographic characteristics 
associated with accepting testing are 
positively associated with HIV infection 
More HIV-infected ANC 
attendees 
PMTCT>ANC 
 Socio-demographic characteristics 
associated with accepting testing are 
negatively associated with HIV infection 
Fewer HIV-infected 
PMTCT participants 
PMTCT<ANC 
Table 2.3  Expected direction of bias in ANC HIV surveillance estimates due to selective participation in 
PMTCT programmes. 
 
Specific to the quality and availability of PMTCT data, operational challenges 
were reported in four of the six studies directly comparing PMTCT and ANC 
surveillance data (Kenya [89], Uganda [94], Zimbabwe [95], and Botswana [96]. 
Commonly reported problems included missing and illegible data. In Zimbabwe, age 
data to stratify results for an UNGASS indicator was not available. In the case of 
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Botswana, the authors concluded that problems encountered there, primarily missing 
data, could be addressed with additional resources and staff training when PMTCT 
data would be collected for surveillance purposes. The other three countries, 
however, reported problems of a sufficient scale such that they did not recommend 
PMTCT data be used for surveillance purposes.   
While the above conclusions could generate more concern than confidence in 
using PMTCT data for surveillance purposes, the primary limitation is that all but two 
of these studies (Kenya and Botswana) were conducted when HIV testing in PMTCT 
services were offered using ‘opt-in’ rather than ‘opt-out’ testing. However, since this 
time, most countries have moved to ‘opt-out’ testing, and many of the other 
challenges such as accessing the data and ensuring adequate standardization of 
data have been addressed [79, 201]. Given this new context, it is possible that future 
biases in PMTCT data may be less severe. 
 
2.6 A note on the Manicaland HIV/STD Prevention Project 
Data from the Manicaland HIV/STD Prevention Project have been used to assess 
key questions about the usefulness of ANC surveillance and PMTCT programme 
data in a number of chapters in this thesis, including those mentioned above. In 
Chapter 3, the mathematical model constructed to evaluate the usefulness of ANC 
surveillance data for monitoring trends is parameterized with data from this project. 
In Chapter 5, ANC surveillance and household population survey data are used to 
assess the representativeness of prevalence trends among youth. In Chapter 6, 
ANC surveillance and PMTCT programme data are compared. Therefore, a 
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summary of the study is provided as background to these chapters, although study 
details relevant to each analysis are also included in the individual chapters. 
The Manicaland Project has collected socio-demographic, behavioural and 
biomarker data on an open cohort of participants living in 12 communities in three 
districts in eastern Zimbabwe and ANC attendees at selected clinics in the study’s 
catchment area [20]. The 12 communities can be grouped into four socio-economic 
geographical areas: (i) towns, (ii) tea, coffee and forestry estates, (iii) subsistence 
farming areas; and (iv) roadside trading centres.  
Data from the Manicaland Project have been collected over four rounds, with 
the first round beginning in July 1998 and ending in February 2000. Subsequent 
rounds have been carried out from July 2001 to February 2003 (round 2), July 2003 
to August 2005 (round 3) and August 2006 to November 2008 (round 4). At the start 
of each round, a preliminary household census was conducted through interviews 
with each dwelling’s head of household.  
Of the persons enumerated in the household, criteria for inclusion in the 
individual survey are applied by study staff to select potential participants. Criteria for 
participant inclusion have changed over the survey rounds. In round 1 and 2 of the 
household survey, all unmarried men aged 17 to 54 years and women aged 15 to 44 
years were eligible to participate. Among married or cohabitating couples, only one 
person in the partnership meeting the age criteria was chosen to participate. Visitors 
in the household, defined as those who at the time of the interview did not consider 
their home to be the household where the interview was occurring or who stayed in 
the household fewer than four days in the last month, were excluded from 
participating. New in-migrants in round 2 were included only in communities 5 to 12 
given funding limitations [20]. In round 3, the inclusion criteria were expanded to 
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include all men and women aged 15 to 54 years, regardless of marital status and 
whether or not a person was a visitor in the household. In round 4, individuals in only 
two thirds of the households identified during the census were selected at random to 
participate in the individual household survey. 
  For those individuals eligible to participate in the household survey, interviews 
in English and Shona (the primary local language) were conducted for each round in 
a private setting by trained social science graduates. Questionnaires were designed 
to minimize changes across the study rounds, although questions are added or 
modified to promote compatibility with changes in international measures of 
knowledge and practices. Questionnaires were back-translated from Shona to 
English to ensure consistency between the languages.  
The structure of the individual interviews consisted of a brief description of the 
study and a request for consent to the participants to answer basic socio-
demographic questions. Responses to subsequent questions of a sensitive nature 
about sexual behaviours were collected using an informal confidential voting 
interview method by respondents who reported themselves to be literate. A study of 
this method found that interviews using the voting box method were more likely to 
report a higher number of sexual partners, signalling that bias due to social 
desirability may have been reduced [202].  
Following questions about the individual’s basic socio-demographic 
background and sexual behaviour, serological samples were collected using dried 
blood spots. Testing of dried blood spots were done at the Biomedical Research and 
Training Institute laboratory in Harare, Zimbabwe. At round 1, a highly sensitive and 
specific (both 99.6%) dipstick-dot ICL-HIV1 & 2 Dipstick EIA was used to detect HIV 
antibodies [20]. Combaids-HIV-1 & 2 Dipstick was used in subsequent rounds. Apart 
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from the principal investigators, research staff were blinded to participants' HIV 
status. In addition to testing for the study, all participants at each round were offered 
free confidential VCT at a mobile clinic provided by the study along with free STI 
testing and treatment. 
At the conclusion of the interview, all sexually active participants are asked to 
provide a detailed fertility history, including access to and uptake of ANC services 
during each pregnancy. For individuals participating in multiple rounds, only fertility-
related events occurring since the previous round were collected.  
With regard to ANC surveillance carried out by the Manicaland study, 
participating clinics were selected in the catchment areas of the 12 communities to 
maximize the number of participants seen during the surveillance period. As a result, 
not all clinics were continuously sampled. In Rounds 1, 2 and 3, 29 clinics were 
consistently sampled, with seven additional clinics sampled in some rounds but not 
others. At round 4, all 36 clinics were included. Of these, four clinics were located in 
towns, 14 in tea, coffee and forestry estates, 13 in subsistence farming areas and 5 
in roadside trading centres. 
While the procedures for carrying out ANC-based surveillance in the 
Manicaland study largely follow WHO’s ANC surveillance guidelines [39], two 
exceptions were made. First, Manicaland participants were considered eligible 
regardless of whether the visit for prenatal care was their first visit or a subsequent 
visit. Second, women who were referred to clinics from other health centres were 
included. These allowances were made to increase the sample size of the women 
interviewed at the clinic. Where relevant, potential biases introduced as a result of 
these adaptations are discussed in the individual chapters. The same methods for 
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collecting and testing dried blood spots for HIV antibodies employed in the 
household survey were also used in the ANC surveillance round. 
Study enrolment for ANC surveillance and in the individual household survey 
was conditional on participants' written consent at each round, although ANC data 
were anonymous. The Medical Research Council of Zimbabwe and St Mary's Local 
Research Ethics Committee, London, provided ethical approval for rounds 1 through 
4. All data were entered electronically into custom-designed data entry forms in 
Zimbabwe by trained data entry staff. In London, data were cleaned and validated by 
a senior researcher using Access and Stata. Additional quality control checks and 
data cleaning were made at the time of analysis.  
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Chapter 3: Comparisons of ANC 
surveillance and population HIV 
prevalence estimates and trends in 
selected countries in sub-Saharan 
Africa 
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3.1 Aims and organization of the chapter 
The overall aim of this chapter is to explore the extent to which historical 
ANC-derived HIV prevalence estimates and trends among adults and youth (aged 15 
to 24 years) have been representative of household-based population prevalence 
estimates and trends in rural and urban areas for seven countries in SSA. This 
chapter begins with a brief review of why these types of comparisons are now 
possible, primarily due to the increase in the number of repeat DHS and DHS-like 
household-based population surveys since 2000 in countries in SSA that include HIV 
testing. This is followed by a brief discussion of three published community-based 
longitudinal studies (one of which is described in more detail in Chapter 5) that have 
previously made these types of comparisons within smaller geographic areas. Next, 
the methods used to compare trends from ANC surveillance and household-based 
population surveys are described, with results presented for each of the seven 
countries disaggregated by rural and urban area and gender. Possible reasons for 
differences in trends for those settings identified as not having representative ANC 
data are explored.  
 
3.2 Introduction 
Monitoring population-level HIV prevalence trends can be a challenge when 
HIV testing is not universally available and accessed. Data from national household-
based population surveys incorporating HIV testing are often considered the best 
available data source to monitor the impact of the epidemic on the population, 
although conducting these surveys requires substantial financial contributions and 
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human resources. As a result, the frequency with which these surveys can be carried 
out in many sub-Saharan African countries has been limited [18]. 
To complement national household-based population surveys during the 
interim time periods, UNAIDS recommends that countries conduct annual or semi-
annual HIV surveillance to get repeated estimates of HIV prevalence among ANC 
attendees over time [39]. These data are then combined with national household-
based population survey data to estimate trends and levels of HIV prevalence in 
most countries with generalized epidemics in SSA. This method assumes, however, 
that repeated estimates from pregnant women reflect changes in HIV prevalence in 
the general population over time. In Chapter 2, Section 2.3, reasons why ANC and 
population survey trends might differ, including (i) variation in the natural dynamics of 
infection in these groups, (ii) changes with regard to the timeliness of adopting safer 
sexual behaviours and (iii) more recently, the impact that ART use might have on 
fertility patterns, were considered in more detail. Changes in methods used to 
conduct ANC surveillance and population surveys may also contribute to differences 
in trends over time. 
Since 2000, seven countries (Botswana, Lesotho, Kenya, Mali, Niger, 
Tanzania and Zambia) have conducted two population surveys [203-215] and two 
countries (Sierra Leone and South Africa) have conducted three [72, 216-219] 
through 2010. These surveys are most often carried out with technical assistance 
from MEASURE DHS. Owing to the standard methods adopted by MEASURE DHS, 
household-based population survey data are typically comparable across countries. 
When repeated over time, these surveys can be used to validate trends from the 
more frequently-conducted ANC surveillance, which typically are conducted 
according to standard WHO guidance [39]. 
106 
 
Assessing the representativeness of ANC surveillance data at the national 
level in SSA has only been possible in the last few years with the addition of these 
repeated household-based population surveys. Longitudinal analyses considering 
the extent to which biases in ANC surveillance data have changed over time have 
been performed previously on a smaller scale, however, using data from two 
community-based studies among adults in Tanzania [50] and Zambia [116] and one 
among youth aged 15 to 24 years in Zimbabwe [220] (See Chapter 5). In the Kagera 
region of Tanzania, ANC trends from 1990 to 1996 were found to be generally 
reflective of female and male population prevalence trends from 1987 to 1996. In 
Lusaka, Zambia, ANC estimates from 1994 to 2002 were observed to substantially 
understate HIV prevalence declines in the population overall from 1995 to 2003, 
largely due to changing fertility and education patterns of younger women. In 
Manicaland, Zimbabwe, overall trends among young people were determined to be 
similar to those among ANC attendees from 1998 to 2005, although more severe 
declines in population prevalence were observed initially, possibly due to early 
reductions in risk behaviour in the general population and to changes in the 
composition of the study participants across rounds also (see Chapter 5). 
A limitation of the Tanzanian and Zambian studies, but not the Manicaland 
study, was that statistical tests to compare trends in ANC and population prevalence 
relied on separate statistical analyses of the two data sources. In Tanzania and 
Zambia, trends in HIV prevalence among pregnant women and in the population 
were considered similar if estimates in both data sources declined and if the declines 
were linear. In practice, however, declines in one dataset could have outpaced 
declines in the other, but this difference would have not been detected by the 
statistical tests which were performed. To correct for this limitation, a Z-score test for 
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trends was used in the Manicaland study to directly compare the proportional change 
in HIV prevalence among young pregnant women with that from the population aged 
15 to 24 years over the study periods. As indicated, this test permits comparison of 
the proportional reduction in HIV prevalence over time, rather than relying on odds 
ratios, which are limited to expressing relative differences only.  
In this chapter, a similar method to that which was developed for the 
Manicaland study evaluation was used to assess whether there is evidence for the 
representativeness of ANC trends in countries in SSA with two or more nationally-
representative household surveys conducted from 2000 to 2010. ANC surveillance 
trends were compared to household survey estimates among adults aged 15 to 49 
years stratified by gender and, where available, by urban and rural residence. Similar 
comparisons were also made for youth aged 15 to 24 years in Lesotho, South Africa 
and Zambia, where data were available. For all of these comparisons, an HIV 
prevalence ratio (PR) of ANC compared to population estimates was constructed to 
more easily visualize relative changes in bias in ANC HIV prevalence trends over 
time. Findings from these analyses are a useful measure of the validity of historical 
ANC-derived trends in SSA. They also provide insight for where additional analyses 
may be warranted into why differences are occurring in particular settings or within 
specific groups. 
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3.3 Methods 
3.3.1 Inclusion criteria and data sources 
Countries in SSA were considered eligible for inclusion in the analysis if they 
met the following criteria: (i) had conducted and reported results from two or more 
ANC surveillance rounds through 2010 and (ii) had published results from a 
nationally-representative household-based population survey with HIV testing within 
two years of a corresponding ANC surveillance round. Countries meeting these 
criteria were: Lesotho, Kenya, Mali, Tanzania and Zambia with two household-based 
surveys and Sierra Leone and South Africa with three. Countries excluded from 
analyses were Niger, where three years separated the ANC sentinel surveillance 
round and the closest household-based population survey, and Botswana, which did 
not publically make data available from their second household-based survey. Upon 
further review of the data from countries with three surveys, the first survey in Sierra 
Leone and the third in South Africa were excluded from analyses because of 
insufficient published data on HIV prevalence among those aged 15 to 49 years 
disaggregated by gender. Also, in South Africa, methods for conducting ANC 
surveillance changed from 2005 and 2008, such that the number of participating 
clinics quadrupled and it was not possible to ensure the comparability of trends after 
2005.  
For the ANC surveillance data, national surveillance reports were reviewed to 
capture relevant information about the methods used to conduct surveillance at each 
round. To construct ANC surveillance trends for most countries, UNAIDS provided 
electronic data files that were originally obtained by the organization for other 
reporting and analyses purposes [personal communication, January 15, 2011]. 
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These files included HIV prevalence estimates and sample sizes per clinic stratified 
by urban and rural location for each year that ANC surveillance was conducted. In 
Kenya and Tanzania, data for the 2008-2009 ANC surveillance round and the 2008 
round respectively had to be abstracted from national reports that were obtained 
from in-country staff [221, 222]. In both of these reports, estimates of HIV prevalence 
from semi-urban clinics were combined with those from rural clinics to permit 
comparable comparisons of trends over time, as estimates in the first round were 
disaggregated only by rural and urban clinics. 
In addition to the ANC surveillance data files described above, UNAIDS 
provided clinic-specific HIV prevalence estimates, but not overall sample sizes, for 
young pregnant women aged 15 to 24 years in South Africa, Tanzania and Zambia. 
Estimates for those aged 15 to 24 years were not available for the other four 
countries or for older pregnant women aged 25 to 49 years. In the latter case, HIV 
prevalence estimates among this age group are not routinely analysed or presented 
separately in international reports. Also, data disaggregated by regions or 
geographic divisions other than rural and urban areas were not available in the 
electronic files, as UNAIDS publishes data stratified by rural and urban residence 
only.  
To avoid constructing trends in HIV prevalence that reflected changes in the 
clinic selection process over time, only those clinics that participated in both 
surveillance rounds corresponding to the population survey were included. As 
previously mentioned, in South Africa, clinic-specific estimates were not available, 
thus the number of clinics contributing to the trends changed from 396 in 2002 to 336 
in 2005. South African ANC surveillance data also are not disaggregated by rural 
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and urban areas, so only national-level comparisons of median ANC HIV prevalence 
for all clinics and population survey trends were presented.  
For the household population survey estimates, data for most countries were 
abstracted from published reports on the MEASURE DHS website 
(http://www.measuredhs.com/). For the 2005 survey in Sierra Leone and for both 
surveys in South Africa, data were obtained from UNAIDS-supplied electronic 
reports because these surveys were not supported by MEASURE DHS [72, 216-
219]. South African surveys are also available at 
http://www.wsu.ac.za/hsrc/html/baseline.html (accessed on March 1, 2012). 
Abstracted data for all countries, unless otherwise noted, included the survey year 
(or years, if the survey spanned multiple years), the age range of participants by 
gender, gender-specific participation levels, and testing ratios by gender, residence 
(urban versus rural) and age (15 to 24 years versus 25 to 49 years).  
With regard to the representativeness of the household population survey, 
participation levels were published in DHS reports as the proportion of eligible 
individuals, regardless of age, who were located during the survey period and who 
consented to an HIV test as part of the survey. A secondary analysis of the data 
specific to HIV testing among accepters aged 15 to 49 years was performed as part 
of this analysis to determine how the ratio of individuals testing in one group versus 
another (e.g., female and males) may have changed across survey periods. To 
provide an indication of the representativeness of the ANC surveillance data, the 
proportion of women in the survey who reported attending an ANC clinic at their last 
pregnancy, if that pregnancy was within five years of the survey period, was 
abstracted from published reports. For the 2005 household-based population survey 
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in Sierra Leone and for both surveys in South Africa, some of these data were either 
not collected or not reported in the published findings. 
 
3.3.2  Statistical analyses 
Country-specific HIV prevalence estimates and trends stratified by gender and 
rural/urban areas were constructed based on the abstracted data described above. A 
secondary analysis was done of ANC surveillance data provided by UNAIDS to 
obtain national and urban/rural-specific median HIV prevalence for only those clinics 
that participated consistently in those ANC surveillance rounds for which the 
household-based population survey data were available. For the population survey 
data, weighted estimates of HIV prevalence overall (by gender and urban and rural 
distribution) and estimates stratified by gender and residence were taken from 
published reports. In both data sets, the HIV prevalence estimate was attributed to 
the earliest year of data collection if the data were collected over two years. In all 
countries except Kenya in 2003, South Africa in 2002 and 2005, and Tanzania in 
2003-2004, the years in which the ANC surveillance round and the population survey 
were conducted differed, although none of the comparisons were made using 
estimates separated by more than two years. 
To assess the representativeness of the ANC surveillance data relative to the 
population survey data, a two-staged approach was used. In the first stage, a PR 
trend was calculated to visualize the representativeness of the ANC surveillance 
data over time relative to population HIV prevalence trends. Average PR values were 
calculated overall, within regions (i.e., southern and eastern Africa, consisting of 
Kenya, Lesotho, South Africa, Tanzania, and Zambia and western Africa, consisting 
of Mali and Sierra Leone) and separately by country. The PR within a country was 
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defined as the median estimate of HIV prevalence among pregnant women divided 
by the population survey estimate in the same year. PR values for the regions and 
overall were taken to be the average of the country-specific PRs. As South Africa did 
not have disaggregated urban and rural data, they only contributed results to 
national estimates.  
Construction of PR trends within countries was limited to the years for which 
the inter-survey periods and inter-surveillance periods overlapped, meaning HIV 
prevalence estimates had to be imputed for the start or end data of whichever survey 
or surveillance period was longer. To do this, a linear change in HIV prevalence 
between the earlier and later rounds was assumed and an imputed estimate for the 
corresponding year of the missing estimate was calculated. For example, in Kenya, 
where the 2010 ANC surveillance round occurred two years after the population 
survey in 2008-2009, the steady decline of 0.5% in HIV prevalence among ANC 
attendees from 8.2% in 2003 to 4.8% in 2010 would have meant HIV prevalence 
among ANC attendees in 2008 was around 5.8%. The impact of this assumption is 
considered in the discussion.  
Where a stable PR trend (regardless of its overall level) was observed, ANC 
estimates and population HIV prevalence estimates were determined to be similar 
over time. When the value of the PR changed over time (i.e., increased or 
decreased), ANC surveillance data were considered less representative. The 
relationship between the PR trend and the representativeness of ANC surveillance 
HIV prevalence estimates over time is summarized in Table 3.1.  
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 PR trend is declining 
over time 
PR trend is increasing 
over time 
Population prevalence is 
declining 
ANC surveillance 
overstates a decline 
ANC surveillance 
understates a decline 
Population prevalence is 
increasing 
ANC surveillance 
understates an increase 
ANC surveillance 
overstates an increase 
Population prevalence is 
moving in opposition to ANC 
prevalence 
ANC surveillance 
incorrectly signals a 
decline 
ANC surveillance lags 
in identifying a decline 
 
Table 3.1  Interpreting the prevalence ratio (PR) trend relative to population prevalence.   
 
 
In the second stage, for those countries where the PR was found to vary over 
time, ANC and population HIV prevalence trends were compared directly using the 
Z-score test statistic to determine if those trends differed significantly. For these 
comparisons, the same imputed estimate of HIV prevalence calculated for the PR 
trend also was used when the inter-survey and inter-surveillance periods differed. 
When comparing ANC surveillance and population survey trends, the null hypothesis 
that there was no difference in trends over the time period considered was rejected 
when the absolute value of the Z-score was greater than 1.96 (i.e., a p-value<0.05). 
To calculate the Z–score, the formula: 
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(3.1) 
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was used, where ANC indicated the ANC surveillance data and POP indicated the 
population survey data. The proportional change in prevalence in each data source 
(e.g., ANC or POP) was calculated as:   
∆P12= 
(     )
  
, 
 
where:  
P1 = HIV prevalence at round 1 in the data source,  
 
and 
 
P2 = HIV prevalence at round 2 in the data source. 
 
To approximate the variance in the Z-score formula, which was too complex 
to calculate directly, the delta method based on the Taylor series expansion was 
used [223]. The formula for approximate variance around each trend was:  
 
  (
     
  
)   
 
  (    )(  )(          )     (      
 )
   , 
 
and the variance of the binomial distribution (σ2) equal to: 
σ2       =  
  (    )
 
   , 
 
the variance of the difference in the HIV prevalence at round 1 and round 2 was 
calculated according to: 
(3.2) 
(3.3) 
(3.4) 
(3.5) 
(3.6) 
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    , 
 
and the covariance: 
 
            = - σ
2. 
 
The assumption that the population survey trend was the “gold standard”, or best 
representation of true underlying population prevalence in the study area, is 
considered in more detail in the discussion section. 
Calculations for both the PR values and the Z-score tests were done using 
Excel. A worksheet is available upon request for countries to analyse their own data. 
An example of the template using data from Kenya for females aged 15 to 49 years 
is shown in Table 3.2. As the outcome panel illustrates, the proportional decline in 
median ANC prevalence was 29% compared to just 8% in female population HIV 
prevalence from 2003 to 2008. The p-value of the Z-score test confirms that the 
decline in the ANC-based HIV prevalence trend was significantly greater than the 
decline in population HIV prevalence trend from 2003 to 2008 (p-value=0.009). 
These declines in prevalence corresponded to a PR trend which fell from 0.9 in 2003 
to 0.7 in 2008.  
(3.7) 
(3.8) 
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Table 3.2  Excel spreadsheet example for Kenya comparing ANC sentinel surveillance (ANC) and female 
population prevalence (POP) trends. See the accompanying text for all abbreviations and formulae used to 
calculate outcomes. 
 
 
 
3.4 Results 
Characteristics of the ANC surveillance rounds and the household-based 
population surveys by country and year are summarized in Table 3.3 and Table 3.4 
respectively. With regard to the ANC surveillance data, all countries reported using 
WHO published guidance as the basis for conducting surveillance, although as 
previously noted, South Africa used different clinic selection procedures than those 
recommended by WHO and did not report estimates by rural and urban areas [39]. 
All HIV prevalence estimates were obtained using similar data collection methods 
based on UAT procedures. Despite this comparability, the number and geographic 
distribution of the participating ANC clinics varied across countries and over time. 
For example, in Kenya and Tanzania, the number of rural clinics selected to 
participate increased from the first to second rounds, but since most of the original 
Round 1
(2003)
Round 2 
(2008*)
Survey 1
(2003)
Survey 2 
(2008)
Sample size (N) 10500 12339 3151 3641
HIV Prevalence (P) 8.2% 5.8% 8.7% 8.0%
σ2 7.2E-06 4.4E-06 2.5E-05 2.0E-05
σ2(P2-P1) 1.2E-05 4.5E-05
Cov(P1,P2-P1) -7.2E-06 -2.5E-05
σ2((P2-P1)/P1) 1.2E-03 5.5E-03
Outcomes: 
2003-2008 ANC change -29.3% 95%  CI:  (-35.9, -22.5)
2003-2008 POP change -8.0% 95%  CI: (-22.6, 6.5)
Z-test value (trends are the same): -2.60
P-value (trends are the same): 0.009
2003 ANC:POP PR 0.9
2008 ANC: POP PR 0.7
ANC surveillance 
(ANC)
Population survey
(POP)
Comparison groups: 
ANC to Females 
(aged 15 to 49 years)
* The 2008 ANC surveillance estimate is imputed assuming a linear decline in prevalence 
between the 2003 and the 2010 rounds
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clinics were retained, trends could still be constructed for a large proportion of clinics. 
In Sierra Leone, Mali and Lesotho, only a few clinics participated, but each 
contributed data to both rounds. Finally, in Mali and Sierra Leone, the number of 
urban clinics exceeded the number of rural clinics, despite the fact that two thirds of 
the countries’ populations lived in rural areas throughout the decade [224].  
 Given that the construction of trends was based on only those clinics that 
participated consistently, the number of ANC attendees was approximately similar 
over time within countries. The exception to this was in Kenya, where the target 
participation level per clinic in urban areas was raised from 300 pregnant women in 
2003 to 400 pregnant women in 2010. Target participations levels for rural clinics 
were also lowered from 300 pregnant women to 250 pregnant women per clinic 
during the same time periods. Kenya also changed their eligibility criteria between 
2003 and 2010 to include women of all reproductive ages as opposed to only those 
15 to 49 years of age. This latter change is unlikely to have had a major impact on 
HIV prevalence trends, however, as those who were under 15 or over 49 years of 
age were less than one percent of all ANC attendees in the 2010 surveillance round.  
118 
 
 
Table 3.3 Characteristics of the ANC surveillance rounds by country and year. Clinics not consistently participating in all surveillance rounds were excluded from the 
analysis, with the exception of South Africa where median estimates of prevalence were not available separately by clinic or stratified by rural/urban area.
Country Year Age range
Urban 
(#)
Rural 
(#)
Total 
(#)
Urban 
(#)
Rural 
(#)
Total 
(#)
Urban 
participants 
(#)
Rural 
participants 
(#)
Total 
participants 
(#)
Kenya 2003 15-49 16 22 38 3993 6507 10500 90
2010
†
All women 16 29 43 6325 6014 12339 92
Lesotho 2003 All women 2 4 6 1200 1466 2666 90
2007 All women 2 4 6 1077 1588 2665 92
Mali 2002 All women 7 2 9 2228 548 2776 58
2007 All women 7 2 9 2742 641 3383 70
Sierra Leone 2006 All women 9 1 10 2188 265 2453 NC
2007 All women 9 1 10 2468 300 2768 94
South Africa 2002 15-49 NC* NC 396 396 NC NC 16587 97
2005 15-49 NC NC 339 339 NC NC 16510 95
Tanzania 2003-2004 15-49 25 32 57 9846 8129 17975 97
2008
†
15-49 46 88 134 9375 7859 17234 97
Zambia 2002 15-44 12 12 24 6827 5299 12126 93
2006 15-44 12 12 24 7013 5546 12559 97
* Data were either not collected (NC) or reported in the published report
† Rural data includes women living in semi-urban and other non-urban areas
¶ As reported among women aged 15 to 49 years who were pregnant in the five years prior in the population survey data
56
23
10
Reported ANC 
attendance at last 
pregnancy
¶
 (% )
24
11
1
NC
32
12
9
NC
Consistent clinics (used in analysis of trends)All clinics
37
6
9
21
4
2
16
2
7
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Based on the relatively high and stable proportion of women reporting 
prenatal attendance during their last pregnancy in most countries as measured in the 
population surveys, ANC surveillance data should be a reasonably good 
representation of prevalence trends among females living in the catchment area of 
these clinics. The exception to this was in Mali, where only about half of pregnant 
women in 2001 and under three quarters in 2006 reported seeking ANC services at 
their last pregnancy. 
Table 3.4 summarizes selected characteristics of the household surveys by 
country and year. As most countries partnered with MEASURE DHS to conduct the 
household surveys, sampling and testing strategies were largely comparable across 
countries and over time. Exceptions to this, as previously noted, were in Sierra 
Leone in 2005 and in South Africa in 2002 and 2005. In South Africa, since HSRC 
oversaw the implementation of both surveys, the results across rounds are more 
likely to be internally comparable as compared to in Sierra Leone, where the first 
survey was supported by a private Ghanaian consulting group and the second was 
supported by MEASURE DHS. In Sierra Leone, both surveys were based on 
sampling frameworks from national population censuses, thus, coverage is likely to 
be similar. 
With regard to the actual representativeness of the survey estimates, 
participation levels were generally higher among women as compared to men, 
except in Kenya in 2003, where approximately the same proportion of men and 
women participated at round 1. Participation levels also increased from the first to 
the second survey in all countries other than Sierra Leone and Zambia. The greatest 
increases were observed in Lesotho, for men and women separately. In Sierra 
Leone, participation levels in the 2005 survey were atypically high, while the 2008 
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levels were comparable to those observed in other MEASURE DHS-supported 
surveys throughout SSA. The decline in participation in the Zambian surveys from 
2001-2002 to 2007-2008 was less dramatic than those observed in Sierra Leone, 
although both Zambian surveys and those from South Africa had the lowest 
participation levels of any of the countries.   
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Table 3.4 Characteristics of nationally-representative household-based population surveys by country and 
survey years. 
 
 
 
Country Year Females Males* Total
Female 
to male
Urban 
to rural
Youth (15-24 
years) to adult 
(25-49 years)
Kenya 2003 Eligible (N) 4303 4183 8486
Testing (%) 81 82 81
2008-2009 Eligible (N) 4418 3910
† 
8328
Testing (%) 92 84 88
Lesotho 2004 Eligible (N) 3758 3305 7063
Testing (%) 81 68 75
2009 Eligible (N) 4112 3493 7605
Testing (%) 94 88 91
Mali 2001 Eligible (N) 4556 4062 8618
Testing (%) 85 76 81
2006 Eligible (N) 5157 4643 9800
Testing (%) 92 84 88
Sierra Leone 2005 Eligible (N) NR NR 8450
Testing (%) NR NR 98
2008 Eligible (N) 3954 3541 7495
Testing (%) 86 80 83
South Africa
‡
2002 Eligible (N) 3555 2766 6331
Testing (%) 67 58 63
2005 Eligible (N) 10204 13923 24127
Testing (%) 68 62 65
Tanzania 2003-2004 Eligible (N) 7154 6196 13350
Testing (%) 84 77 81
2007 Eligible
†
(N) 9735 7935
† 
17670
Testing (%) 90 80 85
Zambia 2001-2002 Eligible (N) 2689 4928 7617
Testing (%) 79 77 78
2007 Eligible (N) 7408 7146 14554
Testing (%) 77 72 75
* Unless otherwise specified, the number of eligible men and the testing coverage rate were among those aged 15 to 59 years
§ 
Testing ratios are calculated using the number tested in the first  group divided by the number tested in the second group (e.g., 
females versus males)
‡ 
The survey included persons under 15 and over 49 years of age but results on eligibility and testing coverage were available 
seperately for those aged 15 to 49 years also
Testing Ratio
§
† Number of eligible men was available for those aged 15 to 54 years 
** Data were either not collected (NC) or reported in the published report
HIV participation levels
1.1 0.3 0.7
0.70.31.2
1.5 0.3 0.9
0.90.4
1.4
1.4
1.2
1.3
0.4
0.6
0.5 NC**
0.6
0.7
0.8
0.50.6
1.5 NC
1.3
0.8NC1.6
0.7
0.70.41.4
1.3 0.3
1.2 0.6 0.7
0.70.81.2
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Despite the fact that participation levels in the household surveys changed 
over time in most countries, the ratio of those testing by gender, urban and rural 
residence, and age remained relatively constant.  
 
 
3.4.1 HIV prevalence estimates and trends for those aged 15 to 49 years 
Table 3.5 shows the comparison of HIV prevalence estimates from ANC 
surveillance and household-based data for the seven countries with repeat 
household based population survey data from 2001 through 2010. Taking into 
account that the population survey included men and coverage of rural areas was 
more likely more extensive than ANC surveillance data, HIV infection levels overall 
were higher among pregnant women than the population of men and women 
combined for most countries. Relative differences in prevalence were typically 
greatest between pregnant women and men, especially in Mali, Sierra Leone and 
South Africa.  
For countries in southern and eastern African countries, ANC and population 
prevalence estimates among women were roughly similar, although urban and rural 
ANC estimates understated estimates for these countries as a result of the exclusion 
of data from South Africa, where differences between ANC and female population 
prevalence were especially large. The greatest understatements of HIV prevalence 
were observed in the rural areas of southern and eastern African countries, primarily 
in Kenya and Tanzania. In the second round in Kenya, HIV prevalence among ANC 
attendees was just over half that of females generally (4.8% versus 8.0% 
respectively).   
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Table 3.5  Country-specific HIV prevalence estimates among those aged 15 to 49 years using data from national 
population based surveys and ANC surveillance and stratified by the year of the survey/surveillance round, 
gender and urban/rural area.  
 
 
(% ) N (% ) N (% ) N (% ) N (% ) N (% ) N (% ) N
Kenya
1 ANC (2003) 8.2 10500 10.5 3993 7.0 6507 -- -- -- -- -- -- -- --
POP (2003) 8.7 3151 12.3 779 7.5 2372 4.6 2851 7.5 716 3.6 2135 6.7 6001
2 ANC (2010) 4.8 12339 7.1 6325 4.3 6014 -- -- -- -- -- -- -- --
POP (2008-2009) 8.0 3641 10.4 862 7.2 2779 4.3 3066 3.7 798 4.5 2268 6.3 6707
Lesotho
1 ANC (2003) 28.5 2666 35.0 1200 25.3 1466 -- -- -- -- -- -- -- --
POP (2004) 26.4 3031 33.0 735 24.3 2295 19.3 2012 22.0 407 18.6 1606 23.5 5043
2 ANC (2007) 28.7 2665 36.7 1077 23.9 1588 -- -- -- -- -- -- -- --
POP (2009) 26.7 2856 31.0 1235 24.6 2543 18.0 2041 21.4 806 16.6 2050 23.0 3778
Mali
1 ANC (2002) 3.4 2776 3.4 2228 3.5 548 -- -- -- -- -- -- -- --
POP (2001) 2.0 3584 2.5 1009 1.9 2873 1.3 2978 1.9 863 1.1 2206 1.7 6846
2 ANC (2007) 2.6 3383 3.2 2742 1.3 641 -- -- -- -- -- -- -- --
POP (2006) 1.4 4528 1.8 1557 1.2 2971 0.9 3614 1.3 1361 0.6 2253 1.2 8141
Sierra Leone
1 ANC (2006) 3.5 2453 4.0 2188 1.9 265 -- -- -- -- -- -- -- --
POP (2005) 1.6 4812 2.2 1626 1.3 3186 1.5 3496 1.9 996 1.3 2500 1.5 8308
2 ANC (2007) 4.0 2768 4.7 2468 1.0 300 -- -- -- -- -- -- -- --
POP (2008) 1.7 3448 2.7 1205 1.2 2243 1.2 2726 2.2 1040 0.6 1686 1.5 6174
South Africa
1 ANC (2002) 26.5 16587 NR* NR NR NR -- -- -- -- -- -- -- --
POP (2002) 17.7 2372 NR NR NR NR 12.8 1609 NR NR NR NR 15.6 4795
2 ANC (2005) 30.2 16510 NR NR NR NR -- -- -- -- -- -- -- --
POP (2005) 20.2 5650 NR NR NR NR 11.7 3595 NR NR NR NR 16.2 9245
Tanzania
†
1 ANC (2003-2004) 6.8 17975 9.6 9846 3.6 8129 -- -- -- -- -- -- -- --
POP (2003-2004) 7.7 5755 12.0 1771 5.8 3982 6.5 4994 9.6 1505 4.8 3490 7.0 10747
2 ANC (2008) 5.4 17234 7.1 9375 4.5 7859 -- -- -- -- -- -- -- --
POP (2007-2008) 6.6 8179 10.6 2065 5.3 6114 4.6 6865 6.4 1605 4.0 5260 5.7 15044
Zambia
1 ANC (2002) 18.9 12126 26.7 6827 9.7 5299 -- -- -- -- -- -- -- --
POP (2001-2002) 17.8 2073 26.3 808 12.4 1265 12.9 1734 19.2 676 8.9 1058 15.6 3807
2 ANC (2006) 16.1 12559 22.5 7013 10.0 5546 -- -- -- -- -- -- -- --
POP (2007-2008) 16.1 5502 23.1 2317 11.0 3185 12.3 4942 15.9 2148 9.4 2795 14.3 10444
* Data were not reported (NR) in the published report 
† 
Rural ANC surveillance data includes women living in semi-urban and other non-urban areas
Country/
Data Source/Years
National
MalesFemales
National Urban Rural National Urban Rural
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A review of the ANC surveillance and population survey data with regard to 
trends showed the epidemic overall to be either declining or stable in most countries 
regardless of the source of the data (See Table 3.6). Among pregnant women, 
declines in HIV prevalence nationally and separately by urban and rural residences 
were observed in Kenya and Mali. In Tanzania and Zambia, declines were observed 
nationally and in urban areas but not in rural areas. In the population survey, among 
women in South Africa, HIV prevalence increased from 17.7% in 2002 to 20.2% in 
2005. Prevalence among men also primarily declined, although increases were 
observed for men in urban areas of Sierra Leone and in rural areas of Kenya and 
Zambia. 
For those groups for whom HIV prevalence was falling, the steepest 
proportional declines (as measured for the overlapping inter-survey and inter-
surveillance periods) were observed among ANC attendees in the rural areas of Mali 
(-51%) and Sierra Leone (-47%). The relative reduction in HIV prevalence among 
females generally in Mali was also large (-33%) but considerably smaller among 
women in Sierra Leone (-8%). Among men, proportional declines were greatest in 
the urban areas of Kenya (-51%) and in the rural areas of Mali (-40%) and Sierra 
Leone (-46%). Proportional increases in either data set were more tempered, with 
the largest relative gain in prevalence of 25% observed among men in Kenya. More 
typically, relative increases of HIV prevalence were less than 5%, as they were in 
both data sets in Lesotho and Sierra Leone. 
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Table 3.6 Comparison of proportional changes in HIV prevalence during the overlapping inter-survey and inter-surveillance periods for adults aged 15 to 49 years using data 
from ANC surveillance (ANC) and population-based surveys (POP). Prevalence ratios (PR) represent HIV prevalence among ANC attendees versus HIV prevalence in the 
population. Cell colours show similarity with regard to the representativeness of the ANC surveillance data (e.g., orange cells show ANC declines were greater than 
population prevalence declines). Prevalence ratio values for which only one number is presented indicate that the value did not change over time.
ANC 
change 
(% ) 
POP 
change 
(% )
Trend 
difference 
(p-value)
Representativeness 
of ANC 
surveillance data
ANC 
change 
(% ) 
POP 
change 
(% )
Trend 
difference 
(p-value)
Representativeness 
of ANC 
surveillance data
2003 2008 Sierra Leone 2006 2007
Females -29.3% -8.0% 0.009 0.9 0.7 ANC↓ > POP↓* Females 14.3% 6.3% 0.758 2.2 2.4 ANC↑ > POP↑
Urban -22.9% -15.4% 0.563 0.9 0.8 ANC↓ > POP↓ Urban 17.5% 12.5% 0.877 1.7 1.9 ANC↑ > POP↑
Rural -27.1% -4.0% 0.038 0.9 0.7 ANC↓ > POP↓* Rural -47.4% -7.7% 0.407 1.5 0.8 ANC↓ > POP↓
Males
†
-- -6.5% 0.530 1.8 1.3 ANC↓ > POP↓ Males -- -14.3% 0.286 2.5 3.1 ANC↑ & POP↓
Urban -- -50.7% 0.022 1.4 2.2 ANC↓ < POP↓* Urban -- 10.0% 0.845 2.0 2.2 ANC↑ > POP↑
Rural -- 25.0% 0.007 2.0 1.1 ANC↓ & POP↑* Rural -- -45.5% 0.967 1.8 1.2 ANC↓ > POP↓
National -- -6.0% 0.001 1.2 0.9 ANC↓ > POP↓* National -- 0.0% 0.536 2.3 2.7 ANC↑&  POP=
Lesotho 2004 2007 Tanzania 2003 2007
Females 3.0% 1.5% NA NA Females -16.2% -14.3% NA NA
Urban 3.7% -8.5% 0.180 1.1 1.2 ANC↑ & POP↓ Urban -20.8% -11.7% 0.311 0.8 0.7 ANC↓ > POP↓
Rural -4.4% 1.6% NA NA Rural 19.4% -8.6% 0.034 0.5 0.8 ANC↑ & POP↓*
Males -- -9.3% 0.213 1.5 1.6 ANC↑ & POP↓ Males -- -29.2% 0.841 1.1 1.2 ANC↓ < POP↓
Urban -- -3.6% 0.572 1.6 1.7 ANC↑ & POP↓ Urban -- -33.3% 0.178 1.0 1.2 ANC↓ < POP↓
Rural -- -15.1% 0.252 1.3 1.5 ANC↓ < POP↓ Rural -- -16.7% 0.008* 0.6 1.1 ANC↑ & POP↓*
National -- -3.0% 0.594 1.2 1.3 ANC↓ > POP↓ National -- -18.6% NA ANC↓ < POP↓
Mali 2002 2006 Zambia 2002 2006
Females -17.6% -26.3% 0.640 1.8 2.0 ANC↓ < POP↓ Females -14.8% -6.3% 0.151 1.1 1.0 ANC↓ > POP↓
Urban -5.9% -21.7% 0.563 1.5 1.8 ANC↓ < POP↓ Urban -15.7% -8.5% NA NA
Rural -51.4% -33.0% 0.464 2.0 1.5 ANC↓ > POP↓ Rural 3.1% -8.2% NA NA
Males -- -25.0% 0.744 2.8 3.1 ANC↓ < POP↓ Males -- -3.1% 0.123 1.5 1.3 ANC↓ > POP↓
Urban -- -27.8% 0.465 1.9 2.5 ANC↓ < POP↓ Urban -- -11.8% NA NA
Rural -- -40.0% 0.691 3.5 2.9 ANC↓ > POP↓ Rural -- 3.3% NA NA
National -- -25.0% 0.665 2.1 2.3 ANC↓ > POP↓ National -- -5.8% 0.720 1.2 1.1 ANC↓ > POP↓
South Africa 2002 2005
Females 14.0 14.1 NA NA
Males -- -8.6 0.003 2.1 2.6 ANC↑ & POP↓*
National -- 3.8 0.037 1.7 1.9 ANC↑ > POP↑*
1.0
1.0
* Z-score values indicate that differences in the ANC and population survey trends are 
significant (p-value<0.05)
† Comparisons are made relative to the closest ANC estimate (e.g., ANC change (%) among 
rural females compared to POP change (%) in rural males; national compared to ANC females)
0.9
1.1
1.4
1.0
0.8
PR trend 
(ANC: POP)
PR trend 
(ANC: POP)
2004-2007
2002-2006
2002-2005
2003-2008 2006-2007
2003-2007
2002-2006
Kenya
1.1
1.5
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With regard to the representativeness of ANC surveillance data for monitoring 
population HIV prevalence trends as measured by changes in the PR values over 
time, the overall ratio of HIV prevalence among ANC attendees versus population 
HIV prevalence was observed to be remarkably stable over time in southern and 
eastern Africa as illustrated in Table 3.7. Temporal bias was less stable for the two 
countries in western Africa, however, especially when stratified by gender in the rural 
areas (see Figures’ 3.1a-b). 
 
 
Table 3.7  Comparison of regional HIV prevalence ratio (PR) trends for adults aged 15 to 49 years stratified by 
gender and rural/urban area from ANC surveillance (ANC) and population (POP) prevalence data. Urban and 
rural southern and eastern Africa comparisons exclude South Africa, for which no disaggregated estimates were 
available. Prevalence ratio values for which only one number is presented indicate that this value did not change 
over time. 
 
   
Females 1.1 1.0 2.0 2.2
Urban females 1.6 1.8
Rural females 1.1 0.9 1.7 1.1
Males 1.9 2.0 1.6 1.4 2.6 3.1
Urban males 1.6 1.9 1.4 1.6 2.0 2.4
Rural males 1.7 1.5 2.6 2.1
Total 1.5 1.6 1.3 1.2 2.2 2.5
0.91.2
1.4
1.2
0.8
All
Southern and Eastern 
Africa Western Africa
PR trend (ANC: POP) PR trend (ANC: POP) PR trend (ANC: POP)
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. 
Figure 3.1  Comparison of adult prevalence ratios (PR) values from the two time periods in a) five southern and 
eastern African countries (Kenya, Lesotho, South Africa, Tanzania and Zambia) and b) two countries in western 
Africa (Mali and Sierra Leone).  Urban and rural southern and eastern Africa comparisons exclude South Africa, 
for which no urban or rural estimates were available.  Prevalence ratio values are calculated as the HIV 
prevalence among ANC surveillance attendees relative to population prevalence HIV estimates for the inter-
survey and inter-surveillance period. 
a) 
b) 
PR trend is increasing  
(e.g., ANC data are 
 less representative)  
PR trend is decreasing 
(e.g., ANC data are 
 less representative)  
PR trend is increasing  
(e.g., ANC data are 
 less representative)  
PR trend is decreasing 
(e.g., ANC data are 
 less representative)  
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As the country-specific PR trends from Table 3.6 show, however, these 
regional aggregations masked considerable country-specific variation. For example, 
among all seven countries, only 8 of the 45 comparison groups had PRs that agreed 
over time (see national and gender-specific comparisons in Figure 3.2a and gender-
specific comparisons disaggregated by urban/rural residence in Figure 3.2b). At the 
national level, this included comparisons between ANC and household-based data 
for Tanzania, and among females, also for Tanzania and for Lesotho and South 
Africa. Comparisons of trends between ANC attendees and men typically showed 
less steady PRs across all seven countries; however, when stratified by rural and 
urban residence, ANC data performed extremely well in Zambia for men (as they did 
for women). Trends in HIV prevalence in rural areas of Lesotho among women were 
also comparable over time, although not for females generally.   
Of the 37 country-specific groupings where some variation over time in the PR 
values was observed, ANC surveillance data could still be considered generally 
representative of underlying population HIV prevalence trends in 29 of the 
comparisons (as measured by a p-value≥0.05 from the Z-score test for trend). In 
eight instances, however, ANC surveillance and population survey trends were found 
to differ significantly (i.e., p-value<0.05). For those 29 comparisons where the trends 
were not found to differ according to the Z-score test, ANC data were still relatively 
less representative of HIV prevalence trends among men as opposed to women.  
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Figure 3.2 Comparison of prevalence ratios (PR) using data from national population-based surveys and ANC 
surveillance for adults aged 15 to 49 years, stratified by a) gender and b) gender and urban/ rural area. Markers 
in red indicate significant differences in trends over time as determined by the Z-score test. Prevalence ratio 
values are calculated as the HIV prevalence among ANC surveillance attendees relative to population 
prevalence HIV estimates for the inter-survey and inter-surveillance period. 
 
a) 
b) 
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In the eight instances where trends differed significantly, the poorest 
performance by ANC data occurred in three countries, Kenya, South Africa and 
Tanzania, and primarily involved comparisons with men or with those who lived in 
rural areas. In Kenya, Figure 3.3a shows the proportional declines among ANC 
attendees nationally and in rural areas, which were found to be significantly steeper 
than those occurring among females in the population generally. In the case of 
comparisons of ANC surveillance data to men, however, trends in HIV prevalence 
among pregnant women in urban areas understated declines in prevalence in the 
surrounding populations by about half as much. ANC surveillance data also failed to 
reflect an increase in HIV prevalence that was occurring in rural areas as well (see 
Figure 3.3b). The combination of differences in urban and rural trends and those 
between females and males resulted in a misrepresentation by the ANC surveillance 
data of population prevalence at the national data (see Figure 3.3c). Similar to the 
patterns among women as compared to ANC attendees overall and in rural areas, 
relative declines in HIV prevalence among pregnant women were nearly five times 
greater than that which was occurring in the population generally. 
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Figure 3.3 Comparison of HIV prevalence trends for those aged 15 to 49 years from ANC surveillance and 
household surveys in Kenyan a) females nationally and in rural areas; b) males in urban and rural areas; and c) 
nationally, among females and males combined from 2003 to 2008.  
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In South Africa, as was the case in Kenya, differences in patterns of HIV 
prevalence among female ANC attendees and men generally were also observed 
(see Figure 3.4a). As a result of these differences, national HIV prevalence trends 
were found to differ (as shown in Figure 3.4b), even though ANC surveillance data 
were very representative of patterns of infection among females over time.  
 
 
Figure 3.4 Comparison of HIV prevalence trends from ANC surveillance and household surveys in South 
Africa among adults aged 15 to 49 years a) nationally; and b) among males from 2002 to 2005.  
 
a) 
b) 
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Finally, in Tanzania, ANC surveillance data in rural areas showed an increase in HIV 
prevalence that contrasted significantly with a decline in HIV prevalence among men 
in rural areas (see Figure 3.5).  
 
Figure 3.5 HIV prevalence trends among males aged 15 to 49 years from national population based surveys and 
ANC surveillance in Tanzania from 2003 to 2007. 
 
 
In the urban areas and for men nationally, however, ANC surveillance trends tended 
to understate these declines, albeit not at a statistically significant level.  
As can be observed from the above comparison of trends found to differ 
significantly, very few common patterns with regard to the overall representatives of 
ANC surveillance data were evident (see Table 3.6). In general, the tendency across 
countries was for ANC surveillance data to signal that the epidemic in the general 
population was declining faster than it actually was in the majority of comparisons; 
however, the data also frequently understated population prevalence declines or 
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showed increasing HIV prevalence for some groups, even as the underlying 
population prevalence trend among the comparison group had already begun to fall. 
In part, this may be explained by the poor representativeness of ANC clinics in rural 
areas and the differences in the rates of decline in median HIV prevalence in urban 
areas versus rural areas. However, no patterns were noticeably apparent when 
stratified by gender and according to urban or rural areas either.  
 
3.4.2 HIV prevalence estimates and trends for those aged 15 to 24 years 
Median ANC surveillance and population survey HIV prevalence estimates and 
trends for those aged 15 to 24 years for three countries, Lesotho, South Africa, and 
Zambia, are presented in Table 3.8. 
 
  
Table 3.8 HIV prevalence estimates and trends among youth aged 15 to 24 years by gender and urban rural area 
using data from national population based surveys and ANC surveillance.  
 
Country/Data Source (% ) N (% ) N (% ) N (% ) N (% ) N (% ) N (% ) N
Lesotho
1 ANC (2003) 24.7 NR 25.9 NR 24.0 NR -- -- -- -- -- -- -- --
POP (2004) 15.4 1342 21.4 273 13.9 1069 6.0 1026 4.7 160 6.2 866 11.3 2368
2 ANC (2007) 20.3 NR 24.8 NR 16.0 NR -- -- -- -- -- -- -- --
POP (2009) 13.6 1674 17.9 482 11.9 1192 4.2 1411 5.8 356 3.6 1055 9.3 3084
South Africa
1 ANC (2002) 23.5 8263 NR NR NR NR -- -- -- -- -- -- -- --
POP (2002) 12.0 1123 NR NR NR NR 6.1 976 NR NR NR NR 9.3 2099
2 ANC (2005) 28.6 5402 NR NR NR NR -- -- -- -- -- -- -- --
POP (2005) 16.9 2335 NR NR NR NR 4.4 1785 NR NR NR NR 10.3 4120
Zambia
1 ANC (2002) 18.6 NR 26.7 NR 9.5 NR -- -- -- -- -- -- -- --
POP (2001-2002) 11.0 855 15.2 394 7.5 461 3.0 675 3.7 276 2.6 399 7.5 1530
2 ANC (2006) 16.7 NR 22.5 NR 8.7 NR -- -- -- -- -- -- -- --
POP (2007-2008) 8.5 2225 11.1 1032 6.2 1193 4.3 2028 5.7 990 2.9 1038 6.5 4253
Females Males
National
Rural
* Data were not reported (NR) to UNAIDS
National NationalUrban UrbanRural
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The relationship between HIV prevalence estimates among young ANC surveillance 
attendees and population survey participants was remarkably consistent across the 
three countries. The most extreme differences in HIV prevalence levels by gender 
and data source were observed between ANC attendees and young men. These 
differences reflect the higher risk of HIV infection among women at younger ages as 
compared to young men in SSA, the relatively older ages of pregnant women 
attending ANCs as compared to their peers in the general population, and the 
selection for risky sexual behaviour among women which differentially exposes them 
to HIV infection and to pregnancy [117]. Among young ANC attendees in the three 
countries, HIV prevalence was very high, and in some countries including South 
Africa and Zambia, higher than HIV prevalence among all ANC attendees, 
regardless of age. 
With regard to trends among youth, ANC prevalence data generally reflected 
the underlying trend in the female population in Lesotho and South Africa, although 
differences were larger in Zambia than might have been expected given the 
relatively good agreement among adult female and ANC estimates (see Table 3.9). 
The largest proportional declines in HIV prevalence were observed among ANC 
attendees in rural Lesotho (-27.3%), although this was small compared to declines in 
the population among men in rural areas (-58.1%) and overall (-41.7%). Substantial 
increases in proportional HIV prevalence were also observed in all three of the 
countries, primarily among urban men in Lesotho and Zambia. In South Africa, 
prevalence appeared to be rising among women aged 15 to 24 years, regardless of 
the source of the data.  
136 
 
  
Table 3.9 Comparison of HIV prevalence trends among youth aged 15 to 24 years by gender and urban rural 
area using data from national population based surveys and ANC surveillance. Prevalence ratio (PR) values are 
calculated as the HIV prevalence among ANC surveillance attendees relative to population prevalence HIV 
estimates for the same year. Z-score tests for the significance of trends could not be done for Lesotho and 
Zambia because the sample sizes of the ANC populations were not available. Trends differences for these 
comparisons are indicated as not available (NA) 
 
In terms of the representativeness of the data, comparison of PR values over time 
showed only those from women in the urban areas in Zambia to be the same (See 
Figure 3.6). Generally, however, bias in ANC data was relatively stable over time in 
all comparisons to young females. As was true of comparisons of adult trends, ANC 
data appeared to be less representative of trends among young men. In rural areas 
of Lesotho, for example, among young men, the PR ratio increased from 3.4 in 2004 
ANC 
change 
(% ) 
POP 
change 
(% )
Trend 
difference 
(p-value)
Representativeness 
of ANC 
surveillance data
Lesotho 2004 2007
Females -14.0% -16.2% NA* 1.5 1.6 ANC↓ < POP↓
Urban -3.1% -22.9% NA 1.2 1.5 ANC↓ < POP↓
Rural -27.3% -20.1% NA 1.6 1.4 ANC↓ > POP↓
Males
†
-- -41.7% NA 3.9 5.8 ANC↓ > POP↓
Urban -- 31.9% NA 5.5 4.0 ANC↓ & POP↑
Rural -- -58.1% NA 3.4 6.3 ANC↓ < POP↓
National -- -24.8% NA 2.1 2.4 ANC↓ < POP↓
South Africa 2002 2005
Females 21.7% 40.8% 0.162 2.0 1.7 ANC↑ < POP↑
Males -- -27.9% <0.001 3.9 6.5 ANC ↑ & POP↓*
National -- 10.8% 0.271 2.9 2.8 ANC↑ > POP↑
Zambia 2002 2006
Females 7.7% -16.0% NA 1.5 1.9 ANC ↑ & POP↓
Urban -18.8% -18.6% NA NA
Rural -8.4% -12.3% NA 1.3 1.4 ANC↓ < POP↓
Males -- 28.1% NA 4.8 4.1 ANC↑ < POP↑
Urban -- 35.0% NA 6.2 4.2 ANC↓ & POP↑
Rural -- 7.4% NA 3.2 3.1 ANC↓ & POP↑
National -- -8.2% NA 2.1 2.5 ANC↓ > POP↓
PR trend (ANC: POP)
2002-2006
2002-2005
2004-2007
1.9
* Z-score values indicate that differences in the ANC and population survey trends are significant (p-
value<0.05)
†
 Comparisons are made relative to the closest ANC estimate (e.g., ANC change (%) among rural females 
compared to POP change (%) in rural males; national compared to ANC females)
. Tests could not be done for Lesotho and Zambia because the ANC sample sizes were not available (NA). 
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to 6.3 in 2007 while the change in women was from 1.6 to 1.4. The same was true 
for young men and young women in urban areas in Zambia. 
 
Figure 3.6 Comparison of HIV prevalence ratios (PR) among youth aged 15 to 24 years using data from 
national population-based surveys and ANC surveillance nationally, by gender and within urban or rural area. 
The marker in red for South African men indicates a significant difference in trends over time as determined by 
the Z-score. Prevalence ratio (PR) values are calculated as the HIV prevalence among ANC surveillance 
attendees relative to population prevalence HIV estimates for the same year. 
 
In South Africa, where the difference in trends could be compared directly, Figure 3.7 
shows that ANC and male population HIV prevalence trends differed significantly (p-
value<0.001).  
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Figure 3.7 HIV prevalence trends from national population based surveys and ANC surveillance among youth 
aged 15 to 24 years in South Africa from 2002 to 2005. 
 
 
In this case, HIV prevalence among young ANC attendees was observed to be rising 
while HIV prevalence trends among young men over the same time period had 
fallen.  
 
3.5 Discussion 
Comparisons of ANC surveillance and population prevalence trends among 
adults showed that ANC surveillance data generally performed better as a means of 
monitoring population prevalence trends in countries in southern and eastern SSA as 
opposed to in the two countries in western SSA. ANC surveillance data were also 
observed in these comparisons to be more representative of adult female population 
prevalence trends, as opposed to trends among men, and of urban areas, as 
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opposed to rural areas. For countries with data for youth aged 15 to 24 years, similar 
conclusions about the representativeness of ANC surveillance data among females 
and in urban areas can be drawn, although these conclusions are based on data 
from three countries only. Comparisons of estimates in ANC surveillance data in 
particular may be influenced by differences in rates of declines in urban and rural 
areas, thus results stratified by gender and rural and urban areas may provide the 
best indication of the representativeness of these data.  
The patterns described above are useful when assessing the general 
representativeness of ANC surveillance data to monitor population prevalence trends 
regionally and globally; however, these generalizations masque a variety of 
experiences at the individual country level. For example, ANC surveillance 
seemingly performed best in Zambia for monitoring adult population prevalence 
trends in particular; however, they also performed very poorly in Kenya in almost 
every instance. In Sierra Leone, bias in national estimates increased between survey 
rounds at a pace that was even greater than that which was observed in Mali. 
Notably, the conclusion that ANC surveillance data were especially 
representative of population prevalence trends in Zambia contrasts with a previous, 
smaller study by Michelo and colleagues, where estimates from an urban ANC clinic 
in Lusaka from 1995 to 2002 were found to significantly understate HIV prevalence 
declines in the surrounding catchment population over the same time period [116]. 
Increasing levels of education associated with a later age at first marriage and first 
pregnancy among young women were thought to explain the temporal bias in ANC 
trends. Results presented here for Zambia similarly showed that ANC surveillance 
data understated declines in HIV prevalence among young urban woman, although 
this difference was not found to be significant. Differences in methods used to 
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quantify the comparisons and the geographical scope of the comparisons (e.g., in 
Lusaka versus national) can explain these contrasting conclusions, although 
differences in the timing of the two studies are the most likely explanation. In the 
Lusaka study, the proportion of females and males aged 16 to 24 years attending 
school in Zambia rose between 1992 and 2002, however, from 2002 to 2007 this 
proportion remained unchanged [214, 215, 225, 226]. This suggests that temporal 
changes in bias due to changing educational and fertility patterns among young 
women would have been relatively smaller in the 2000s, as is apparent from the 
results presented here.  
In Kenya, where ANC surveillance data were found to be particularly poor at 
monitoring population prevalence trends, significant differences in trends were 
observed among a variety of groups, including for comparisons at the national level, 
among females generally and those living in rural areas, and separately among men 
and for those men living in either urban or rural areas. For the majority of these 
comparisons, HIV prevalence among pregnant women appeared to be declining 
more steeply than in the population. Importantly, these trends have been reported 
separately in national reports [206, 222] but a more thorough exploration of the 
differences has not yet been published. One possible explanation for the poor 
performance of ANC estimates (although not the only one) is that the geographic 
coverage of participating clinics is insufficient. Using data from the 2003 DHS survey 
in Kenya, Montana and colleagues found unusually large sub-regional differences in 
prevalence of the country by gender and rural and urban residence which suggest 
that the epidemic is highly heterogenic [119]. When taken together with the results 
presented here, there is strong evidence for a need to increase the number and 
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geographical representativeness of ANC clinics in the country or to move away from 
ANC surveillance in Kenya if the number and diversity of clinics cannot be improved.  
One of the key findings to emerge from this analysis, as highlighted by the 
results in Kenya, is that very few similarities were evident with regard to the ways in 
which ANC surveillance data mis-represented underlying population HIV prevalence 
trends. Strictly speaking, ANC surveillance data among adults more frequently 
overstated population prevalence declines, although other patterns were apparent in 
South Africa, Sierra Leone and Tanzania. In a previous study, Gouws and 
colleagues recommended that ANC estimates used to construct national HIV 
prevalence estimates in EPP should be adjusted downwards by 20% for those 
countries without a population survey [45]. Application of this adjustment method 
here across the southern and eastern region of SSA where prevalence is highest 
would appear to be appropriate, however, at the individual country level, the 
application of a constant standard could distort population prevalence trends.  
With regard to the reasons why trends were observed to differ in some 
countries, three explanations are possible.  First, ANC and population survey trends 
could be observed to differ due to changes in sexual behaviour over time. For 
example, some studies have shown that ANC data will understate population 
prevalence declines among women due to a rapid increase in the age of sexual 
debut [117, 227] or successful condom prevention programmes [113]. The 
increasing availability of repeat DHS data should permit a greater understanding of 
the impact of changes in sexual risk behaviour on HIV prevalence trends. 
A second possible explanation for differences could be that fertility and age 
patterns of HIV infection in the country are changing over time, which results in the 
differential inclusion or exclusion of HIV-infected women in the ANC sample over 
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time. For example, HIV prevalence among ANC attendees may decline more steeply 
relative to population prevalence as the epidemic matures because the median age 
of HIV-infected women in the population increases and these women are 
increasingly excluded from the ANC sample due to age and HIV-related sub-fertility 
[115]. HIV prevalence among ANC attendees could also rise more quickly relative to 
the general population, and when compared to women specifically, if new infections 
are increasing among younger women at peak fertility ages or if fertility of HIV 
infected women is restored after introducing ART. In the countries included here, 
neither of these explanations is particularly likely as bias in ANC estimates due to 
changes in age are thought to be stable in mature epidemics [115] and ART access 
was  generally limited in the years in which these surveys were conducted [228]. 
Chapter 4 explores in more detail factors related to changing fertility patterns, age, 
and ART use on bias in ANC surveillance estimates over time.  
A third possible reason for differences between trends from these two 
datasets is that characteristics inherent to the surveys and its participants have 
changed over time. In this analysis, for example, repeated population surveys are 
assumed to be the “gold standard“ indication of population-level HIV prevalence 
trends. In practice, however, participation levels in the population surveys in all 
countries (except Zambia where representativeness of ANC surveillance data were 
generally better than in other countries) were shown to vary across surveys periods, 
thus these data may not be the best measure of true prevalence trends if 
participation is conditioned on HIV status. As discussed in Chapter 1, however, a 
large study by Mishra and colleagues using DHS and DHS-like data from 14 
countries (including much of the data from countries reported here) suggested that 
the effect of non-participation bias on population estimates was likely to be minimal, 
143 
 
especially in countries where HIV prevalence was relatively higher [74]. One key 
limitation to that study’s conclusions, however, was that the accuracy of population 
prevalence estimates adjusted for non-participation depended on the extent to which 
socio-demographic and behavioural characteristics correlated with risk of HIV 
infection. Further analysis suggested that these characteristics were not especially 
predictive of HIV prevalence among testers in the countries considered, thus it is 
possible that the impact of non-participation bias on population survey estimates was 
discounted. A second limitation of that study was that it did not consider the extent to 
which changing levels of refusal bias over time could influence the validity of the data 
to monitor true population prevalence trends, as analyses were limited to a single 
study only. So long as the impact of bias on population estimates at any one survey 
period is negligible, however, temporal bias due to non-participation is unlikely to 
explain the differences in trends.    
ANC surveillance data also suffer from methodological changes that could 
themselves contribute to bias in estimates over time. For example, among ANC 
attendees, socio-demographic factors or behaviour risk associated with HIV infection 
and ANC uptake at a particular clinic could have shifted over time, and these factors 
are seldom described in regard to their potential for contributing to bias in estimates. 
Another potential source of bias can be introduced when ANC uptake is changing 
over time, although uptake for most countries apart from Mali was reasonably high, 
and unchanging over time. Changes in HIV testing algorithms can also play a role in 
introducing bias in estimates over time, although this was not explored in detail here 
as most countries take precautions to validate new testing procedures as they are 
introduced.   
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The methods that were used to compare trends over time were selected so as 
to frame these results in terms of commonly used measurements of proportional 
reductions typically cited by UNAIDS. These methods suffer from a number of 
limitations, however, with the most important one being that the Z-score test takes 
into account the number of ANC participants while in practice, HIV prevalence is 
based on the median clinic HIV prevalence. This is unlikely to have a large influence 
on the validity of the comparisons, however, as overall samples sizes were relatively 
stable over time due to the inclusion of consistently participating clinics. The 
exception to this was in South Africa, where those clinics not consistently 
participating were unable to be removed and in Kenya, where sample size targets 
changed over time in the rural and urban areas. With regard to the latter finding, 
even if sample sizes in Kenya had remained the same at both rounds, findings 
regarding the number and type of significant differences in trends would have 
remained, although the variance around the estimates would have been larger. Still, 
differences with regard to clinic participation in South Africa and lack of rural and 
urban estimates can introduce a substantial challenge when interpreting the 
representativeness of ANC surveillance data in the country.  
Another limitation, though not necessarily of this study specifically, was that 
for many of the countries included here, surveillance rounds and population surveys 
were conducted in different years. As a result, estimates from one survey or 
surveillance round had to be imputed. To address this problem, other studies 
comparing ANC and DHS estimates (rather than trends) have used EPP to construct 
fitted urban and rural HIV prevalence curves from ANC surveillance data (and not 
calibrated to population survey data) and then selected the estimate for the 
appropriate year [45, 46]. As the primary purpose of the analysis here was to 
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compare trends rather than levels, fitted estimates may be less important. Notably, 
the methods used here are similar to those in another analysis of trends using ANC 
surveillance data by Gouws and colleagues, although that analysis did not take into 
account the differences in the time periods compared [21].  
Other limitations of this study in terms of the ability to draw conclusions about 
the usefulness of ANC surveillance data to monitor population prevalence trends is 
that the data presented here are drawn from only two data points (which span less 
than 10 years in time). Also, the number of countries with repeat population survey 
data is limited; thus, these results are extremely limited in their generalizability to the 
region and to SSA as a whole. Furthermore, extreme differences in Sierra Leone’s 
participation levels between survey rounds and the low and changing level of uptake 
of ANC services in Mali suggest that results for these countries in particular are 
susceptible to mis-representation of true population prevalence population and ANC 
trends, respectively. As additional surveys and ANC surveillance data become 
available in the future, it will be important to extend these analyses, especially to 
assess whether patterns in bias become clearer such that an adjustment factor could 
be proposed to compensate for any temporal bias in ANC surveillance data during 
those years in which population survey data are not available. More importantly, 
additional data points can be used to determine the extent to which bias is likely to 
remain stable over time in a country, thus providing reassurances to countries that 
ANC surveillance data are a good indicator of the impact of targeted HIV prevention 
interventions.  
In summary, while the results here do not test specific hypotheses for why 
ANC surveillance trends might differ from those in the underlying population, they do 
provide an easy method for countries with repeat population-based surveys to 
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quickly assess whether or not ANC data are representative of underlying population 
prevalence trends and where differences may be most apparent. They also illustrate 
that for women of all ages and among young women in particular, ANC surveillance 
data do appear to do reasonably well at monitoring population HIV prevalence 
trends, particularly in southern and eastern Africa; although for other groups, caution 
may be required when relying on these data. Finally, the results provide insight into 
where additional investigations may be warranted within these countries to explore 
why interventions in one population group versus another may not be producing an 
expected impact or ways in which ANC surveillance can be improved. In Chapter’s 4 
and 5, further investigations into specific causes of differences in ANC and 
population prevalence trends in selected countries in SSA and among youth in 
Manicaland, Zimbabwe, in particular, are considered. 
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Chapter 4: Mathematical modelling 
of bias in HIV prevalence trends 
among ANC attendees  
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4.1 Aims and organization of the chapter 
The overall aims of this chapter are to (i) validate historical trends in ANC prevalence 
in declining epidemics typical of three countries in SSA (Botswana, Côte d’Ivoire, 
and rural Zimbabwe) and (ii) explore how different scenarios of ART expansion 
associated with changing fertility patterns among women in these countries might 
influence trends in ANC and female population prevalence among adults aged 15 to 
49 years. These scenarios are considered for the pre-ART era from 1985 to 2002, 
and, after introducing ART, from 2003 to 2030 using mathematical modelling for 
each setting.  
The chapter begins briefly by reviewing the reasons why HIV prevalence 
trends might differ between ANC and population data, with a focus on the implication 
for bias given changes in the age and fertility patterns of women in the population 
and the introduction of ART in declining epidemics. In the next section, a description 
of the mathematical model and its parameters is provided. Results from the model 
are presented first for the pre-ART era in the three settings and secondly in the ART 
era (assuming faster and higher levels of ART coverage area in Botswana and 
slower and lower levels of ART coverage in Côte d’Ivoire and rural Zimbabwe).  The 
chapter concludes by comparing these results to previous work and highlights the 
potential areas for concern when using ANC surveillance data to monitor the HIV 
epidemic.    
 
4.2 Introduction 
As Chapters’ 1 and 2 illustrated, ANC surveillance data have historically been used 
as the foundation for monitoring the HIV epidemic in SSA. However, these data have 
been, and continue to be, subject to multiple sources of selection and structural bias. 
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Briefly, these biases are (i) the lack of geographic representativeness in the selection 
of participating ANC clinics [65]; (ii) the self-selection of women who have access to 
and who use ANC services [51]; and (iii) the limitation of testing only those women 
who become pregnant [42, 47, 55, 56, 112]. As has been illustrated, these biases 
can have varying influence on the accuracy of ANC-based estimates and trends.  
As the previous chapter also showed, bias in ANC estimates relative to 
population survey data does appear to be changing over time in some countries. 
However, because the period of time over which these comparisons can be made is 
relatively short, it is ultimately difficult to draw conclusions about the 
representativeness of ANC surveillance data. Also, little can be said about the 
historical representativeness of ANC surveillance data before the 2000s, or the 
representativeness of ANC data beyond 2012, and most importantly during the ART 
era. One of the biggest concerns, historically, has been whether age-specific fertility 
patterns and HIV-associated morbidity, in addition to changes in the average age of 
women who are infected, will affect the reliability of ANC surveillance trends, 
especially as incidence declines due to changes in behaviour [41, 115].  More 
recently, the influence of a recent and rapid expansion of ART on the validity of ANC 
trends in SSA also has the potential to bias estimates. As of 2008, nearly 3 million 
people were receiving ART in SSA, representing a 30-fold increase in coverage 
since 2003 [229]. Based on this expansion, it is predicted that HIV estimates in the 
population may begin to decline more slowly or even rise due to extended survival. 
Whether HIV prevalence among ANC attendees, who are younger and likely more 
recently infected, will accurately capture these changes in prevalence in the ART era 
is unknown. Finally, it has been hypothesised that women on ART could experience 
different fertility levels due to improved health or behaviour change. If ART use 
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results in a decline in fertility, possibly due to increased contraceptive use, 
differences in trends could be exacerbated over time as HIV-positive women are 
increasingly excluded from the ANC sample. If, however, ART use results in an 
increase in fertility, which is most biologically plausible [165], differences in trends 
over time may dissipate gradually. Predicting the magnitude and direction of these 
changes will be critical in future years if ANC surveillance data continue to be the 
primary source for monitoring population prevalence trends. 
To explore how ART expansion might influence trends in ANC and population 
prevalence, and to validate historical trends in ANC prevalence in a declining 
epidemic, a mathematical model that quantifies bias in ANC trends was developed. 
These patterns are assessed during the pre-ART era from 1985 to 2002, and, after 
introducing ART from 2003 to 2030. A range of potential fertility patterns among ART 
users as compared to uninfected women is explored. Model parameters and 
methods for measuring temporal biases are described further below.  
 
4.3  Methods 
An individual-based stochastic cohort model written in C++ was developed by Dr. 
Tim Hallett of Imperial College London to study the relationship between HIV 
prevalence trends in pregnant women and women of all reproductive ages (defined 
as aged 15 to 49 years) from 1985 to 2030. Under his guidance, model parameters 
were selected to reflect HIV epidemics typical of sub-Saharan Africa over a forty-five 
year period, namely: (i) high and declining HIV incidence, as in Botswana [20] and 
rural Manicaland, Zimbabwe [26, 230]; and (ii) low and declining HIV incidence, 
characteristic of Western African countries such as Côte d’Ivoire [22]. The effect of 
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naturally declining fertility rates in rural Zimbabwe, for which there is some evidence 
in the late 1980s through the early 2000s [153], is also investigated. A brief 
description of the stochastic cohort model follows. A full description of the original 
model by Hallett and colleagues is described in a previous publication [231, 232]. 
 
4.3.1 Model description 
As previously noted, this model is based on an earlier approach to explore the 
impact of treatment on health outcomes and the potential for bias in child mortality 
statistics in countries in SSA with generalized HIV epidemics [231, 232]. Detailed 
specifications on the construction of the birth cohorts, probability of death without 
HIV, and the iterative nature of that model are provided in the online appendix [232]. 
Briefly, model is individual-based stochastic micro-simulation model that 
probabilistically calculates the time to the next event (e.g., pregnancy, HIV infection, 
death) for each individual according to specified parametric distributions. This 
process then repeated until the individual dies. With regard to the simulation within 
the broader population, the model is run 50 times, with the same set of model 
parameters so that the only variability is the stochastic variability. Results are then 
averaged across the 50 runs to produce a single set of estimates of trends in HIV 
prevalence among pregnant women and the general population. To reduce 
computation time in the model, one woman in the simulation represents 100 women 
in the population. Appendix B summarizes the model’s key parameter values. 
Briefly, to model bias in estimates, a series of birth cohorts representing 
women born between 1955 and 2015 is created. Yearly population size is 
determined by country-specific census data estimates and projections published by 
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the UN Population Division [224]. Women in each birth cohort form the adult female 
population who are then tracked over their life during the years between 1980 and 
2030. An illustration of a woman’s life course (Figure 4.1a) and fertility cycle (Figure 
4.1b) as modelled in the simulation is shown below. 
 
 
Figure 4.1 Illustrated depiction of the a) life expectancy and b) annual fertility cycle of a woman in the 
stochastic cohort model. Gray rectangles indicate an event of interest in the model for an HIV-negative woman. 
Red rectangles indicate an event of interest in the model for an HIV-infected woman. Ovals represent 
parameters determining the outcome of the event (e.g., HIV-infected or not, pregnant or not, on ART or not). 
Parameter ovals applicable to only HIV-positive women are shown in red. ART is introduced only after the 
2002 calendar year (CY). 
 
In the model, a woman’s exposure to four events is tracked: (i) HIV infection; 
(ii) pregnancy (and an ANC visit at three months when she is tested); (iii) ART use; 
and (iv) death. Beginning at age 15, women are subjected to a per annum and age-
specific HIV infection hazard which is used to determine probabilistically the timing of 
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the infection or whether the women is never infected. Calculations of hazards are 
based on estimates of annual incidence in women from ANC and population survey 
HIV prevalence data provided by UNAIDS (personal communication 18/01/2011). 
For Zimbabwe, because the focus of the simulations was on trends in rural areas 
rather than nationally, estimated incidence rates were available in rural areas for 
both sexes combined only. HIV incidence data used to parameterize the simulations 
in Botswana, Côte d’Ivoire and rural Zimbabwe are for illustrative purposes only. 
Figure 4.2 shows the trends in HIV incidence through 2010 provided by UNAIDS.  
 
Figure 4.2 Assumed calendar year trends in HIV incidence per 100 persons aged 15 to 49 years per year in 
Botswana (red line), Côte d’Ivoire (blue line) and rural Zimbabwe (green line), 1980-2010. In Botswana and 
Côte d’Ivoire, incidence is for women only. In rural Zimbabwe, trends are for men and women combined. 
Beyond 2010, incidence is assumed to decline through 2030 based on the average decline from 2005 to 2010.  
 
Beyond 2010, HIV incidence in all three settings is assumed to decline through 2030 
based on a moving average of the decline over the previous 5 years.  
Age-specific relative HIV incidence patterns were constructed by Hallett using 
prevalence data from repeated national population surveys [75]. These estimates are 
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shown in Figure 4.3, and describe incidence patterns per 100 person years by age 
relative to the average incidence in the country. For Botswana, because not all 
required data were publically available to construct these estimates, national 
Zimbabwe population survey data were used instead [233, 234]. For rural Zimbabwe 
simulations, direct measurement was made from rural Manicaland cohort data [235]. 
Estimates of incidence in Côte d’Ivoire were based on estimates of HIV prevalence 
from the 2005 DHS survey. Constant prevalence was assumed to produce the age-
specific estimates of incidence for the model. This resulted in an estimate of HIV 
incidence for those aged 40 to 49 years that is well above what might be expected in 
sub-Saharan Africa. Additional investigation is needed to understand whether these 
rates truly reflect higher incidence or are more likely the result of peculiarities in 
migration or mortality patterns in the population, differences in the 
representativeness of the population survey data over time, or random statistical 
error. In the latter case, for example, CIs around the estimates for those aged 40 to 
49 are extremely wide (not shown). 
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Figure 4.3  Patterns of HIV incidence among women by five year age groups in Botswana, Côte d’Ivoire and 
rural Zimbabwe, calculated from repeated national population surveys. For Botswana, because not all required 
data were available to construct these values, national Zimbabwe population survey data were used instead [233, 
234]. For rural Zimbabwe, direct measurement was made using previously published data from the Manicaland 
cohort [235]. 
 
In the model, for each year of a woman’s life, the hazard of pregnancy is used 
to determine probabilistically the timing of pregnancy. A woman’s likelihood of 
becoming pregnant is determined by age-specific fertility rates and her HIV status. 
For HIV-negative women in Botswana and Côte d’Ivoire, DHS data from the mid-
1980s and early 1990s (prior to when HIV might have negatively influenced fertility 
rates) were used (See Figure 4.4) [236, 237].  
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Figure 4.4  Age-specific fertility rates (per 1000 HIV-negative women) in Botswana (red line) and in Côte 
d’Ivoire (blue line) [236, 237]. 
 
In rural Zimbabwe, scenarios where fertility rates are either (i) stable or (ii) declining 
over time (and independent of the HIV epidemic) are explored. Stable age-specific 
fertility rates from rural Zimbabwe are taken from the 1988 DHS [238]. Fertility rate 
declines are calculated as a linear decrease between the 1988 estimates and age-
specific estimates from the Manicaland HIV-negative cohort in 2005 (See Figure 
4.5). Women can become pregnant any number of times through her lifetime subject 
to her age, HIV status and, in the case of Zimbabwe, the year.  
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Figure 4.5  Calendar-year fertility rates (per 1000) among HIV-negative women in rural Zimbabwe (1985-
1988)  [238] (solid green line) and Manicaland, Zimbabwe (1998-2005) (dotted green line). 
 
For HIV-positive women, the hazard of pregnancy is restricted from the original HIV-
negative age-specific fertility rates by a 35% reduction within four years and a 60% 
reduction after four years of infection to account for HIV-related sub-fertility [158]. 
The model assumes that all women who become pregnant regardless of HIV status 
attend an ANC and are tested for HIV three months after conception, whereas in 
SSA, some women may not  
Life expectancy in the absence of HIV is calculated at birth using cohort data 
from Manicaland, Zimbabwe [239]. Estimates are typical of non-HIV-related child and 
adult survival times for SSA. Net survival of HIV-infected women is modelled on 
combined age-stratified estimates taken from observational cohort studies in Africa 
[240]. HIV-infected women not on ART survive a median of 10 years, with CD4 
counts reaching <200 two to seven years after infection.  
If the calendar year is after 2003 in the ART era simulations, women with CD4 
counts<200 will access ART with the probability of coverage as determined within 
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linearly from 0% to 75% from 2003 to 2020 and (ii) faster and higher levels of 
coverage, where coverage increases linearly from 0% to 95% from 2003 to 2013. 
The slower and lower levels of coverage are characteristic of Côte d’Ivoire and rural 
Zimbabwe, while the faster and higher coverage levels are characteristic of 
Botswana. Survival after initiating ART is approximately 10 years [25].  
The primary question of interest is the extent to which trends among pregnant 
women mirror true HIV prevalence in the population as age-specific and HIV-related 
fertility patterns change over time. In the era of ART, changes in fertility levels of 
users are explored for a range of values from a complete reduction in fertility       
(i.e., -100% or no further births) to a complete rebound (i.e., +100% or fertility at the 
same level as an HIV-negative women of the same age). Figure 4.6 summarizes the 
range of fertility levels which may be experienced by women on ART in the model. 
 
 
 
 
 
 
 
 
 
 
Figure 4.6  Fertility resumption and reduction scenarios for an HIV-infected woman on ART compared to an 
uninfected woman of similar age. Females on ART are subject to the new fertility rate immediately after 
initiating ART. This rate is unchanged over time.  
 
 
+100% - Resumption of fertility to levels typical of 
HIV-uninfected woman of the same age   
-100% - Complete reduction of fertility  
0% - Fertility level equal to an HIV-infected woman 
not on ART of the same age and with the same 
time since infection. 
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4.3.2 Outcomes 
Two measures of HIV prevalence are calculated in the model. The first, prevalence 
among ANC attendees in the model, serves as a proxy for ANC surveillance 
estimates and is calculated as the number of pregnant women testing positive at 
ANC in a particular year divided by the number of women attending ANC that year. 
Factors influencing overall HIV prevalence in ANC surveillance include (i) HIV 
incidence; (ii) fertility rates in HIV-negative women; (iii) fertility rates in HIV-positive 
women; (iv) HIV-related mortality; and (v) non-HIV-related mortality. Selection bias 
related to the timing and profile of women’s attendance and the clinics selected to 
participate in ANC surveillance are not accounted for in the model. The second 
measure is true annual population HIV prevalence among women in the general 
population, which is calculated as the prevalence (women infected and alive divided 
by women alive) at the year mid-point. Population prevalence is influenced by (i) HIV 
incidence; (ii) HIV-related mortality; (iii) non-HIV-related mortality; and (iv) survival 
beyond the upper age bracket of 49 years when a woman no longer contributes to 
population prevalence estimates.  
The overall outcome of interest is the extent to which the trend in HIV 
prevalence from ANC surveillance mirrors the true population HIV prevalence trend. 
Similar to Chapter 3, representativeness, or lack thereof defined as “bias”, is 
measured as the ratio of HIV prevalence among pregnant women to that of the true 
female population. The PR -- rather than the absolute difference between the point 
estimates from the two data sources -- is used to emphasise how estimates move 
relative to one another.  
To remove noise from the stochastic simulation, the final PR trend is shown 
as a five-year moving average through time of the results from the 50 runs per 
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simulation.  Shown below is an example of typical stochastic variation around the 
mean PR trend during the pre-ART era from 1985 to 2002 in Botswana (See Figure 
4.7a) and Côte d’Ivoire (Figure 4.7b). Results for the post-ART era from 2003 to 
2030, are also displayed, assuming 100% rebound fertility in Botswana, with faster 
and higher ART coverage (Figure 4.7c),  and Côte d’Ivoire, with slower and lower 
levels of coverage (Figure 4.7d).  
 
 
 
 
 
Figure 4.7  An example of typical stochastic variation around the mean PR from the 50 simulations for the pre-
ART era (1985-2002) in a) Botswana (solid red line) and b) Côte d’Ivoire (solid blue line). Also results from the 
50 runs are shown in the post-ART era (2003-2030) assuming 100% rebound fertility in c) Botswana (dashed 
red lines) and d) Côte d’Ivoire (dashed blue line).  
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As expected, stochasticity in the simulations is greatest in the largest 
epidemic (e.g., Botswana versus Côte d’Ivoire) and just as the epidemic takes off 
(1985-1990 versus 1995-2030). As time passes, however, infections relative to 
population size increase and a narrower (i.e. more stable) variability in potential PR 
trends result. Because patterns of variance were similar to those above for 
Zimbabwe and with regard to the remaining ranges of positive, no and negative 
associations between fertility and ART, the remaining graphs are not shown. 
When assessing the representativeness of ANC trends, the data are 
considered to mirror true population prevalence trends if the PR trend is stable over 
time. When the trend in the PR is declining or increasing, ANC surveillance data are 
considered less reliable and will either understate or overstate true population 
prevalence trends. Table 3.1 from Chapter 3 summarizes this relationship.  To 
isolate possible causes for trend differences, selected analyses are presented 
separately for women aged 15 to 24 and 25 to 49 years old. Results from the pre-
ART era span from 1985 to 2002. The impact of introducing ART in 2003 through 
2030 is then considered in Section 4.4.2.  
 
4.4 Results 
4.4.1 The pre-ART era (1985-2002) 
If the fertility rates of uninfected women in Botswana, Côte d’Ivoire and rural 
Zimbabwe were stable over time, then results from the simulation indicate that ANC 
sentinel surveillance would have generally represented true population trends among 
women aged 15 to 49 years through the first 10 years or so of the epidemic. 
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However, these estimates would have been less representative in subsequent years 
as the epidemic progressed (See Figure 4.8a).  
 
 
Figure 4.8  Measures of a) trends in HIV prevalence among ANC attendees (dashed lines) compared to women 
of reproductive age (15 to 49 years) (solid lines) in Botswana (red lines), Côte d’Ivoire (blue lines) and rural 
Zimbabwe (green lines) and b) the predicted HIV prevalence ratio (PR – i.e. annual ANC HIV prevalence 
compared to female HIV prevalence) assuming stable fertility rates among HIV-negative women. 
 
In the early years, which were marked by increases in HIV incidence, bias in 
ANC trends would have been reasonably stable (as shown in Figure 4.8b). This is 
because the average age of HIV-infected women in the population remained 
relatively stable over time and women with more recently-acquired HIV infections 
would have experienced less HIV-related sub-fertility. As a result, fewer HIV-infected 
women would have been excluded from the ANC sample initially.  
As the epidemic progressed and incidence began to decline, however, ANC 
trends in prevalence would have become less representative of underlying 
population estimates for two reasons. First, HIV-related sub-fertility would have 
excluded women from the ANC sample as the average time since HIV infection in 
the population grew. Second and more importantly, the rise in the average age of the 
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HIV-infected population beyond their most fertile years would have excluded an 
increasing number of HIV-positive women from the ANC sample. As a consequence 
of these dynamics, HIV prevalence among ANC attendees would have risen less 
steeply, peaked earlier, and declined more rapidly than female population 
prevalence overall.   
Using data from the Botswana simulation, the shifts described above in the 
average age of HIV-infected women and the average number of years since infection 
can be observed in Figure 4.9.  
 
Figure 4.9 Increases in the mean age (in years on the left y-axis) of HIV-infected women (solid red line) and the 
mean time (in years on the right y-axis) since infection among women (dotted green line) in the population 
result in increasing sub-fertility among HIV-infected women. The consequence of these shifts over time can be 
seen in the decline in the mean age (in years) of pregnant women (dashed red line) in Botswana, 1985-2002.   
 
In the graph, the decline in the mean age of pregnant women over time is a 
consequence of the fact that older HIV-infected women are increasingly excluded 
from the ANC sample. This shift, in turn, introduces a greater bias in the ANC 
estimates as the epidemic progresses.  
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Given the relationship between age, HIV infection, and fertility patterns in 
Botswana, it might be expected that the representativeness of ANC-based trends 
would differ by age. Stratification of results by women aged 15 to 24 years and those 
aged 25 to 49 years shows that ANC prevalence trends for younger ages do more 
accurately capture underlying population trends among young women in the 
population (see Figure 4.10a and Figure 4.10c) as compared to a similar scenario for 
older women (see Figure 4.10b and Figure 4.10d).  
  
  
Figure 4.10 Measures of trends in HIV prevalence among ANC attendees compared to women in Botswana (red 
lines), Côte d’Ivoire (blue lines) and rural Zimbabwe (green lines) for those aged a) 15 to 24 years and b) aged 
25 to 49 years and the predicted HIV prevalence ratio (PR: i.e., annual ANC HIV prevalence compared to 
female HIV prevalence), also for those aged c) 15 to 24 years and d) 25 to 49 years.  
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The reason why ANC surveillance trends in younger women are more 
representative than when compared to older ages is that younger HIV-infected 
women will be less frequently excluded from the ANC sample because sero-
conversion is more recent and HIV-related sub-fertility is less severe. Furthermore, 
for many younger women, natural fertility levels will increase, rather than decline, as 
they age. Among older HIV-infected women, however, natural declines in fertility with 
age will lead to greater exclusion from the ANC sample as the average age of 
infected women increases beyond peak reproductive years. Also, because women in 
these age groups are less likely to be recently infected, the influence of HIV-related 
sub-fertility will be greater initially, although as mean time since infection in the group 
increases as the epidemic progresses, the effect of this bias will become less severe 
because older women will already be subjected to the maximum sub-fertility level.   
Again in Botswana, the magnitude of the bias resulting from HIV-related sub-
fertility and natural aging of the HIV-infected population by age group can be 
observed from the simulation. As shown in Figure 4.11a, if younger women 
experienced no HIV-related sub-fertility, HIV prevalence in the ANC sample would 
have risen more quickly, peaked later and fallen slightly faster than prevalence in the 
general population. This is because the age distribution of the ANC sample is older 
than the age distribution in the general population. 
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Figure 4.11 Measures of a) ANC-based and population HIV prevalence trends and b) the predicted HIV 
prevalence ratio (PR – i.e. annual ANC HIV prevalence compared to female HIV prevalence) for women in 
Botswana, aged 15 to 24 years (in red) and 25 to 49 years (in blue) assuming the effects of sub-fertility 
(indicated by dashed lines) and no sub-fertility (indicated by dotted lines).  
 
If HIV-related sub-fertility was included, however, some HIV-infected women 
would have been selectively removed from the ANC sample over time as their 
infections progressed, resulting in a reduction in the overall numbers of HIV-infected 
pregnant women relative to the population and, as a consequence, a sharp decline 
in the trend in the PR over time as ANC surveillance estimates increasingly 
overstated population prevalence declines (see Figure 4.11b). The situation for those 
aged 25 to 49 years is similar, although the primary reason for the more severe 
decline in the PR trend (as shown in 4.11b) is not the inclusion of HIV-related sub-
fertility but rather the increase in the average age of infected women which subjects 
them to lower natural fertility levels. Accordingly, the slope of the PR trend is only 
slightly steeper with respect to the effect of sub-fertility as compared to without it in 
the later years. 
Since fertility patterns in Côte d’Ivoire and rural Zimbabwe are similar to those 
in Botswana, bias in ANC-based trends within the age groups and among females 
overall would be expected to be similar. However, in Côte d’Ivoire, the higher relative 
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level of HIV incidence among older women (as indicated in Figure 4.3) would result 
in about a 5% relative increase in the magnitude of bias in the PR over time, since 
natural fertility levels would already be lower among these older HIV-infected 
women. As hypothesized, in rural Zimbabwe, similar patterns of bias in ANC trends 
to Botswana were evident because age-specific fertility and incidence patterns in the 
two settings were similar.  
If age-specific fertility levels instead declined with time and independent of the 
influence of HIV, as was most likely occurring in rural Zimbabwe from the late 1980s 
through the early 1990s [241], however, the patterns of bias could have differed. 
Surprisingly, the temporal bias from non-HIV-related fertility rates declining was 
minimal (See Figure 4.12).  
 
Figure 4.12 The predicted HIV prevalence ratio for those aged 15 to 49 years assuming stable (dashed green 
line) versus declining (dotted green line) background fertility patterns in rural Zimbabwe. 
 
The reason for this very small difference when assuming an overall decline in the 
natural fertility rate is because the decline is of a similar magnitude for age groups 
with the highest fertility levels. However, if fertility reductions had occurred over a 
short period of time in one group as opposed to others in Zimbabwe (e.g., a rapid 
rise in the age of sexual debut from the teens to twenties), then the ANC sample 
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eventually would have exaggerated the declines in population prevalence more 
severely.  
 
4.4.2 The ART era (2003-2030) 
4.4.2.1 Modelling bias in ANC prevalence trends given no association 
between ART use and fertility
If it is first assumed in the simulations for each of the three settings that there is no 
relationship between ART use and fertility, then the representativeness of ANC 
trends will be primarily influenced by the changing age-profile of HIV-infected women 
due to increased survival on ART. In the earliest years after the introduction of ART, 
for example, ANC-based estimates of prevalence will overstate declines in true 
population prevalence (as it did in the pre-ART era) because any gains from 
extended survival in either the ANC sample or the population will be negligible still.  
As ART coverage expands, however, the trend in HIV prevalence among 
pregnant women will eventually begin to diverge from true population prevalence. 
Among pregnant women, the sub-set of ART users will benefit from a longer 
reproductive lifespan (even though they are still constrained by pre-ART sub-fertility 
levels), and ANC prevalence will begin to stabilize. In contrast, true population HIV 
prevalence trends will continue to fall, in part because an increasing number of HIV-
infected women will now survive beyond age 49 years and thus be excluded from 
contributing to estimates of true population prevalence.  
The consequences of the changes described above, as measured by 
prevalence trends and the trend in the PR, are shown in Figure 4.13a and Figure 
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4.13b, respectively, for Botswana. For comparison, a measure for a scenario in 
which ART is not available has also been included 
 
Figure 4.13  Measures of a) ANC-based and population HIV prevalence trends and b) the predicted HIV 
prevalence ratio (PR – i.e. annual ANC HIV prevalence compared to female HIV prevalence) for women aged 
15 to 49 years (dashed line) versus pregnant women (dotted lines) assuming rapid ART scale-up (red lines) in 
2003 or no ART (pink lines) in Botswana, 2000-2030. 
 
As expected, the overall PR trend rises for women aged 15 to 49 years as compared 
to a scenario in which ART was never introduced. This is because ANC prevalence 
fails to capture the slight decline in true population prevalence among women. 
Results from simulations for those aged 15 to 24 years and 25 to 49 years (see 
Figure 4.14a and Figure 4.14b) underscore the contributions to bias by older HIV-
infected women who are benefitting the most from a longer reproductive lifespan in 
the ANC sample, but who are also aging out of the population sample at the same 
time. 
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Figure 4.14 The predicted HIV prevalence ratio (PR: i.e., annual ANC HIV prevalence compared to female 
HIV prevalence) for those aged a) 15 to 24 years and b) 25 to 49 years after the introduction in 2003 of ART 
(red line) as compared to if ART had never been introduced (dashed pink line) in Botswana.   
 
The dynamics discussed above for the age-stratified groups also operate similarly for 
women of all ages in Côte d’Ivoire (See Figure 4.15a) and Zimbabwe (see Figure 
4.15b). In both settings, ANC prevalence initially declines faster than true population 
prevalence and similar to a scenario in which ART had never been introduced. In 
later years as ART scale-up expands, however, ANC prevalence eventually 
stabilizes while population prevalence continues to decline – as it did in Botswana. 
Because the scale up of ART coverage is less rapid and reaches fewer people, 
however, the rise in the trend of the PR is somewhat less severe than if the scale-up 
was faster and reached more women. A faster implementation of ART, which is also 
shown in Figure 4.15a and Figure 4.15b for Côte d’Ivoire and rural Zimbabwe would 
result in a more severe bias initially, although trends would then stabilize more 
quickly.  
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Figure 4.15 The predicted HIV prevalence ratio (PR: i.e., annual ANC HIV prevalence compared to female HIV 
prevalence) for those aged 15 to 49 years in a) Côte d’Ivoire (blue lines) and b) rural Zimbabwe (green lines) 
after the slower and lower levels of ART introduction in 2003 (solid lines) and as compared to if ART had never 
been introduced (dashed line) or with faster and higher coverage (dotted lines).  
 
4.4.2.2 Modelling bias in ANC prevalence trends given a negative 
relationship between ART use and fertility 
If instead of assuming there was no relation between ART use and fertility, a 
negative relationship (i.e., women on ART are less fertile than uninfected women of 
the same age) was assumed, then the representativeness of ANC trends would still 
be influenced by the changing age-profile of HIV-infected women. This is due to 
increased survivorship in the population due to ART. However, the additional bias 
from HIV-infected women self-selecting out of the ANC sample would also need to 
be considered. As Figures’ 4.16a – c, a negative association would initially draw the 
trend in the PR lower for each location as compared to if there was no association.  
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Figure 4.16 The predicted HIV prevalence ratio (PR: i.e., annual ANC HIV prevalence compared to female HIV 
prevalence) for those aged 15 to 49 years as ART has either no association (solid line), a 25% reduction (dashed 
line), a 50% reduction (dotted lines), or a complete reduction (diamond markers) in fertility for a) Botswana, b) 
Côte d’Ivoire and c) Zimbabwe.  
2000 2005 2010 2015 2020 2025 2030
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Prevalence Ratio (15-49 years)
A
N
C
:P
O
P
 H
IV
 P
re
v
a
le
n
c
e
 
 
No association
25% reduction
50% reduction
Complete reduction
2000 2005 2010 2015 2020 2025 2030
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Prevalence Ratio (15-49 years)
A
N
C
:P
O
P
 H
IV
 P
re
v
a
le
n
c
e
 
 
No association
25% reduction
50% reduction
Complete reduction
2000 2005 2010 2015 2020 2025 2030
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
A
N
C
:P
O
P
 H
IV
 P
re
v
a
le
n
c
e
Prevalence Ratio (15-49 years)
 
 
No association
25% reduction
50% reduction
Complete reduction
a) Botswana 
b)   Côte d’Ivoire 
c)   Rural Zimbabwe 
ART introduced 
in 2003 
ART introduced 
in 2003 
ART introduced 
in 2003 
173 
 
 
The reason for the more severe decline is because, as fertility among ART users is 
reduced, they appear less frequently in the ANC sample. Not unexpectedly, the 
magnitude of bias when fertility of users is 25% to 50% less than uninfected women 
is relatively smaller and occurs over a shorter period of time as compared to when 
fertility among users is completely reduced (i.e., -100% or no further births). Among 
women aged 15 to 24 years in Botswana, for example, trends still appear reasonably 
representative of true population prevalence trends among their peers regardless of 
the new level of reduced fertility (Figure 4.17a). Among older women aged 25 to 49 
years in Botswana, however, the increasing influence of reductions in fertility among 
those who otherwise would have had the highest levels of fertility is more apparent 
(Figure 4.17b) 
 
Figure 4.17  The predicted HIV prevalence ratio (PR: i.e., annual ANC HIV prevalence compared to female 
HIV prevalence) for those aged a) 15 to 24 years and b) 25 to 49 years as ART has either no association (solid 
line), a 25% reduction (dashed line), a 50% reduction (dotted lines), or a complete reduction (diamond markers) 
in fertility in Botswana.  
 
Similar results by age groups were also found for Côte d’Ivoire and Zimbabwe.   
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4.4.2.3 Modelling bias in ANC prevalence trends given a positive 
relationship between ART use and fertility 
If, in a third and final scenario, where ART is assumed to lead to some 
immediate increase in fertility relative to age-matched uninfected women, then the 
trend in the PR would be expected to rise commensurate with the strength of the 
association. This rise would result from the addition of previously sub-fertile HIV-
infected women back into the ANC sample. Figures’ 4.18a, 4.18b and 4.18c 
demonstrate the shift in the PRs for Botswana, Côte d’Ivoire and rural Zimbabwe 
respectively.
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Figure 4.18  The predicted HIV prevalence ratio (PR: i.e., annual ANC HIV prevalence compared to female HIV 
prevalence) for those aged 15 to 49 years as ART has either no association (solid line), a 25% increase (dashed 
line), a 50% increase (dotted lines), or a complete resumption (diamond markers) in fertility for a) Botswana, b) 
Côte d’Ivoire and c) rural Zimbabwe.  
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When stratified by age groups, as is the case below in Figure 4.19a and 4.19b in 
Botswana, trends are less severely biased. In the case of the younger women aged 
15 to 24 years, the addition of women back into the sample has a relatively modest 
impact on the younger age groups as does increased survival since these women 
are most likely to have been relatively recently infected and not yet eligible for ART. 
Among the older women, however, the addition of HIV-infected women back into the 
ANC sample still pulls the PR up but it is less dramatic because natural fertility 
declines associated with age and time since infection limit the rise.
Figure 4.19  The predicted HIV prevalence ratio (PR: i.e., annual ANC HIV prevalence compared to female 
HIV prevalence) for those aged a) 15 to 24 years and b) 25 to 49 years as ART, which was introduced in 2003, 
has either no association (solid line), a 25% increase (dashed line), a 50% increase (dotted lines), or a complete 
resumption (diamond markers) in fertility in Botswana.  
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Results by age group for Côte d’Ivoire and Zimbabwe were largely similar, although in 
Zimbabwe, the PRs for the range of positive fertility associations among those aged 25 
to 49 years span a slightly wider range than in Botswana and Côte d’Ivoire over time 
because natural fertility rates are also declining. 
 
4.5 Discussion 
By simulating HIV-prevalence trends among pregnant women and women in the 
population of reproductive ages, it has been possible to explore and describe the 
magnitude and direction of bias that might be present in ANC surveillance trends as the 
epidemic progresses in Botswana, Côte d’Ivoire and rural Zimbabwe. The most 
important finding from these simulations is that primarily relying upon ANC data to 
monitor true population prevalence trends for women of reproductive aged 15 to 49 
years in the pre-ART era may have been problematic. During this time, ANC prevalence 
would have misrepresented changes in true population HIV prevalence in all three 
locations. In the case of Botswana, as an example, this bias would have led to a gradual 
understatement of the relative increase in population prevalence trends by 10% from 
1997 to 2002. As overall prevalence is quite high in Botswana, a 10% understatement 
would have corresponded to an absolute difference in prevalence in the two datasets of 
8% in 1997 and 12% in 2002, which is a relatively large change. Conversely, in Côte 
d’Ivoire and rural Zimbabwe, declines in population prevalence would have been 
overestimated by ANC surveillance data by a similar magnitude.   
As noted previously, the primary causes of temporal bias in pre-ART era ANC-
based trends would have been the initial progressive effect of HIV-related sub-fertility 
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and the later increase in the average age of HIV-infected women beyond the their most 
fertile years. As the simulations showed, this second cause would have had an 
especially strong negative influence on the representativeness of trends for older 
women aged 25 to 49 years. Among these older women, ANC prevalence would have 
clearly overstated declines in true population prevalence. Fortunately, trends in ANC 
prevalence among younger women 15 to 24 years of age, which are also used by most 
countries in SSA to measure changes in incidence among youth [64], would have been 
a better indicator of true population prevalence declines among young women. Even for 
this younger age group, however, the model suggests that some modest over-
estimation of reported declines in true population prevalence still could have occurred 
from the mid-1990s to the early 2000s. This bias should be taken into account when 
assessing the effectiveness of the country’s response to the HIV epidemic in SSA 
among youth.  
With regard to simulations conducted for the ART era, under our model 
assumption, results suggest that the introduction of ART would not be expected to 
greatly influence the representativeness of ANC surveillance data with respect to 
underlying population HIV prevalence trends even if fertility among HIV-infected women 
of all ages or among youth rebounded fully to pre-HIV infection rates. However, if ART 
reduced fertility by 50% or more, as shown in the model results for Botswana, an 
increasing bias of more than 25% between ANC and population survey estimates will be 
observed for around the next twenty years, and mostly among adults and those aged 25 
to 49 years. Smaller fertility reductions up to a quarter of overall age-specific fertility 
levels resulted in less bias, although comparatively more than when fertility on ART 
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increased. The reason for this is because fertility reductions can result in no further 
pregnancies, while the limit of any increase depends on the length of a woman’s 
remaining reproductive span in addition to the relative level of rebound actually 
explored. Across all scenarios, prevalence trends at ANC among 15-24 year-olds 
closely matched those among the wider population of women aged 15-24, indicating 
that a focus on young women may be the safest way to guard against biases introduced 
by these factors 
The above results highlight two issues that are important when considering the 
representativeness of ANC surveillance trends in the ART era. First, knowing the 
strength and direction of the association between ART use and fertility (when compared 
to fertility in uninfected women) as well as the pace of the scale-up of ART services in a 
country will be critical. Although a negative association between fertility and ART use 
typically resulted in a lower PR than if there was no or a lesser association -- and the 
inverse was true for a positive association – patterns of bias could vary across countries 
or over time. As a result, it would be difficult to develop a systematic approach to 
adjusting for this bias for women that could be uniformly applied to ANC estimates from 
across all countries in SSA in the future.   
Second, and as was true in the pre-ART era, HIV prevalence trends from the 
ANC surveillance data by age group were generally more robust for younger ages (i.e., 
15 to 24 years) compared to older ages (i.e. 25 to 49 years) and this was also true for 
the younger groups regardless of the association between ART and fertility or the level 
of scale-up of treatment services. As a result, ANC prevalence should still remain a 
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reasonably good indicator of underlying population prevalence trends for young women 
in the ART era.  
The findings from these simulations are similar to previous evidence supporting 
the use of ANC-based trends among young women aged 15 to 24 years to monitor 
prevalence trends among youth [50, 116, 117, 220]. Results from the model appear to 
conflict, however, with the original assumption that ANC estimates were stable enough 
over time to permit their use when monitoring true population prevalence trends for 
women of all reproductive ages. In the case of the previous modelling efforts by Garnett 
and Gregson in 2000, the main difference between their model and the model here is 
that, with the benefit of hindsight, the newer model more accurately captures 
transmission dynamics over the last 30 years in SSA. It is possible that using parameter 
values for incidence similar to those used here, the original model might produce 
patterns of bias that are consistent with our results, however, additional testing would be 
required to validate this assumption. 
With regard to the empirical study in rural Tanzania [50], which also found 
evidence to support the representativeness of ANC-based trends, several possible 
factors could explain the discordance between this model and their study results. First, 
changes in behavioural risk and mortality, which are not explicitly measured and 
reported in the study, could have contributed in an equal but offsetting way to the 
declines in population and ANC-based prevalence and these patterns might have 
differed from the parameters used here.  A second possible explanation is that trends in 
the Tanzanian study were measured and compared over a nine year period only, which 
may have been too short of a time frame to detect the gradual shifts in the magnitude of 
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bias which were observed in the model. Third, and finally, the model is simpler in its 
consideration of bias than that which will operate on trends in a real-world setting. In 
practice, empirical trends will be influenced by the quality of data collection and HIV 
testing across surveys, shifts in non-responder bias with time, and changes in access to 
and uptake of ANC surveillance that may be associated with HIV-status. As a result, 
these changes could explain the discordance in the findings between the Tanzanian 
study and those results presented here. 
A final source of evidence with regard to the similarity or differences in trends 
and validation of this model’s results is the unpublished findings reported in Chapter 3. 
Although the statistical analyses of these trends generally indicate that ANC data are 
reasonably representative for most countries in SSA, the PR in each of the settings was 
observed to vary for males and in rural areas in particular. Because those comparisons 
also covered shorter time periods and were influenced by the sources of bias described 
in the Tanzanian study, it is not possible to definitively conclude that the results in 
Chapter 3 differ from the simulations here. Countries using historical ANC trend data to 
measure the effectiveness of previous prevention efforts in particular should consider 
the real possibility that, aside from younger women, ANC prevalence trends may have 
overstated historical declines in true population prevalence in the pre-ART era.   
While the reliability of ANC prevalence trends in the pre-ART era can be 
reasonably assessed through the model, it is considerably more difficult to validate 
output from the ART era, where scale-up in many countries in SSA is on-going. To do 
this in the future, additional data on the relationship between ART initiation (assuming a 
current initiation when a woman’s CD4 counts reaches 200 as explored here -- or other 
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starting values based on new WHO recommendations) and subsequent fertility patterns 
among users compared to non-HIV-infected women in SSA is required. For example, in 
the simulations, the upper range of the positive association between ART and fertility 
was 100%, although ART users who may have taken steps to avoid pregnancy prior to 
initiating ART may also change their behaviour in such a way in the future that fertility 
on ART exceeds that of uninfected women. Also, this model assumes that fertility 
changes for ART users are immediate rather than gradual and do not differ by location. 
In reality, however, several studies have already indicated that fertility outcomes could 
change with time and according to age [167-169] and no study has looked at the extent 
to which ART users in more urban areas, for example, might respond differently to 
those in rural areas with regard to their fertility choices.  
A final limitation in this model, which merits further consideration in subsequent 
studies of the representativeness of ANC surveillance data over time, is the extent to 
which risk of HIV infection is associated with pregnancy or contraceptive use. Although 
there is also some evidence that pregnant women are at higher risk of HIV infection 
during their pregnancy, either due to behavioural or biological changes [163], the 
influence of this latter bias on ANC trends is likely to be minimal, provided the infection 
is detectable at a woman’s first ANC surveillance visit. If infection does occur within the 
first few months of becoming pregnant, ANC surveillance estimates may under-
represent HIV prevalence among pregnant women because tests used for surveillance 
purposes may not be sensitive enough to detect a recent infection, but this infection 
would be detected in the general population in the model. However, even to the extent 
that this is occurring, the implication for changes in bias would be small unless fertility 
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patterns in the population are also shifting over time for other reasons not related to HIV 
infection. With regard to hormonal contraception, the extent to which hormonal 
contraceptive use may place women at a greater risk of either acquiring HIV or 
experiencing more rapid disease progression [154] could reduce bias in ANC estimates 
over time if prevention programmes recommend additional prevention measures, such 
as condom use, or other contraceptive methods for those at highest risk. This once 
again highlights the importance of having detailed data in countries in SSA on whether 
and how fertility patterns are changing over time.  
In summary, this model has highlighted some of the historical and potential 
challenges of using ANC data to monitor true population prevalence trends among 
women of reproductive ages based on a current understanding of the HIV epidemic in 
selected SSA settings. Moving forward, while additional, more rigorous studies on 
associations between fertility and ART use are being carried out, steps to identify 
whether ANC-based trend data are subject to bias in the ART era can still be taken now 
in many countries in SSA. For example, collecting data at the time of the ANC 
surveillance round on whether ANC attendees are or have been on ART, the date when 
ART was initiated, and a brief pregnancy history could be used to identify HIV-infected 
women who are returning to the clinic after long periods of sub-fertility. In the course of 
providing PMTCT counselling, these questions are likely to be routinely discussed and 
thus would not violate the ethical principles associated with unlinked anonymous 
surveillance [242].  As it is difficult to identify the extent to which HIV-infected women on 
ART are not appearing in ANC clinics, however, other methods for measuring trends, 
particularly for older women and women of all reproductive ages might need to be 
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considered. Using interpolations of prevalence – and incidence – from repeated 
population surveys [75] or estimates arising from the application of incidence assays 
(should they become available) [243] may also be preferred until such a time when bias 
in ANC surveillance trends in the ART era is more easily quantifiable. Along these lines, 
this model could be modified in future revisions to explore the extent to which HIV 
prevalence trends among young pregnant women are representative of HIV incidence 
trends among youth, which is often assumed. These issues are discussed in greater 
detail in the concluding chapter.  
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Chapter 5: Monitoring trends in HIV 
prevalence among young people, 
aged 15 to 24 years, in Manicaland, 
Zimbabwe 
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5.1 Aims and organization of the chapter 
The aims of this chapter are twofold. First, it is to assess progress toward the United 
Nations General Assembly Special Session (UNGASS) target of reducing HIV 
prevalence among young women and men, aged 15 to 24 years, by 25% in the worst-
affected countries by 2005 using repeated household-based population serosurvey data 
in Manicaland, Zimbabwe. Second, it is to validate the representativeness of 
surveillance data from young pregnant women, aged 15 to 24 years, attending antenatal 
care (ANC) clinics, which UNAIDS recommends for monitoring population HIV 
prevalence trends in this age group. Changes in socio-demographic characteristics and 
reported sexual behaviour of participants were also investigated to identify possible 
causes for any disparities.  
The chapter begins by summarizing why monitoring trends among young people 
is important and what factors might contribute to differences between ANC and 
population HIV prevalence over time. Following that, background is provided on the 
Manicaland HIV/STD Prevention Project specific to the analyses performed here. A 
discussion on the statistical methods used to make comparisons is also included. 
Finally, results and a discussion of the main findings are provided. 
 
5.2 Introduction 
As mentioned in Chapter 1, in June 2001, the United Nations General Assembly Special 
Session (UNGASS) set a target of reducing HIV prevalence among youth, aged 15 to 
24 years, by 25% in the worst-affected countries by 2005, and by 25% globally by 2010 
[244]. Recently infected youth experience low HIV-related mortality [245, 246]. 
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Accordingly, changes in prevalence over time among young people should signal 
underlying changes in incidence. Changes in incidence are useful when gauging the 
effectiveness of prevention and treatment efforts [41, 49].  
Chapters’ 3 and 4 have shown that monitoring HIV prevalence trends in the 
general population using ANC surveillance data can be challenging; however, repeated 
national population surveys, which are believed to be a better source of data for 
monitoring the epidemic, are often too costly and complex to conduct more frequently 
[39]. Also, laboratory assays to detect recent infections have so far proven unreliable in 
sub-Saharan Africa [65, 247]. As a result, the Joint United Nations Programme on 
HIV/AIDS (UNAIDS) continues to recommend that countries in SSA use data from 
surveillance among pregnant women, also aged 15 to 24 years, attending antenatal 
care (ANC) clinics, to monitor progress toward the UNGASS target [64].  
Implicit in the UNAIDS recommendation is an assumption that ANC prevalence 
trends will mirror those among male and female youth in the general population. 
However, as the previous chapters have also shown, changes in sexual behaviour 
could cause ANC estimates to misrepresent general population trends. For example, 
prevention interventions promoting delays in initiating sex and/or consistent condom use 
could lead to general population HIV prevalence declines from reduced risk behaviour, 
even as prevalence at ANC clinics remains steady since, by definition, attendees are 
having unprotected sex. Conversely, if interventions, such as consistent condom use 
following HIV testing, successfully target infected individuals, a sudden drop in the ANC 
estimate of HIV prevalence could be observed (due to a fall in pregnancy rates in HIV-
positive women) that would not be representative of the general population.  
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Beyond these sources of bias, ANC surveillance data are also subject to other 
biases that could change with time, including: (i) ANC attendance varying with regard to 
availability and uptake and (ii) HIV-infected women having different levels of 
contraceptive use and lower fertility rates [42, 45, 47, 51, 55]. To address these 
potential biases in ANC data, UNAIDS recommends using population survey data to 
validate ANC estimates wherever possible, and analysing sexual behaviour data and 
characteristics of the testing populations to provide context to observed changes in 
prevalence [39, 64].  
In this chapter, data from the open-cohort, population-based household survey in 
Manicaland, Zimbabwe, conducted at three time intervals from 1998 to 2005 is used to 
assess directly whether the UNGASS indicator for prevalence reductions of 25% by 
2005 was met among youth aged 15 to 24 years. Also, the extent to which HIV 
prevalence trends in the general population mirror those among ANC attendees is 
considered, as many countries, including Zimbabwe, will not have access to repeated 
population survey data spanning the period covered by the UNGASS target. To validate 
the ANC surveillance data, the proportional changes in HIV prevalence are compared 
over the three rounds among pregnant women attending ANC clinics with those from 
the three parallel rounds of the general population survey in the same geographic 
areas. Finally, changes in participation, HIV prevalence by socio-demographic 
characteristics, such as educational status, and trends in sexual behaviour that could 
explain differences in the patterns of HIV estimates observed between the two datasets 
over time are explored. Previous assessments in this population using data from 1998 
to 2003 have shown substantial declines in population and ANC-derived HIV prevalence 
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estimates for men and women aged 15 to 49 years in this mature epidemic, primarily 
linked to behaviour change [26, 27]. 
 
5.3 Methods 
5.3.1 Study population and data collection procedures 
Data for the open-cohort, household-based population survey were collected in 12 
communities in Manicaland Province, representing four geographic strata (two small 
rural towns, two roadside trading centres, four tea, coffee and forestry estates, and four 
subsistence farming areas). For the ANC surveillance, clinics offering services to 
pregnant women in the population survey catchment areas were selected.  
Prior to each population survey round, all households and their residents in the 
study area were enumerated by local census. At round 1 and round 2, males aged 17 to 
54 years and females aged 15 to 44 years resident in the study households were 
considered eligible, except that only one eligible household member of each 
cohabitating or marital union was selected (at random) to participate. To be considered 
resident in a household, an individual must have slept in that house for at least four 
nights in the past month and also been present in the household at the same time one 
year previously.  
At round 2, residency requirements were dropped to include household visitors. 
Due to funding constraints, however, new in-migrants (i.e., individuals from existing and 
new households moving from outside the study area into the study area between round 
1 and round 2) were only included in communities 5 to 12. Starting at round 3, eligibility 
was further expanded to include in-migrants in all 12 communities and those aged 15 to 
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54 years for both sexes, regardless of marital status. Participants excluded in a prior 
round but joining the study in round 2 or round 3 were classified by their previous status 
(e.g. in-migrant, spouse) for that subsequent round. For consistency in exploring trends, 
individuals reporting having moved into a community where they were interviewed at 
round 1 within two years of the study date were identified as in-migrants for that round, 
although this likely represents an overestimate of the in-migrant population at round 1 
as some individuals may have reported a move that was internal to the study area. With 
regard to the change in inclusions criteria related to exclusion of spouses at round 1 and 
round 2, spouses were considered to be routine participants, since in this younger age 
group, they represented less than 2% of the total population aged 15 to 54 years at 
round 3. 
In the parallel ANC surveillance, all women seeking prenatal care at participating 
clinics (22 in all three rounds and seven additional clinics in one or two rounds only) 
during the population survey period were considered eligible. Surveillance was typically 
conducted over a six to eight week period in each community. In round 2 and round 3, 
women attending ANC clinics that were not their local clinic were considered eligible, 
but also identified as non-local attendees. In round 1, information on the number of non-
local attendees was not collected; however it was hypothesized that attendance by  
women from more rural communities outside the study and clinic catchment areas may 
have biased ANC surveillance estimates downward [55]. In round 2, 15.6% of women 
reported non-local clinic attendance. In round 3, that proportion was 14.4%.  
Study enrolment and eligibility for both the population survey and ANC 
surveillance was conditional on participants’ written consent at each round, although 
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ANC data were anonymised at data entry. The Medical Research Council of Zimbabwe 
and St Mary’s Local Research Ethics Committee, London, provided ethical approval. 
Round 1 was completed from July 1998 to February 2000; round 2 began in July 2001; 
and round 3 began in July 2003. Further details on study methods were summarized in 
Chapter 2, Section 2.6 and have been published previously [26]. 
 
5.3.2 HIV diagnostics 
The Biomedical Research and Training Institute laboratory in Harare, Zimbabwe, 
performed all HIV testing. At round 1, a highly sensitive and specific (both 99.6%) 
dipstick-dot ICL-HIV1 & 2 Dipstick EIA was used to detect HIV antibodies [26, 248]. 
Combaids-HIV-1 & 2 Dipstick was used in subsequent rounds, which was also 
determined in laboratory conditions to have high sensitivity and specificity (>99.9%). A 
small in-house comparison of these two dipstick tests showed 100% agreement 
between testing results from 160 positive and negative samples. For each round, all 
positive test results and a 10% sample of negatives were confirmed using a Plate EIA 
(Abbott 3rd Generation HIV 1 & 2 EIA, USA or Genelavia MIXT HIV1&2, Sanofi 
Diagnostics Pasteur S.A., France). [248] . Research staff were blinded to participants’ 
HIV status. 
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5.3.3 Data analysis 
5.3.3.1 Inclusion criteria 
In the population survey, all women aged 15 to 24 years and men aged 17 to 24 years 
resident in the study area at each round were included in the analysis. This led to the 
exclusion of 251 visitors (135 in round 2 and 116 in round 3) and 567 men aged 15 to 
16 years in round 3 from the analysis. Excluding these individuals permitted a more 
accurate description of changes in underlying HIV prevalence among individuals living 
in the study area over all three rounds. The total number of remaining individuals was 
4366 in round 1, 3289 in round 2 and 6371 in round 3.  
In the ANC surveillance, women aged 15 to 24 years seen at the 22 ANC clinics 
participating in all three surveillance rounds were included (i.e., data from seven clinics 
participating in one or two rounds were not used as recommended by UNAIDS and the 
World Health Organization to construct trends) [39]. The total number of participants 
was 676 in round 1, 667 in round 2 and 700 in round 3.  
 
5.3.3.2 Statistical analyses 
To describe HIV prevalence by data source (e.g., the population survey and ANC 
surveillance), crude HIV prevalence was calculated as the number of individuals testing 
positive divided by the number of individuals tested in the survey or surveillance round. 
To account for differences in population survey estimates across rounds due to shifts in 
the demographic composition of the population, crude estimates were adjusted by five 
year age groups and marital status (and sex, in the case of overall population survey 
estimates). Adjustments were made using a simple direct standardization method [249], 
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where the reference population was the distribution of all individuals at round 3. To 
account for the change in the inclusion of in-migrants in the study, demographic-
standardized estimates were similarly adjusted. Other methods to account for changes 
in migration were also explored, including (i) imputing missing HIV prevalence estimates 
by age and marital status for in-migrants in communities 1 through 4 (based on the 
round 3 distributions) and then standardizing estimates for demographic differences, 
and (ii) excluding in-migrants. In the ANC surveillance, crude and age-marital 
standardized estimates were calculated, also using the round 3 ANC surveillance 
participants as the standard population.  
To quantify uncertainty in population survey and ANC surveillance HIV 
prevalence estimates, 95% binomial confidence intervals (CIs) were calculated. 
Confidence intervals for round 1 and round 3 ANC-based surveillance estimates were 
widened to account for over-dispersion, which was detected by comparing the sum of 
the saturated log likelihood across clinics to the sum of the log likelihood assuming 
constant (e.g., average) prevalence within the clinics using the chi-square test (DF=21) 
[223]. The null hypothesis (e.g., no over- dispersion) was rejected when the resulting p-
value for the chi-square value was <0.05. The adjustment factor to the 95% CI was 1.26 
times the standard error in round 1 and 1.14 times the standard error in round 2.  
To calculate the relative proportional change in prevalence across rounds (round 
1 to round 3) and between rounds (round 1 to round 2; round 2 to round 3) as described 
in the UNGASS indicator, the difference between the earlier and the later round 
estimates was divided by the earlier estimate. When validating ANC surveillance trends 
relative to those in the population survey, proportional differences in HIV prevalence 
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across (round 1 to round 3) and between rounds (round 1 to round 2; round 2 to round 
3), the Z-score test-statistic was used. To approximate variance in these proportional 
differences, which was too complex to obtain analytically, the delta method based on 
the Taylor series expansion of the variance was used [223]. The null hypothesis for 
trend similarity was rejected where |Z| >1.96 (i.e., p-value <0.05). This approach was 
adopted, rather than an odds ratio regression analysis, to permit comparison of the 
proportional change in HIV prevalence. A limitation of this approach, however, is that 
the Z-score test assumes independence in the samples across rounds, whereas in the 
population survey, the same individual may be tested across multiple rounds. The 
influence of this limitation on study findings is considered further in the discussion.    
For the purposes of these analyses, general population survey trends were 
assumed to be the “gold standard” or the best representation of true underlying 
population prevalence in the study area; hence, the representativeness of ANC data 
was considered relative to that of the general population survey. Due to the rolling 
nature of the survey start date, the UNGASS indicator baseline measurement against 
which proportional prevalence change by 2005 was measured was assumed to be 
round 1, which spanned the period from 1998 to 2000.  
Changes in behaviour between rounds in the sample dataset, including the 
proportion of non-sexually active youth, new partnership formation in the past year, 
consistent condom use among unmarried persons and partner’s age for individuals 
reporting sex in the past two weeks were compared using two-tailed Z-scores and 
Student’s t-tests. Behavioural data were collected using informal confidential voting 
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interviews, which have been associated with less reported “social desirability bias” than 
conventional face-to-face interviewing methods in the study population [202].  
The first three behavioural indicators from the survey data most closely 
approximate UNAIDS recommendations for monitoring behaviour change among youth 
as part of the 2001 UNGASS targets [64]. The fourth indicator, partner age, has been 
shown previously to be an important factor in HIV transmission in this population [250]. 
Other key factors, such as changes in sexually transmitted infections (STIs), were not 
investigated: STI biomarkers were not included in the survey, self-reported symptoms 
can be unreliable, and prevalence of STIs are thought to be low in this population [248]. 
 
5.4 Results 
5.4.1 Study participant characteristics 
Figure 5.1 shows the results of household- and individual-level participation levels in the 
population survey and ANC surveillance datasets by round among eligible individuals. 
Enrolment in the population survey was high, with more than 94% of households 
agreeing to participate in each round. Among youth in the participating households, 
participation levels were similar for males and females, except that fewer males (73.7%) 
compared to females (83.4%) participated in round 3 (p-value <0.001). Absenteeism, as 
opposed to refusals, primarily explained lower individual participation levels. In the ANC 
surveillance, agreement to participate was nearly universal (97.7%-100%).  
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* Men aged 17 to 24 years only. 
Figure 5.1 Round-specific household and individual participation levels for the Manicaland project general 
population survey (green-shaded boxes) and ANC surveillance (red-shaded box). Round 1 (R1): 1998-2000; Round 
2 (R2): 2001-2003; Round 3 (R3): 2003-2005 
 
Specific to the socio-demographic characteristics in each data set, the sex ratio 
(males/females) fluctuated over time in the population survey from 0.94 in round 1 to 
0.77 in round 2 and 0.68 in round 3. Across rounds, the mean age of individuals in the 
population survey was younger (19.6 years) than that in the ANC surveillance (20.3 
years) (p <0.001). The proportion of men aged 17 to 19 years was approximately 47% 
in all three rounds. The proportion of women in the population survey aged 15 to 19 
years was roughly the same at round 1 and round 3 (55.2% and 53.5%), but was 
significantly higher at round 2 (62.8%) (p-value <0.001).  
‘Head of Household’ consent levels for family  
members to participate in survey: 
R1 * : 98.0% (8211/8376) 
R2 † : 94.2% (7102/7543) 
R3 ‡ : 95.9% (9579/9990) 
Individual participation levels  (aged 15 to 24 years)* 
within consenting households: 
R1 Male: 77.9% (2112/2711); Female: 75.0% (2254/3004) 
R2 Male: 75.7% (1430/1889); Female: 74.0% (1859/2511) 
R3 Male: 73.7% (2576/3494); Female: 83.4% (3795/4550) 
General population survey ANC surveillance 
Consent levels for pregnant women  
(aged 15 to 24 years) at 22 ANC  
clinics: 
R1: 97.7% (676/692) 
R2: 99.7% (667/669) 
R3: 100.0% (700/700 ) 
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Reflecting their younger ages and the inclusion of men, fewer individuals in the 
population survey were married (24.9% versus 87.2% in ANC surveillance, p-value 
<0.001), but more had secondary or higher education (81.8% versus 64.5% in ANC 
surveillance, p <0.001). With regard to marital status in the population survey, in round 
1, men were slightly less likely to be married (9.5%) as compared to in round 2 (12.5%) 
and round 3 (11.5%). Women, on the other hand, were less likely to be married (29.3%) 
in round 2 as compared to in round 1 (37.3%) and in round 3 (37.9%). This latter 
distribution coincides with the younger ages of the population at round 2.  
The residence of participants in the population survey distribution reflected the 
number of study sites, with 36.1% living in subsistence farming areas, 29.4% in estates, 
19.2% in roadside trading centres, and 15.8% in towns aggregated across all rounds. 
Estimates did not vary greatly across rounds. The proportion of in-migrants was highest 
in towns and estates at all rounds. Relative to the population overall, 31.1% of the 
population reported moving to their community within two years of round 1 (see Figure 
5. 2). At round 2, reflecting in part the exclusion of in-migrants in communities 1 through 
4, the proportion of in-migrants was just 14.2%. In round 3, in-migrants comprised 
19.6% of the total population.  
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Figure 5.2 Routine participants and in-migrants in the population survey in Manicaland, Zimbabwe, 1998-2005. In-
migrants at round 1 were identified as those individuals who moved to their community with two years of the first 
interview date.  
 
In the ANC surveillance, 32.9% of participants attended clinics in subsistence farming 
areas, 33.7% in estates, 15.8% in roadside trading centres, and 18.6% in towns, and 
this also did not vary across rounds.  
Considering the potential representativeness of ANC surveillance data, in the 
population survey, 21.8% of sexually active women at round 1, 20.6% at round 2 and 
25.4% at round 3 identified themselves as being either currently pregnant or having 
completed a pregnancy in the six months prior to the interview date. Clinic attendance 
among these women was 81.9% in round 1, 82.4% in round 2 and 84.6% in round 3. Of 
those seeking ANC services, approximately 80% at each round reported attending their 
local clinic. Similar levels of local clinic attendance at round 2 and round 3 were also 
reported in the ANC surveillance.  
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* In-migrants at round 1 were identified as those 
individuals who moved to their community within two 
years of the interview date.
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5.4.2 Population-based and ANC HIV prevalence among youth 
Table 5.1 summarizes crude and adjusted HIV prevalence levels and trends 
among youth (women aged 15 to 24 years and men aged 17 to 24 years separately, 
and combined) in the general population survey and among ANC attendees at each 
survey round between 1998 and 2005. In the columns following each set of estimates, 
the proportional changes in HIV prevalence across and between rounds, along with the 
accompanying 95% confidence intervals, are provided.    
In general, crude HIV population prevalence separately by sex, and among men 
and women combined, was lower than ANC prevalence at each round (see Table 5.1 
and Figure 5.3a. The higher levels of HIV prevalence among all ANC attendees 
reflected the older average age of pregnant women as compared to the general 
population and the selection for high-risk sexual activity that exposes women to 
pregnancy and HIV infection. In the population survey, women, in comparison to men, 
also had higher HIV prevalence levels, suggesting that females compared to males are 
at a higher risk of HIV infection generally at young ages in the study area.  
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Table 5.1  Crude and adjusted (i.e., standardized) HIV prevalence and proportional reductions in the general population survey and ANC surveillance in 
Manicaland, Zimbabwe, 1998-2005.  
 
Round 1 (1998 - 2000) Round 2 (2001-2003) Round 3 (2003-2005)
N 
(#)
HIV+ 
(n)
HIV+ 
(%) 95% CI
N 
(#)
HIV+ 
(n)
HIV+ 
(%) 95% CI
N 
(#)
HIV+ 
(n)
HIV+ 
(%) 95% CI
Population survey 
  Women
Crude 2254 349 15.5 (14.0 - 17.0) # 1859 149 8.0 (6.8 - 9.3) 3795 311 8.2 (7.3 - 9.1) -47.1% (-54.7, -39.5) -48.2% (-57.6, -38.8) 2.2% (-16.9, 21.4)
Standardized (demographics)* 15.6 (14.1 - 17.0) # 9.3 (7.9 - 10.8) 8.2 (7.3 - 9.1) -47.4% (-54.9, -39.8) -39.9% (-50.5, -29.6) -12.4% (-27.9, 3.1)
Standardized (migration & demographics)
†
15.4 (13.9 - 16.8) # 9.1 (7.7 - 10.5) 8.2 (7.3 - 9.1) -46.7% (-54.4, -39.1) -40.6% (-50.9, -30.4) -10.3% (-26.3, 5.7)
  Men
Crude 2112 100 4.7 (3.9 - 5.7) # 1430 44 3.1 (2.2 - 4.1) 2576 74 2.9 (2.2 - 3.5) -39.3% (-57.6, -12.4) -35.0% (-57.6, -12.4) -6.6% (-40.9, 27.7)
Standardized (demographics)* 5.0 (4.0 - 5.9) # 2.9 (2.1 - 3.8) 2.9 (2.2 - 3.5) -41.0% (-61.7, -20.2) -41.0% (-61.7, -20.2) -2.2% (-38.7, 34.3)
Standardized (migration & demographics)
†
4.6 (3.7 - 5.6) # 2.9 (2.1 - 3.8) 2.9 (2.2 - 3.5) -40.6% (-50.9, -30.4) -36.3% (-59.0, -13.7) -2.2% (-38.7, 34.3)
  Men and women combined
Crude 4366 449 10.3 (9.4 - 11.2) # 3289 193 5.9 (5.1 - 6.7) 6371 385 6.0 (5.5 - 6.6) -41.2% (-48.9, -33.7) -42.9% (-55.2, -33.7) 3.0% (-14.3, 20.2)
Standardized (demographics)* 11.3 (10.3 - 12.2) # 6.7 (5.9 - 7.7) 6.0 (5.5 - 6.6) -46.4% (-53.2, -39.5) -40.1% (-49.2, -31.0) -10.6% (-24.8, 3.7)
Standardized (migration & demographics)
†
10.5 (9.6 - 11.4) # 6.6 (5.7 - 7.5) 6.0 (5.5 - 6.6) -42.6% (-50.0, -35.1) -41.2% (-46.8, -27.3) -8.7% (-23.4, 5.5)
ANC surveillance data
Crude 676 125 18.5 (15.6 - 21.6) # 667 88 13.2 (10.7 - 15.8) 700 69 9.9 (7.8 - 12.3) -46.7% (-64.0, -29.4) -28.7% (-48.6, -8.7) -25.3% (-49.3, -1.3)
Standardized (demographics)* 18.4 (15.5 - 21.3) # 13.2 (10.7 - 15.8) 9.9 (7.8 - 12.3) -46.6% (-63.9, -29.3) -28.1% (-48.1, -8.1) -25.7% (-49.5, -1.8)
#
* Estimates adjusted (i.e. standardized) across rounds for changes in participation by 5 year age groups, marital status, and sex (for women and men combined) using the population stratum totals in round 3 as 
the standard.
† 
 Estimates adjusted (i.e., standardized) across rounds for changes in participation by 5 year age groups, marital status , and sex (for men and women combined) and for in-migration using the population stratum 
totals in round 3 as the standard.
Round 1 to 3 Round 1 to 2 Round 2 to 3
Proportional 
Change (95% CI)
Proportional 
Change (95% CI)
Proportional 
Change (95% CI)
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With regard to the UNGASS indicator in the population survey, larger crude 
proportional reductions in HIV prevalence during the study period were observed among 
women (-47.1%; 95% CI: -54.7%, -39.5%) than men (-39.3%; 95% CI: -57.6%, -12.4%). 
The increasing ratio of women to men between round 1 and round 3, however, reduced 
the overall magnitude of the decline for men and women combined (-41.2%; 95% CI: -
48.9%, -33.7%). Not surprisingly, the proportional reduction in HIV prevalence among 
women from round 1 to round 3 was most similar to that observed among ANC 
attendees (-46.7%; 95% CI: -64.0%, -29.4%). Regardless of the data source or sub-
population considered, however, crude round 1 to round 3 reductions in HIV prevalence 
comfortably exceeded the UNGASS target of 25% by 2005. Also, no statistically 
significant differences were identified in the comparison of round 1 to round 3 trends, 
indicating that crude ANC estimates reasonably reflected the proportional reduction 
overall in HIV prevalence in the population without adjusting estimates. 
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Figure 5.3 Estimates of HIV prevalence in the general population and ANC surveillance a) unadjusted and b) 
adjusted for demographic shifts in the composition of the population only and c) also for migration patterns in 
Manicaland, Zimbabwe, 1998-2005. Round 3 is the reference population for all adjustments.  
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Despite this latter finding, as Figure 5.3a shows, intermediary trends in the two 
data sources were less comparable. From round 1 to round 2, which covered about five 
of the eight years of the study, the tendency was for the proportional reduction in the 
ANC crude prevalence estimate to greatly understate that in the population survey. In 
the case of men and women combined, the general population decline between 1998 
and 2001 was 42.9% (95% CI: -55.2%, -33.7%) as compared to 28.7% (95% CI: -
48.6%, -8.7%) in the ANC surveillance over the same time period. In the period 
covering the last three years approximately, from round 2 to round 3, the reduction in 
the ANC estimate (-25.3%; 95% CI: -49.3%, -1.3%) contrasted with an increase in the 
population survey estimate (3.0%; 95% CI: -14.3%, 20.2%). This rise was driven by the 
higher proportion of women, relative to men, at round 2 and round 3, and the larger 
proportion of female in-migrants at round 3 with disproportionately high HIV prevalence 
in comparison to the routine female participants (see Figure 5.4a).  
 
 
 Figure 5.4  HIV prevalence of a) women aged 15 to 24 years and b) men aged 17 to 19 years by participant status 
(e.g., routine and in-migrant).  
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Although none of the differences in intermediary trends reached a level of statistical 
significance at the 95% level (p-value<0.05), comparison of ANC surveillance trends 
with those among females, and females and males combined between round 1 and 
round 2 produced p-values that were less than 0.10.  
Standardization of ANC and population survey data to account for changes in the 
demographic composition of participants over time did not dramatically influence 
intermediary trends, although the proportional increase in the prevalence among women 
only, and men and women combined, from round 2 to round 3 was reversed in the 
standardized estimates (See Table 5.1 and Figure 5.3b). This reversal resulted from 
increasing the relative weight of HIV prevalence among married women at round 2, 
consistent with that of round 3, and among men and women combined, accounting for 
the shifting ratio of male to female participants. Even after adjusting for demographic 
differences, however, ANC estimates still declined less steeply from round 1 to round 2 
and more steeply from round 2 to round 3 as compared to the population survey trends, 
in part due to the higher HIV prevalence among in-migrant females at round 3. Notably, 
however, the overall decline among men and women combined (-46.4%; 95% CI: -
53.2%, -39.5%) more closely resembled the proportionate reduction in ANC estimates 
from round 1 to round 3, reflecting the standard distribution of females compared to 
males.  
Further standardization of these estimates to account for changing migration 
patterns also did not alter overall or intermediary trends substantially (see Table 5.1 and 
Figure 5.3c), although the lower HIV prevalence at round 2 among women (relative to 
the demographic-standardized estimate) highlighted the unusual finding that the higher 
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HIV prevalence among in-migrants was concentrated in unmarried women aged 15 to 
19 years only. In round 1 and round 3, all female in-migrants regardless of age or 
marital status had higher HIV prevalence than the general population.  Imputing HIV 
prevalence estimates for missing in-migrants in communities 1 through 4 and then 
standardizing them for demographic and in-migrant differences also resulted in no 
change. This was true because even though the potential HIV prevalence among 
missing in-migrants in communities 1 through 4 by sex would likely have been higher 
than the estimates among in-migrants in communities 5 through 12  (females: 11.0% 
versus 9.5% and males: 10.1% versus 4.8%), the proportion of missing in-migrants 
relative to the overall population size was very small.  
One final consideration with regard to in-migrants was whether ANC surveillance 
data would be more representative of persons living in the study area for at least two 
years (i.e., excluding in-migrants). In this case, proportional changes in crude and 
standardized estimates would have slightly outpaced those observed among ANC 
attendees as compared to when in-migrants were included, although overall reductions 
were in both data sets were similar (see Table 5.2). More importantly, however, 
exclusion of in-migrant females generated more consistent reductions between rounds, 
after standardization for demographic changes in the population, than when in-migrants 
were included. Among men, exclusion of in-migrant participants did not appear to 
improve the representativeness of ANC surveillance data either. 
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 Table 5.2  Crude and adjusted (i.e., standardized) HIV prevalence and proportional reductions among non-in-migrants in the general population survey and 
ANC surveillance attendees in Manicaland, Zimbabwe, 1998-2005.  
Round 1 (1998 - 2000) Round 2 (2001-2003) Round 3 (2003-2005)
N 
(#)
HIV+ 
(n)
HIV+ 
(%) 95% CI
N 
(#)
HIV+ 
(n)
HIV+ 
(%) 95% CI
N 
(#)
HIV+ 
(n)
HIV+ 
(%) 95% CI
Population survey (excluding in-migrants)
  Women   
Crude 1559 214 13.7 (12.1 - 15.5) 1587 123 7.8 (6.5 - 9.2) 2919 195 6.7 (5.8 - 7.6) -51.3% (-60.3, -42.4) -43.5% (-55.4, -31.7) -13.8% (-32.5, 4.9)
Standardized (demographics)* 13.4 (11.8 - 15.0) # 8.6 (7.2 - 10.0) 6.7 (5.8 - 7.6) -50.2% (-59.4, -40.9) -35.8% (-48.9, -22.7) -22.4% (-38.7, -6.1)
  Men
Crude 1448 55 3.8 (2.9 - 4.9) 1234 39 3.2 (2.3 - 4.3) 2201 62 2.8 (2.2 - 3.6) -25.8% (-52.3, 0.6) -16.8% (-50.3, 16.8) -10.9% (-46.0, 24.3)
Standardized (demographics)* 4.6 (3.1 - 5.2) # 2.9 (2.1 - 4.0) 2.8 (2.1 - 3.5) -31.9% (-55.7, -8.2) -26.7% (-56.1, 2.7) -7.1% (-44.2, 30.1)
  Men and women combined
Crude 3007 269 8.9 (7.9 - 10.0) 2821 162 5.7 (4.9 - 6.7) 5120 257 5.0 (4.4 - 5.7) -43.9% (-53.1, -34.6) -35.8% (-47.9, -23.7) -12.6% (-29.3, 4.1)
Standardized (demographics)* 9.2 (8.2 - 10.2) # 6.1 (5.2 - 7.0) 4.9 (4.4 - 5.6) -45.2% (-54.2, -36.3) -33.5% (-45.7, -21.3) -17.7% (-33.1, -2.2)
ANC surveillance data
Crude 676 125 18.5 (15.6 - 21.6) # 667 88 13.2 (10.7 - 15.8) 700 69 9.9 (7.8 - 12.3) -46.7% (-64.0, -29.4) -28.7% (-48.6, -8.7) -25.3% (-49.3, -1.3)
Standardized (demographics)* 18.4 (15.5 - 21.3) # 13.2 (10.7 - 15.8) 9.9 (7.8 - 12.3) -46.6% (-63.9, -29.3) -28.1% (-48.1, -8.1) -25.7% (-49.5, -1.8)
#
Round 1 to 3 Round 1 to 2 Round 2 to 3
Proportional 
Change (95% CI)
Proportional 
Change (95% CI)
Proportional 
Change (95% CI)
* Estimates adjusted (i.e. standardized) across rounds for changes in participation by 5 year age groups, marital status, and sex (for women and men combined) using the population stratum totals in round 3 as the 
standard.
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5.4.3 Socio-demographic predictors of trend differences 
Using the Z-score test statistic to compare gender-specific proportional changes in 
overall and intermediary adjusted HIV prevalence trends (e.g., round 1 to round 2 and 
round 2 to round 3) by socio-demographic strata (e.g., 15 to 19 year olds versus 20 to 
24 year olds), no stratum-specific differences in trends between the two data sources 
were identified (see Table 5.3). Nevertheless, from these stratum-specific comparisons, 
it was evident that ANC surveillance data did not reflect changes in HIV prevalence 
trends among men as well as they did among women. In particular, among men aged 
17 to 19 years and those who were single, estimates were observed to fluctuate 
between rounds, whereas among ANC attendees, they declined sharply. Equally, 
reductions in adjusted HIV prevalence among men who were single or who resided in 
towns declined considerably less steeply than those among ANC attendees in similar 
stratum. 
 
         
 208 
 
Table 5.3  HIV prevalence estimates by socio-demographic characteristics among young women and men aged 15 to 24 years in the general population survey 
and ANC surveillance in Manicaland, Zimbabwe, 1998-2005.  
Adjusted 
HIV (%)
95% CI 
(adjusted)
Adjusted 
HIV (%)
95% CI 
(adjusted)
Adjusted 
HIV (%)
95% CI 
(adjusted)
HIV 
(%)
95% CI HIV 
(%)
95% CI HIV 
(%)
95% CI
Women
   Age* 15-19 years 6.3 (5.0 - 7.7) 3.2 (2.2 - 4.3) 3.0 (2.2 - 3.7) 13.2 (9.4 - 18.0) 7.7 (4.8 - 11.6) 5.0 (2.8 - 8.2)
 20-24 years 25.8 (23.1 - 28.6) 15.9 (13.1 - 18.8) 14.2 (12.6 - 15.9) 22.0 (17.9 - 26.2) 16.7 (13.2 - 20.7) 13.1 (10.0 - 16.7)
  Marital status
† Single 10.4 (8.9 - 11.9) 6.2 (4.8 - 7.6) 5.4 (4.5 - 6.3) 20.0 (10.8 - 32.3) 10.0 (5.3 - 16.8) 7.3 (2.7 - 15.2)
Married 23.6 (20.7 - 26.5) 14.0 (10.9 - 17.0) 12.8 (11.1 - 14.5) 18.3 (15.4 - 21.6) 13.9 (11.1 - 17.1) 7.6 (7.9 - 12.9)
  Education
‡ None/primary 24.9 (21.4 - 28.4) 17.6 (13.3 - 22.0) 14.7 (12.1 - 17.2) 18.9 (14.4 - 24.1) 11.4 (7.6 - 16.3) 11.0 (7.2 - 15.8)
Secondary/higher 12.3 (10.8 - 13.8) 7.1 (5.6 - 8.5) 6.6 (5.7 - 7.4) 18.2 (14.6 - 22.3) 14.1 (11.0 - 17.8) 9.3 (6.9 - 12.3)
  Residence
‡§ Town 26.0 (20.2 - 30.0) 16.4 (11.6 - 21.1) 13.5 (10.9 - 16.2) 19.8 (13.0 - 28.3) 12.3 (6.9 - 19.7) 9.3 (4.9 - 15.7)
Commercial estate 19.0 (15.9 - 22.1) 10.0 (7.3 - 12.8) 8.8 (7.0 - 10.47) 20.8 (15.7 - 26.7) 14.3 (10.0 - 19.5) 11.2 (7.5 - 16.0)
Subsistence farm 10.1 (8.2 - 12.0) 7.1 (4.3 - 10.0) 6.1 (4.9 - 7.3) 18.4 (13.5 - 24.2) 11.8 (7.9 - 16.8) 11.1 (7.4 - 15.8)
Roadside trading 12.1 (9.1 - 15.1) 6.7 (4.0 - 9.4) 7.1 (5.4 - 8.9) 12.8 (7.4 - 20.3) 14.7 (8.5 - 23.1) 4.8 (15.8 - 10.9)
Men
   Age* 17-19 years 0.8 (0.3 - 1.4) 0.6 (0.10 - 1.3) 1.5 (0.8 - 2.2)
 20-24 years 7.9 (6.2 - 9.7) 4.9 (3.4 - 6.4) 4.1 (3.0 - 5.1)
  Marital status
† Single 3.4 (2.6 - 4.3) 2.0 (1.2 - 2.8) 2.2 (1.6 - 2.8)
Married 13.6 (8.5 - 18.8) 10.0 (5.8 - 14.4) 8.1 (5.0 - 11.2)
  Education
‡ None/primary 5.9 (3.4 - 8.4) 5.7 (2.7 - 8.8) 3.2 (12.6 - 5.1)
Secondary/higher 4.5 (3.6 - 5.6) 2.4 (0.14 - 5.9) 2.8 (2.2 - 3.5)
  Residence
‡§ Town 6.6 (3.1 - 7.9) 5.6 (2.4 - 8.7) 5.3 (2.3 - 7.5)
Commercial estate 6.0 (4.5 - 8.2) 3.6 (0.80- 7.4) 3.7 (2.4 - 5.1)
Subsistence farm 3.3 (1.8 - 4.8) 1.8 (0.74 - 2.8) 1.8 (0.9 - 2.6)
Roadside trading 5.5 (2.4 - 6.5) 2.0 (0.2 - 3.8) 1.7 (0.6 -2.7)
¶  
The residence of ANC attendees is defined as where the woman attended the ANC and not her actual household residence.
Population survey ANC surveillance 
Round 1 Round 2 Round 3 Round 1 Round 2 Round 3
Socio-demographic characteristics 
* Estimates adjusted across rounds for changes in participation by marital status across all rounds and in-migration using the population stratum totals in round 3 as the standard
† Estimates adjusted across rounds for changes in participation by 5 year age group across all rounds, and in-migration using the population stratum totals in round 3 as the standard
‡ Estimates adjusted across rounds for changes in participation by 5 year age group and marital status across all rounds and in-migration using the population stratum totals in round 3 as 
the standard
(1998-2000) (2001-2003) (2003-2005) (1998-2000) (2001-2003) (2003-2005)
See above for estimates among female ANC attendees
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5.4.4 Behavioural risk factors 
Table 5.4 shows trends in selected behavioural indicators reported in the 
general population dataset that could explain observed intermediary differences. For 
both sexes and age groups, the proportion of those not yet initiating sex increased 
significantly from round 1 to round 2. From round 2 to round 3, evidence of a continued 
and significant increase was limited to men only. Among younger women (aged 15 to 19 
years), the proportion not yet initiating sex declined slightly (from 79.5% to 78.4%) while 
the decline among older women aged 20 to 24 years was significant (17.6% to 14.1%; 
p-value=0.029).  
For those who had sex within the past year, the proportion of women reporting 
none, 1 or 2 or more partners did not change from round 1 to round 2. From round 2 to 
round 3, however, a significant decline in the number of women reporting one partner 
and an increase in the proportion reporting no new partners was observed. Among men 
reporting of one new partner in the previous year increased from round 1 to round 2 
(34.1% to 40.1%; p-value=0.006), but then remained relatively unchanged from round 2 
to round 3.  
Estimates of mean partner age of persons having sex in the past two weeks 
and consistent condom use among unmarried women and men generally tended toward 
less risky behaviour, although among women, mean partner age did not change greatly. 
With regard to the partner’s mean age among men, the overall significant increase from 
round 1 to round 2 likely reflected the increasing proportion of men delaying initiation of 
sex. From round 2 to round 3, however, a significant decrease in mean partner age, 
was observed, from 19.2 years to 18.6 years (p-value=0.001).   
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Finally, with regard to the behavioural indicators, among unmarried women and 
men, steady increases were observed in consistent condom use. From round 2 to round 
3, this increase was significant for both sexes (p<0.001) and reflect the relative 
emphasis in the study area on interventions promoting safe sex in this age group. 
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Table  5.4 Selected behavioural indicators among young women aged 15 to 24 years and men (aged 17 to 24) in the general population survey in Manicaland, 
Zimbabwe, 1998-2005. 
  Female
    15-19 years of age 829 1243 66.7 928 1167 79.5 1593 2032 78.4
    20-24 years of age 108 1011 10.7 122 692 17.6 249 1763 14.1
  Male
    17-19 years of age 512 1013 50.5 475 664 71.5 1045 1204 76.2
    20-24 years of age 152 1100 13.8 153 766 20.0 327 1372 23.8
  Female
0 new partners 773 1104 70.0 401 571 70.2 1051 1328 79.1
1 new partner 302 1104 27.4 151 571 26.4 249 1328 18.8
2+ new partners 29 1104 2.6 19 571 3.3 28 1328 2.1
  Male
0 new partners 446 1127 39.6 231 604 38.3 202 555 36.4
1 new partner 384 1127 34.1 242 604 40.1 218 555 39.3
2+ new partners 297 1127 26.4 131 604 21.7 135 555 24.3
  Female 27.9 27.7 27.2
  Male 18.4 19.2 18.6
  Female 61 113 54.0 48 74 64.9 297 336 88.4
  Male 263 373 70.5 97 145 66.9 584 655 89.2
Men aged 15 to 16 years were excluded in round 3 and data were not collected for these ages at round 1 and round 2.
*Inclusion criteria changed to include in-migrants in communities 5-12 at round 2 and all in-migrants at round 3. 
Consistent condom use with the last partner in the previous two weeks among unmarried individuals (n, N, % )
0.141 <0.001
0.423 <0.001
(18.1 - 18.7) (18.7 - 19.8) (18.4 - 18.8) 0.070 0.001
(27.5 - 28.4) (17.1 - 28.2) (26.9 - 27.4) 0.455 0.0849
0.032 0.2865
Partner’s mean age and 95%  CIs (in years) for those reporting sexual intercourse in the past two weeks
0.589 0.413
0.013 0.883
0.415 0.117
0.929 <0.001
0.691 <0.001
Number of new partners among those having sex in the last year (n, N, % )
<0.001 0.020
<0.001 0.040
<0.001 0.454
<0.001 0.029
Individuals not yet initiating sex (n, N, % )
Round 2 to 3
p-values(1998-2000) (2001-2003) (2003-2005)
Round 1 Round 2* Round 3 Round 1 to 2 
p-values
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5.5 Discussion 
Data from the three large population surveys conducted from 1998 to 2005 in 
Manicaland, Zimbabwe have shown that the UNGASS target of a reduction of 25% 
in HIV prevalence by 2005 among young women aged 15 to 24 years and young 
men aged 17 to 24 years was most likely achieved, and possibly substantially 
exceeded, in the study area. Among women, the proportional reduction in HIV 
prevalence over the three study rounds (from 1998 to 2005) was about 47%. Among 
men, as compared to women alone, reductions in crude and standardized estimates 
were modestly smaller, at around 40%, but still above the 25% UNGASS target. 
Considering the study population as a whole, HIV prevalence fell by 46.4%, after 
accounting for changes in the demographic composition and shifts in in-migration 
patterns over the study rounds. Similar proportional declines of approximately 46% 
were observed among ANC attendees at clinics over the same time period, 
suggesting that these data were generally representative of population HIV 
prevalence trends. The 95% confidence intervals for all proportional HIV prevalence 
reductions comfortably exceeded 25%, except among men where the reduction 
could have been less.  
Despite these results, which are broadly encouraging of HIV prevention 
interventions in the study area and the use of ANC surveillance data to monitor 
population prevalence trends among youth, there were some findings which merit 
further consideration. Most importantly, with regard to the usefulness of ANC 
surveillance data, although proportional reductions were similar between the two 
data sources, intermediary trends were observed to differ. In particular, crude 
population-level HIV prevalence reductions were considerably greater than those 
observed among ANC attendees from round 1 to round 2, but substantially smaller 
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than – and in the case of women, even in opposition to – the reductions observed in 
the ANC estimates from round 2 to round 3.  
Before exploring whether these intermediary differences reflect changes in 
behaviour between ANC and general population participants, it is first important to 
account for possible participation biases in the data sources as these may change in 
magnitude over time. In the population survey, one of the biggest sources of 
participation bias that could be quantified and accounted for using adjustment 
methods arose from the changing distribution of the socio-demographic profile of 
survey participants at each round. For example, at round 2, as compared to round 1 
or round 3, the proportion of females who were younger and unmarried with low HIV 
prevalence was much larger than the proportion of those who were older and 
married with higher HIV prevalence. Adjusting for these differences reduced the bias 
in estimates at round 2 such that population prevalence among women no longer 
increased over the last two survey rounds. Among men, however, the proportional 
distribution of age categories and marital status was more consistent across the 
rounds, thus adjusting estimates made only a modest difference to the intermediary 
trends. In the population survey, the adjusted estimates would be a better reflection 
than the crude estimates for changes in the intermediary population HIV prevalence 
trends.  
The other source of participation bias that could be directly measured and 
accounted for in the population survey estimates was that resulting from changes in 
the ratio of men to women across the population survey rounds. As a consequence 
of women becoming increasingly over-represented in the survey at each round, 
crude reductions among men and women combined would have been smaller as 
time progressed since women were at higher risk of HIV generally when compared 
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to men. Standardization of estimates by sex for men and women combined across 
rounds thus permitted a less biased indicator of changes in population trends.  
A third source of bias in the population survey estimates resulted from the 
changes more generally in the distribution of in-migrants across the survey rounds, 
and the exclusion of in-migrants in four of the 12 communities at round 2 specifically.  
Adjusting for in-migration, however, did not considerably change the large 
intermediary differences in trends that were also present in the demographically-
adjusted estimates. Attempting to impute values for in-migrants excluded from round 
2 also resulted in no appreciable difference in the intermediary trends. The limitation 
to both of these analyses, however, is that data on HIV prevalence among in-
migrants at round 2 for the four communities was ultimately unknown and 
associations between HIV infection and in-migration was different at round 2 when 
compared to round 1 and round 3, especially among women. Excluding in-migrants 
from the population study completely resulted in the best representation of 
intermediary reductions in trends as represented by the ANC surveillance data. 
With regard to the choice of the standard population for adjusting estimates 
for changes in the demographic composition in the population survey, it should be 
noted that using either round 1, round 3 or the average across the rounds produced 
similar estimates, given that round 1 and round 3 shared similar distributions of age 
and marital status. Round 3 was selected as the standard population, however, as it 
had the fewest restrictions on participation, included the largest number of 
participants in any round, and had the most reliable information on in-migrants in the 
study area. In terms of the previously discussed limitation of using the Z-score test in 
non-independent groups to evaluate differences in trends, taking into account that 
the repeated measures would have only widened confidence intervals further, this 
source of bias would not be a factor in interpreting the results presented here.   
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In addition to the biases discussed above, a final source of bias in the 
population survey that must also be considered is that related to refusal and 
absentee levels. Among men, participation was found only marginally lower at each 
progressive survey round. Among women, participation at round 3 was higher 
compared to the other rounds. To the extent that men who knew or suspected 
themselves to be HIV positive refused or were absent with greater frequency over 
time, the intermediary estimates of HIV prevalence in this group could have 
increasingly understated true underlying prevalence in the area. Conversely, among 
women, the higher levels of consent at round 3 may have presented a more accurate 
estimate of underlying HIV prevalence as opposed to the estimates at round 1 or 
round 2, where participation levels were lower and HIV prevalence also could have 
been understated. In this case, the differential exclusion of HIV infected women at 
round 1 and round 2 would not have likely explained the steep reductions observed 
from round 1 to round 2, but could have contributed to the slower decline from round 
2 to round 3. 
Even considering this possibility, however, it is unlikely that the magnitude of 
any participation bias due to selective absenteeism or refusal among HIV infected 
individuals would have been greater at any one study round. Overall participation 
levels observed in the survey among both men and women were consistent with 
those achieved in other HIV population surveys in SSA [67], and which have been 
shown to produce minimally biased HIV prevalence estimates [74]. Also, knowledge 
of serostatus at all ages in the study area was low, with only 11% in round 2 [251] 
and 8.6% in round 3 [252] reported having ever been tested and received their test 
result. Accordingly, few people would have avoided participation based on a 
confirmed HIV diagnosis. Finally, a study of individuals participating at round 1 who 
later migrated to more urban areas did not show out-migrants to have higher levels 
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of HIV prevalence [253], thus even relatively high levels of male absenteeism at 
round 3 would have a limited influence on trends. Mobility, and therefore 
absenteeism, is likely to be high in this population since many individuals will move 
out of the study area for educational or employment opportunities elsewhere, 
independent of their HIV status. Recently married women will also be more likely to 
leave their village to move to the village of their husband. Still, because HIV 
prevalence was not able to be measured among non-participants, and previous 
studies showing the magnitude of bias due to non-response are limited by the 
assumption that testers and non-testers have similar demographic and risk profiles, it 
is important to consider the potential for this type of bias when interpreting 
prevalence trends in these types of longitudinal cohort surveys.  
Although biases were more likely to have been present in the population 
survey, ANC surveillance data can also be biased differentially with time and this 
could have affected the results described here. Although participation in ANC 
surveillance was nearly universal at each round, it is still possible that changes in the 
profile of women who became pregnant and who sought ANC services might have 
influenced ANC trends differentially over time. With regard to fertility levels in the 
area, the proportion of women pregnant in the population survey did not change over 
time, indicating that ANC data should be, at minimum, representative of pregnant 
women in the surrounding communities. With regard to differences in those who 
sought ANC services, the profile of women by age and marital status also did not 
change greatly over time, as evidenced by the very small adjustments in the 
standardized estimates. As a result, it is unlikely that these shifts would have 
contributed to the differences between the ANC and population survey intermediary 
trends. Also, although data was not collected to identify those from outside the clinic 
catchment area at round 1, the proportion of non-local ANC attendees was similar, 
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as were their respective levels of HIV prevalence, at round 2 and round 3. As a 
result, the inclusion of non-local ANC attendees would have not been a great source 
of bias in the trends, even if the overall levels of HIV prevalence differed from those 
in the surrounding communities.   
A more recent consideration with regard to possible biases in the ANC 
surveillance data is the extent to which the scale-up of HIV testing and prophylaxis 
services for pregnant women also could have introduced a differential upwards bias 
over time in estimates, especially at round 3; however, in Mwanza, Tanzania, while 
the quality and type of ANC services influenced where women sought prenatal care, 
these preferences were not differentially associated with a woman’s HIV status [123]. 
Furthermore, this study occurred during a period when HIV testing and prophylaxis 
services for pregnant women in Zimbabwe were still limited; thus, a selective 
increase in uptake of ANC services by HIV-positive women over time, leading to less 
steep reductions from round 2 to round 3, is unlikely.   
While it is possible that any number of the biases described above could have 
influenced the observed patterns of intermediary change in the ANC and the 
population survey data, it is also possible that these differences are real. From round 
1 to round 2, steeper reductions could have reflected the rapid expansion and impact 
of HIV prevention campaigns in the early 2000s that were occurring throughout the 
country [254, 255]. The impact of these campaigns may be evident in the early 
increases in the proportion of women and men at all ages delaying initiating sex. 
Also, and as was the case in Uganda, another sub-Saharan Africa country with high 
prevalence early on in the epidemic, a visible increase in HIV-related mortality in the 
late 1990s among the participating communities may have accelerated very earlier 
behaviour change among youth, the impact of which would be captured from round 1 
to round 2 [254]. Similar declines in HIV prevalence were observed among young 
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women and ANC attendees nationally in Zimbabwe, although the time frame for that 
comparison was from 2001 to 2007 [21].   
A similar study from Lusaka, Zambia, also comparing trends in the general 
population and among ANC attendees found that HIV prevalence among youth 
between 1995 and 2003 declined more rapidly than among ANC attendees due to 
increases in educational attainment leading to postponement in ages at first sex and 
first pregnancy [116]. As was the case in Lusaka, one possible explanation for these 
divergences in Manicaland is that changes in sexual behaviour in the general 
population were not reflected initially among ANC attendees. Primarily, the 
postponement of sexual debut and, to a lesser extent, reductions in the number of 
new partners and the age of partners, and increases in consistent condom use 
among youth generally from round 1 to round 2 could have rapidly reduced HIV 
transmission in this population while having a more limited impact on the declining 
fraction who continued to become pregnant by practicing unprotected sex. 
Mathematical modelling by Zaba and colleagues supports this hypothesis, showing 
how young pregnant women become increasingly less representative of the general 
population with regard to their sexual behaviour as the age of sexual debut increases 
and risk of HIV transmission declines, although these biases eventually will stabilize 
[117].  
With regard to the round 2 to round 3 changes, the relatively slower declines 
in prevalence could indicate that prevention efforts in later years may have been less 
effective in reaching high-risk individuals. This is supported by the significant 
increase in the proportion of women aged 20 to 24 years initiating sex from round 2 
to round 3 and the lack of further increases among women aged 15 to 19 years. At 
the same time, reports of consistent condom use did increase steadily over all three 
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rounds among men and women, suggesting that some prevention messages may 
have been more effective than others at reaching young men and women. 
One of the issues highlighted throughout is the profile of in-migrants into the 
study area and the differences in their underlying risk of HIV infection. ANC 
estimates in the area should reflect changes in migration so long as those individuals 
have similar fertility patterns as the populations into which they move. At round 2, 
however, in-migrants were more likely to be younger, not yet married, and more 
likely to be HIV infected than other in-migrant groups. At round 3, migrants were 
equally likely as non-migrants to have been recently pregnant, but it is possible that 
those pregnancies occurred before they moved into the study area, suggesting yet 
another reason why ANC estimates might differ from those in the surrounding 
population. Removing in-migrants from the rounds highlighted the fact that ANC 
estimates may best reflect those women living in the study area the longest and that 
factors related to in-migration should be carefully considered when assessing the 
representativeness of trends in small geographic areas, such as was done here.  
A remaining, albeit important concern, apart from the issue of the validity of 
ANC data to monitor population trends generally, is their usefulness in monitoring 
trends among men specifically. Although the UNGASS indicator assumes that ANC 
surveillance data accurately reflects changes in prevalence among men and women, 
results here highlighted some challenges. In particular, the overall round 1 to round 3 
changes in HIV prevalence among men was less than those observed among 
women, and relying on ANC surveillance data to monitor trends among men could 
significantly understate prevention gains. Also, estimates of HIV prevalence by 
socio-demographic characteristics in the two data source indicated further 
inconsistencies in trends. It may be better for countries to find alternative measures 
of trends in HIV prevalence among men or to explore methods for adjusting ANC 
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surveillance data to overcome these limitations. The analyses here were also limited 
by incomplete data available on men aged 15 to 16 years. As HIV prevalence in this 
population is extremely low though, it is unlikely that their inclusion across the rounds 
would have changed these findings. 
As most countries will not have access to repeated population survey data, 
the results of this comparison between ANC and population survey data, showing 
that ANC-based surveillance data broadly reflected the overall change in HIV 
prevalence among young men and women in the general population between 1998 
and 2005, are still encouraging. Nevertheless, the ANC estimates appeared to be 
less sensitive to intermediary changes in prevalence occurring in the general 
population. This was either because of differences in the speed with which less risky 
behaviour was adopted by pregnant women or because the population survey data 
produced an unreliable measure of trends in this population. This issue will be 
important to explore over subsequent rounds in Manicaland, Zimbabwe to ensure 
that ANC surveillance data are a reliable indicator of more recent changes HIV 
prevalence, and by extension, incidence among youth in the study area.  Additional 
studies in other countries with longitudinal or repeated cross-sectional surveys would 
also be useful to further validate comparisons such as these.  
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Chapter 6: Using HIV testing data 
from PMTCT programmes for HIV 
surveillance, in Manicaland, 
Zimbabwe 
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6.1 Aims and organization of the chapter 
The primary aim of this chapter is to determine whether HIV prevalence 
estimates from PMTCT programme data are an accurate measure of prevalence 
among pregnant women attending ANCs in Manicaland, Zimbabwe between 2006 
and 2008. HIV prevalence estimates among ANC attendees who were offered 
testing, versus not, and among those who accepted testing, versus refused, are 
compared using data from round 4 of the ANC surveillance and the household 
population survey (which spanned the years’ 2006 to 2008). In the ANC surveillance 
data, HIV prevalence estimates are compared in non-PMTCT and PMTCT clinics, 
and in PMTCT clinics grouped according to similar levels of the proportion of women 
who were tested. Additionally, individual-level socio-demographic and behavioural 
risk factors were assessed for their potential to explain differences in prevalence 
between those women testing and not testing as part of the PMTCT programme.  
The concluding section identifies the strengths and limitations of using PMTCT data 
for surveillance purposes from the Manicaland Project study. 
 
6.2 Introduction 
As discussed in previous chapters, in resource-limited settings in SSA, annual 
or bi-annual anonymous HIV surveillance among pregnant women routinely seeking 
ANC has been conducted to monitor HIV population prevalence trends [39]. In recent 
years, whether PMTCT programme data can be used to complement, or even 
replace, ANC surveillance to monitor population prevalence trends, has been 
increasingly debated [256]. Although HIV testing rates among pregnant women in 
many countries in SSA have typically been very low, the introduction of ‘opt-out’ 
testing policies and greater availability of nevirapine and other efficacious ART 
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regimens have pushed up HIV testing rates to greater than 80% in a few countries, 
including Botswana, Namibia, South Africa, and Zambia [257].  
Using PMTCT data for surveillance purposes offers certain advantages over 
ANC surveillance alone. Most importantly, since data on the number of women 
testing and their HIV status are routinely collected as part of PMTCT programme 
monitoring activities, estimates of HIV prevalence among pregnant women should be 
easier to obtain from clinics. Additionally, ethical concerns of using leftover blood to 
test women for HIV without consent for ANC surveillance purposes could be avoided 
[128, 242]. Finally, using PMTCT data from ANC clinics could improve the 
geographic representativeness of trends since many more ANC clinics offer PMTCT-
based HIV testing than participate in ANC surveillance.  
Despite the considerable financial and epidemiologic advantages associated 
with using PMTCT data for surveillance purposes, some possible disadvantages 
have been identified also. Of greatest concern has been that estimates of HIV 
prevalence among PMTCT attendees may be distorted by biases in participation [88, 
91, 98, 192]. For example, if HIV-infected women, due to stigma or inaccessibility of 
treatment or prophylaxis are not offered or choose not to test, estimates derived from 
the PMTCT programme will understate HIV prevalence among ANC surveillance 
attendees. If the opposite is true, and HIV-infected women have access to, are 
offered, and accept testing more often than uninfected women, PMTCT-based 
estimates will overstate HIV prevalence among all ANC attendees [88, 91]. Equally 
concerning, any change in participation biases over time could distort the validity of 
trends in HIV prevalence constructed from PMTCT data [93]  
Previous studies in SSA have identified many of the advantages and 
disadvantages described above, with studies in Cameroon [97], Uganda [93], and 
Botswana  [96] concluding that PMTCT programme data should be used to monitor 
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HIV prevalence in pregnant women while others, also from Uganda [91, 94], as well 
as Kenya [89], and Zimbabwe [95], suggesting that the data are still of limited use 
due to biases in who is tested. One of the primary drawbacks in all but two of the 
studies (Kenya and Botswana) was that they occurred at a time when geographic 
coverage was limited and strategies for delivering PMTCT services relied on an ‘opt-
in’ testing strategy, which has been shown to result in much lower rates of testing 
[80, 83].  
This was the situation in 2004 in Zimbabwe when the Ministry of Health and 
Child Welfare (MOHCW) investigated and determined that estimates of HIV 
prevalence from PMTCT data did not accurately reflect HIV prevalence estimates 
among pregnant women in 19 ANC surveillance clinics where both activities were 
occurring. During the time of the study, national policy specified the provision of ‘opt-
in’ client-initiated testing programmes [95]. In practice, this meant that women would 
have had to have requested HIV testing during their prenatal visit, although the 
importance of testing for the mother and baby would have been communicated 
during group or individual pre-test counselling at the start of the visit.  
Using data from the national PMTCT reporting system, the proportion of women 
who were reported to have been tested during the study period at the 19 clinics was 
42.1%. The MOHCW cited refusals by clients, stock-outs of test kits, and insufficient 
availability of trained staff as reasons for the low testing level. Comparison of ANC 
and PMTCT data showed that, although HIV prevalence among pregnant women 
was similar at the national level (21.3% in ANC surveillance data and 21.8% in 
PMTCT data), very large clinic-specific discrepancies were observed. As a result, 
MOHCW staff concluded that PMTCT data, at least as reported to the national level, 
were ultimately not suited for surveillance purposes in Zimbabwe. 
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In the year following the 2004 study, the MOHCW adopted an overall 
objective to increase uptake of PMTCT services by moving to an ‘opt-out’ provider-
initiated testing approach, strengthening pre-test counselling, and augmenting the 
number of staff trained to provide testing with lay counsellors [95].  Also, the number 
of clinics where PMTCT services were offered was expanded greatly, such that, by 
2008, 55% of ANC clinics offered HIV testing integrated into a woman’s prenatal 
care visit [258]. Due to the economic and political turmoil in Zimbabwe during 2007 
and 2008, however, many women continued to experience problems accessing ANC 
and PMTCT services [259]. 
Despite the economic and political pressures which severely disrupted the 
provision of health care services in Zimbabwe, the results of the MOHCW PMTCT 
policy shift and programme expansion in 2005 were still notable in the Manicaland 
Project study area. From 2003 to 2005, which corresponded to round 3 of the 
survey, only 6 of the 29 clinics participating in ANC surveillance offered testing. In 
the follow-up survey, carried out between 2006 and 2008, which corresponded to 
round 4, 20 of the 36 participating clinics were reported to offer PMTCT services.  
These data on uptake of PMTCT services provide a unique opportunity to assess 
whether estimates of HIV prevalence from them are similar to or differ from those 
collected through ANC surveillance. Additionally, determining what factors influence 
the validity of PMTCT estimates can provide insight into mechanisms for possibly 
adjusting for these biases in the future. 
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6.3  Methods 
6.3.1  ANC surveillance  
In the study catchment area, ANC surveillance was conducted on a sequential 
(i.e., rolling) basis at 36 clinics from August 2006 to November 2008. At 20 of the 
clinics, PMTCT-based HIV testing was reported to be available during at least some 
of the time when ANC surveillance was on-going. In 2006, two of the eight clinics 
surveyed reported offering PMTCT services. In 2007, seven of the 16 clinics did. In 
2008, all but one of the 12 clinics reported the availability of PMTCT services.  
Information obtained during the surveillance interview was used to determine 
whether PMTCT-based HIV testing had been offered to an attendee during her 
prenatal care visit, and if so, whether she accepted testing. Women attending follow-
up visits were also asked about testing at their first visit, since MOHCW policy is to 
provide HIV testing to all women on their first visit. More detailed information 
regarding methods for conducting surveillance and the questionnaire were provided 
in Chapter 2. 
 
6.3.2 Household survey data 
Information on access to and acceptance of HIV testing through PMTCT 
services was obtained from women aged 15 to 49 years participating in the round 4 
household survey. Individual interviews were conducted over approximately the 
same time period as the ANC surveillance in the 12 study sites. Serological samples 
were collected for all women at the time of the interview.   
In the household survey interview, women who attended an ANC clinic at their 
last pregnancy were asked if PMTCT services, including HIV testing, were offered at 
the clinic they attended, and whether they accepted or refused testing. Information 
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about which clinic a woman attended was not collected to verify whether PMTCT 
services were actually available during the pregnancy. Further information on the 
Manicaland Project study methods, laboratory testing procedures, and the individual 
questionnaire are provided in Chapter 2 of this thesis and a previous publication [26].  
 
6.3.3 Statistical Analysis 
Analyses to assess the usefulness of PMTCT data for surveillance purposes 
were performed separately for each data source (i.e., ANC surveillance and the 
household survey) given differences between data collection methods and the 
populations included. For both the surveillance and the household survey, the 
primary outcome of interest was HIV prevalence among PMTCT participants (e.g., 
those pregnant women tested as part of the provision of PMTCT programme 
services) compared to HIV prevalence among all ANC attendees as determined by 
testing through the study. Women in the household survey who provided information 
about pregnancies prior to 2006 were excluded from the analysis since PMTCT 
services in the study area were not routinely offered at the time, and, when they 
were, they were most likely provided using an ‘opt-in’ testing approach. 
Bias in the PMTCT HIV prevalence estimate was calculated as the relative 
difference between the PMTCT and ANC surveillance estimates. HIV prevalence 
was also calculated separately for women who were offered (as opposed to not 
offered) testing and for those who accepted (as opposed to refused) testing for each 
data source. Where comparisons of HIV prevalence estimates involved two separate 
groups of individuals (e.g., those offered versus those not offered HIV testing), 
statistical testing for significant differences in HIV prevalence was done using a chi 
square test with one degree of freedom. P-values of <0.05 were considered 
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statistically significant. For those comparisons where the same women were 
included in both the PMTCT and ANC surveillance groups (e.g., PMTCT versus ANC 
surveillance estimates), statistical testing was not done as the estimates were 
considered dependent. In these instances, only the descriptive results, including 
95% binomial confidence intervals, are presented.  
Factors potentially influencing the validity of the PMTCT-based estimates 
were also considered in both data sets. In the ANC surveillance data, associations 
between PMTCT testing and HIV prevalence were explored at the clinic level using a 
Cochran-Armitage test for trend [260]. Clinics were categorized according to whether 
overall testing levels were (i) high (75% or greater offered testing; n=2); (ii) medium 
high (50%-74% offered testing; n=8); (ii) medium low (25%-49% offered testing; 
n=8); or (i) low (<25% offered testing; n=2). Previous studies in SSA have only noted 
the extent to which estimates differed when the proportion of women testing in the 
PMTCT programme was less than 70% [89, 91].  
At the individual level, a Poisson regression model with a robust error 
variance was used to compare HIV infection levels among women not tested and 
tested as part of the PMTCT programme. The prevalence proportion ratio (PPR) and 
robust 95% confidence interval (CI) from the regression model was used to 
determine the strength and direction of associations between HIV prevalence and 
PMTCT-based HIV testing. A PPR value greater than one would indicate that HIV-
infected women were more likely to get tested in the PMTCT programme than 
uninfected women. Conversely, a PPR less than one would signal an avoidance of 
PMTCT-based testing by HIV-infected women as compared to uninfected women. 
The Poisson method is recommended, as opposed to a standard logistic regression 
model, when the outcome of interest is not rare (e.g. greater than 10%) [261, 262].  
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Poisson regression modelling also was used to determine which socio-
demographic, health access and behavioural risk factors might explain differential 
testing in the PMTCT program by HIV status. A similar strategy using logistic 
regression was first used by Glynn and colleagues to compare HIV prevalence in 
ANC clinics and the general population in three cities in Africa, Yaoundé, Cameroon, 
Kisumu, Kenya, and Ndola, Zambia, and to isolate those factors that could explain 
the differences that were identified [51]. This method was also used later to explore 
differences in HIV prevalence estimates in the Karonga district in Malawi [53].  
In the multivariate model for the Manicaland comparisons, factors that shifted 
the crude PPR for the association between HIV status and testing in the PMTCT 
programme toward the null after adjustment were considered to ‘explain’ the bias in 
PMTCT-based testing by HIV-infected women. Factors explored in both data 
sources included age, parity, time at current residence, socio-economic designation 
of the location of the area (e.g., town, estate), residence relative to the clinic where 
women sought prenatal care (i.e., local to or visiting), marital status, education, 
previous health status, and history of STDs.  
Due to differences between the ANC and individual survey questionnaires, not 
all of the factors were comparable between data sets. In the ANC surveillance round, 
the socio-economic category of the clinic where a woman sought ANC services was 
collected, whereas in the household survey, this designation refers to a woman 
residence where she was interviewed. Also in ANC surveillance, women were asked 
about whether they had ever been treated for an STD, while in the household 
survey, women were asked about ever having had STD symptoms. For analysis 
purposes, women in the household survey with either no or one previous birth were 
grouped together when considering associations with parity, because only those 
women with at least one previous pregnancy who attended an ANC were eligible to 
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be included in the analysis (i.e., as a result, very few women had no previous births). 
Finally, data on the number of children dead, employment status, risk perception, 
and the number of lifetime regular and non-regular sexual partners were asked about 
in the household survey questionnaire only. Elsewhere in SSA, these factors have 
been found to be associated with higher infection levels and increased uptake of 
PMTCT testing [91, 98, 192]. 
6.4 Results 
6.4.1 ANC surveillance data 
During the ANC surveillance round, a total of 1277 women sought routine 
prenatal care at the 36 participating clinics in the study area. All attendees consented 
to be interviewed and to provide a blood sample for anonymous HIV testing in the 
ANC surveillance round, regardless of whether or not they were offered an 
opportunity or elected to participate in PMTCT services. ANC surveillance 
questionnaires were incomplete for 34 women, leaving 1243 women in the analysis.  
Using the anonymous test results from ANC sentinel surveillance and 
knowledge of participation in the PMTCT programme, overall HIV prevalence was 
observed to be lower among ANC surveillance participants (13.4%) than among 
PMTCT participants (16.2%) in the study area. This difference corresponded to an 
upwards bias of 20.9% in the PMTCT estimate as compared to the ANC surveillance 
estimate across all 36 clinics. 
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Figure 6.1 HIV prevalence estimates among women at non-PMTCT and PMTCT clinics at round 4 of the ANC 
surveillance in Manicaland, Zimbabwe, 2006-2008.  
  
Stratification of the data by the 16 non-PMTCT and 20 PMTCT clinics showed 
that the geographic distribution of PMTCT services in the study area was not a likely 
source of bias since similar HIV prevalence among all ANC surveillance attendees 
was observed in both groups (13.3% versus 13.8%; p-value = 0.811). However, at 
those clinics where PMTCT services were offered, women who accepted testing in 
the PMTCT programme had markedly higher HIV prevalence than women who (i) 
were not offered testing as part of the PMTCT programme (10.6%) or (ii) who 
refused PMTCT-based HIV testing when offered (12.0%). Since the proportion of 
women accepting PMTCT-based HIV testing was so high (94.4%), the majority of 
bias in the PMTCT estimate would have come from the higher prevalence (15.8%) 
among the 52.2% of women who were offered the opportunity to test. 
ANC 
surveillance participants 
(N=1243) 
HIV prev: 13.4% (11.6% – 15.5%)
ANC surveillance participants 
at PMTCT clinics
(N=851)
HIV prev: 13.3% (11.1% – 15.6%) 
Offered PMTCT-based HIV testing
(N=444)
HIV prev: 15.8% (12.5% – 19.5%)
PMTCT participants
(i.e., accepted HIV testing)
(N=419) 
HIV prev: 16.2% (12.6% - 20.4%)
PMTCT non-participants
(i.e., refused HIV testing)
(N=25)
HIV prev: 12.0% (2.5% - 31.2%)
Not offered 
PMTCT-based HIV testing
(N=407)
HIV prev: 10.6% (7.8% - 14.0%)
ANC surveillance participants 
at non-PMTCT clinics
(N = 392)
HIV prev: 13.8% (10.5% – 17.6%)
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From clinic-specific comparisons of the testing data, it was clear that the level 
of bias in the PMTCT estimate at a clinic depended on the proportion of women 
offered and accepting testing there (See Figure 6.2). As this overall proportion 
declined, HIV prevalence among those women tested in the PMTCT programme 
increased significantly (test for trend p-value=0.021). 
 
 
Figure 6.2 HIV prevalence estimates at 20 clinics where ANC surveillance and the provision of PMTCT 
services overlapped at round 4 in Manicaland, Zimbabwe, 2006-2008. The figure shows an increasing trend in 
HIV prevalence by level of testing (p-value=0.021) among those tested in the PMTCT programme versus all 
ANC surveillance attendees (p-value=0.873).   
 
Since HIV prevalence was comparable among all ANC surveillance participants 
when grouped according to the level of testing at the clinic (p-value=0.873), it is more 
likely that individual factors, rather the geographic location of clinics, explained the 
increasingly higher levels of HIV prevalence observed. This was especially true for 
the 10 clinics where the proportion of women testing in the PMTCT programme was 
less than 50% and the disparity in HIV prevalence between the two groups was 
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largest. The mean proportion of women tested in clinics offering PMTCT services 
during the study period was 49.2%.  
Figure 6.3 illustrates in more detail clinic-specific differences between HIV 
prevalence estimates from PMTCT participants and ANC attendees according to the 
level at which women tested.  
 
Figure 6.3 HIV prevalence among ANC surveillance and PMTCT participants in the 20 clinics in Manicaland, 
Zimbabwe, 2006-2008. Dot size represents the number of ANC surveillance participants. Dot colour represents 
the percent of women tested through the PMTCT programme during the surveillance period. Green dots indicate 
clinics that provided PMTCT-based testing to the most women (e.g., >75%). Those testing under a quarter of 
participants are marked with red dots. Dots closer to the bold parallel line indicate better agreement between 
ANC surveillance and PMTCT estimates. 
 
In general, the tendency was for PMTCT-based estimates to be higher than those in 
the ANC clinic generally, with only 6 of the 20 clinics having PMTCT-based 
estimates that understated HIV prevalence among all ANC attendees. Half of these 
clinics were in facilities where between 25% and 49% of women were tested and the 
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other half were in clinics where between 50% and 74% of women were tested. In the 
four clinics where PMTCT-based estimates exceeded ANC surveillance-based 
estimates by the greatest margin (St Augustines, Nyanga Hospital, Nyazura Clinic 
and Nyahukwe Clinic), women tested had approximately four times the level of HIV-
infection as women not tested (i.e., those not offered or refusing). Across all 20 
PMTCT clinics, HIV prevalence was 50% higher among PMTCT participants as 
compared to non-PMTCT participants (PPR: 1.50; 95% CI: 1.06 – 2.13). This 
corresponded to an HIV prevalence of 16.0% among PMTCT participants and 10.6% 
among non-PMTCT participants.    
Table 6.1 shows the individual socio-demographic, behavioural risk and 
health factors explored in the Poisson regression model for their association with HIV 
prevalence and PMTCT-based testing at the 20 clinics. Although many of the factors 
were associated with significantly higher HIV prevalence among ANC attendees 
generally, including increasing age above 20 years (with peak prevalence observed 
among those aged 25 to 29 years), having one or two previous live births, being 
unmarried, living in their current residence for more than two years, and reporting 
having had a serious illness or ever having sought treatment for an STD infection, 
only those having a recurring or serious illness were found to have significantly 
higher testing rates in the PMTCT programme. With regard to other significant 
factors differently distributed among those testing versus not, women with higher 
education compared to lower education were more likely to be tested through the 
PMTCT programme as were those in subsistence farming areas and roadside 
trading centres relative to those living in towns and estates. Notably, although 
marginally non-significant, visitors were less likely to test in the PMTCT programme 
as compared to local attendees and also less likely to test positive.    
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 Table 6.1  Factors associated with HIV prevalence among ANC surveillance participants and differentially 
distributed between women testing and not testing as part of the PMTCT programme in 20 ANC clinics in 
Manicaland, Zimbabwe, 2006-2008.   
 
 
Results from the Poisson regression considering the relationship between HIV 
prevalence and PMTCT-based testing by the many factors showed bias in the 
PMTCT estimate to be due, in part, to differential uptake of testing depending on 
age, parity, marital status, geographic location of the clinic, residence (local versus 
visitors), and, as previously identified in the factor-specific analyses, the health 
status of those testing (see Figure 6.4). When adjusting for these factors individually, 
 
Women 
tested 
(N=419)
Factors (N) % (n) Crude PPR* 95% CI % (n) Crude PPR* 95% CI
Age group
15-19 years 23.3 (198) 5.6 (11) 1.00 -- 50.5 (100) 1.00 --
20-24 years 34.8 (305) 10.8 (33) 1.94 (1.01 - 3.76) 45.9 (140) 0.91 (0.76 - 1.09)
25-29 years 20.3 (173) 24.3 (42) 4.37 (2.32 - 8.22) 53.2 (92) 1.05 (0.87 - 1.28)
30 - 44 years 20.6 (175) 15.4 (27) 2.78 (1.42 - 5.43) 49.7 (87) 0.98 0.80 - 1.21)
Parity†
  0 40.4 (344) 8.1 (28) 1.00 -- 46.5 (160) 1.00 --
  1 28.3 (241) 15.8 (38) 1.94 (1.22 - 3.07) 51.9 (125) 1.12 (0.94 - 1.32)
  2+ 31.3 (266) 17.7 (47) 2.17 (1.40 - 3.37) 50.4 (134) 1.08 (0.91 - 1.27)
Marital status
  Married/Cohabitating 95.0 (808) 12.8 (103) 1.00 -- 48.9 (395) 1.00 --
  Not married 5.0 (43) 23.3 (10) 1.82 (1.04 - 3.23) 55.8 (24) 1.14 (0.87 - 1.50)
Education
  None/primary 22.6 (192) 13.5 (26) 1.00 -- 39.6 (76) 1.00 --
  Secondary/higher 77.4 (659) 13.2 (87) 0.98 (0.65 - 1.47) 52.1 (343) 1.31 (1.09 - 1.59)
Clinic location
  Town 24.4 (208) 13.5 (28) 1.00 -- 38.0 (79) 1.00 --
  Estate 15.0 (128) 12.4 (49) 0.92 (0.60 - 1.42) 31.3 (40) 0.82 (0.60 - 1.12)
  Substistence farming area 40.8 (347) 11.7 (53) 0.87 (0.57 - 1.34) 58.8 (204) 1.55 (1.27 - 1.88)
  Roadside trading centre 19.7 (168) 19.8 (37) 1.47 (0.94 - 2.30) 57.2 (96) 1.50 (1.21 - 1.87)
Time at current address
  <2 years 26.9 (229) 10.0 (23) 1.00 -- 49.3 (113) 1.00 --
  2+ years 73.1 (622) 14.5 (90) 1.44 (0.94 - 2.22) 49.2 (306) 1.00 (0.85 - 1.16)
Residence relative to clinic
  Local  70.6 (601) 14.5 (87) 1.00 -- 51.4 (309) 1.00 --
  Visitor 29.4 (250) 10.4 (26) 0.72 (0.48 - 1.09) 44.0 (110) 0.86 (0.73 - 1.00)
Health status
  Healthy 90.5 (770) 11.6 (89) 1.00 -- 48.2 (371) 1.00 --
  Recurring or serious illness 9.5 (81) 29.6 (24) 2.56 (1.73 - 3.78) 59.3 (48) 1.23 (1.01 - 1.49)
Ever been treated for an STD
  No 92.2 (785) 12.1 (95) 1.00 -- 49.2 (386) 1.00 --
  Yes 7.8 (66) 27.3 (18) 2.25 (1.46 - 3.49) 50.0 (33) 1.01 (0.79 - 1.31)
† Higher HIV prevalence as parity increased was due to confounding by age. Adjusting age-specific HIV prevalence for parity resulted in a 
non-significant difference in risk for all  parity groups.
ANC surveillance 
(N=851)
HIV prevalence 
Difference in 
distribution between 
women tested and not 
tested
* Prevalence proportion ratios (PPRs) and 95% confidence intervals in bold indicate a significant difference  for that factor.
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the PPR shifted toward 1 (i.e., no difference in estimates between PMTCT and non-
PMTCT participants). For some of the factors, including marital status, the proportion 
of the difference explained was relatively small.  
 
Figure 6.4  Comparison of HIV prevalence among PMTCT and non-PMTCT participants at 20 clinics where 
ANC surveillance and PMTCT services overlapped in Manicaland, Zimbabwe, 2006-2008. 
Not surprisingly, having reported a recurring or serious illness accounted for the 
single largest proportion of the bias, reducing the crude PPR of 1.50 to an adjusted 
value of 1.43 (95% CI: 1.01-2.02). Education, time at residence and history of a self-
reported STD treatment did not explain why HIV positive women were tested more 
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* Blue boxes  and upper and lower diamonds show the HIV prevalence proportion 
ratio (PPR) and 95% confidence interval (CI) of being tested as part of the PMTCT 
programme versus not when adjusted for a factor (e.g., age, parity, marital status, 
etc.). A PPR greater than 1 indicates that HIV prevalence among those tested is 
greater than that among those not tested. The dotted blue line represents the 
crude difference in HIV prevalence between PMTCT and non-PMTCT participants. 
The solid black line (at PPR=1) indicates no difference in HIV prevalence between 
PMTCT and non-PMTCT participants.
†Adjusted PPRs and 95% CIs reflect the extent to which the upwards bias in the 
estimate of HIV prevalence among those tested can be explained by confounding 
by this factor (e.g., age). 
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frequently, as adjusting for these factors either shifted the PPR away from 1 or the 
PPR remained unchanged from the crude value.   
HIV prevalence estimates among women not testing and testing by the 
confounding factors are shown in Table 6.2. Although HIV prevalence estimates did 
not differ statistically between these two groups, the largest disparities were 
observed among those reporting a recurring or serious illness and among visitors.   
 
Table 6.2  Comparison of HIV prevalence among non-tested and PMTCT participants at 20 ANC clinics where 
PMTCT services were available in round 4 ANC surveillance in Manicaland, Zimbabwe,  2006-2008. 
 
Adjusting for these, and all other confounders, reduced the PPR from 1.50 to 1.32 
(95% CI: 0.92 – 1.88). This also eliminated any significant difference in estimates 
among non-tested and PMTCT participants. Nonetheless, a large portion of the 
Non-testing 
participants
HIV prevalence 
(N=432)
PMTCT 
participants
HIV prevalence 
(N=419)
Confounders % % PPR (95% CI)
Age group*
  15-19 years 4.1 (4) 7.0 (7) 1.72 (0.52 - 5.7)
  20-24 years 8.5 (14) 13.6 (19) 1.56 (0.81 - 3.02)
  25-29 years 22.2 (18) 26.1 (24) 1.17 (0.68 - 1.99)
  30 - 44 years 11.4 (10) 19.5 (17) 1.68 (0.82 - 3.43)
Parity†
  0 8.2 (15) 8.1 (13) 1.09 (0.54 - 2.23)
  1 11.2 (13) 20.0 (25) 1.75 (0.94 - 3.26)
  2+ 14.6 (18) 21.6 (29) 1.60 (0.94 - 2.72)
Marital status†
  Married/Cohabitating 10.4 (43) 15.2 (60) 1.45 (1.00 - 2.09)
  Not married 15.8 (3) 29.2 (7) 1.78 (0.56 - 5.60)
Clinic location
  Town 10.1 (13) 19.0 (15) 1.89 (0.95 - 3.75)
  Estate 6.8 (6) 12.5 (5) 1.83 (0.59 - 5.68)
  Substistence farming area 10.5 (15) 12.8 (26) 1.21 (0.67 - 2.21)
  Roadside trading centre 16.7 (12) 21.9 (21) 1.31 (0.69 - 2.49)
Residence relative to clinic
  Local  12.3 (36) 16.5 (51) 1.34 (0.90 - 1.99)
  Visitor 7.1 (10) 14.6 (16) 2.04 (0.96 - 4.32)
Health status
  Healthy 10.0 (40) 13.2 (49) 1.32 (0.89 - 1.95)
  Recurring or serious illness 18.2 (6) 37.5 (18) 2.06 (0.91 - 4.66)
Adjusting for all confounders -- -- 1.32 (0.92 - 1.88)
* PPR adjusted for marital status
† PPR adjusted for age
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overall bias in HIV prevalence among those women participating in the PMTCT 
programme still remained unexplained. 
 
6.4.2 Household survey 
Participation in the household survey at round 4 was high, with only 6.9% of 
eligible households not interviewed. In the household survey, 3.2% (216/6748) of 
eligible women were excluded due to refusals or because of incomplete pregnancy 
histories or socio-demographic information. Of the remaining women, 18.9% 
(1228/6532) provided information about a previous pregnancy between 2006 and 
2008; 12.5% (846/6540) of women provided information about their last pregnancy, 
which occurred prior to 2006 and were excluded. Of the women with pregnancies 
between 2006 and 2008, 87.5% (1075/1228) reported attending an ANC at their last 
pregnancy. 
Based on the results of the anonymous HIV testing conducted during round 4 
of the individual household survey, the estimate of HIV prevalence among women 
accepting testing as part of the PMTCT programme from 2006 to 2008 was found to 
be lower than the estimate of HIV prevalence among all women reporting ANC 
attendance (13.5% versus 17.4%) from 2006 to 2008 (see Figure 6.5).  
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Figure 6.5 HIV prevalence estimates for women in the household survey at round 4 who reported ANC 
attendance at their last pregnancy in Manicaland, Zimbabwe, 2006-2008. 
 
 
This difference would have resulted in an overall bias downwards in the PMTCT 
estimate by 22.4%. Unlike the ANC surveillance results where bias resulted primarily 
from not offering HIV-infected women an opportunity to test, in the population survey 
data, refusal to test in addition to not offering testing could both contribute to the 
bias. Overall, the proportion of women reporting having been offered PMTCT-based 
testing was 69.4%, and, of those, the proportion who reported accepting was 77.6%. 
Compared with HIV-uninfected women, HIV-infected women were 40% less likely to 
participate in PMTCT-based HIV testing (RR: 0.61; 95% CI: 0.47 – 0.80). This 
corresponded to a 13.5% (95% CI: 10.8% – 16.5%) HIV prevalence among PMTCT 
participants and a 22.0% (95% CI: 18.4% – 25.9%) prevalence among non-PMTCT 
participants.  
ANC attendees 
(N=1075) 
HIV prev: 17.4% (15.1% – 19.7%)
Offered 
PMTCT-based HIV testing
(N=746)
HIV prev: 15.2% (12.6% – 17.9%) 
PMTCT participants
(i.e., accepted HIV testing)
(N=579)
HIV prev: 13.5% (10.8% - 16.5%)
PMTCT non-participants
(i.e., refused HIV testing)
(N=167)
HIV prev: 21.0% (15.1% - 27.4%)
Not offered 
PMTCT-based HIV testing
(N = 329)
HIV prev: 22.5% (17.8% – 27.1%)
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With regard to whether socio-demographic, health and risk behaviour factors 
could explain why HIV-infected women reported less frequent participation in the 
PMTCT programme, higher HIV prevalence was associated significantly with age (25 
to 44 years), greater parity (2 or more previous live births), and a history of one or 
more children having died. Women who were not married, who lived in a town, or 
who were employed were also at higher risk of HIV infection. Self-reported poorer 
health status and more risky sexual behaviours (as defined by having previously had 
an STD, a self-assessed past risk of HIV infection, and more regular and non-regular 
lifetime partners) were also associated with higher HIV prevalence among previously 
pregnant women generally.  
In terms of the distribution of these factors between PMTCT and non-PMTCT 
participants, PMTCT participants were significantly more likely than non-PMTCT 
participants to have fewer children, a history of no children having died, to be better 
educated, to live outside of an estate, to have attended an ANC clinic other than their 
local clinic, and to have reported a self-assessed past risk of HIV infection. The only 
common significant factors explaining lower HIV prevalence among PMTCT 
participants as compared to non-participants was parity and the number of previous 
children who had died. Women with two or more births were more likely to be 
infected than those with no or one previous birth, but these women were also less 
likely to be offered testing. Similarly, women with more than one child who died were 
more likely to be infected but less likely to report having participated in the PMTCT 
programme.   
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Table 6.3  Factors associated with HIV prevalence among non-testing and women testing as part of the PMTCT 
programme and factors differentially distributed between these two groups among household survey participants 
at round 4 in Manicaland, Zimbabwe, 2006-2008.   
PMTCT 
participants 
(N=579)
Factors (N) % (n) Crude RR 95% CI % (n) Crude PPR* 95% CI
Age group
  15-19 years 11.7 (126) 7.1 (9) 1.00 - - - - - 57.9 (73) 1.00 - - - - - 
  20-24 years 35.9 (385) 11.7 (45) 1.64 (0.823 - 3.25) 57.9 (223) 1.00 (0.84 - 1.19)
  25-29 years 26.1 (280) 24.6 (69) 3.45† (1.78  - 6.69) 48.2 (135) 0.83 (0.69 - 1.01)
  30-44 years 26.4 (284) 22.5 (64) 3.15 (1.62 - 6.14) 52.1 (148) 0.90 (0.74 - 1.08)
Parity
  0/1 37.3 (401) 12.0 (48) 1.00 - - - - - 57.9 (232) 1.00 - - - - - 
  2+ 62.7 (674) 20.6 (55) 1.72 (1.27 - 2.33) 51.5 (347) 0.89 (0.80 - 0.99)
Dead children
  0 88.5 (951) 15.3 (145) 1.00 - - - - - 55.1 (524) 1.00 - - - - - 
  1+ 11.5 (124) 33.9 (42) 2.22 (1.67 - 2.96) 44.4 (55) 0.80 (0.66 - 0.99)
Marital status
  Married/Cohabitating 86.1 (926) 15.8 (146) 1.00 - - - - - 54.0 (500) 1.00 - - - - - 
  Not married 13.9 (149) 27.5 (41) 1.74 (1.29 - 2.36) 54.0 (79) 0.98 (0.83 - 1.16)
Education
  None/primary 23.2 (249) 20.9 (52) 1.00 - - - - - 41.4 (103) 1.00 - - - - - 
  Secondary/higher 826 (76.8) 15.2 (135) 0.78 (0.587 - 1.04) 57.6 (476) 1.39 (1.19 - 1.63)
Household location
  Town 14.2 (153) 30.1 (46) 1.00 - - - - - 61.4 (94) 1.00 - - - - - 
  Estate 18.2 (196) 15.8 (31) 0.52 (0.35 - 79) 28.1 (55) 0.46 (0.35 - 0.59)
  Substistence farming 41.6 (447) 15.6 (74) 0.55 (0.40 - 0.76) 56.4 (252) 0.92 (0.79 - 1.07)
  Roadside trading 26.0 (279) 12.9 (36) 0.43 (0.29 - 0.63) 63.8 (178) 1.04 (0.89 - 1.21)
Time at current address
  <2 years 16.1 (173) 17.3 (30) 1.00 - - - - - 56.01 (97) 1.00 - - - - - 
  2+ years 83.9 (902) 17.4 (157) 1.00 (0.703 - 1.41) 53.4 (482) 0.95 (0.82 - 1.10)
Residence relative to clinic
  Local  85.5 (919) 17.9 (164) 1.00 - - - - - 52.1 (479) 1.00 - - - - - 
  Visitor 14.5 (156) 14.7 (23) 0.82 (0.553 - 1.24) 64.1 (100) 1.23 (1.08 - 1.40)
Employment status
  Unemployed 81.6 (877) 16.0 (140) 1.00 - - - - - 51.7 (453) 1.00 - - - - - 
  Employed 18.4 (198) 23.7 (47) 1.49 (1.11 - 1.99) 63.6 (126) 1.23 (1.09 - 1.39)
Health status
  Healthy 86.0 (923) 15.9 (147) 1.00 - - - - - 53.1 (490) 1.00 - - - - - 
  Recurring or serious illness 14.0 (150) 26.7 (40) 1.67 (1.23 - 2.27) 58.7 (88) 1.11 (0.95 - 1.28)
Ever had STD symptoms (self-report)
  No 96.5 (1037) 16.4 (170) 1.00 - - - - - 54.0 (560) 1.00 - - - - - 
  Yes 3.5 (38) 44.7 (17) 2.73 (1.86 - 3.99) 50.0 (19) 0.93 (0.67 - 1.28)
Self-assessed past risk of HIV infection
  No 92.8 (986) 14.4 (142) 1.00 - - - - - 53.4 (526) 1.00 - - - - - 
  Yes 7.2 (76) 54.0 (41) 3.74 (2.89 - 4.85) 67.1 (51) 1.25 (1.06 - 1.49)
Regular lifetime partners
  0/1 87.4 (940) 14.7 (138) 1.00 - - - - - 54.7 (65) 1.00 - - - - - 
  2+ 12.6 (135) 36.3 (135) 2.47 (1.88 - 3.24) 48.2 (65) 0.88 (0.73 - 1.06)
Non-regular lifetime partners
  0 75.7 (814) 15.9 (129) 1.00 - - - - - 53.6 (436) 1.00 - - - - - 
  1+ 24.3 (261) 22.2 (58) 1.40 (1.06 - 1.85) 54.8 (143) 1.02 (0.90 - 1.16)
† Prevalence proportion ratios (PPRs) and 95% confidence intervals in bold indicate a significant difference  for that factor.
* HIV prevalence  and other factors were measured at the time of the survey round rather than when the woman was pregnant. Only 
women pregnant from 2006 to 2008 were included in the analysis.
Difference in distribution 
between PMTCT and non-
PMTCT participants
Pregnant women attending an ANC*
(N=1075)
HIV prevalence
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 Exploration of factors that might explain the bias in the estimates among 
those testing using Poisson regression modelling showed that most factors, other 
than employment status, health status and past risk of infection, were marginally 
influential (See Figure 6.6).  Adjusting for these factors shifted the PPR toward 1. 
  
Figure 6.6  Comparison of HIV prevalence in non-testing women and women testing as part of the PMTCT 
programme in Manicaland, Zimbabwe, 2006 to 2008. 
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* Blue boxes  and upper and lower diamonds show the HIV prevalence proportion 
ratio (PPR) and 95% confidence interval (CI) of being tested as part of the PMTCT 
programme versus not when adjusted for a factor (e.g., age, parity, marital status, 
etc.). A PPR less than 1 indicates that HIV prevalence among PMTCT participants is 
lower than that among those not tested. The dotted blue line represents the crude 
difference in HIV prevalence between PMTCT and non-PMTCT participants. The 
solid black line (at PPR=1) indicates no difference in HIV prevalence between 
PMTCT and non-PMTCT participants.
†Adjusted PPRs and 95% CIs reflect the extent to which the downwards bias in the 
estimate of HIV prevalence among those tested can be explained by confounding 
by this factor (e.g., age). 
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The location of the household, employment status, and past risk of infection shifted 
the PPR away from one. Accounting for differences in the distribution of testers and 
non-testers by age, parity, the number of dead children, and the number of regular 
lifetime partners individually had the largest effect. Nevertheless, no single factor, or 
combination of factors, could completely explain the bias. As Table 6.4 shows, 
women reporting testing had consistently lower HIV prevalence when stratified by 
sub-groups within the factor. Also, for many factors, these differences were 
significant.  
  
Table 6.4  Comparison of HIV prevalence among non-testers and women testing in the round 4 household 
survey in Manicaland, Zimbabwe,  2006-2008. 
 
Non-testers
HIV 
prevalence 
(N=496)
Testers
HIV 
prevalence 
(N=579)
Confounders % (n) % (n) PPR (95% CI)
Age group*
  15-19 years 13.2 (7) 2.7 (2) 0.258 (0.52 - 1.27)
  20-24 years 13.6 (22) 10.3 (23) 0.757 (0.434 - 1.32)
  25-29 years 29.0 (42) 20.0 (27) 0.734 (0.487 - 1.11)
  30-44 years 27.9 (38) 17.6 (26) 0.618 (0.400 - 0.956)
Parity†
  0/1 14.8 (25) 9.9 (23) 0.706 (0.420 - 1.19)
  2+ 25.7 (84) 15.9 (55) 0.630 (0.463 - 857)
Dead children†
  0 19.7 (84) 11.6 (61) 0.626 (0.464 - 0.846)
  1+ 36.2 (25) 30.9 (17) 0.838 (0.501 - 1.40)
Marital status†
  Married/Cohabitating 20.2 (86) 12.0 (60) 0.631 (0.467 - 0.853)
  Not married 32.9 (23) 22.8 (18) 0.825 (0.500 - 1.36)
Residence relative to clinic
  Local  22.5 (99) 13.6 (65) 0.603 (0.454 - 0.802)
  Visitor 17.9 (10) 13.0 (13) 0.728 (0.341 - 1.56)
Ever had STD symptoms (self-report)
  No 20.8 (99) 12.7 (71) 0.611 (0.462 - 0.808)
  Yes 52.6 (10) 36.8 (7) 0.700 (0.335 - 1.46)
Regular lifetime partners
  0/1 17.1 (73) 12.7 (65) 0.738 (0.542 - 1.00)
  2+ 51.4 (36) 20.0 (13) 0.389 (0.227 - 0.667)
Non-regular lifetime partners
  0 21.4 (81) 11.0 (48) 0.514 (0.370 - 0.714)
  1+ 23.7 (28) 21.0 (30) 0.884 (0.561 - 1.39)
Adjusting for age, dead children and regular lifetime partners 0.692 (0.533 - 0.897)
* Prevalence proportion ratio (PPR) adjusted for marital status
† PPR adjusted for age
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Adjusting the crude PPR for the three most influential confounders (i.e., age, having 
previously children, and the number of regular lifetime partners) resulted in the least-
biased adjusted PPR of 0.692 (95% CI: 0.533 – 0.897). Inclusion of the other 
remaining confounding factors did not explain any additional difference.  
 
6.5 Discussion 
Findings from this first single cross-sectional analysis of data from 
Manicaland, Zimbabwe suggest that PMTCT programme data would have provided 
an unsuitable estimate of HIV prevalence among ANC attendees in the study area, 
especially if adjustments for non-participation bias could not be made. In the ANC 
surveillance data, unadjusted HIV testing data from the PMTCT programme would 
have overstated HIV prevalence among ANC attendees by 20.9%. In the household 
survey, the crude estimate of HIV prevalence among PMTCT participants would 
have led to a 22.0% underestimate in the overall HIV prevalence among all pregnant 
women attending ANC clinics from 2006 to 2008.  
Differences in the levels of PMTCT-based testing by HIV-infected and 
uninfected women were observed in both data sources, and these differences 
contributed to the biases described above. In the ANC surveillance data, the overall 
proportion of women who reported being offered testing in the PMTCT programme 
was just over half (52.2%). As the proportion of women tested declined at PMTCT-
based clinics, the overall HIV prevalence of these women rose. Clinics where fewer 
than half of women were tested showed the largest difference in estimates between 
those tested and not tested. Across the 20 clinics offering PMTCT services during 
the study period, HIV prevalence was 50% higher among PMTCT participants 
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compared to those who did not participate in the PMTCT programme, despite the 
fact that when offered, almost all women accepted to participate.  
In the ANC surveillance data, factors explaining why HIV-infected women 
were more likely to participate in the PMTCT programme than uninfected women 
were difficult to isolate. Although adjusting for the age of the woman, her parity, 
marital status, the location of the clinic where the woman was tested, her residence 
relative to the clinic and whether she had a recurring or serious illness partially 
explained the bias in estimates at the 20 clinics where ANC surveillance and PMTCT 
services overlapped, HIV prevalence among PMTCT participants were still biased by 
about 30% as compared to non-participants. While this level of bias is more extreme 
than what would have been observed in comparisons of PMTCT and ANC 
surveillance estimates generally, ANC surveillance data would have been required to 
further adjust these data to discount the remaining, unexplained bias.  
The strongest reason for selective testing among HIV-infected women as 
identified through the Poisson regression analysis was having a recurring or serious 
illness. Although women were not asked how they defined a recurring or serious 
illness, this information appeared to be relevant in assessing a woman’s risk of 
having acquired HIV infection and therefore influential in the decision about whether 
or not to be tested. Similar motivations for testing have been reported in urban 
Uganda where women who reported that they believed themselves exposed to HIV 
infection or who knew their partner to be infected were more likely to accept testing 
when offered and to test positive [91]. Discussions about illness, risk and a partner’s 
status may alert healthcare providers to the importance of selectively testing women 
at higher risk, especially when overall access to or uptake of testing in the clinic 
generally is low.  
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The other large differential in HIV prevalence observed between PMTCT and 
non-PMTCT participants was with regard to a woman’s residence relative to the 
clinic where she sought ANC care. In an earlier ANC surveillance round in this 
population, HIV prevalence estimates were hypothesized to be biased downwards by 
the attendance of visitors from more rural areas where HIV prevalence was lower 
biases [55]. Results from this analysis of more recent data suggest, however, that 
while some women from rural areas with low HIV prevalence continue to attend ANC 
clinics outside their local catchment areas, other visitors with a greater risk of HIV 
infection may be selectively attending clinics which are known to provide HIV-related 
prenatal care services. Women might opt to visit these clinics rather than their local 
clinic if the local clinic does not provide HIV care, they perceive the HIV services at 
another clinic to be superior, or they fear the stigma of accessing HIV testing and 
care services within their community.  Regardless of the reason, it will be important 
to distinguish between these two different profiles of visitors when explaining and 
accounting for bias in PMTCT-based surveillance estimates at clinics in the study 
area.   
Given that the ANC surveillance study was conducted during a time when the 
MOHCW policy for providing PMTCT services was an ‘opt-out’ HIV testing strategy, 
the tendency toward preferentially testing HIV-infected women in the PMTCT 
programme during ANC visits is somewhat surprising since all women should have 
been offered an opportunity to test who attend an ANC clinic. At ANC clinics, PMTCT 
services are typically described to all ANC attendees during a group pre-test 
counselling session. Estimates of HIV prevalence among women tested versus not 
at those clinics where participation was especially low, however, suggests that 
standard PMTCT policies and procedures were not being followed or that the ‘opt-
out’ testing policy had not yet been fully adopted. Because the exact date of a 
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woman’s visit was not recorded, it is difficult to ascertain information about testing 
strategies or approaches on a particular day; however, the disruption in services due 
to the political and economic turmoil in Zimbabwe at the time could explain the 
intermittent availability of PMTCT services in locations, even where they were 
described as available during the round 4 study period.  
One other surprising aspect of the results from the ANC surveillance study is 
that nearly all of the bias would have resulted from women being offered testing as 
opposed to refusing or accepting differently by HIV status once offered. In previous 
studies elsewhere in SSA, bias has primarily resulted from women refusing testing 
when offered  [91] [96]. Several factors might explain why few ANC attendees 
refused in this study, however, and some of these may be important when 
considering the generalizability of the findings. In terms of limitations, acceptance 
rates may have been pushed upwards (and resulted in greater participation bias) by 
the presence of the Manicaland Project study nurses, who were involved with service 
provision and data collection. For example, faced with the knowledge that testing 
opportunities were limited in some of clinics due to insufficient test kits or availability 
of trained personnel on a particular day, study staff may have encouraged women at 
higher risk of infection to return PMTCT services on another day or to be provided an 
HIV test even if test kits were scarce. Alternatively, participation bias may have been 
reduced compared to other periods or outside the study area if study staff presented 
additional information about the importance of HIV testing to ANC attendees that 
resulted in their accepting a service they might otherwise have refused. 
Despite these potential limitations, the high acceptance levels observed in this 
study may not be unique to the study area, thus, the results may be generalizable 
beyond the study area.  Elsewhere in Zimbabwe, very high levels of testing uptake 
among women who were offered testing were demonstrated in Harare, where 
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acceptance levels at a clinic rose from 65% in the six months before opt-in testing in 
2005 to 99.9% in the six months after opt-out testing in 2006 [83]. In the Manicaland 
study, factors such as stigma around testing may have been of less of a concern 
since the majority of ANC attendees at PMTCT clinics were interviewed for 
pregnancies which occurred in 2007 and 2008, well after integrated PMTCT services 
were introduced into the area. Also, women may respond to the strong incentives for 
testing with the availability of HIV prophylaxis and antiretroviral therapy, thus may 
find few reasons to refuse to test when offered. 
With regard to the household survey results, which contrasted with those from 
the ANC surveillance, conclusions about the usefulness of PMTCT data for 
surveillance purposes are more difficult to make as several limitations in the data 
affect interpretation of the results. First, and most importantly, in the household 
survey, women were asked to report on activities that occurred at their ANC visit for 
a pregnancy that could have occurred up to three years prior. Consequently, recall 
bias of women in the household survey data with regard to access to and 
acceptance of PMTCT services, including testing, is likely to be higher than in the 
ANC surveillance data, where the interview occurred on the same day as the 
provision of the ANC care being asked about. Also with regard to recall bias, women 
may have remembered receiving a battery of pre-natal tests, including syphilis, 
which requires a blood draw, and therefore may have believed themselves to have 
been tested for HIV also, even if that test was not offered. Finally, reports of testing 
may also have been influenced upwards by a social desirability bias, since many 
women may have heard about the importance of HIV testing subsequent to their 
pregnancy and preferred to answer interviewer’s questions with what they now know 
to be the standard practice for HIV testing during pregnancy in the study area. As 
evidence of the likely influence of these sources of bias on the household survey 
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findings, the proportion of women reporting they were offered testing by their health 
care provider and accepted testing was substantially higher than in the ANC 
surveillance round, despite the fact that the majority of women in survey would have 
been pregnant earlier than women in ANC surveillance  
A second reason why the household survey findings are more difficult to 
interpret and also are less credible compared to those in the ANC surveillance, is 
that the HIV status of the women in the household survey was determined up to 
three years after their most recent pregnancy; thus, some women may have been 
HIV-negative at the time of their pregnancy but sero-converted in the interim. The 
extent to which individual socio-demographic and behavioural factors are further 
confounded by this type of misclassification bias would be difficult to quantify, 
although preliminary comparisons of incidence between round 3 and round 4 has 
remained stable and low (personal communication from Simon Gregson, April 13, 
2011). Nonetheless, without access to HIV test results from the PMTCT programme 
and knowledge of their behaviour at the time of the pregnancy, it is not possible to 
quantify the  magnitude of this bias on estimates.  
A third and final limitation in relying on the household survey data to assess 
the usefulness of PMTCT surveillance data is that the clinic where a woman sought 
prenatal care is unknown, thus making it difficult to determine whether particular 
clinics or geographic areas where a woman sought service might be responsible for 
or contribute to differential uptake of HIV testing by women. As was evident in the 
ANC surveillance data, knowing which clinic women attended was important with 
regard to explaining why participation bias may have been occurring.   
Despite these caveats, there are still two interesting findings from the 
population household survey that merit further consideration. First, owing to the 
timing of the survey between 2006 and 2008, as mentioned previously, the majority 
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of women participating in the individual household interview would have reported on 
pregnancies that occurred earlier on during the survey period during a time when 
PMTCT services were being rolled out and the availability of nevirapine or ART 
treatment still might have been limited in the study area. As a result, HIV infected 
women may have refused to participate in PMTCT services more frequently because 
there were fewer incentives to learn their HIV status. In part, this could explain why 
HIV prevalence estimates among non-PMTCT participants were higher than those 
among PMTCT participants in the household survey and the reverse was observed 
in the ANC surveillance, where most women participating in ANC and PMTCT 
surveillance did so at a later time, on average, in 2007 and 2008.   
Second, the higher HIV infection levels among those who refused PMTCT-
based HIV testing could have reflected the early stigma toward testing among 
women who perceived themselves to be exposed or infected. Stigma has been 
identified as a reason for high refusal rates in many other studies in SSA and in 
Zimbabwe specifically [189, 193, 199, 263-266]. Perhaps as evidence of this shift in 
attitudes toward testing over time in the household survey data, 36.2% (21/58) of all 
HIV-positive women who were offered testing by their health care provider reported 
refusing testing in 2006. In 2007, this proportion fell to 27.9% (12/43). By 2008, only 
15.4% (2/13) HIV-positive women had refused testing.  
These latter data encouragingly suggest that over time, HIV prevalence 
estimates from PMTCT data might become more representative of prevalence 
among all ANC attendees as the proportion of clients refusing testing declines.  
Worryingly, however, the data also demonstrate the potential for participation bias to 
shift over time. Unfortunately, another limitation of the household survey is that 
women who reported refusing HIV testing for PMTCT purposes were not asked 
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about their motivation for refusing testing, thus it is difficult to ascertain exactly why 
HIV-infected women were not tested.  
Given the limitations in the household survey, it is likely that the ANC 
surveillance data provide the most accurate insight into the potential usefulness of 
PMTCT data for surveillance purposes in the study area. Even still, reasons why 
certain women as opposed to others participated in the PMTCT programme were 
difficult to ascertain. In previous studies in SSA using similar methods to those used 
here, testing positive and accepting testing was weakly associated with such basic 
socio-demographic factors as having (i) lived at a current address for two years or 
less, (ii) cohabitated with but not married their current partner, (iii) a partner with a 
non-agricultural occupation [92], less education [91] and older age [192]. Behavioural 
risk factors that have been associated with increased HIV infection and testing 
included (i) reporting the self-perception of greater risk of HIV infection; (ii) having an 
HIV-infected partner; and (iii) believing themselves exposed to HIV [91]. Other 
factors associated with uptake of testing and testing positive included a history of 
miscarriage [192]. Two differences with these studies as compared to the 
Manicaland study, however, were that the former were conducted at a time when 
‘opt-in’ client-initiated testing was in place and each took place in a single clinic only.  
One possible way to understand the role of testing motivation better is to 
consider the subset of women who reported visiting a clinic that was not their own. In 
the ANC surveillance data, only 5% of women visiting clinics reported doing so 
because PMTCT services were offered there, while no women reported visiting a 
clinic because PMTCT services were not offered. These women were also 
significantly less likely to be offered testing. In the household survey, the opposite 
was true. There, visitors were much more likely to report being offered testing, 
although they were not more likely to accept testing when offered. These differences 
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in HIV prevalence and the level at which visitors were offered testing suggests that 
more detailed data about whether a women chooses to attend an ANC clinic outside 
her local residence and why should be collected as a routine variable in ANC and 
PMTCT-based surveillance activities.   
While it is possible that other factors not measured in the study (such as 
knowing a partner’s or a child’s HIV status to be positive) were used by health care 
staff to determine whether or not a woman should be offered testing, it seems 
unlikely that these decisions would explain any large or substantial bias in the 
PMTCT estimates. Even when HIV prevalence in the area is high, only a small 
proportion of women would likely be subject to these other factors. As a result of this, 
and the limited insight into why particular women either were offered testing or 
accepted testing when offered, it seems difficult to apply a statistical adjustment 
factor that would account for the participation bias observed in the estimates across 
the clinics. This method was used successfully in a previous study in Uganda, 
although the adjustment was made for data from a single clinic only where biases in 
participation by HIV status and socio-demographic characteristics were smaller and 
more easily quantified [93]. Additional studies incorporating future rounds of data 
from the Manicaland Project would be required to assess the consistency of the 
magnitude of the bias over time in the two data sets also. 
As previously mentioned, the structure of the ANC visit in most clinics in 
Manicaland includes offering HIV testing during a group pre-test counselling session 
which is provided to all women at the start of the day. If standard PMTCT policies 
and procedures are appropriately carried out at the clinic, it is possible that the bias 
from participation due to preferential offering of testing might dissipate with time. 
Other policies and practices specific to the provision of PMTCT services may be at 
odds with ANC surveillance though. Notably, in Uganda, where HIV testing only 
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occurs on the second visit, estimates of HIV prevalence from PMTCT data could be 
biased if those women who attend only one ANC visit differ with regard to their HIV 
status as compared to women who attend two or more visits  [98]. In Uganda, one of 
the clinic-based studies compared basic socio-demographic characteristics of 
women offered versus not offered testing and found them to not differ substantially, 
although direct comparisons of HIV prevalence estimates was not possible [98]. In 
another location in Uganda, this possible source of bias was not able to be assessed 
due to lack of information [91].  Most studies conducted to date have not specifically 
reported the subset of the population that is not offered testing in PMTCT 
programmes.  
In summary, the low levels of participation in PMTCT programme in the 
Manicaland, Zimbabwe study area and period generally, and the difficulties 
associated with identifying specific socio-demographic characteristics that 
adequately explained these differences in the ANC surveillance data in particular, 
make it difficult to recommend PMTCT data for HIV surveillance purposes. 
Nevertheless, it is possible that just as the proportion of women testing and the 
number of sites offering PMTCT services increased from round 3 to round 4, similar 
increases will be observed in future rounds to a point where most women are offered 
testing at ANC clinics and acceptance is nearly universal. When this is true, the utility 
of PMTCT data will be a welcome addition to or a replacement for ANC surveillance 
as means for monitoring HIV prevalence trends in this population. 
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Chapter 7: Conclusions  
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7.1  Aims and organization of the chapter 
The aim of this chapter is to summarize the findings from this work and to discuss 
their broader implications for using HIV surveillance data to monitor the HIV 
epidemic in SSA. In the first section, the main conclusions of each chapter are 
summarized. Next, answers to the key research questions first referenced in this 
thesis are suggested. Those key questions were: (i) have trends in HIV prevalence 
among pregnant women mirrored those in the population historically in SSA?; and (ii) 
can ANC surveillance data be used to reliably monitor future population HIV 
prevalence trends? With regard to the use of PMTCT data, which is a relatively 
newer area of investigation, questions explored were: (i) do estimates of HIV 
prevalence among women participating in PMTCT programmes accurately reflect 
HIV prevalence among ANC attendees?; and (ii) what factors related to the 
geographic scale-up of services or selective participation (either being offered or 
accepting testing) by HIV status might bias these estimates? Finally, remaining gaps 
and suggested research priorities based on these gaps are outlined as future work 
along with a few concluding remarks. 
 
7.2 Summary of main findings  
Chapter 1 began with an overview of the HIV epidemic globally and in SSA, along 
with the methods typically used to collect HIV-related surveillance and programme 
data. This review highlighted the unique aspects of HIV infection, including the long 
asymptomatic period and the stigma associated with testing positive, which have 
made it difficult to measure infection levels and trends in the population accurately.  
Given these challenges, the benefits of using anonymous, clinic-based ANC 
surveillance data and PMTCT data were explored in more detail, even though these 
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data also potentially suffer from selective biases that must be considered. These 
biases include (i) the purposeful selection of participating clinics; (ii) the self-selection 
of women who access ANC services and (iii) only testing women who became 
pregnant.  
Due to biases from the purposeful selection of clinics, it was noted that ANC 
surveillance data are no longer used to estimate levels of HIV infection in the 
population. Nonetheless, ANC surveillance data are still thought to be a valid 
measure of population prevalence trends, since the latter two sources of selection 
bias are assumed to be largely static. A comprehensive discussion on the role of 
population surveys in SSA is provided to better understand the strengths and 
limitations of these data also. To the extent that refusals or absenteeism is 
differentially associated with HIV status or high risk population groups are missed, 
population survey data can also provide a distorted picture of true prevalence. For 
this reason, many countries in SSA have implemented a range of population and 
facility-based biomarker and behavioural surveys that permit triangulation of data to 
interpret how the epidemic is evolving over time. In the last section of Chapter 1, 
examples are provided of how ANC surveillance data have been used in SSA to 
monitor the epidemic and to measure the impact of intervention. A review of the 
methods for estimating population prevalence trends from ANC surveillance data 
using the UNAIDS EPP-Spectrum software package are also described in more 
detail, as ANC surveillance data are the cornerstone for producing projections for 
most countries in SSA.  
Chapter 2 provided some insights through a literature review into why biases 
in ANC surveillance data might change in magnitude and direction with time. In the 
first section, the large body of literature describing how biases in ANC surveillance 
data have led to overestimates or underestimates of population and female HIV 
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prevalence in SSA were discussed. In summary, selection for more urban clinics, 
where prevalence is highest, often results in an overestimate of HIV prevalence 
among men and women. This bias is often balanced by lower estimates of HIV 
prevalence among pregnant women due to HIV-related sub-fertility. At the same 
time, high-risk sexual behaviour in ANC clinics often introduces an overestimation of 
HIV prevalence in the younger female population, especially when the age of sexual 
debut is late. Overall levels of contraception use and access to ANC and PMTCT 
services can also temper or exaggerate these differences.  
Given that ANC data are well-known to be biased at the local level, the 
primary focus of Chapter 2 was to explore under what conditions these biases in 
ANC surveillance data might change with time. The three empirical studies and four 
mathematical models that informed much of the work in Chapters 3 through 5 were 
reviewed. These explorations primarily considered the potential for changes in the 
magnitude and direction of bias in ANC estimates to be influenced by the natural 
dynamics of the epidemic and the scale-up of effective HIV prevention and treatment 
interventions.  
A final section following on from these discussions that summarize the work 
that has been done to adjust for biases in ANC data is provided. The methods 
proposed, which range from simple standardization for differences in age and other 
socio-demographic characteristics between the two populations to more complicated 
adjustments taking into account relative fertility differences between HIV infected and 
uninfected women, are reviewed. Studies validating or exploring these methods are 
also presented, with some limitations particularly with regard to the collection of 
additional surveillance data noted. The problems with adjusting ANC estimates by 
age are also described as this can lead to even greater differentials due to 
increasing the weight of lower prevalence in the older ANC population. Notably, 
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however, none of the proposed adjustments of studies validating or applying these 
adjustments considered their application over time with the exception of Garnett, 
who shows that age-standardization is one way to prevent changes in the magnitude 
of bias in ANC estimates over time. Given that UNAIDS recommends using ANC 
surveillance data to monitor population prevalence trends, there may be merit in 
reconsidering the usefulness of age-standardized estimates.  
In addition to the review of literature on bias in ANC estimates and ANC 
trends, a secondary focus of Chapter 2 was to explore how PMTCT data have been 
used to monitor the HIV epidemic in SSA. In particular, Chapter 2 highlighted the 
possibility for selective participation bias in PMTCT programme data to either 
overstate or understate HIV prevalence among ANC attendees. This chapter also 
considered the extent to which changes in the scale-up of PMTCT services might 
result in differential levels of bias over time.  
Country experiences varied with regard to their perception of the usefulness 
of PMTCT data for monitoring population HIV prevalence. In SSA, no country has 
begun using PMTCT data for surveillance purposes as of yet. Most importantly, as 
few of the countries evaluated PMTCT systems with “opt-out” testing programmes, 
the generalizability of findings from these earlier studies are limited. Selective 
participation biases in an “opt-out” setting (which is the recommended approach for 
providing PMTCT services currently) were examined in Manicaland, Zimbabwe and 
results described in Chapter 6.  
Chapter 3 was the first of four chapters presenting new analytical work on 
bias in ANC HIV prevalence trends. In Chapter 3, estimates of HIV prevalence, 
stratified by gender and rural and urban areas, in seven countries in SSA, were 
compared using data from repeated ANC surveillance and DHS and DHS-like 
surveys conducted from 2001 through 2009. Results show that ANC surveillance 
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data performed reasonably well at capturing changes over time in HIV prevalence 
levels in many countries, especially in southern/eastern Africa, and especially when 
used to monitor trends among adult and young women living in urban areas. ANC 
surveillance performed especially poorly, however, when monitoring trends among 
young men and in some countries, including Kenya. Given the low prevalence 
among young men generally in SSA, it is not surprising that ANC surveillance data, 
which reflect the behaviour of the riskiest young women, do not perform well for this 
age group.  
By adapting commonly used statistical methods, an approach to directly 
compare trends in ANC surveillance and population survey data was proposed in 
this chapter. Using this method, significant differences between trends from the two 
datasets were found for three countries: Kenya, South Africa and Tanzania. These 
differences were found to occur primarily among men (or nationally where data from 
men were included) or in rural areas. However, no consistent relationship with regard 
to the ways in which ANC data overstated or understated population HIV prevalence 
trends was evident. The chapter concluded by highlighting the possible reasons why 
ANC surveillance data might not have reflected accurately the underlying changes in 
population HIV prevalence in these settings, and in particular, the potential strengths 
and weaknesses of ANC surveillance and population surveys, each of which can 
introduce their own types of biases in estimates over time.  
In Chapter 4, a stochastic cohort mathematical model was used to simulate 
HIV-prevalence trends among pregnant women and women in the population of 
reproductive ages. Using this model, it was possible to describe potential changes in 
the magnitude and direction of bias in ANC surveillance trends in settings similar to 
those in Botswana, Côte d’Ivoire and rural Zimbabwe since the start of the epidemic 
but before the introduction of ART (from 1985 to 2002) and in the ART era (from 
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2003 to 2030). In the ART era, a variety of scenarios were explored with regard to 
scale-up and interactions with fertility, including with what speed and coverage ART 
was made available in a country and to what degree in magnitude and direction ART 
use led to changes in fertility levels among HIV-infected women.   
One of the most important findings from these simulations in the pre-ART era 
was that relying on ANC data to monitor true population prevalence trends for 
women of reproductive aged 15 to 49 years may have been problematic historically. 
From the start of the epidemic through the mid-1990s, ANC prevalence would have 
initially been representative of underlying population prevalence. As the epidemic 
progressed, though, ANC surveillance estimates over time would have likely 
understated the rise in population HIV prevalence in all three settings. When 
population prevalence began to decline in Côte d’Ivoire and rural Zimbabwe during 
this time period, ANC surveillance data would have overstated the decline. This was 
due to an increase in the average age of HIV-infected women beyond their most 
fertile years, especially as incidence declined. Fortunately, trends in ANC prevalence 
among younger women aged 15 to 24 years would have been a better indicator of 
true population prevalence trends among young women. Even for this younger age 
group, however, the model suggests that some modest over-estimation of declines in 
true population prevalence could have occurred between the mid-1990s and the 
early 2000s.  
From the ART-era simulations, three noteworthy findings emerged. First, ANC 
trends continued to overstate declines in population prevalence among women aged 
15 to 24 years for the first few years after treatment was introduced. Eventually, 
though, these biases either stabilized or reversed depending on the association 
between ART use and fertility and the speed and coverage with which ART was 
introduced. The second finding, which can be surmised from the first, is that the 
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magnitude and direction of bias in the ANC surveillance trends in the ART era 
differed across the settings and also over time, although the potential magnitude of 
bias was greater when fertility was reduced. Taking this into account, it would be 
difficult to develop a systematic approach to adjusting for changes in bias based on 
these findings without a clear indicator of fertility patterns among women on ART 
over time. Third, and finally, as was true in the pre-ART era, HIV prevalence trends 
from ANC surveillance data were generally more robust for younger ages (i.e., aged 
15 to 24 years) compared to older ages (i.e. aged 25 to 49 years) regardless of the 
strength and direction of the association between ART and fertility or the level of 
scale-up of treatment services. As a result, this chapter concludes by suggesting that 
ANC prevalence should be considered a reasonably good indicator of underlying 
population prevalence trends for young women especially. Suggestions for future 
work with this model are also provided. For example, the model could be easily 
adapted to explore the validity of ANC surveillance data for monitoring trends in HIV 
incidence among youth and to consider the impact of associations between HIV and 
pregnancy or contraception use. 
Chapter 5 also explores the representativeness of ANC surveillance data in 
comparison to population trends, this time using empirical data from a population 
cohort survey among young females aged 15 to 24 years and males aged 17 to 24 
years resident in Manicaland, Zimbabwe from 1998 to 2003. Similar methods for 
comparing trends were used to those in Chapters’ 3 and 4. To account for potential 
biases due to changes in the population survey inclusion criteria related to migration 
and changes in the demographic structure in general, which were especially evident 
at round 2, HIV prevalence estimates in the population survey were standardized by 
age, marital status and migration history. Results showed that after adjusting for 
demographic differences alone in the population (e.g., not migration), reductions of 
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around 47% in the general population survey (among women alone and men and 
women combined) and 46% in the ANC surveillance were observed. These levels 
were well above the 25% reduction target for 2005 set by UNGASS. A similar level of 
decline was observed using national population survey and ANC data by Gouws and 
colleagues in Zimbabwe. Taken as a whole, these findings suggest that the HIV 
epidemic in Zimbabwe among young people has declined substantially.  
One interesting finding from this work was that the comparison of trends 
across survey rounds suggested that most of the declines in HIV prevalence in the 
population occurred early on in the epidemic from 1998 to 2003, while the declines in 
prevalence among young pregnant women were steadier over this period. This 
finding corresponds to the experience in Lusaka, Zambia, where ANC surveillance 
data also appeared to understate declines in population prevalence. Adjusting for 
demographic changes and changing patterns of migration in the population survey 
tempered some of the larger reductions originally observed in the population data 
early on, although reductions among women were still around 40%. Reductions 
among men were considerably smaller and less consistent with those in the ANC 
surveillance data set between rounds independent of whether the data were 
standardized or not.  
One of the factors determined to contribute to the difference in estimates over 
time was in-migration. Exclusion of persons who had moved to the study area either 
two years in advance of the first study round or had newly moved into the area 
between subsequent survey rounds were resulted in a decline in HIV prevalence of 
around 30% from round 1 to round 2 among residents, which was very similar to the 
26% decline observed among ANC attendees. In particular, it could be that ANC 
surveillance data do not adequately reflect HIV prevalence of people coming from 
outside of the study area, especially when they are very young, single and at higher 
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risk of HIV infection. This was the case in particular for young women moving into 
the study area between round 1 and round 2. Other possible biases in the ANC 
surveillance data, including changes in the demographic composition of the pregnant 
women and women from outside the study catchment area did not appear to 
introduce any particular bias.  
Taking into account biases in the population survey, particularly at round 2, it 
was determined that ANC surveillance estimates were generally a good reflection of 
the underlying trends in population prevalence in the study area. Still, there were 
substantial changes in round 1 to round 2 behaviours among the population 
(including delays in sexual debut and increased condom use) that could also explain 
some of the differential bias in the ANC estimates where it was observed. Previous 
research by Zaba and colleagues (using a mathematical model) suggest that the 
patterns observed from round 1 to round 2 in Manicaland are consistent with these 
results. Additional analyses describing the sexual behaviour of women moving into 
the study area in comparison to usual residents may add additional insight into the 
extent to which migration is associated with riskier sexual behaviour and HIV 
transmission in SSA. 
One final issue that the more detailed comparisons by sex illustrated, which 
was noted above, is that ANC surveillance trends, overall and by key socio-
demographic factors, are more reflective of changes in population prevalence among 
women as compared to men. This finding was similar to the observations made in 
Chapter 3 when using national population survey data. In Manicaland, among men, 
reductions in HIV prevalence were generally smaller as compared to ANC trends, 
even when excluding in-migrants and adjusting for differences in age and marital 
status. This finding is considered in the following section.   
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In the last analysis chapter of this work, Chapter 6, HIV prevalence estimates 
from round 4 of the Manicaland Project ANC surveillance and household survey data 
were compared to estimates from women who were offered and who accepted 
PMTCT-based HIV testing. Round 4 occurred between 2006 and 2008 at a time 
when an ‘opt-out’ testing approach had been adopted by the MOHCW. Factors 
associated with testing and HIV status were determined for ANC surveillance 
participants and among previously pregnant women who reported attending ANCs 
during their last pregnancy.  
Results from the comparison of ANC and PTMTCT estimates strongly 
suggested that data from the PMTCT programme would have been unsuitable for 
monitoring prevalence among ANC attendees during this period in Manicaland, 
Zimbabwe. In ANC surveillance, PMTCT data would have overstated HIV prevalence 
among ANC attendees around 20%. This differential appeared to result from the 
selective testing of women who were more likely to be HIV positive at clinics where 
the proportion of women offered testing was below 50%, although this was observed 
to vary by clinic.  
To assess why this bias might have occurred, Poisson regression with a 
robust error variance was used to identify factors associated with testing and with 
HIV infection. Results from this analysis show confounding due to a variety of 
factors. In particular, the health status and visitors in the ANC surveillance data was 
most strongly identified with why HIV-infected women were more likely to participate 
in the PMTCT programme. Other factors including age, residence and parity also 
explained this difference but to a more limited extent. The role of residence with 
regard to the clinic where a woman attended was revealed to have an interesting 
effect on the PMTCT estimate, suggesting that the profile of visitors with regard to 
their HIV status may be changing over time due to the scale-up of PMTCT services. 
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This is in contrast to a previous study in this population where rural participants 
attending more urban clinics were thought to be uniformly at lower risk of HIV 
infection. Notably, not all of the bias in the PMTCT data could be explained, 
suggesting that other factors not measured in the study may be leading to differential 
participation in the PMTCT programme among HIV-infected women.  
In the household data, a similar analysis was also undertaken to identify 
factors that might explain a downward bias of approximately 20% in the PMTCT 
estimate. Many factors were shown to marginally influence or explain the bias in 
estimates when adjusted for, although substantial bias remained unexplained. Due 
to the limitations of the household survey data, including recall bias and the potential 
for mis-classification, it is difficult to interpret these data as representative of the 
usefulness of PMTCT data for surveillance purposes in the area. Instead, ANC 
surveillance data may provide a more accurate indicator of the current strengths and 
limitations of using PMTCT data for surveillance purposes in Manicaland, Zimbabwe. 
This point is also considered in the following section.  
  
7.3  Implications and recommendations for using data from pregnant women 
for HIV surveillance purposes 
In the following sub-sections, an attempt is made to draw out some of the key 
answers to the four proposed research questions summarized in Section 7.1. Also, 
the wider implications of relying on HIV surveillance methods for monitoring the 
epidemic in SSA are considered in more detail. 
7.3.1  Validity of historical ANC surveillance trends (1985 to 2010) 
Within this body of work, Chapters’ 3 through 5 have generated some insights into 
the question of the historical validity of ANC-based surveillance trends from 1985 
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through 2010. In part, these analyses confirm some of the assumptions that were 
originally made with regard to the usefulness of ANC surveillance data for monitoring 
HIV prevalence trends. For example, as analyses from Chapters 3, 4 and 5 illustrate, 
the UNAIDS recommendation to use ANC surveillance data to monitor population 
prevalence trends among young people aged 15-24 years was generally validated 
[64]. One important caveat that arose from this work, however, is that ANC 
surveillance data were not likely to have been particularly representative of 
prevalence among young men. Based on the results presented here, UNAIDS 
should consider revising the UNGASS core indicator in future years to specify that 
ANC surveillance data should be used to monitor reductions in prevalence among 
young women only. To monitor population prevalence trends among young men, 
more frequent household-based population surveys may be required. 
 The broader assumption about the representativeness of ANC surveillance 
data with regard to women of all ages, as originally hypothesised by Garnett, was 
determined to be slightly less robust in these analyses [115]. In the micro-simulation 
model used here, for example, there was a tendency for ANC surveillance trends to 
have historically overstated HIV population prevalence declines, both in the pre-ART 
era for Côte d’Ivoire and Zimbabwe (and in the early part of the ART era, regardless 
of the association between ART and fertility). In large part, this was due to the 
increasing age of HIV-infected women in the population, which led more HIV-infected 
women to be excluded from ANC surveillance.  
One limitation of this model is that it does not reflect the additional sources of 
bias that routinely influence ANC data over time. For these reasons, the evidence 
from Chapter 3, which suggests that ANC surveillance data have provided a 
reasonably good measure of underlying female population prevalence trends in all 
countries except Kenya, is encouraging. Stratification of trends for women by age, 
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and possibly by rural and urban areas, should also be considered standard when 
presenting these data. The lack of representativeness of rural ANC estimates 
relative to female population prevalence that was observed in the empirical study 
has been previously reported, thus it is not surprising that these data also observed 
to perform poorly over time with respect to trends. Countries should consider this fact 
in particular when presenting trend data from EPP.  
Similar to the caution raised with regard to using ANC surveillance data to 
monitor population prevalence trends among young men, the same caution should 
apply to using these data to monitor trends among adult men. Based on the results 
from the empirical study in Chapter 3, ANC surveillance data did not appear to reflect 
underlying trends in prevalence among adult men, and stratification by rural and 
urban areas did not appear to be particularly useful either, aside from in Zambia. As 
a lack of representatives in ANC surveillance data to monitor trends among men can 
influence the overall representativeness of trends nationally, countries should also 
be cautious when interpreting national prevalence curves obtained from EPP, 
particularly where only one national population survey has been done. For those 
countries without repeat surveys, it may be necessary to present these data with a 
caution that ANC surveillance data may not reflect changes in prevalence among 
men.     
One finding that was previously noted in Chapter 3 to be particularly 
concerning was that it was difficult to discern any pattern in terms of the way in which 
ANC surveillance data were biased. In the mathematical model, the direction of the 
bias was clearer, however. For example, during the first few years of scale-up of 
ART, it does not appear as important to know the direction and magnitude of bias 
associated with changing fertility patterns, as regardless of this association, ANC 
surveillance were found to overstate population prevalence declines. This finding 
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should be taken into account when ANC surveillance data are used to estimate and 
project population HIV prevalence in EPP-Spectrum regardless of the other biases 
that can potentially influence ANC estimates over time. Already, EPP-Spectrum 
takes into account the impact of ART on the population when measuring incidence, 
but does not consider the impact that changes in the age patterns of HIV-infected 
pregnant women will have on artificially drawing down HIV prevalence estimates in 
the population [106]. Additional population survey data will be useful in determining 
the extent to which the modelled biases observed are similar to those observed in 
the countries themselves. 
   
7.3.2  Prospects for using ANC surveillance data in the future (2011 and 
beyond)  
Results from Chapter 4 represent the first attempt to determine if ANC 
surveillance data from countries in SSA can be used to monitor future HIV 
prevalence in the population, especially given the roll-out of ART and its potential 
association with fertility patterns among female users. In general, the model shows 
that the prospects for using ANC surveillance data in the future will be highly 
dependent on the speed with which the scale-up of treatment services occurs and 
the direction of the association between fertility and ART use. If ART use has a 
negative impact on fertility among users, fewer HIV-infected women will be included 
in the ANC sample, thereby making the ANC data less representative over time. If 
ART use results in greater fertility among users, then more HIV-infected women will 
return to the ANC sample. However, the changing age structure of the infected 
population, as well as the ageing out of HIV-infected women from the age groups 
typically included in population surveys (e.g., aged 15 to 49 years), will need to be 
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considered on a country-by-country basis. This is especially true when using EPP-
Spectrum to produce short-term projections of HIV prevalence trends in the 
population. A functionality that could be added to a future version of EPP-Spectrum 
software to address the concern regarding the association between ART use and 
fertility is the ability to define age-specific fertility rates for women on ART that can 
vary with time.  
At this time, however, (and as noted in Chapter 4), the primary limitation for 
predicting future changes in bias is that very little is known about how fertility 
patterns of HIV-infected women might vary with time. Also not known is the time 
period over which these variations might be detectable at the population-level or how 
other factors, such as changes in risk behaviour might influence the magnitude and 
direction of bias in ANC surveillance estimates. As a result, it is difficult to 
recommend a standard approach to adjusting for bias in ANC surveillance data that 
would work for all countries. Instead, countries will have to evaluate the impact of 
ART use on fertility rates over time, among other shifts, and take this into account 
when interpreting trends in prevalence at the population level. 
The above recommendation to monitor associations between ART use and 
fertility patterns obviously will have a broader public health benefit, as countries will 
be able to determine whether family planning needs of HIV-infected individuals are 
being met. Still, these types of evaluations require technical and financial resources, 
on top of those already dedicated to conducting ANC surveillance on a bi-annual 
basis. Given this context, it is possible that some countries in SSA might consider 
whether it is more cost-effective to increase the frequency of nationally-
representative population surveys, rather than to continue using ANC surveillance 
data to monitor population prevalence trends. Although nationally-representative 
population surveys will be on an order of magnitude more costly than ANC 
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surveillance, the data they provide are likely to be more widely used. As previously 
mentioned, repeated DHS data can be used to monitor changes in HIV incidence 
and transmission among men. Since DHS data also provide insight into reproductive 
and other health issues, however, other public health programmes would benefit 
from an increase in their frequency.  
For countries that are not able to increase the frequency of population 
surveys, however, there is some reason to be hopeful that ANC surveillance data will 
continue to be useful for monitoring population HIV prevalence trends in the future, 
even if the associations between ART use and fertility remain unclear. As was true in 
the pre-ART era, HIV prevalence trends from ANC surveillance were generally more 
representative of population survey data for younger ages (i.e., aged 15 to 24 years), 
regardless of the strength and direction of the association between ART and fertility 
or the level of scale-up of treatment services. This should provide some level of 
assurance going forward to countries that rely on ANC surveillance data to monitor 
incidence among youth, aged 15 to 24 years -- so long as other biases due to 
changes in the age of sexual debut and behaviours remain largely stable. 
 
7.3.3 The accuracy of PMTCT programme estimates in reflecting prevalence 
among ANC attendees  
The study in Manicaland, Zimbabwe of PMTCT and ANC surveillance data, 
which is presented in Chapter 6, is one of the first outside Botswana (where uptake 
of testing is very high) to assess the accuracy of HIV prevalence estimates from 
PMTCT data in an opt-out testing setting. It is also one of the few studies to explicitly 
analyse the impact of offering HIV testing versus not offering HIV testing to women 
on the representativeness of PMTCT programme estimates. In previous studies, the 
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influence of not offering testing on bias has been assessed either superficially, 
through the comparison of socio-demographic characteristics in women offered 
versus not offered testing [98], or not at all [91].  
The fact that HIV prevalence was found to differ by participation levels at 
individual clinics is not new. However, that this occurred as a result of not offering 
women testing is important. Future studies should consider the extent to which 
women are being differentially offered HIV testing. Even in Thailand, the evaluation 
of the usefulness of PMTCT data for surveillance purposes focused on acceptance 
rates and comparisons among women offered testing as opposed to all women, 
rather than women who had not been offered testing during their prenatal visit [267, 
268].  
7.3.4 Factors associated with being offered and accepting testing in PMTCT 
programmes 
One of the most important findings from the Manicaland study is that adjusting 
for non-participation bias, as was recommended by Fabiani and colleagues in one 
clinic in rural Uganda [93] may be difficult in conditions that more closely mimic those 
under which ANC surveillance is typically carried out (e.g., at multiple clinics with 
different levels of and possible reasons for participation bias). In Manicaland, 
participation bias appeared to differ by individual clinics, and, it is unlikely that they 
would be similar for all participating clinics even if motivations for testing could be 
accurately captured. It would seem that the best – and most obvious – solution to 
addressing participation bias in PMTCT-derived estimates is to ensure that as many 
women as possible are encouraged to participate. Not coincidentally, this solution is 
consistent with the broader WHO and UNAIDS strategy to provide ‘opt-out’ testing to 
all women seeking ANC services.  
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A second concern is that as HIV testing opportunities increase in the future, 
HIV infected women may increasingly opt-out of testing or self-refer to clinics that 
provide comprehensive HIV treatment and care. In these cases, data collection and 
reporting forms will need to include all women and indicate their status, regardless of 
whether they are tested, so as to ensure that overall estimates of HIV prevalence 
among attendees is accurate and do not reflect biases due to the expansion of 
testing and treatment programmes. 
7.4  Remaining research gaps and future directions 
Despite the desirability of using ANC and PMTCT data for HIV surveillance 
purposes in SSA, there are still many uncertainties about the reliability of these data 
for monitoring population-level HIV prevalence trends. Most importantly, methods for 
quantifying, and describing factors leading to bias in ANC surveillance data are 
needed. In this thesis, an easy-to-use Excel spreadsheet was developed to compare 
trends in prevalence over time. When sample sizes are small, however, as they 
could be in ANC surveillance data, the confidence intervals around the relative 
proportional change estimates can become large and it is possible that they do not 
accurately reflect the public health importance of differences in trends. As a result, 
other statistical methods such as fixed-effects logistical models might be preferable. 
However, the limitation in these methods, including logistical regression, is that the 
outcome of the statistical model does not explicitly measure whether the difference in 
the proportional change is significant. Since UNAIDS recommends that countries 
measure the proportional change in HIV prevalence estimates over time, particularly 
when evaluating the UNGASS indicator for incidence among youth, the methods 
proposed here seem most suited to the task.  
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With regard to this latter point, additional consensus is needed regarding the 
statistical methods for determining the similarity in levels and trends, both between 
ANC surveillance and population survey data and between PMTCT and ANC 
surveillance data. Owing to small sample sizes at the clinic level, comparisons of 
site-specific estimates using overlapping 95% confidence intervals may be 
meaningless. Instead countries may need to conduct these statistical evaluations 
comparing trends at the national level, and stratified by rural and urban and age-
specific categories only, and to determine an acceptable level of relative differences 
at the clinic-level that will be used to decide the comparability of estimates. This 
standardized approach to analysing bias in ANC surveillance data will improve the 
dialogue between the public health community and stakeholders about the overall 
confidence in using these data for monitoring the HIV epidemic over time. 
In the case of ANC surveillance data, the scale-up of ART services and its 
potential interaction with the fertility of women on ART needs to be carefully 
documented. With regard to PMTCT programmes, bias in estimates due to low or 
changing levels of uptake over time need to be explored. Further mathematical 
modelling of biases may be one approach to dealing with the challenge of collecting 
data to describe these influences, as it can often be difficult to obtain nationally-
representative repeated samples that permit such detailed analyses.  
Of particular concern with regard to the representativeness of PMTCT data 
and bias over time is the extent to which the introduction of PMTCT services 
preferentially draws HIV-positive women to clinics. This factor needs to be better 
documented in SSA. The gradual roll-out of these services may temporarily or 
permanently shift catchment areas to the extent that estimates among pregnant 
women, whether derived from ANC surveillance or through PMTCT service data, no 
longer reflect trends in the population. Additional information on the providence of a 
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woman and the primary reasons for seeking services outside of their local clinic 
should be collected in PMTCT registries and in ANC surveillance to aid in these 
analyses.  
 
7.5  Concluding remarks 
During the past thirty years, one fact that remains unchanged is that the HIV virus 
has evolved and adapted to the world in which it exists. The purpose of this thesis 
has been to consider to what extent the methods used to monitor HIV prevalence in 
the population have also evolved and adapted over time, and what additional efforts 
will need to be considered in the future.  
Over the next thirty years, the expansion of ART and PMTCT programmes, 
along with on-going efforts to change people’s sexual behaviour, will have a 
sweeping, and perhaps even unpredictable, effect on the epidemic. As this thesis 
suggests, it cannot be assumed, however, that these changes will be similarly 
adopted by all population groups equally, and more specifically, by women who are 
of reproductive age and at risk of acquiring HIV through unprotected sex.  
For this reason, the public health community will need to continually and 
carefully consider the role of data collected from testing HIV pregnant women and 
the extent to which these data reflect the true evolution of the epidemic. Anything 
less than a best effort to accurately monitor the epidemic with the limited resources 
available will undermine and diminish the even greater contributions that public 
health practitioners are making on a daily basis in SSA to mitigate the spread of this 
epidemic.  
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Supplemental Table 2.1  Bias in ANC estimates relative to population surveys 
Author Location Population Methods Outcomes Study limitations 
Montana, et 
al. [46] 
 
Multi-country 
study 
(Ethiopia, 
Kenya, Malawi, 
Tanzania, and 
Uganda) 
DHS and ANC 
surveillance 
participants; 
Sample sizes 
varied by study 
and country. 
Comparison of HIV 
prevalence estimates 
from ANC surveillance 
and DHS surveys 
nationally and within 
15 kilometres of 
participating ANC 
surveillance site. 
 ANC>DHS national HIV 
prevalence in all but Uganda, 
where ANC<DHS. 
 ANC=DHS in catchment areas.  
 ANC<DHS for older women (25+ 
years) 
ANC>DHS for young women (15-
24 years). 
 DHS data can be used to 
calibrate ANC data but bias must 
be taken into account. 
 Geographic comparisons 
assume that clinic catchment 
area can be captured by the 
15km radius. 
 DHS data may be biased by 
differential non-response. 
Gouws, et al. 
[45] 
Multi-country 
study among 
those with 
generalized 
HIV epidemics 
(n=26, or 
which 24 are in 
SSA) in the 
2000s 
DHS and ANC 
surveillance 
participants; 
Sample sizes 
varied by study 
and country. 
HIV prevalence 
estimates from 
national population-
based surveys and 
ANC clinics. 
Correction factors 
proposed based on 
differences.  
 ANC>DHS national HIV 
prevalence in most countries by 
about 20% (95% CI: 10% to 
30%). Eastern/Western Africa 
differences (about 10%) < 
Western/Central African (up to 
40%.) differences. Rural 
differences> urban differences. 
  Reduce ANC estimates by 20% 
for countries with no population 
survey. 
 DHS data may be biased by 
non-response.  
 ANC surveillance data may 
be biased due to clinic 
selection; biases may 
change over time.  
 ART may affect HIV infection 
and fertility patterns, 
resulting in a change in the 
correction factor required 
over time. 
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Gonese, et al. 
[108] 
Zimbabwe, 
2006 ANC and 
2005-2006 
DHS 
7202 ANC 
participants; 6947 
women in DHS, of 
which 2943 were 
in 30km of ANC 
clinic and 777 had 
a previous birth 
and attended an 
ANC. 
Comparison of HIV 
prevalence estimates 
from ANC surveillance 
and DHS survey 
nationally, within 30 
kilometres of ANC 
clinic, and with those 
who attended an ANC 
clinic at last birth. 
 ANC of 17.9% (95% CI: 17.0%-
18.8%)=DHS HIV prevalence 
nationally of 18.1% (16.9%-
18.8%) 
 ANC<DHS HIV prevalence 
among women and women living 
within 30km of ANC clinic. 
 ANC surveillance data provide a 
reasonable estimate of national 
prevalence. 
 Geographic comparisons 
assume that clinic catchment 
area can be captured by the 
30km radius. 
 DHS data may be biased by 
differential non-response. 
 
Kayibanda, et 
al. [109] 
Rwanda ANC 
surveillance 
and DHS data 
from 2005 
5641 women 
aged 15-49 years 
and 13745 
women in 30 ANC 
clinics. 
Comparison of ANC 
surveillance and 
female population 
survey estimates of 
HIV prevalence by 
rural and urban area. 
Comparisons made 
using log-binomial 
regression and direct 
standardization. 
 ANC prevalence of 4.1% (3.8%-
4.5%)>DHS nationally of 3.6%; 
(95% CI: 3.1%-4.1%), due to 
selection of more urban clinics. 
 ANC>DHS female estimates 
Data standardized by age, 
marital status and urban rural 
areas of residence reduced 
differences. 
 Specific fertility-related 
differentials and biases were 
not explored. 
 Women in urban ANC clinics 
may have come from rural 
areas, thus estimates in 
urban areas may be biased 
by non-local attendees.  
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Musinguzi, et 
al. [110] 
Uganda 
population 
survey and 
ANC 
surveillance 
data in 2005 
9688 ANC 
attendees and 
16,936 population 
survey 
participants. 
Comparison of ANC 
surveillance and 
population prevalence 
trends and within 
catchment areas 
(30km). 
 ANC prevalence of 6.0% (95% 
CI: 5.5%-6.5%) = population 
survey estimate of prevalence 
5.9%. 
 ANC prevalence>prevalence 
females in surrounding 
catchment areas among those 
aged 15-19 years, were similar 
for all other ages.  
 ANC prevalence<prevalence 
among women overall (6.0% vs. 
7.4%) and urban women (7.6% 
vs. 12.7%) but was similar to 
rural women (5.3% vs. 4.9%). 
 ANC sites clearly 
underestimate HIV 
prevalence in urban areas 
suggesting that urban clinics 
are misclassified. 
 Women resident to the area 
in ANC surveillance could 
not be determined, thus ANC 
estimates may be lower in 
urban areas due to rural 
participants. 
 Not able to assess trends, 
but authors noted the 
potential for these dynamics 
to shift over time. 
Dzekedzeke, 
et al. [70] 
Zambia 2001-
2002 ANC 
surveillance 
and DHS data 
from 2001-
2002 
1484 in urban 
areas and 2322 in 
rural areas in 
DHS data (men 
and women 
combined); 7405 
women in urban 
areas and 4584 
women in rural 
areas. 
Comparison of ANC 
surveillance and 
population survey 
estimates of HIV 
prevalence by rural 
and urban area. 
 ANC (adjusted national 16.9%; 
95% CI: 16.6-17.2)=DHS 
national HIV prevalence of 15.6% 
(95% CI: 14.4-16.9). 
 Non-response bias in DHS did 
not influence survey estimates. 
 ANC data can be used to provide 
a reasonable estimate of 
population HIV prevalence in 
Zambia.  
  Non-response bias could 
affect validity of comparison; 
however, authors found no 
evidence for the levels 
needed to introduce a 
significant bias.  
  305 
Supplemental Table 2.1  Bias in ANC estimates relative to population surveys 
Author Location Population Methods Outcomes Study limitations 
Boisier, et al. 
[43] 
Niger 2002 6055 participants 
in DHS; no 
sample size 
provided for ANC. 
Comparison of ANC 
surveillance and 
population survey 
estimates of HIV 
prevalence . 
 ANC of 2.8% >DHS national HIV 
prevalence of 0.87 (95% CI: 0.5-
1.3%). 
 Non-response bias could 
affect validity of comparison. 
Grassly, et al. 
[40] 
 
11 
communities 
with estimates 
ranging from 
1995 through 
2003 
ANC attendees 
and adult men 
and women in 
surrounding 
communities; 
Sample sizes 
varied by study 
and country. 
Mathematical model 
to compare estimates 
of adult prevalence in 
community studies 
compared with 
prevalence estimates 
in ANCs in the same 
community around the 
same time.  
 ANC sample slightly 
underestimates community 
prevalence among adult males 
and females but difference is not 
significant. 
 Comparisons were at 
community not national level 
where other biases can be 
introduced. 
 Variance around the ANC 
estimate was high, 
suggesting that experience 
across communities may 
differ. 
 Comparisons were made 
from survey periods up to 1 
year apart. 
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Fylkenes, [48] 
(Note: data 
included in 
Grassley 
study) 
Chelston, 
urban Lusaka 
and Kapiri 
Mposhi, 1994-
1996 
4195 population 
survey 
participants aged 
15 and above, 
ANC attendees 
aged 15-39 years. 
Comparison of 
unadjusted estimates 
of HIV prevalence in 
the population survey 
and ANC surveillance 
in urban and rural 
areas. 
 ANC<population prevalence 
 ANC urban estimate of 24.4% 
(95% CI: 20.9-28.0)<overall HIV 
prevalence of 26.0% (95% CI: 
23.4%-28.6%) but difference was 
not significant. 
 ANC rural estimate of 12.5% 
(95% CI: 9.3%-15.6%)<16.4% 
(95% CI: 12.1%-20.6%). 
 ANC prevalence for 15-19 year 
olds>prevalence in the 
population. 
 Women with higher levels of 
education, which was associated 
with lower HIV prevalence, were 
under-represented in the ANC 
sample.  
 Differences in tests (saliva 
based in population survey, 
serum based in ANC) and no 
validation possible. 
 Non-consent among males 
was high relative to women 
in the population survey 
(71.3% versus 92%) mostly 
due to men being away from 
the home. 
 Rural survey occurred more  
than one year later than the 
ANC surveillance. 
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Rice, et al. 
[269] 
Rural sub-
district of 
Hlabisa; six 
government 
clinics within 
the district, 
2005 
1111 ANC and 
14476 general 
female 
population, of 
which 1444 were 
estimated to 
have been 
pregnant and 
attended a local 
ANC. 
Comparison of 
estimates, 
standardized by age 
and location (e.g., clinic 
for ANC-based 
estimates and 
residence for 
population–based 
estimates). 
 ANC prevalence of 
37.7%>female population 
prevalence of 25.2%. 
 ANC prevalence of 
37.7%>prevalence of 23.7% 
among pregnant women local to 
the catchment area. 
 Population survey data may be 
biased downward by 
unrepresentative testing by HIV 
status, residence and age.  
 ANC estimates are biased 
upwards due to selection bias in 
terms of age, sexual debut and 
contraceptive use. 
 
 Contraceptive use was 
high and fertility in this 
rural population was 
low, thus results may 
not be generalizable to 
other countries in SSA. 
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Gregson, et al. 
[113] 
Less developed 
countries with 
high fertility 
rates 
Simulated 
population of 
women of 
childbearing age 
and pregnant 
women 
assuming 
different fertility 
rates for HIV 
infected and 
uninfected 
women. 
Mathematical 
modelling of age-
specific fertility patterns 
in HIV infected and 
uninfected women and 
the impact on HIV 
prevalence estimates 
from pregnant women 
and all women of 
reproductive age. 
 ANC>female prevalence for 
those <20 years. 
 ANC<female prevalence for 
those 20+ years. 
 Lower prevalence in older 
women will outweigh bias in 
younger women, thus  
ANC<female population 
prevalence. 
 Age standardization reduces 
ANC estimates further as it gives 
more weight to older ages, so 
unstandardized estimates are 
preferable. 
 Bias in ANC estimates increases 
as prevalence increases up to 
50% in the female population. 
 ANC>female prevalence if 
condom use is widespread in 
less developed countries. 
 If female prevalence falls, due to 
successful condom promotion 
ANC could fail to capture the full 
extent of this decline. 
 
 Very limited data on 
methods for 
constructing the model 
 Condom use levels are 
unlikely to reach those 
explored in the general 
population. 
 Model results do not 
consider influence of 
other contraceptive 
methods beside 
condoms or changes in 
sexual behaviour. 
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Zaba, et al. 
[47]; Lewis, et 
al. [114] ; 
  
Review of 19 
community-
based studies 
in sub-Saharan 
Africa, of which 
6 were 
originally 
reviewed by 
Zaba and 
colleagues 
Pregnant women 
and the general 
female 
population. 
Fertility rate ratio for 
HIV-positive vs. HIV-
negative women is 
calculated. The relative 
odds of being infected 
for pregnant women 
compared with the 
general female 
population provides a 
measure of difference 
between ANC and 
female population 
prevalence estimates. 
 
 HIV-infected women have 
between 25 and 40% lower 
fertility than HIV-uninfected 
women, except for those at the 
youngest ages where selection 
for early sexual activity results in 
higher fertility for the HIV infected 
(from Zaba).  
 ANC estimates of HIV 
prevalence <female population 
prevalence in high fertility low 
contracepting areas. 
 Assumes that fertility in 
HIV negative women is 
unaffected by HIV in 
the population. 
 Does not provide a 
direct measure of sub-
fertility or infertility due 
to STIs other than HIV. 
 
 
Crampin, et al. 
[53] 
Karonga District 
ANC 
surveillance in 4 
clinics and 
community-
based survey, 
1999-2000 
342 women in 
the community 
and 3013 ANC 
attendees aged 
15-49 years. 
Logistic regression to 
identify demographic 
and fertility-related 
factors associated with 
differences in HIV 
prevalence among 
ANC attendees and 
females in the 
community. 
 Unadjusted ANC prevalence of 
9.2% in 1999-2001<age-location 
adjusted female prevalence of 
13.9%. 
 Differences in distribution of ANC 
and general female population by 
age, area, marriage and 
migration (over the last 5 years) 
and associations with HIV 
infection explained differentials. 
Fertility differences found, but 
adjustments for parity and birth 
interval did not explain 
differences. 
 Estimates of 
community prevalence 
may be biased by non-
response. 
 Patterns of HIV 
infection across clinics 
and within the district 
varied greatly, thus 
aggregate findings may 
not be representative of 
any one smaller 
geographic area.  
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Gregson, et al. 
[55] 
Manicaland, 
Zimbabwe, 
1998-2000 
1215 ANC 
attendees in the 
surveillance 
round; 5138 
females in the 
surrounding 
population, of 
which 576 were 
recently 
pregnant . 
Comparison of ANC 
surveillance and 
population estimates 
using a risk ratio. 
 Prevalence in recently pregnant 
women of 25.7% = all women 
25.5% due to contraceptive use 
and delays in sexual activity. 
 ANC prevalence of 
21.2%<prevalence in all women 
of 25.5% due to more rural 
attendees where prevalence is 
lower. 
 More educated ANC attendees 
have higher risk of HIV than 
female population, where HIV 
risk is highest among less 
educated young women. 
 Catchment areas for 
comparison are difficult 
to validate. Information 
on residence was not 
able to be collected, 
thus it was not possible 
to verify rural 
estimates. 
 
Glynn, et al. 
[51] 
ANC and 
general 
population 
surveys in 
Yaoundé, 
Cameroon, 
Kisumu, Kenya, 
and Ndola, 
Zambia in 
1997-1998 
Sample sizes 
varied by study 
and setting. 
Comparison of ANC 
and general population 
HIV prevalence 
estimates to identify 
factors associated with 
differences in HIV 
prevalence in the two 
groups (i.e., community 
and ANC) using logistic 
regression. 
 ANC<female population in 
Cameroon and Ndola. 
 Factors explaining differences 
varied by site - Cameroon: age, 
marital status, contraception, no 
previous children; Kisumu: no 
previous children only; Ndola: 
age, marital status, 
contraception, marriage, no 
previous children. 
 Variation in factors explaining 
differences in prevalence makes 
it difficult to propose standard 
adjustment methods. 
 Community survey data 
may be biased by 
differential non-
response. 
 The prevalence of STIs 
other than syphilis 
(which was explored 
but not found to be 
important) could 
explain differences in 
HIV prevalence 
between the two 
groups. 
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Glynn, et al. 
[112] 
ANC 
surveillance in 
Yaoundé, 
Cameroon, 
Kisumu, Kenya, 
and Ndola, 
Zambia in 1998 
Women 
attending ANC 
clinics in the 
three cities. 
Cox regression to 
explore influence of 
HIV on time to first birth 
and birth interval in 
order to determine sub-
fertility in HIV infected 
women. 
 Birth interval for HIV positive 
women>HIV negative women, 
between 16% and 26% lower risk 
of pregnancy. 
 Interval between sexual debut 
and first birth in HIV infected 
women>interval in uninfected 
women (except in Ndola after 
adjusting for age and other 
socio-demographic factors. 
 ANC< female prevalence due to 
HIV-related sub-fertility. Timing 
of ANC visits may influence 
differences if HIV-infected 
women miscarry earlier or later in 
the pregnancy. 
 Measures of STIs other 
than syphilis could not 
be taken into account 
as a source of non-
HIV-related sub-fertility. 
 
 
Fontanet, et al. 
[111] 
 
Addis Ababa, 
Ethiopia, 1994 
and 1996 
1145 pregnant 
women at ANC 
clinics and 671 
women in the 
catchment area. 
Comparison of ANC 
surveillance estimates 
with those in the 
female population. 
 ANC prevalence of 17.8%>5.2% 
prevalence among women in the 
surrounding area. 
 Comparisons were 
made two years apart 
as the epidemic in 
Ethiopia was growing. 
Changalucha, 
et al. [52] 
12 rural 
communities in 
the Mwanza 
Region 
2265 ANC 
attendees and 
5676 women 
aged 15-44 
years, 1991-
1992 
Comparison of 
unadjusted ANC and 
female population HIV 
prevalence. 
 ANC prevalence of 3.6%<female 
prevalence in the population of 
4.7% 
 ANC prevalence<female 
population prevalence in all age 
groups except those aged 15-19 
years. 
 Not able to analyse to 
what extent women 
from outside clinic 
catchment areas were 
attending ANCs. 
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Garnett, et 
al. [115] 
Indicative of a 
generalized 
HIV epidemic 
in SSA   
Pregnant women 
and women of all 
reproductive ages. 
Sex, age, and sexual 
activity specific 
mathematical model of 
HIV transmission used 
to explore bias in ANC 
trends due to 1) low 
fertility from STIs other 
than HIV; 2) HIV-
related sub-fertility 
unrelated to the stage 
of infection, and 3) HIV-
related sub-fertility 
related to the stage of 
infection. Fertility rates 
vary by age, sexual 
activity, and HIV status. 
Trends are compared 
from time 0 to 30 years. 
 ↑ANC trends >↑POP trends as 
the average age of HIV infected 
women increases until peak 
fertility as the epidemic evolves. 
 ↑ANC trends <↑POP  trends as 
sub-fertility due to HIV increases 
as the epidemic evolves. 
 ↑ANC <↑POP due to morbidity 
from other STIs, but this quickly 
resolves. 
 ANC trends are a reasonably 
good measure of prevalence 
trends among females. 
 Bias in age-specific fertility levels 
over time is static after five years.  
 
 
 
 Study assumes HIV 
prevalence levels 
remain high. 
 Does not quantify the 
level of bias in trends 
that suggest that ANC 
data reasonable 
measure of the 
underlying population 
HIV prevalence trend 
among female.  
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Zaba, et al. 
[117] 
Indicative of a 
generalized 
HIV epidemic 
in SSA   
Young pregnant 
women and young 
women aged 15 to 
24 years. 
Mathematical cohort 
model used to explore 
bias in ANC trends due 
to 1) reduced 
transmission due to 
changes in sexual 
activity; 2) delays in 
sexual debut; and 3) 
reductions due to 1 and 
2. Trends are 
compared from time 0 
to 25 years. 
 Declines in transmission (from 5% 
to 2% incidence over 3 years) 
alone due to risk reduction 
behaviour (e.g., condom 
increase) resulted in stable bias 
throughout the 25 years (due to 
limited sub-fertility and mortality in 
young people). 
 Delays in sexual debut (rise in 
median age at first sex from 15 to 
20 years over 3 years) alone or in 
addition to declines in 
transmission led ANC data to lag 
behind, then to underestimate 
declines, then to overestimate 
declines.  
 
 
 
 Scenarios for increasing 
age of sexual debut by 
five years in the span of 
3 years likely overstate 
the actual changes that 
would be observed in 
most countries. 
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Hallett, et 
al. [27] – 
describing 
modelling 
results only 
of bias in 
ANC 
estimates 
Countries with 
generalised 
epidemics 
Pregnant women 
and women of all 
reproductive ages. 
Deterministic sex, age, 
and sexual activity 
specific mathematical 
model of HIV 
transmission. 
 Initial exclusion of HIV infected 
women due to sub-fertility will 
lead ANC declines to overstate 
those in the population. Bias will 
stabilize rapidly once average 
time since infection stabilizes. 
 ANC prevalence increases and 
decreases will be most extreme 
since high risk women are most at 
risk of HIV and pregnancy and 
these women will be most likely to 
suffer from HIV-related sub-
fertility (and therefore excluded). 
If not replaced in the population, 
ANC prevalence will fall more 
rapidly. 
 Model assumes that 
fertility rates are 
constant over time.  
 
Gregson, 
et al. [113] 
Less 
developed and 
more 
developed 
countries 
Pregnant women 
and all women. 
Application of 
Bongaarts’ proximate 
determinants model to 
explore fertility levels in 
HIV infected and 
uninfected women and 
HIV prevalence in both 
groups based on a 
range of differences in 
fertility levels. 
 
 ANC data will understate decline 
in population prevalence in the 
case of successful condom 
promotion campaigns because 
only women at high risk of HIV 
(i.e., non-condom users) will 
become pregnant. 
 Model assumes only 
condom use and no 
other contraceptives. 
 Risk associated with 
condom use is assumed 
to be low in the 
population. 
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Michelo, et 
al. [116] 
Lusaka, 
Zambia. 
Population 
survey: 1995, 
1999, and 
2003; ANC 
surveillance: 
1994, 1998 
and 2002.  
Pregnant women 
and all women. 
Comparison of 
prevalence in ANC and 
population using linear 
regression. 
 ANC prevalence declined from 
20.0% (25.0%-19.9%) in the 
youngest women (aged 15-24 
years). Prevalence declined in the 
general population by 49% (15-24 
years) and by 44% in women only 
(15-24 years). 
 Declines in prevalence in the 
ANC understated declined in 
population prevalence trends due 
to changes in fertility and 
education patterns.  
 
 
 
 Statistical tests do not 
allow for direct 
comparison of trends. 
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Kwesibago, 
et al. [50] 
Kagera, 
Tanzania, 
Buboka 
district. 
Population 
study 1987, 
1993 and 
1996; ANC 
surveillance in 
1990, 1993 
and 1996 
Pregnant women 
and all women. 
Comparison of age-
adjusted prevalence in 
ANC and population 
using linear regression. 
 ANC prevalence declined from 
22.4% (20.6%-25.2%) in 1990 to 
16.1% (95% CI: 15.9-18.8% in 
1993 and 13.7% (95% CI: 11.8-
14.3%) in 1996.  Population 
prevalence declined from 29.1% 
(95% CI: 24.4%-34.6%) in 1987 
to 18.7% (95% CI: 24.4%-34.6%) 
in 1993 to 14.9% (95% CCI: 
12.0%-17.1%) in 1996. 
 Trends in prevalence were similar 
and ANC data can be used to 
monitor population HIV 
prevalence trends. 
 ANC uptake was above 90% for 
the country and well above in the 
district. 
 Study occurred at a time 
when declines in 
prevalence were likely 
due to mortality and 
natural dynamics of the 
epidemic rather than 
behaviour change, thus 
comparability may be 
different if declines were 
due to behaviour 
change. 
 Refusal rates in 
population survey 
differed over time from 
86% in 1987, 66% in 
1993 and 74% in 1996. 
 Statistical tests do not 
allow for direct 
comparison of trends. 
Gouws [21] Zimbabwe 
(2001/2002 
and 2006), 
Zambia 
(2001/2002 
and 2007), 
South Africa 
(2002 to 2005) 
Pregnant women 
and all women 
aged 15 to 24 
years. 
Comparison of HIV 
prevalence in repeated 
national surveys and 
among ANC attendees 
aged 15 to 24 years. 
 Prevalence declines were 
consistent between the two data 
sets for Zimbabwe and Zambia.  
 In South Africa, HIV prevalence 
among young pregnant women 
was stable but observed to 
increase in the female population. 
 Time periods for 
comparisons were 
different. 
 Statistical tests do not 
allow for direct 
comparison of trends. 
 
  
  317 
Supplemental Table 2.4  Proposed methods and applications of methods for adjusting bias in ANC estimates due to HIV-related sub-fertility 
Author Location/Year Population  Methods/Application Outcome Limitations 
Lessner [178] New York, 
United States, 
1988 
HIV positive 
women 
identified 
through 
Newborn HIV 
Seroprevalence 
Study. 
Proposed method: 
Adjustment of number 
of women infected 
through age 
standardization to 
obtain estimate of total 
number of HIV infected 
women.   
 Estimates number of 
infected=23,430 women 
aged 15-44 years; no 
estimate of original 
number of infections 
reported provide. 
 Assumes HIV infected and 
uninfected women have the same 
fertility rates, thus will 
underestimate the total number of 
HIV infected women due to HIV-
related sub-fertility. 
 No validation of estimates. 
Nicoll, et al. 
[179] 
England and 
Wales, 1994 
Women with 
known HIV 
infections 
reported 
through an 
existing study 
(n=507). 
Proposed method: 
ANC estimates are 
adjusted for 
differences between 
live birth rates and 
termination rates in 
women known to be 
HIV infected and those 
in the general 
population (called the 
relative inclusion ratio 
or RIR). 
 Live birth rates among 
HIV infected and 
uninfected women in 
London were similar. 
Outside London, an RIR 
of 0.80 (CI: 0.71-0.89) 
indicates prevalence 
among pregnant women 
would underestimate 
prevalence in the female 
population.  
 Requires knowing live birth rates 
and termination rates in HIV 
infected women. 
 RIR will be diluted if prevalence in 
the female population is high. 
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Zaba, et al. 
[42] 
Multi-country 
study 
(Tanzania, 
Uganda, 
Zimbabwe) 
ANC attendees 
in Kisesa, 
Tanzania and 
Masaka, 
Uganda 
(n=5373), and 
in Manicaland, 
Zimbabwe 
(n=5129), 
Khutson, South 
Africa. 
Proposed method: 
Estimates of ANC-
based prevalence are 
adjusted for relative 
risks for infertility and 
sub-fertility in low 
(<20%) and high 
contraception (20%) 
areas and estimates 
are then adjusted to 
the overall distribution 
of these groups in the 
population using DHS 
data. 
 Uganda and Tanzania: 
HIV prevalence in 
pregnant women: 7.7% 
adjusted to 10.3%. 
Similar to community-
based female estimates.  
 Low contraception 
adjustment factors: 80% 
of prevalence in 
primigravida childless 
women; 150% of 
multigravida mother.  
 High contraception: 60% 
factor in primigravida 
childless women; 110% 
in multigravida mother. 
 Requires the collection of birth 
interval data which is not routinely 
done, assuming that adjustments 
for sub-fertility as more important 
than infertility. 
 Does not take into account 
differences in ANC uptake by HIV 
infected and uninfected women. 
 Assumes the effect of HIV on 
fertility patterns has stabilized. 
 No quantification of acceptable 
differences in adjusted ANC 
surveillance and population 
survey estimates among females 
is provided. 
Fabiani, et al. 
[57] 
Gulu district 
ANC clinic in 
Northern 
Uganda, 1993-
1997 
8555 ANC 
attendees aged 
15 to 39 years. 
Proposed method: 
Age-specific ANC 
prevalence estimates 
adjusted for 
differences in fertility 
risk between HIV 
infected and 
uninfected women, 
and then the overall 
prevalence estimate is 
standardized to the 
general female 
population age 
structure. 
 ANC estimates were 
26.0% in 1993 and 16.1% 
in 1997.  
 Estimated prevalence in 
the population using the 
adjustment method was 
25.4% in 1993-1994 to 
17.8% in 1996-1997, 
indicating a slightly 
greater decline in 
prevalence among ANC 
surveillance participants. 
 No data were available to 
validate female population 
estimates. 
 Assumes relative risks of fertility 
are constant over time and not 
changing (due to increases in 
age of sexual debut, condom 
use, etc.) in the calculation of 
female population prevalence 
trends. 
 May overstate population 
prevalence when applied to ANC 
surveillance data because some 
pregnant will abort before giving 
birth. 
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Changalucha, 
et al. [52] 
Rural Mwanza 
Tanzania, 
1991-1992 
2265 ANC 
attendees and 
5675 women 
aged 15-44 
years. 
Application: Zaba's 
parity-based method. 
 HIV prevalence among 
ANC attendees 
unadjusted was 3.6% 
compared with 4.7% in 
population (p-value-
0.025). Adjusted 
prevalence of ANC data 
to account for fertility 
differences was 4.6% (p-
value=0.95). 
 Validation was done early on in 
the epidemic and the authors' 
question whether the method 
might work as the epidemic 
evolved. 
Gregson, et 
al. [55]  
Manicaland, 
Zimbabwe, 
1998-2000 
1215 local ANC 
attendees and 
5138 women in 
population-
based survey. 
Application: Estimates 
of ANC prevalence 
were adjusted and 
compared to 
prevalence among 
women in the general 
population using a 
method proposed by 
Zaba, et al. 
 HIV prevalence among 
women reporting local 
ANC attendance of 
27.0% adjusted to 22.6% 
with adjustment for birth 
interval and 23.5% 
without adjustment for 
birth interval, which were 
lower than population 
survey estimates 
(25.5%). 
 Application to ANC 
surveillance data reduced 
HIV prevalence to 20.8% 
to 19.2%. 
 Birth interval information in ANC 
surveillance was missing in 6% of 
the population. 
 No quantification of acceptable 
differences in adjusted ANC 
surveillance and population 
survey estimates among females 
is provided. Prevalence was still 
only two thirds as high as 
prevalence in the surrounding 
female population. 
 Non-response and refusals in 
both the population survey and 
the ANC surveillance data may 
have introduced other biases in 
estimates. 
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Fabiani, et al. 
[180] 
Multi-country 
study (Uganda, 
Tanzania, 
Zambia), data 
from mid-
1990s   
ANC and 
general female 
population; 
sample sizes 
varied. 
Application/validation: 
HIV prevalence 
estimates among ANC 
attendees were 
adjusted using 
methods by Fabiani 
and Zaba. 
 Estimates of prevalence 
using the Fabiani method 
were more accurate than 
estimates from the Zaba 
method in Lusaka, 
Zambia in 1994 and 
1998. 
  Estimates using Zaba’s 
methods were better in 
rural Mwanza and Ndola.  
 The Zaba method could 
not be applied to 4 sites 
due to lack of information 
on HIV prevalence by 
parity among ANC 
attendees.  
 Adjustment method by Fabiani 
requires data on differences in 
fertility risks either from the 
population of interest or in other 
geographic areas (assuming 
similar relative risks can be 
applied). 
 Adjustment method by Zaba 
requires more detailed data on 
parity and birth intervals from 
ANC surveillance attendees and 
more complicated analyses to 
obtain estimates that take into 
account sub-fertility and infertility. 
 Validation was limited to settings 
where HIV prevalence was 
relatively high and contraceptive 
use was low. 
Crampin, et 
al. [53] 
Karonga 
District, 
Malawi, 1998-
2001 
ANC and 
general female 
population 
aged 15 to 49 
years. 
Application: Zaba 
method. 
 ANC prevalence was 
estimated to be 9.2% 
(95% CI: 9.1%-10.3%), 
adjusted prevalence was 
15.0% compared with 
13.9% estimated from 
the community. 
 Community estimates may be 
biased by non-response and 
missing mobile populations at 
higher risk of HIV. 
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Supplemental Table 2.4  Proposed methods and applications of methods for adjusting bias in ANC estimates due to HIV-related sub-fertility 
Author Location/Year Population  Methods/Application Outcome Limitations 
Rice, et al. 
[269] 
Rural sub-
district of 
Hlabisa; six 
government 
clinics within 
the district, 
2005 
1111 ANC and 
14476 general 
female 
population, of 
which 1444 
were estimated 
to have been 
pregnant and 
attended a 
local ANC. 
Application: 
Comparison of crude 
and age-location 
standardized 
estimates of ANC 
surveillance data with 
population prevalence 
data. Crude ratios of 
HIV prevalence among 
pregnant women and 
the population are 
calculated and then 
compared to Zaba’s 
proposed standard. 
 ANC estimates were 
standardized by age and 
location. Adjustment 
factors were calculated to 
be 50% in primigravida to 
childless women and 
70% in multi-gravida 
women. 
 Population survey estimates were 
skewed by non-participation bias, 
which could in turn affect the 
accuracy of the adjustment factor 
as well as other standardized 
comparisons. 
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Supplemental Table 2.5  Associations between accepting HIV testing and HIV serostatus in PMTCT programmes 
Author Location/ 
Year 
Population/ 
sample size 
Methods Research 
questions/outcomes 
Study limitations 
Fabiani, et 
al. [98] 
Lacor Hospital, 
Gulu District, 
Northern 
Uganda (2001-
2003)  
 
ANC 
surveillance*: 
3,580  
PMTCT: 
14,040; 13% 
not offered 
testing; 48% 
accepted; 39% 
refused.  
Comparison of age-
standardized HIV 
prevalence estimates 
in ANC and ‘Opt-in’ 
PMTCT attendees; Log 
binomial regression to 
identify factors 
associated with testing 
and testing positive. 
 Is acceptance of HIV 
testing associated with 
HIV status? Yes, but 
weakly. 
 Are PMTCT and ANC 
estimates similar? Yes, 
when age-standardized 
or age-specific. 
 Should PMTCT data be 
used for surveillance 
purposes? Yes, in north 
Uganda. 
 No method for comparing 
estimates.  
 Results are specific to one rural 
clinic; generalizability beyond 
unknown. 
 Evaluation of opt-in PMTCT 
services with low-uptake may 
introduce different biases than 
current recommended opt-out 
testing strategies. 
 No recommendation on what level 
of bias is acceptable. 
Mpairwe, 
et al. [91] 
Entebbe 
General 
Hospital, 
Wakiso district, 
Uganda (May 
2002 – April 
2003)  
ANC 
surveillance:  
833  
PMTCT: 4,867; 
25% not offered 
testing; 54% 
accepted 
testing; 20% 
refused testing. 
Comparison of HIV 
prevalence estimates 
in ANC and ‘Opt-in 
PMTCT attendees 
using chi2-test; Logistic 
regression to identify 
factors associated with 
testing and testing 
positive. 
 
 Is accepting HIV testing 
associated with HIV 
status?  Yes. 
 Are PMTCT and ANC 
estimates similar? Yes, 
when uptake is >70% or 
annual. 
 Should PMTCT data be 
used for surveillance 
purposes? Not useful 
when services are new or 
uptake is low (<70%). 
 Results are specific to one urban 
clinic; generalizability unknown. 
 Strategies for implementing 
PMTCT programmes have 
changed.  
 HIV prevalence estimates are 
compared for those accepting vs. 
refusing testing, not vs. all 
attendees; Results will be more 
extreme. 
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Supplemental Table 2.5  Associations between accepting HIV testing and HIV serostatus in PMTCT programmes 
Pignatelli, 
et al. [192] 
St. Camille 
Medical Centre, 
Ouagadougou, 
Burkina Faso 
(May 2002-April 
2004)  
ANC 
surveillance: no 
sample size 
stated 
PMTCT: 6,639; 
18% accepted; 
82% refused.  
Logistic regression to 
identify factors 
associated with ‘opt-in’ 
testing and testing 
positive. 
 Is acceptance of HIV 
testing associated with 
HIV status? Yes, but 
women who test 
represent a select and 
motivated population. 
 Are PMTCT and ANC 
estimates similar? No. 
 PMTCT and ANC estimates were 
from different times, thus not 
comparable. 
 No recommendation is made on 
what level of bias is acceptable. 
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Supplemental Table 2.6  Studies directly comparing PMTCT programme and ANC surveillance estimates 
Author Location/ 
Year 
Population/ 
sample size 
Methods Research 
questions/outcomes 
Study limitations 
Seguy, et 
al. [89] 
6 sites where 
ANC 
surveillance 
and PMTCT  
activities 
overlapped in 
Kenya (2003)  
ANC 
surveillance: 
1,852  
PMTCT: 2,239; 
Overall uptake: 
56%. 
Comparison of 
estimates was not 
done as opt-in 
PMTCT and ANC 
surveillance groups 
were not 
independent. 
 Are PMTCT and ANC 
estimates similar?  
Overall, yes, and even 
when uptake is <60%. 
ANC surveillance 
estimates were lower in 5 
of 6 sites, however. 
 PMTCT data should not 
be used due to clinic-
level disparities in 
estimates and data 
quality problems. 
 Opt-out testing still resulted in low 
uptake, which could lead to 
greater levels of bias. 
 Recommendation made to collect 
five years of PMTCT data before 
evaluating usefulness of 
estimates. 
 No recommendation made on 
what level or temporal change in 
bias is acceptable. 
Macauley, 
et al. [97] 
Unknown 
number of 
PMTCT and 
surveillance 
sites in 
Cameroon’s 10 
provinces 
(2003)  
ANC 
surveillance: 
6,745 
PMTCT: 69% 
(42,731 
attendees). 
Descriptive statistics 
presented. 
 Are PMTCT and ANC 
estimates similar? 
Overall, yes, and in 9 of 
10 provinces. 
 PMTCT data can be used 
to estimates HIV 
prevalence in place of 
ANC surveillance data. 
 No additional data available on 
number of clinics participating, 
uptake levels, and magnitude of 
difference or similarity of estimates 
by province (personal 
communication with co-author). 
 No information on how estimates 
were compared/determined 
similar. 
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Supplemental Table 2.6  Studies directly comparing PMTCT programme and ANC surveillance estimates 
Author Location/ 
Year 
Population/ 
sample size 
Methods Research 
questions/outcomes 
Study limitations 
Finkbeiner, 
et al. [94] 
7 sites where 
ANC 
surveillance 
and PMTCT  
activities 
overlapped in 
Uganda (2003)  
 ANC 
surveillance: 
11,946 
PMTCT:  No 
information on 
uptake 18,191 
accepted.  
No information on 
type of PMTCT 
provided, descriptive 
statistics presented. 
 Are PMTCT and ANC 
estimates similar? 
Overall, yes, but 
estimates in 2 of 7 clinics 
showed significant 
disparities. 
 PMTCT data would be 
difficult to use because of 
clinic-level differences 
and data quality problems 
 
 
 
 
 
 
 
 
 
 
 No recommendation made on 
what level of bias would be 
acceptable. 
 No information available on testing 
acceptance levels. 
Gonese, et 
al. [95] 
19 sites where 
ANC 
surveillance 
and PMTCT  
activities 
overlapped in 
Zimbabwe 
(2004);  
ANC 
surveillance: 
sample size not 
stated. 
 PMTCT: median 
clinic uptake 
42%. 
Opt-in testing, 
comparisons made 
without access to age 
of PMTCT acceptors. 
Descriptive 
presentation of 
PMTCT and ANC 
surveillance 
estimates. 
 Are PMTCT and ANC 
estimates similar? Yes, 
but large clinic-level 
disparities in estimates. 
 PMTCT data cannot be 
used because of low 
uptake, clinic-level 
disparities, and 
aggregate data. 
 PMTCT data were restricted to 
aggregate reports at the national 
level, thus did not include age and 
would not be useful in monitoring 
trends by age groups.  
 No recommendation made on 
what level of bias would be 
acceptable. 
  326 
Supplemental Table 2.6  Studies directly comparing PMTCT programme and ANC surveillance estimates 
Author Location/ 
Year 
Population/ 
sample size 
Methods Research 
questions/outcomes 
Study limitations 
Seipone, et 
al. [96] 
48 of 270 sites 
(all with dual 
ANC 
surveillance 
and PMTCT 
activities) in 
Botswana  
ANC 
surveillance: 
2005: 2472; 
2006: 2714; 
2007: 2542 
PMTCT: 2005: 
2803; 2006: 
2950; 2007: 
2943; Uptake: 
95%. 
Opt-out testing; chi2 
test for differences in 
PMTCT and ANC 
surveillance 
estimates.  
 Are PMTCT and ANC 
estimates similar? Yes, 
overall and by rural, 
urban distribution. Similar 
among 5 year age 
groups, particularly at 
youngest ages. 
 Can be used based on 
similarity in estimates. 
Improvements in data 
quality needed. 
 No recommendation made on 
what level of bias would be 
acceptable when using PMTCT 
data for surveillance purposes. 
Fabiani, et 
al. [93] 
Lacor Hospital, 
Gulu District, 
Northern 
Uganda (2004-
2005)  
ANC 
surveillance: 
1,059 in 2004; 
1,166 in 2005 
Opt-in PMTCT 
for 2004: 1,701; 
49.9% 
(849/1,701); 275 
not offered; 849 
accepted; 577 
refused. Opt-in 
PMTCT: 2005: 
Uptake: 54% 
(1,255/1,892); 
388 not offered; 
1,255 accepted; 
249 refused.  
Opt-in testing, Age-
specific logistic 
regression models 
used to estimate risk 
coefficients of being 
infected for 10 
predictor variables 
among PMTCT 
acceptors. 
 Are PMTCT and ANC 
estimates similar? Age 
adjusted estimates not 
similar; Non-participation 
bias must be adjusted for. 
 Adjusted data useful in 
northern Uganda. 
 No recommendation made on 
what level of bias would be 
acceptable when using PMTCT 
data. 
 Adjustment method for PMTCT 
estimate to account for refusers 
has not been validated beyond a 
single clinic. 
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Female birth cohorts 
Year    
Botswana 
female 
population   
Côte d’Ivoire 
female 
population 
Zimbabwe 
female 
population 
1955-1960   11155   80995 81830 
1960-1965   12610   98940 96530 
1965-1970   14550   121735 112210 
1970-1975   16490   149380 132790 
1975-1980   19400   183330 156800 
1980-1985   22310   213885 177870 
1985-1990   22795   239590 187180 
1990-1995   22795   266750 193060 
1995-2000   23280   294395 189630 
2000-2005   22310   328345 184730 
2005-2010   22795   347745 184730 
2010-2015   23280   363750 191100 
2015-2020   23280   372965 200900 
2020-2025   22795   379270 198450 
2025-2030   22310   385090 189140 
2030-2035   21825   389455 184240 
Female birth cohort size for Botswana, Côte d’Ivoire and Zimbabwe  
taken from UN POP Division [224]. 
 
HIV negative age-specific fertility rates (per 1000  women) 
 
    Côte  Manicaland, Zimbabwe 
Age-group Botswana d’Ivoire (1985-1988) (1998-2005) 
15-19 125 151 114 98 
20-24  212 245 289 220 
25-29 202 240 276 171 
30-34  191 227 251 140 
35-39 148 172 184 80 
40-44  83 82 93 29 
45-49 38 26 40 6 
Age specific fertility rates in Botswana from the 1989 Botswana Family Health Survey II 
[236], from the 1995 DHS in Côte d’Ivoire [237], and from the Manicaland DHS (1985-1988) 
[238]  and the Manicaland Cohort Data (1998-2005), which was published previously [232]. 
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Fertility ratio for HIV infected versus non infected women: 
 
Time since infection 
Fertility ratio 
(HIV+/HIV-) 
 ≤4 years 0.66   
>4years 0.40   
Ratio of fertility for HIV-infected women relative to uninfected women by years since infection 
estimated from rural Uganda cohort data [158] 
 
 
Age-specific HIV incidence for women of reproductive age  
Age-group Botswana Côte d'Ivoire 
Manicaland, 
Zimbabwe 
15-19 years 1.10 0.49 1.34 
20-24 years 1.35 0.80 1.43 
25-29 years 1.62 1.39 1.87 
30-34 years 1.36 0.99 0.65 
35-39 years 0.81 0.46 0.73 
40-44 years 0.53 1.11 0.46 
45-49 years 0.25 1.76 0.54 
Age-specific incidence rates for Botswana are based on national Zimbabwe population 
survey data [233, 234]. Côte d’Ivoire data were provided by Hallett based on previously 
methods published [75]. For rural Zimbabwe, direct measurement was made using 
previously published data from the Manicaland cohort [235]. 
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Annual HIV Incidence (per 100 persons per year) 
 
Year Botswana 
(female) 
Côte 
d’Ivoire 
(female) 
Rural Zimbabwe 
(men and 
women) 
1980 0.03 0.02 0.03 
1981 0.04 0.03 0.05 
1982 0.06 0.04 0.09 
1983 0.10 0.06 0.15 
1984 0.15 0.09 0.24 
1985 0.24 0.14 0.40 
1986 0.37 0.20 0.64 
1987 0.57 0.29 1.03 
1988 0.86 0.41 1.61 
1999 1.29 0.56 2.40 
1990 1.95 1.19 3.39 
1991 2.76 1.50 4.39 
1992 3.72 1.70 5.13 
1993 4.71 1.69 5.37 
1994 5.52 1.51 5.00 
1995 5.96 1.26 4.28 
1996 5.95 1.02 3.49 
1997 5.58 0.84 2.82 
1998 5.03 0.70 2.33 
1999 4.44 0.60 1.99 
2000 3.91 0.52 1.77 
2001 3.51 0.45 1.62 
2002 3.19 0.40 1.52 
2003 2.86 0.30 1.45 
2004 2.54 0.25 1.39 
2005 2.32 0.25 1.33 
2006 2.18 0.22 1.28 
2007 2.06 0.19 1.23 
2008 1.92 0.13 1.19 
2009 1.82 0.13 1.13 
Temporal trend in incidence is estimated using Spectrum and provided by UNAIDS for 
illustrative purposes only [Personal communication: Mary Mahy, January 2010] 
 
Survival rates for HIV-negative individuals 
Adult females: 5+weibull(shape: 7, scale: 61.8) 
Survival rates for HIV-negative individuals taken from a previous publication by Hallett [75]. 
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Survival with HIV at time of infection (no ART)  
Age at infection Weibull 
parameters 
Scale 
(lambda) 
Shape (kappa) 
 
 
15-19 16 2  
20-24 15.4 2  
25-29 14.1 2  
30-34 12.1 2  
35-39 11.0 2  
40-44 10.1 2  
45-49 7.9 2  
Survival times for HIV infected adults, stratified by age at infection, were taken to be Weibull 
distributed and based on estimates from African observational cohort studies [270]. 
 
Rate of disease progression 
Disease progression Average time in years 
AIDS to death 1 
CD4=200 to AIDS 2 
Time to death on 
treatment 
10  
CD4 counts for women reached 200 cells/mm3, approximately 3 years (exponentially 
distributed) before AIDS [271]. Time to death on treatment was taken from cohort estimates 
in SSA [25, 143]. 
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